,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
3119,GO:0043228,0.00236896220209729,0.99923609284424,22,48,non-membrane-bounded organelle,CC,ACTN2;MYO7A;CDKN1A;FRMPD1;KITLG;MRO;PHLDA1;CAMSAP3;PLEKHH2;SDC4;PRKACB;HMGN5;PTPN7;ACSL4;FHOD3;MARK4;ESPN;PDE4B;UNC119;CGN;WT1;MSN
3123,GO:0043232,0.00236896220209729,0.99923609284424,22,48,intracellular non-membrane-bounded organelle,CC,ACTN2;MYO7A;CDKN1A;FRMPD1;KITLG;MRO;PHLDA1;CAMSAP3;PLEKHH2;SDC4;PRKACB;HMGN5;PTPN7;ACSL4;FHOD3;MARK4;ESPN;PDE4B;UNC119;CGN;WT1;MSN
4060,GO:0051017,0.00539292910243472,0.999719537131684,5,6,actin filament bundle assembly,BP,PIK3R1;SDC4;ITGB5;ESPN;CTGF
4734,GO:0061572,0.00539292910243472,0.999719537131684,5,6,actin filament bundle organization,BP,PIK3R1;SDC4;ITGB5;ESPN;CTGF
677,GO:0005813,0.011117972484161,0.998942625319945,5,7,centrosome,CC,CAMSAP3;PRKACB;MARK4;PDE4B;UNC119
990,GO:0007266,0.0123807158972934,1,3,3,Rho protein signal transduction,BP,RHOB;RHOJ;ITGA3
490,GO:0003723,0.0127693827621205,1,3,3,RNA binding,MF,HMGN5;WT1;MSN
645,GO:0005730,0.0173806180676331,0.998921935526658,4,5,nucleolus,CC,CDKN1A;MRO;PHLDA1;WT1
5470,GO:0098858,0.0175301183420479,0.997438562845194,6,9,actin-based cell projection,CC,ACTN2;MYO7A;KITLG;ESPN;ITGA3;MSN
1934,GO:0030038,0.0179499963440679,0.998874309444015,4,5,contractile actin filament bundle assembly,BP,PIK3R1;SDC4;ITGB5;CTGF
3093,GO:0043149,0.0179499963440679,0.998874309444015,4,5,stress fiber assembly,BP,PIK3R1;SDC4;ITGB5;CTGF
12,GO:0000086,0.0188560084852297,1,3,3,G2/M transition of mitotic cell cycle,BP,CDKN1A;PHLDA1;FOXO4
3385,GO:0044839,0.0188560084852297,1,3,3,cell cycle G2/M phase transition,BP,CDKN1A;PHLDA1;FOXO4
989,GO:0007265,0.0189409261201702,0.997207189232926,5,9,Ras protein signal transduction,BP,CDKN1A;RHOB;KITLG;RHOJ;ITGA3
1085,GO:0008092,0.024618723332323,0.991581337542817,13,27,cytoskeletal protein binding,MF,ACTN2;MYO7A;REEP1;CAMSAP3;PLEKHH2;FHOD3;RAB39B;MARK4;ESPN;DAAM2;PDE4B;CGN;MSN
934,GO:0007050,0.0269567416452404,0.996283955966561,4,8,cell cycle arrest,BP,CDKN1A;GAS6;HMGN5;FOXO4
2134,GO:0031032,0.0290137712375693,0.994603313782478,6,10,actomyosin structure organization,BP,ACTN2;PIK3R1;SDC4;ITGB5;FHOD3;CTGF
1074,GO:0008037,0.0306315009485877,1,3,3,cell recognition,BP,MFGE8;LAMA5;MSN
693,GO:0005902,0.0313247456430936,1,3,3,microvillus,CC,MYO7A;ESPN;MSN
4891,GO:0071156,0.0337072963336368,0.99700511320806,3,5,regulation of cell cycle arrest,BP,CDKN1A;HMGN5;FOXO4
919,GO:0007015,0.0347408345328578,0.991197159473088,8,14,actin filament organization,BP,ACTN2;PLEKHH2;PIK3R1;SDC4;ITGB5;FHOD3;ESPN;CTGF
2549,GO:0033158,0.038707936752152,1,2,2,regulation of protein import into nucleus, translocation,BP,CDKN1A;GAS6
2146,GO:0031091,0.0427116726448861,0.997060994138806,3,4,platelet alpha granule,CC,ACTN2;GAS6;SERPINA5
203,GO:0001968,0.0433332188335836,0.99699921575442,3,4,fibronectin binding,MF,SDC4;CTGF;ITGA3
4004,GO:0050839,0.0440566449409447,0.988842195468602,7,13,cell adhesion molecule binding,MF,ACTN2;MFGE8;LAMA5;CGN;CTGF;ITGA3;MSN
2640,GO:0034605,0.0442981567444809,1,2,2,cellular response to heat,BP,CDKN1A;SLC52A3
4351,GO:0060041,0.0443424111667492,1,2,2,retina development in camera-type eye,BP,RHOJ;DLL1
5625,GO:1901654,0.0453709512385338,0.993220750137526,4,7,response to ketone,BP,CDKN1A;GAS6;CLDN1;MSN
1967,GO:0030175,0.04570855326781,0.994195634732557,4,6,filopodium,CC,ACTN2;KITLG;ITGA3;MSN
579,GO:0005178,0.0465005596134508,0.991923606479683,5,8,integrin binding,MF,ACTN2;MFGE8;LAMA5;CTGF;ITGA3
5164,GO:0072341,0.0465676785863941,0.99525622843463,3,5,modified amino acid binding,MF,MFGE8;GAS6;PTGES
4091,GO:0051128,0.0467094138797017,0.978225420483705,19,54,regulation of cellular component organization,BP,ACTN2;CDKN1A;RHOJ;MFGE8;CAMSAP3;PLEKHH2;PIK3R1;GAS6;SDC4;FHOD3;ESPN;DLL1;UNC119;CLDN1;CTGF;ITGA3;WT1;MSN;SH3BP4
4093,GO:0051130,0.0467128829825375,0.982351122127643,11,29,positive regulation of cellular component organization,BP,ACTN2;MFGE8;PIK3R1;GAS6;SDC4;ESPN;DLL1;CLDN1;CTGF;ITGA3;MSN
678,GO:0005815,0.0470358819759439,0.990935790861899,5,9,microtubule organizing center,CC,CAMSAP3;PRKACB;MARK4;PDE4B;UNC119
1578,GO:0016043,0.047639161370977,0.975693187011382,37,122,cellular component organization,BP,LAMA1;ACTN2;MYO7A;CDKN1A;NRTN;REEP1;PRND;RHOJ;NUAK2;MFGE8;CAMSAP3;PLEKHH2;PIK3R1;GAS6;LAMA5;SDC4;ITGB5;SEMA6C;ITGB8;SERPINA5;HMGN5;RIN3;ACSL4;CRISPLD2;FHOD3;RAB39B;MARK4;ESPN;DAAM2;DLL1;UNC119;CLDN1;CTGF;ITGA3;WT1;MSN;SH3BP4
5011,GO:0071840,0.047639161370977,0.975693187011382,37,122,cellular component organization or biogenesis,BP,LAMA1;ACTN2;MYO7A;CDKN1A;NRTN;REEP1;PRND;RHOJ;NUAK2;MFGE8;CAMSAP3;PLEKHH2;PIK3R1;GAS6;LAMA5;SDC4;ITGB5;SEMA6C;ITGB8;SERPINA5;HMGN5;RIN3;ACSL4;CRISPLD2;FHOD3;RAB39B;MARK4;ESPN;DAAM2;DLL1;UNC119;CLDN1;CTGF;ITGA3;WT1;MSN;SH3BP4
951,GO:0007160,0.0494363831175823,0.987106612023745,7,13,cell-matrix adhesion,BP,ACTN2;PIK3R1;LAMA5;SDC4;ITGB5;CTGF;ITGA3
3396,GO:0045023,0.0499185193307913,1,2,2,G0 to G1 transition,BP,FOXO4;CTGF
4809,GO:0070316,0.0499185193307913,1,2,2,regulation of G0 to G1 transition,BP,FOXO4;CTGF
1540,GO:0015631,0.0502137183136664,0.993400107688282,4,6,tubulin binding,MF,REEP1;CAMSAP3;MARK4;PDE4B
4538,GO:0060627,0.0504864585889775,0.985468551183877,7,16,regulation of vesicle-mediated transport,BP,ACTN2;MFGE8;GAS6;SDC4;DLL1;UNC119;MSN
3428,GO:0045171,0.0514497726087892,1,2,2,intercellular bridge,CC,PRKACB;UNC119
2624,GO:0034349,0.0528610224220072,1,2,2,glial cell apoptotic process,BP,GAS6;DLL1
2625,GO:0034350,0.0528610224220072,1,2,2,regulation of glial cell apoptotic process,BP,GAS6;DLL1
2626,GO:0034351,0.0528610224220072,1,2,2,negative regulation of glial cell apoptotic process,BP,GAS6;DLL1
2272,GO:0031967,0.0531187720773174,0.988643908378163,5,10,organelle envelope,CC,HMGCS2;REEP1;SLC25A53;ACSL4;PTGES
2276,GO:0031975,0.0531187720773174,0.988643908378163,5,10,envelope,CC,HMGCS2;REEP1;SLC25A53;ACSL4;PTGES
5631,GO:1901681,0.0541200109540367,0.990530369276057,4,8,sulfur compound binding,MF,SERPINA5;CRISPLD2;CTGF;PTGES
1975,GO:0030198,0.0570629109291252,0.981775686080375,9,17,extracellular matrix organization,BP,LAMA1;GAS6;LAMA5;ITGB5;ITGB8;CRISPLD2;CTGF;ITGA3;WT1
3075,GO:0043062,0.0570629109291252,0.981775686080375,9,17,extracellular structure organization,BP,LAMA1;GAS6;LAMA5;ITGB5;ITGB8;CRISPLD2;CTGF;ITGA3;WT1
918,GO:0007010,0.0573686020877663,0.974756993536072,15,38,cytoskeleton organization,BP,ACTN2;RHOJ;NUAK2;CAMSAP3;PLEKHH2;PIK3R1;LAMA5;SDC4;ITGB5;FHOD3;MARK4;ESPN;DAAM2;CTGF;MSN
2318,GO:0032231,0.0581648659561305,0.995404226782027,3,4,regulation of actin filament bundle assembly,BP,PIK3R1;SDC4;CTGF
4203,GO:0051492,0.0581648659561305,0.995404226782027,3,4,regulation of stress fiber assembly,BP,PIK3R1;SDC4;CTGF
648,GO:0005740,0.0599212895498012,0.990102441735218,4,7,mitochondrial envelope,CC,HMGCS2;REEP1;SLC25A53;ACSL4
2271,GO:0031966,0.0599212895498012,0.990102441735218,4,7,mitochondrial membrane,CC,HMGCS2;REEP1;SLC25A53;ACSL4
5267,GO:0090136,0.0599526927363563,1,2,2,epithelial cell-cell adhesion,BP,CAMSAP3;ITGB5
117,GO:0001676,0.0627564119506061,1,2,2,long-chain fatty acid metabolic process,BP,ACSL4;PTGES
5576,GO:1901136,0.0658496618967041,1,2,2,carbohydrate derivative catabolic process,BP,SDC4;PDE4B
2151,GO:0031100,0.0667480864493488,0.994380740414879,3,4,animal organ regeneration,BP,CDKN1A;GAS6;CLDN1
3537,GO:0045786,0.0667550532765778,0.9804114039366,6,16,negative regulation of cell cycle,BP,CDKN1A;RHOB;GAS6;PRKACB;HMGN5;FOXO4
1205,GO:0009314,0.0674130120702,0.9872328206076,4,8,response to radiation,BP,CDKN1A;RHOB;PIK3R1;UNC119
211,GO:0002020,0.0690607667436721,1,2,2,protease binding,MF,SERPINA5;ITGA3
1924,GO:0030016,0.0713275859449281,0.987430785724171,4,7,myofibril,CC,ACTN2;SDC4;FHOD3;PDE4B
142,GO:0001764,0.0721033204823605,1,2,2,neuron migration,BP,GAS6;ITGA3
2996,GO:0042493,0.0735119591057274,0.981769240686659,5,11,response to drug,BP,CDKN1A;GAS6;PDE4B;CLDN1;ITGA3
1154,GO:0008630,0.0755621754636762,1,2,2,intrinsic apoptotic signaling pathway in response to DNA damage,BP,CDKN1A;PIK3R1
2649,GO:0034644,0.0755621754636762,1,2,2,cellular response to UV,BP,CDKN1A;PIK3R1
1928,GO:0030029,0.0775843019087662,0.965925470687676,13,32,actin filament-based process,BP,ACTN2;MYO7A;RHOJ;NUAK2;PLEKHH2;PIK3R1;SDC4;ITGB5;FHOD3;ESPN;DAAM2;PDE4B;CTGF
674,GO:0005801,0.0778380735130531,1,2,2,cis-Golgi network,CC,PIK3R1;CTGF
3250,GO:0043954,0.0789962239690975,1,2,2,cellular component maintenance,BP,CAMSAP3;ITGA3
3117,GO:0043226,0.0791286817910963,0.961498749215979,48,174,organelle,CC,ACTN2;MYO7A;CDKN1A;FRMPD1;HMGCS2;REEP1;RHOB;KITLG;MRO;PHLDA1;RHOJ;NUAK2;MFGE8;CAMSAP3;PLEKHH2;CLDN11;PIK3R1;SLC25A53;GAS6;LAMA5;SDC4;ITGB5;PRKACB;ITGB8;SERPINA5;HMGN5;PTPN7;RIN3;ACSL4;CRISPLD2;FHOD3;RAB39B;FOXO4;GPSM1;MARK4;ESPN;DAAM2;DLL1;TMEM163;PDE4B;UNC119;CGN;CTGF;ITGA3;WT1;MSN;PTGES;SH3BP4
681,GO:0005856,0.0798346175521771,0.962785463708272,15,38,cytoskeleton,CC,ACTN2;MYO7A;FRMPD1;KITLG;CAMSAP3;PLEKHH2;PRKACB;PTPN7;FHOD3;MARK4;ESPN;PDE4B;UNC119;CGN;MSN
2428,GO:0032640,0.080532936432327,1,2,2,tumor necrosis factor production,BP,PIK3R1;GAS6
2440,GO:0032680,0.080532936432327,1,2,2,regulation of tumor necrosis factor production,BP,PIK3R1;GAS6
4376,GO:0060090,0.080532936432327,1,2,2,binding, bridging,MF,PIK3R1;GAS6
4994,GO:0071706,0.080532936432327,1,2,2,tumor necrosis factor superfamily cytokine production,BP,PIK3R1;GAS6
5829,GO:1903555,0.080532936432327,1,2,2,regulation of tumor necrosis factor superfamily cytokine production,BP,PIK3R1;GAS6
1040,GO:0007568,0.0825803026665001,0.982093401413244,4,9,aging,BP,CDKN1A;FOXO4;CLDN1;CTGF
4854,GO:0070663,0.0880437444398676,0.98615324610297,3,6,regulation of leukocyte proliferation,BP,CDKN1A;KITLG;SDC4
1133,GO:0008380,0.0883171204747103,1,2,2,RNA splicing,BP,PIK3R1;WT1
1539,GO:0015630,0.0886734999467328,0.976631748952519,5,11,microtubule cytoskeleton,CC,CAMSAP3;PRKACB;MARK4;PDE4B;UNC119
1002,GO:0007338,0.0894467387930187,0.993904972321477,2,3,single fertilization,BP,MFGE8;SERPINA5
5189,GO:0072583,0.0905549460878877,0.993782417273913,2,3,clathrin-dependent endocytosis,BP,DLL1;UNC119
4186,GO:0051385,0.0925962435440087,0.993554052965449,2,3,response to mineralocorticoid,BP,CDKN1A;CTGF
1933,GO:0030036,0.0932774415470853,0.960128644278476,11,27,actin cytoskeleton organization,BP,ACTN2;RHOJ;NUAK2;PLEKHH2;PIK3R1;SDC4;ITGB5;FHOD3;ESPN;DAAM2;CTGF
9,GO:0000077,0.0939319114169355,0.993402795473157,2,3,DNA damage checkpoint,BP,CDKN1A;FOXO4
2221,GO:0031570,0.0939319114169355,0.993402795473157,2,3,DNA integrity checkpoint,BP,CDKN1A;FOXO4
3374,GO:0044773,0.0939319114169355,0.993402795473157,2,3,mitotic DNA damage checkpoint,BP,CDKN1A;FOXO4
3375,GO:0044774,0.0939319114169355,0.993402795473157,2,3,mitotic DNA integrity checkpoint,BP,CDKN1A;FOXO4
4893,GO:0071158,0.0939319114169355,0.993402795473157,2,3,positive regulation of cell cycle arrest,BP,CDKN1A;FOXO4
5661,GO:1901988,0.0939319114169355,0.993402795473157,2,3,negative regulation of cell cycle phase transition,BP,CDKN1A;FOXO4
5663,GO:1901991,0.0939319114169355,0.993402795473157,2,3,negative regulation of mitotic cell cycle phase transition,BP,CDKN1A;FOXO4
3066,GO:0043015,0.0968165268853514,1,2,2,gamma-tubulin binding,MF,MARK4;PDE4B
4370,GO:0060076,0.0973483456743103,1,2,2,excitatory synapse,CC,PDE4B;ITGA3
1949,GO:0030100,0.0989267178403024,0.9770428880605,4,9,regulation of endocytosis,BP,MFGE8;GAS6;DLL1;UNC119
3969,GO:0050764,0.103955335078285,0.992221737300297,2,3,regulation of phagocytosis,BP,MFGE8;GAS6
3970,GO:0050766,0.103955335078285,0.992221737300297,2,3,positive regulation of phagocytosis,BP,MFGE8;GAS6
2928,GO:0042113,0.104011503843181,0.984767580440225,3,5,B cell activation,BP,CDKN1A;PIK3R1;DLL1
1208,GO:0009416,0.104086622219525,0.984751319017271,3,5,response to light stimulus,BP,CDKN1A;PIK3R1;UNC119
704,GO:0005924,0.104087966569613,0.96310520276703,7,17,cell-substrate adherens junction,CC,ACTN2;RHOB;SDC4;MPZL1;ITGB5;ITGA3;MSN
705,GO:0005925,0.104087966569613,0.96310520276703,7,17,focal adhesion,CC,ACTN2;RHOB;SDC4;MPZL1;ITGB5;ITGA3;MSN
963,GO:0007179,0.104738120863727,0.976573173424975,4,8,transforming growth factor beta receptor signaling pathway,BP,DKK3;ITGB5;CGN;ITGA3
3326,GO:0044429,0.104803154156332,0.976552939145702,4,8,mitochondrial part,CC,HMGCS2;REEP1;SLC25A53;ACSL4
3391,GO:0044877,0.105263669688127,0.955356329646231,10,25,macromolecular complex binding,MF,ACTN2;MYO7A;CDKN1A;MFGE8;PIK3R1;LAMA5;HMGN5;ESPN;CTGF;ITGA3
1829,GO:0021675,0.106468891462436,1,1,1,nerve development,BP,NRTN
5027,GO:0071897,0.10829561631442,0.991685341295566,2,3,DNA biosynthetic process,BP,CDKN1A;CTGF
980,GO:0007229,0.109487578116334,0.972117771857992,5,9,integrin-mediated signaling pathway,BP,LAMA5;ITGB5;ITGB8;CTGF;ITGA3
137,GO:0001755,0.109726247633477,0.983512744080655,3,5,neural crest cell migration,BP,NRTN;KITLG;LAMA5
6,GO:0000060,0.111496348682743,0.991280173397754,2,3,protein import into nucleus, translocation,BP,CDKN1A;GAS6
3120,GO:0043229,0.113636346417226,0.936587271857741,42,152,intracellular organelle,CC,ACTN2;MYO7A;CDKN1A;FRMPD1;HMGCS2;REEP1;RHOB;KITLG;MRO;PHLDA1;NUAK2;CAMSAP3;PLEKHH2;PIK3R1;SLC25A53;GAS6;LAMA5;SDC4;ITGB5;PRKACB;SERPINA5;HMGN5;PTPN7;RIN3;ACSL4;CRISPLD2;FHOD3;RAB39B;FOXO4;GPSM1;MARK4;ESPN;DLL1;TMEM163;PDE4B;UNC119;CGN;CTGF;WT1;MSN;PTGES;SH3BP4
5394,GO:0097458,0.113725974421598,0.950494372908895,10,26,neuron part,CC,ACTN2;MYO7A;NRTN;ACSL4;RAB39B;MARK4;ESPN;TMEM163;PDE4B;ITGA3
1289,GO:0010212,0.117566569067431,0.986930119795359,2,4,response to ionizing radiation,BP,CDKN1A;RHOB
4961,GO:0071479,0.117566569067431,0.986930119795359,2,4,cellular response to ionizing radiation,BP,CDKN1A;RHOB
835,GO:0006720,0.117665049768608,0.990476410540495,2,3,isoprenoid metabolic process,BP,HMGCS2;SDC4
1695,GO:0017016,0.11792057122024,0.986903136830459,3,4,Ras GTPase binding,MF,RIN3;DAAM2;SH3BP4
2178,GO:0031267,0.11792057122024,0.986903136830459,3,4,small GTPase binding,MF,RIN3;DAAM2;SH3BP4
4062,GO:0051020,0.11792057122024,0.986903136830459,3,4,GTPase binding,MF,RIN3;DAAM2;SH3BP4
1206,GO:0009408,0.120614215536525,0.990081530897655,2,3,response to heat,BP,CDKN1A;SLC52A3
629,GO:0005576,0.123614232468399,0.927813882135025,28,97,extracellular region,CC,LAMA1;ACTN2;FRMPD1;NRTN;DKK3;RHOB;KITLG;PRND;RHOJ;MFGE8;CLDN11;GAS6;LAMA5;SDC4;ITGB5;PRKACB;ITGB8;SERPINA5;ACSL4;CRISPLD2;DHH;DAAM2;DLL1;UNC119;CTGF;ITGA3;MSN;SH3BP4
1071,GO:0008017,0.123833291851334,0.9802634850609,3,5,microtubule binding,MF,REEP1;CAMSAP3;MARK4
493,GO:0003779,0.124926150156325,0.952174284836669,8,17,actin binding,MF,ACTN2;MYO7A;PLEKHH2;FHOD3;ESPN;DAAM2;CGN;MSN
3144,GO:0043277,0.125060157992858,0.989473307854488,2,3,apoptotic cell clearance,BP,MFGE8;GAS6
1746,GO:0019209,0.127464459846717,0.989137924873314,2,3,kinase activator activity,MF,CDKN1A;GAS6
2003,GO:0030295,0.127464459846717,0.989137924873314,2,3,protein kinase activator activity,MF,CDKN1A;GAS6
650,GO:0005743,0.127696178257851,0.989105362376467,2,3,mitochondrial inner membrane,CC,HMGCS2;SLC25A53
1793,GO:0019866,0.127696178257851,0.989105362376467,2,3,organelle inner membrane,CC,HMGCS2;SLC25A53
4960,GO:0071478,0.127722777903262,0.976095223106235,3,6,cellular response to radiation,BP,CDKN1A;RHOB;PIK3R1
4884,GO:0070925,0.128963580642342,0.952299826651648,7,16,organelle assembly,BP,ACTN2;MYO7A;LAMA5;SDC4;FHOD3;MARK4;MSN
4852,GO:0070661,0.129395730607357,0.96666056286827,4,9,leukocyte proliferation,BP,CDKN1A;KITLG;SDC4;MSN
1657,GO:0016604,0.131370563682933,0.975075740202637,3,6,nuclear body,CC,CDKN1A;FOXO4;WT1
2939,GO:0042175,0.134624550355035,0.959093635208109,5,11,nuclear outer membrane-endoplasmic reticulum membrane network,CC,REEP1;PIK3R1;ACSL4;GPSM1;PTGES
1035,GO:0007530,0.134676608286241,0.988104725965463,2,3,sex determination,BP,DHH;WT1
4204,GO:0051493,0.13494418874891,0.945440985031098,8,19,regulation of cytoskeleton organization,BP,ACTN2;CAMSAP3;PLEKHH2;PIK3R1;SDC4;FHOD3;ESPN;CTGF
5634,GO:1901700,0.13520853182589,0.928265245310935,15,48,response to oxygen-containing compound,BP,ACTN2;CDKN1A;RHOB;PIK3R1;GAS6;PRKACB;FOXO4;DHH;PDE4B;CLDN1;CTGF;WT1;MSN;PTGES;SH3BP4
3790,GO:0048471,0.135821676702387,0.946657816170857,7,19,perinuclear region of cytoplasm,CC,CDKN1A;PIK3R1;PRKACB;CTGF;ITGA3;MSN;PTGES
2319,GO:0032233,0.13594121268104,0.987919370473615,2,3,positive regulation of actin filament bundle assembly,BP,SDC4;CTGF
4207,GO:0051496,0.13594121268104,0.987919370473615,2,3,positive regulation of stress fiber assembly,BP,SDC4;CTGF
941,GO:0007093,0.13709124462022,0.98321329454586,2,4,mitotic cell cycle checkpoint,BP,CDKN1A;FOXO4
3054,GO:0042953,0.139048330738149,1,1,1,lipoprotein transport,BP,UNC119
3390,GO:0044872,0.139048330738149,1,1,1,lipoprotein localization,BP,UNC119
3541,GO:0045806,0.139048330738149,1,1,1,negative regulation of endocytosis,BP,UNC119
3763,GO:0048261,0.139048330738149,1,1,1,negative regulation of receptor-mediated endocytosis,BP,UNC119
4134,GO:0051233,0.139048330738149,1,1,1,spindle midzone,CC,UNC119
5190,GO:0072584,0.139048330738149,1,1,1,caveolin-mediated endocytosis,BP,UNC119
5535,GO:1900186,0.139048330738149,1,1,1,negative regulation of clathrin-dependent endocytosis,BP,UNC119
6078,GO:2000369,0.139048330738149,1,1,1,regulation of clathrin-dependent endocytosis,BP,UNC119
6184,GO:2001286,0.139048330738149,1,1,1,regulation of caveolin-mediated endocytosis,BP,UNC119
6185,GO:2001287,0.139048330738149,1,1,1,negative regulation of caveolin-mediated endocytosis,BP,UNC119
6038,GO:2000107,0.144342324250794,0.986656317283999,2,3,negative regulation of leukocyte apoptotic process,BP,KITLG;GAS6
2227,GO:0031589,0.146843651446804,0.939238112079798,8,19,cell-substrate adhesion,BP,ACTN2;PIK3R1;GAS6;LAMA5;SDC4;ITGB5;CTGF;ITGA3
1694,GO:0017015,0.14738353189719,0.986185525200507,2,3,regulation of transforming growth factor beta receptor signaling pathway,BP,DKK3;ITGA3
5863,GO:1903844,0.14738353189719,0.986185525200507,2,3,regulation of cellular response to transforming growth factor beta stimulus,BP,DKK3;ITGA3
37,GO:0000287,0.148373496604047,0.986030719603242,2,3,magnesium ion binding,MF,NUAK2;PRKACB
1279,GO:0010033,0.14957316800107,0.913563392808826,20,69,response to organic substance,BP,ACTN2;CDKN1A;DKK3;PIK3R1;GAS6;ITGB5;PRKACB;ACSL4;FOXO4;DHH;DLL1;PDE4B;CGN;CLDN1;CTGF;ITGA3;WT1;MSN;PTGES;SH3BP4
4179,GO:0051346,0.15011200963783,0.958927264963773,4,9,negative regulation of hydrolase activity,BP,CAMSAP3;GAS6;SERPINA5;SH3BP4
979,GO:0007224,0.150616128231172,0.980411252249064,2,4,smoothened signaling pathway,BP,PRKACB;DHH
1941,GO:0030055,0.150939159069448,0.939631115006326,7,18,cell-substrate junction,CC,ACTN2;RHOB;SDC4;MPZL1;ITGB5;ITGA3;MSN
4000,GO:0050821,0.15263935030093,0.985354914022672,2,3,protein stabilization,BP,CDKN1A;PIK3R1
3542,GO:0045807,0.154513839102384,0.968250798921055,3,6,positive regulation of endocytosis,BP,MFGE8;GAS6;DLL1
1125,GO:0008333,0.15606219012206,0.9848024099769,2,3,endosome to lysosome transport,BP,GPRASP1;RHOB
2147,GO:0031093,0.156255982284072,0.98477085565151,2,3,platelet alpha granule lumen,CC,ACTN2;GAS6
1986,GO:0030234,0.156489207504646,0.936739378205657,7,18,enzyme regulator activity,MF,CDKN1A;PIK3R1;GAS6;SERPINA5;RIN3;GPSM1;SH3BP4
1100,GO:0008201,0.156559557588283,0.964893939067546,3,7,heparin binding,MF,SERPINA5;CRISPLD2;CTGF
5649,GO:1901888,0.158348669497451,0.984428248577056,2,3,regulation of cell junction assembly,BP,SDC4;CLDN1
5650,GO:1901890,0.158348669497451,0.984428248577056,2,3,positive regulation of cell junction assembly,BP,SDC4;CLDN1
310,GO:0002544,0.158866727078824,1,1,1,chronic inflammatory response,BP,PTGES
641,GO:0005641,0.158866727078824,1,1,1,nuclear envelope lumen,CC,PTGES
1685,GO:0016853,0.158866727078824,1,1,1,isomerase activity,MF,PTGES
1686,GO:0016860,0.158866727078824,1,1,1,intramolecular oxidoreductase activity,MF,PTGES
1765,GO:0019369,0.158866727078824,1,1,1,arachidonic acid metabolic process,BP,PTGES
1766,GO:0019371,0.158866727078824,1,1,1,cyclooxygenase pathway,BP,PTGES
2274,GO:0031970,0.158866727078824,1,1,1,organelle envelope lumen,CC,PTGES
3149,GO:0043295,0.158866727078824,1,1,1,glutathione binding,MF,PTGES
3930,GO:0050220,0.158866727078824,1,1,1,prostaglandin-E synthase activity,MF,PTGES
5561,GO:1900750,0.158866727078824,1,1,1,oligopeptide binding,MF,PTGES
1459,GO:0014032,0.160022668992322,0.966536689498491,3,6,neural crest cell development,BP,NRTN;KITLG;LAMA5
1460,GO:0014033,0.160022668992322,0.966536689498491,3,6,neural crest cell differentiation,BP,NRTN;KITLG;LAMA5
775,GO:0006396,0.160620475293375,0.984052453672717,2,3,RNA processing,BP,PIK3R1;WT1
1597,GO:0016197,0.161312723357208,0.954528773272176,4,9,endosomal transport,BP,ACTN2;GPRASP1;RHOB;MSN
4075,GO:0051056,0.162342285092152,0.954116953036057,4,9,regulation of small GTPase mediated signal transduction,BP,RHOB;KITLG;RHOJ;ITGA3
4294,GO:0052548,0.162666657133716,0.962830329530601,3,7,regulation of endopeptidase activity,BP,GAS6;SERPINA5;CTGF
697,GO:0005912,0.163473050229529,0.924973787994701,9,24,adherens junction,CC,ACTN2;RHOB;CAMSAP3;SDC4;MPZL1;ITGB5;DLL1;ITGA3;MSN
1951,GO:0030104,0.166288317534802,0.983097356071939,2,3,water homeostasis,BP,PRKACB;CLDN1
4028,GO:0050891,0.166288317534802,0.983097356071939,2,3,multicellular organismal water homeostasis,BP,PRKACB;CLDN1
2001,GO:0030285,0.166859044724836,1,1,1,integral component of synaptic vesicle membrane,CC,TMEM163
2181,GO:0031300,0.166859044724836,1,1,1,intrinsic component of organelle membrane,CC,TMEM163
2182,GO:0031301,0.166859044724836,1,1,1,integral component of organelle membrane,CC,TMEM163
2255,GO:0031901,0.166859044724836,1,1,1,early endosome membrane,CC,TMEM163
5425,GO:0098563,0.166859044724836,1,1,1,intrinsic component of synaptic vesicle membrane,CC,TMEM163
5749,GO:1902903,0.167477948710184,0.939157428247826,6,13,regulation of supramolecular fiber organization,BP,ACTN2;PLEKHH2;PIK3R1;SDC4;FHOD3;CTGF
4689,GO:0061298,0.16757185336915,1,1,1,retina vasculature development in camera-type eye,BP,RHOJ
4690,GO:0061299,0.16757185336915,1,1,1,retina vasculature morphogenesis in camera-type eye,BP,RHOJ
1207,GO:0009411,0.167822673401937,0.982834489186601,2,3,response to UV,BP,CDKN1A;PIK3R1
1073,GO:0008022,0.167851922073239,0.982829460438193,2,3,protein C-terminus binding,MF,LAMA1;CTGF
886,GO:0006910,0.16803453078035,1,1,1,phagocytosis, recognition,BP,MFGE8
887,GO:0006911,0.16803453078035,1,1,1,phagocytosis, engulfment,BP,MFGE8
1135,GO:0008429,0.16803453078035,1,1,1,phosphatidylethanolamine binding,MF,MFGE8
6087,GO:2000425,0.16803453078035,1,1,1,regulation of apoptotic cell clearance,BP,MFGE8
6088,GO:2000427,0.16803453078035,1,1,1,positive regulation of apoptotic cell clearance,BP,MFGE8
932,GO:0007045,0.168694615968135,0.968543331390587,3,5,cell-substrate adherens junction assembly,BP,ACTN2;LAMA5;SDC4
2621,GO:0034333,0.168694615968135,0.968543331390587,3,5,adherens junction assembly,BP,ACTN2;LAMA5;SDC4
3735,GO:0048041,0.168694615968135,0.968543331390587,3,5,focal adhesion assembly,BP,ACTN2;LAMA5;SDC4
149,GO:0001786,0.169324571682332,0.976231442720184,2,4,phosphatidylserine binding,MF,MFGE8;GAS6
563,GO:0005113,0.169348569358102,1,1,1,patched binding,MF,DHH
1989,GO:0030238,0.169348569358102,1,1,1,male sex determination,BP,DHH
2563,GO:0033327,0.169348569358102,1,1,1,Leydig cell differentiation,BP,DHH
2279,GO:0031983,0.172632863304083,0.96248518274107,3,6,vesicle lumen,CC,ACTN2;GAS6;CRISPLD2
2676,GO:0034774,0.172632863304083,0.96248518274107,3,6,secretory granule lumen,CC,ACTN2;GAS6;CRISPLD2
4399,GO:0060205,0.172632863304083,0.96248518274107,3,6,cytoplasmic vesicle lumen,CC,ACTN2;GAS6;CRISPLD2
5608,GO:1901565,0.17273820666347,0.981979979512276,2,3,organonitrogen compound catabolic process,BP,SDC4;PDE4B
4856,GO:0070665,0.172901801730651,0.975392192684194,2,4,positive regulation of leukocyte proliferation,BP,CDKN1A;KITLG
554,GO:0005092,0.17317742337904,0.981902707920438,2,3,GDP-dissociation inhibitor activity,MF,GPSM1;SH3BP4
882,GO:0006898,0.174590679361883,0.974991505836836,2,4,receptor-mediated endocytosis,BP,DLL1;UNC119
1744,GO:0019207,0.17582725901554,0.961430797332739,3,6,kinase regulator activity,MF,CDKN1A;PIK3R1;GAS6
656,GO:0005769,0.176239281778575,0.955872574095444,3,8,early endosome,CC,RHOB;RIN3;TMEM163
3346,GO:0044463,0.177207450754043,0.92171694596446,8,20,cell projection part,CC,ACTN2;MYO7A;PRKACB;MARK4;ESPN;PDE4B;ITGA3;MSN
3148,GO:0043292,0.17841878881459,0.947524451968339,4,9,contractile fiber,CC,ACTN2;SDC4;FHOD3;PDE4B
3340,GO:0044449,0.17841878881459,0.947524451968339,4,9,contractile fiber part,CC,ACTN2;SDC4;FHOD3;PDE4B
3338,GO:0044446,0.17944452329388,0.888363580998227,30,106,intracellular organelle part,CC,ACTN2;MYO7A;CDKN1A;HMGCS2;REEP1;RHOB;MRO;PHLDA1;CAMSAP3;PLEKHH2;PIK3R1;SLC25A53;GAS6;SDC4;PRKACB;SERPINA5;HMGN5;ACSL4;CRISPLD2;FHOD3;FOXO4;GPSM1;MARK4;ESPN;TMEM163;PDE4B;UNC119;CGN;WT1;PTGES
2503,GO:0032944,0.180785806340106,0.969813887168129,2,5,regulation of mononuclear cell proliferation,BP,CDKN1A;SDC4
3937,GO:0050670,0.180785806340106,0.969813887168129,2,5,regulation of lymphocyte proliferation,BP,CDKN1A;SDC4
3147,GO:0043281,0.181903490083018,0.973223522666469,2,4,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,GAS6;CTGF
6042,GO:2000116,0.181903490083018,0.973223522666469,2,4,regulation of cysteine-type endopeptidase activity,BP,GAS6;CTGF
2214,GO:0031491,0.183141708007446,1,1,1,nucleosome binding,MF,HMGN5
2215,GO:0031492,0.183141708007446,1,1,1,nucleosomal DNA binding,MF,HMGN5
1659,GO:0016607,0.183201689106668,0.972904056024727,2,4,nuclear speck,CC,FOXO4;WT1
1925,GO:0030017,0.183794417986915,0.958751890447977,3,6,sarcomere,CC,ACTN2;FHOD3;PDE4B
1926,GO:0030018,0.183794417986915,0.958751890447977,3,6,Z disc,CC,ACTN2;FHOD3;PDE4B
2246,GO:0031674,0.183794417986915,0.958751890447977,3,6,I band,CC,ACTN2;FHOD3;PDE4B
2373,GO:0032403,0.184900725714032,0.912313311398086,9,24,protein complex binding,MF,ACTN2;MYO7A;CDKN1A;MFGE8;PIK3R1;LAMA5;ESPN;CTGF;ITGA3
3320,GO:0044421,0.185854239662991,0.885006664575864,25,88,extracellular region part,CC,LAMA1;ACTN2;FRMPD1;DKK3;RHOB;KITLG;RHOJ;MFGE8;CLDN11;GAS6;LAMA5;SDC4;ITGB5;PRKACB;ITGB8;SERPINA5;ACSL4;CRISPLD2;DHH;DAAM2;UNC119;CTGF;ITGA3;MSN;SH3BP4
2162,GO:0031143,0.185981974560041,0.979583612000453,2,3,pseudopodium,CC,ACTN2;MSN
2366,GO:0032386,0.186954883662939,0.933955687913548,5,12,regulation of intracellular transport,BP,CDKN1A;REEP1;PIK3R1;GAS6;MSN
1911,GO:0022898,0.187612234464003,0.979279116309699,2,3,regulation of transmembrane transporter activity,BP,ACTN2;PDE4B
2374,GO:0032409,0.187612234464003,0.979279116309699,2,3,regulation of transporter activity,BP,ACTN2;PDE4B
2377,GO:0032412,0.187612234464003,0.979279116309699,2,3,regulation of ion transmembrane transporter activity,BP,ACTN2;PDE4B
6179,GO:2001257,0.187612234464003,0.979279116309699,2,3,regulation of cation channel activity,BP,ACTN2;PDE4B
41,GO:0000307,0.188197407041413,1,1,1,cyclin-dependent protein kinase holoenzyme complex,CC,CDKN1A
226,GO:0002069,0.188197407041413,1,1,1,columnar/cuboidal epithelial cell maturation,BP,CDKN1A
227,GO:0002070,0.188197407041413,1,1,1,epithelial cell maturation,BP,CDKN1A
534,GO:0004861,0.188197407041413,1,1,1,cyclin-dependent protein serine/threonine kinase inhibitor activity,MF,CDKN1A
911,GO:0006978,0.188197407041413,1,1,1,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,CDKN1A
1286,GO:0010165,0.188197407041413,1,1,1,response to X-ray,BP,CDKN1A
1290,GO:0010224,0.188197407041413,1,1,1,response to UV-B,BP,CDKN1A
1646,GO:0016538,0.188197407041413,1,1,1,cyclin-dependent protein serine/threonine kinase regulator activity,MF,CDKN1A
1809,GO:0019912,0.188197407041413,1,1,1,cyclin-dependent protein kinase activating kinase activity,MF,CDKN1A
2017,GO:0030332,0.188197407041413,1,1,1,cyclin binding,MF,CDKN1A
2605,GO:0034198,0.188197407041413,1,1,1,cellular response to amino acid starvation,BP,CDKN1A
2844,GO:0036296,0.188197407041413,1,1,1,response to increased oxygen levels,BP,CDKN1A
3046,GO:0042771,0.188197407041413,1,1,1,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,CDKN1A
3047,GO:0042772,0.188197407041413,1,1,1,DNA damage response, signal transduction resulting in transcription,BP,CDKN1A
3520,GO:0045736,0.188197407041413,1,1,1,negative regulation of cyclin-dependent protein serine/threonine kinase activity,BP,CDKN1A
3659,GO:0046685,0.188197407041413,1,1,1,response to arsenic-containing substance,BP,CDKN1A
4189,GO:0051412,0.188197407041413,1,1,1,response to corticosterone,BP,CDKN1A
4332,GO:0055093,0.188197407041413,1,1,1,response to hyperoxia,BP,CDKN1A
4521,GO:0060574,0.188197407041413,1,1,1,intestinal epithelial cell maturation,BP,CDKN1A
4522,GO:0060575,0.188197407041413,1,1,1,intestinal epithelial cell differentiation,BP,CDKN1A
4523,GO:0060576,0.188197407041413,1,1,1,intestinal epithelial cell development,BP,CDKN1A
4842,GO:0070557,0.188197407041413,1,1,1,PCNA-p21 complex,CC,CDKN1A
4964,GO:0071493,0.188197407041413,1,1,1,cellular response to UV-B,BP,CDKN1A
5315,GO:0090399,0.188197407041413,1,1,1,replicative senescence,BP,CDKN1A
5316,GO:0090400,0.188197407041413,1,1,1,stress-induced premature senescence,BP,CDKN1A
5877,GO:1904030,0.188197407041413,1,1,1,negative regulation of cyclin-dependent protein kinase activity,BP,CDKN1A
5675,GO:1902107,0.190121279276364,0.978806398586863,2,3,positive regulation of leukocyte differentiation,BP,KITLG;GAS6
3304,GO:0044325,0.191333015884048,0.978576325824489,2,3,ion channel binding,MF,ACTN2;PDE4B
797,GO:0006508,0.192428925025173,0.921156648596892,6,17,proteolysis,BP,GAS6;PRKACB;SERPINA5;FOXO4;DHH;CTGF
1433,GO:0010948,0.193613070807626,0.949188346016794,3,8,negative regulation of cell cycle process,BP,CDKN1A;HMGN5;FOXO4
4015,GO:0050867,0.193897643142413,0.938598211605552,4,10,positive regulation of cell activation,BP,CDKN1A;PIK3R1;GAS6;CTGF
881,GO:0006897,0.194284971250643,0.90942362633744,8,23,endocytosis,BP,MYO7A;MFGE8;PIK3R1;GAS6;RIN3;DLL1;UNC119;SH3BP4
5751,GO:1902905,0.19446546604168,0.951383066269598,3,7,positive regulation of supramolecular fiber organization,BP,ACTN2;SDC4;CTGF
204,GO:0001972,0.195553415836137,1,1,1,retinoic acid binding,MF,SERPINA5
229,GO:0002080,0.195553415836137,1,1,1,acrosomal membrane,CC,SERPINA5
537,GO:0004867,0.195553415836137,1,1,1,serine-type endopeptidase inhibitor activity,MF,SERPINA5
608,GO:0005501,0.195553415836137,1,1,1,retinoid binding,MF,SERPINA5
1003,GO:0007342,0.195553415836137,1,1,1,fusion of sperm to egg plasma membrane,BP,SERPINA5
1791,GO:0019840,0.195553415836137,1,1,1,isoprenoid binding,MF,SERPINA5
2148,GO:0031094,0.195553415836137,1,1,1,platelet dense tubular network,CC,SERPINA5
2165,GO:0031210,0.195553415836137,1,1,1,phosphatidylcholine binding,MF,SERPINA5
2312,GO:0032190,0.195553415836137,1,1,1,acrosin binding,MF,SERPINA5
2821,GO:0036024,0.195553415836137,1,1,1,protein C inhibitor-TMPRSS7 complex,CC,SERPINA5
2822,GO:0036025,0.195553415836137,1,1,1,protein C inhibitor-TMPRSS11E complex,CC,SERPINA5
2823,GO:0036026,0.195553415836137,1,1,1,protein C inhibitor-PLAT complex,CC,SERPINA5
2824,GO:0036027,0.195553415836137,1,1,1,protein C inhibitor-PLAU complex,CC,SERPINA5
2825,GO:0036028,0.195553415836137,1,1,1,protein C inhibitor-thrombin complex,CC,SERPINA5
2826,GO:0036029,0.195553415836137,1,1,1,protein C inhibitor-KLK3 complex,CC,SERPINA5
2827,GO:0036030,0.195553415836137,1,1,1,protein C inhibitor-plasma kallikrein complex,CC,SERPINA5
3397,GO:0045026,0.195553415836137,1,1,1,plasma membrane fusion,BP,SERPINA5
4054,GO:0050997,0.195553415836137,1,1,1,quaternary ammonium group binding,MF,SERPINA5
4661,GO:0061107,0.195553415836137,1,1,1,seminal vesicle development,BP,SERPINA5
4826,GO:0070405,0.195553415836137,1,1,1,ammonium ion binding,MF,SERPINA5
5363,GO:0097179,0.195553415836137,1,1,1,protease inhibitor complex,CC,SERPINA5
5364,GO:0097180,0.195553415836137,1,1,1,serine protease inhibitor complex,CC,SERPINA5
5365,GO:0097181,0.195553415836137,1,1,1,protein C inhibitor-coagulation factor V complex,CC,SERPINA5
5366,GO:0097182,0.195553415836137,1,1,1,protein C inhibitor-coagulation factor Xa complex,CC,SERPINA5
5367,GO:0097183,0.195553415836137,1,1,1,protein C inhibitor-coagulation factor XI complex,CC,SERPINA5
2593,GO:0034059,0.197389532950449,1,1,1,response to anoxia,BP,CTGF
2813,GO:0035988,0.197389532950449,1,1,1,chondrocyte proliferation,BP,CTGF
4798,GO:0070278,0.197389532950449,1,1,1,extracellular matrix constituent secretion,BP,CTGF
4811,GO:0070318,0.197389532950449,1,1,1,positive regulation of G0 to G1 transition,BP,CTGF
2308,GO:0032153,0.198759080279909,1,1,1,cell division site,CC,RHOB
2309,GO:0032154,0.198759080279909,1,1,1,cleavage furrow,CC,RHOB
2310,GO:0032155,0.198759080279909,1,1,1,cell division site part,CC,RHOB
3007,GO:0042542,0.198759080279909,1,1,1,response to hydrogen peroxide,BP,RHOB
4803,GO:0070301,0.198759080279909,1,1,1,cellular response to hydrogen peroxide,BP,RHOB
5406,GO:0097610,0.198759080279909,1,1,1,cell surface furrow,CC,RHOB
3664,GO:0046718,0.198794366038436,0.953518696242281,3,6,viral entry into host cell,BP,GAS6;ITGB5;CLDN1
631,GO:0005604,0.200245522671748,1,2,2,basement membrane,CC,LAMA1;LAMA5
632,GO:0005605,0.200245522671748,1,2,2,basal lamina,CC,LAMA1;LAMA5
3134,GO:0043256,0.200245522671748,1,2,2,laminin complex,CC,LAMA1;LAMA5
3319,GO:0044420,0.200245522671748,1,2,2,extracellular matrix component,CC,LAMA1;LAMA5
2070,GO:0030695,0.200484555806973,0.952913554545687,3,6,GTPase regulator activity,MF,RIN3;GPSM1;SH3BP4
4527,GO:0060589,0.200484555806973,0.952913554545687,3,6,nucleoside-triphosphatase regulator activity,MF,RIN3;GPSM1;SH3BP4
508,GO:0004421,0.201639610736605,1,1,1,hydroxymethylglutaryl-CoA synthase activity,MF,HMGCS2
830,GO:0006695,0.201639610736605,1,1,1,cholesterol biosynthetic process,BP,HMGCS2
1102,GO:0008203,0.201639610736605,1,1,1,cholesterol metabolic process,BP,HMGCS2
1121,GO:0008299,0.201639610736605,1,1,1,isoprenoid biosynthetic process,BP,HMGCS2
1593,GO:0016125,0.201639610736605,1,1,1,sterol metabolic process,BP,HMGCS2
1594,GO:0016126,0.201639610736605,1,1,1,sterol biosynthetic process,BP,HMGCS2
3703,GO:0046912,0.201639610736605,1,1,1,transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer,MF,HMGCS2
3712,GO:0046950,0.201639610736605,1,1,1,cellular ketone body metabolic process,BP,HMGCS2
3713,GO:0046951,0.201639610736605,1,1,1,ketone body biosynthetic process,BP,HMGCS2
5684,GO:1902224,0.201639610736605,1,1,1,ketone body metabolic process,BP,HMGCS2
5726,GO:1902652,0.201639610736605,1,1,1,secondary alcohol metabolic process,BP,HMGCS2
5727,GO:1902653,0.201639610736605,1,1,1,secondary alcohol biosynthetic process,BP,HMGCS2
223,GO:0002066,0.201702223889555,0.952475653158004,3,6,columnar/cuboidal epithelial cell development,BP,MYO7A;CDKN1A;DLL1
3121,GO:0043230,0.202151997420113,0.878172384334716,19,61,extracellular organelle,CC,ACTN2;FRMPD1;RHOB;RHOJ;MFGE8;CLDN11;GAS6;LAMA5;SDC4;ITGB5;PRKACB;ITGB8;SERPINA5;ACSL4;CRISPLD2;DAAM2;ITGA3;MSN;SH3BP4
4761,GO:0070062,0.202151997420113,0.878172384334716,19,61,extracellular exosome,CC,ACTN2;FRMPD1;RHOB;RHOJ;MFGE8;CLDN11;GAS6;LAMA5;SDC4;ITGB5;PRKACB;ITGB8;SERPINA5;ACSL4;CRISPLD2;DAAM2;ITGA3;MSN;SH3BP4
5832,GO:1903561,0.202151997420113,0.878172384334716,19,61,extracellular vesicle,CC,ACTN2;FRMPD1;RHOB;RHOJ;MFGE8;CLDN11;GAS6;LAMA5;SDC4;ITGB5;PRKACB;ITGB8;SERPINA5;ACSL4;CRISPLD2;DAAM2;ITGA3;MSN;SH3BP4
621,GO:0005539,0.203945739164624,0.945044135333403,3,8,glycosaminoglycan binding,MF,SERPINA5;CRISPLD2;CTGF
1292,GO:0010243,0.206906542254539,0.898090150899296,9,25,response to organonitrogen compound,BP,ACTN2;CDKN1A;PIK3R1;PRKACB;FOXO4;PDE4B;CTGF;WT1;SH3BP4
3923,GO:0048864,0.206939597907024,0.946574654800435,3,7,stem cell development,BP,NRTN;KITLG;LAMA5
4840,GO:0070542,0.20713442940833,0.96671124277482,2,4,response to fatty acid,BP,CLDN1;CTGF
536,GO:0004866,0.207215330558716,0.966689331025345,2,4,endopeptidase inhibitor activity,MF,GAS6;SERPINA5
2023,GO:0030414,0.207215330558716,0.966689331025345,2,4,peptidase inhibitor activity,MF,GAS6;SERPINA5
4664,GO:0061134,0.207215330558716,0.966689331025345,2,4,peptidase regulator activity,MF,GAS6;SERPINA5
4665,GO:0061135,0.207215330558716,0.966689331025345,2,4,endopeptidase regulator activity,MF,GAS6;SERPINA5
4963,GO:0071482,0.207740611151287,0.975346749326884,2,3,cellular response to light stimulus,BP,CDKN1A;PIK3R1
200,GO:0001960,0.208034909844935,1,1,1,negative regulation of cytokine-mediated signaling pathway,BP,GAS6
590,GO:0005245,0.208034909844935,1,1,1,voltage-gated calcium channel activity,MF,GAS6
598,GO:0005262,0.208034909844935,1,1,1,calcium channel activity,MF,GAS6
783,GO:0006465,0.208034909844935,1,1,1,signal peptide processing,BP,GAS6
807,GO:0006611,0.208034909844935,1,1,1,protein export from nucleus,BP,GAS6
1389,GO:0010803,0.208034909844935,1,1,1,regulation of tumor necrosis factor-mediated signaling pathway,BP,GAS6
1390,GO:0010804,0.208034909844935,1,1,1,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,GAS6
1520,GO:0015085,0.208034909844935,1,1,1,calcium ion transmembrane transporter activity,MF,GAS6
1737,GO:0019062,0.208034909844935,1,1,1,virion attachment to host cell,BP,GAS6
1738,GO:0019064,0.208034909844935,1,1,1,fusion of virus membrane with host plasma membrane,BP,GAS6
2004,GO:0030296,0.208034909844935,1,1,1,protein tyrosine kinase activator activity,MF,GAS6
2412,GO:0032571,0.208034909844935,1,1,1,response to vitamin K,BP,GAS6
2442,GO:0032689,0.208034909844935,1,1,1,negative regulation of interferon-gamma production,BP,GAS6
2443,GO:0032692,0.208034909844935,1,1,1,negative regulation of interleukin-1 production,BP,GAS6
2446,GO:0032715,0.208034909844935,1,1,1,negative regulation of interleukin-6 production,BP,GAS6
2447,GO:0032720,0.208034909844935,1,1,1,negative regulation of tumor necrosis factor production,BP,GAS6
2471,GO:0032814,0.208034909844935,1,1,1,regulation of natural killer cell activation,BP,GAS6
2472,GO:0032816,0.208034909844935,1,1,1,positive regulation of natural killer cell activation,BP,GAS6
2473,GO:0032823,0.208034909844935,1,1,1,regulation of natural killer cell differentiation,BP,GAS6
2474,GO:0032825,0.208034909844935,1,1,1,positive regulation of natural killer cell differentiation,BP,GAS6
2550,GO:0033159,0.208034909844935,1,1,1,negative regulation of protein import into nucleus, translocation,BP,GAS6
2738,GO:0035455,0.208034909844935,1,1,1,response to interferon-alpha,BP,GAS6
2739,GO:0035457,0.208034909844935,1,1,1,cellular response to interferon-alpha,BP,GAS6
2766,GO:0035701,0.208034909844935,1,1,1,hematopoietic stem cell migration,BP,GAS6
2771,GO:0035754,0.208034909844935,1,1,1,B cell chemotaxis,BP,GAS6
2890,GO:0039663,0.208034909844935,1,1,1,membrane fusion involved in viral entry into host cell,BP,GAS6
3068,GO:0043027,0.208034909844935,1,1,1,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,GAS6
3069,GO:0043028,0.208034909844935,1,1,1,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,GAS6
3316,GO:0044406,0.208034909844935,1,1,1,adhesion of symbiont to host,BP,GAS6
3350,GO:0044650,0.208034909844935,1,1,1,adhesion of symbiont to host cell,BP,GAS6
3379,GO:0044800,0.208034909844935,1,1,1,multi-organism membrane fusion,BP,GAS6
3382,GO:0044803,0.208034909844935,1,1,1,multi-organism membrane organization,BP,GAS6
3488,GO:0045621,0.208034909844935,1,1,1,positive regulation of lymphocyte differentiation,BP,GAS6
3670,GO:0046813,0.208034909844935,1,1,1,receptor-mediated virion attachment to host cell,BP,GAS6
3674,GO:0046825,0.208034909844935,1,1,1,regulation of protein export from nucleus,BP,GAS6
3675,GO:0046827,0.208034909844935,1,1,1,positive regulation of protein export from nucleus,BP,GAS6
3954,GO:0050710,0.208034909844935,1,1,1,negative regulation of cytokine secretion,BP,GAS6
3955,GO:0050711,0.208034909844935,1,1,1,negative regulation of interleukin-1 secretion,BP,GAS6
4104,GO:0051168,0.208034909844935,1,1,1,nuclear export,BP,GAS6
4577,GO:0060761,0.208034909844935,1,1,1,negative regulation of response to cytokine stimulus,BP,GAS6
4775,GO:0070168,0.208034909844935,1,1,1,negative regulation of biomineral tissue development,BP,GAS6
4913,GO:0071307,0.208034909844935,1,1,1,cellular response to vitamin K,BP,GAS6
5188,GO:0072577,0.208034909844935,1,1,1,endothelial cell apoptotic process,BP,GAS6
5195,GO:0072604,0.208034909844935,1,1,1,interleukin-6 secretion,BP,GAS6
5201,GO:0072661,0.208034909844935,1,1,1,protein targeting to plasma membrane,BP,GAS6
5336,GO:0097017,0.208034909844935,1,1,1,renal protein absorption,BP,GAS6
5337,GO:0097018,0.208034909844935,1,1,1,renal albumin absorption,BP,GAS6
5339,GO:0097028,0.208034909844935,1,1,1,dendritic cell differentiation,BP,GAS6
5341,GO:0097048,0.208034909844935,1,1,1,dendritic cell apoptotic process,BP,GAS6
5377,GO:0097241,0.208034909844935,1,1,1,hematopoietic stem cell migration to bone marrow,BP,GAS6
5378,GO:0097252,0.208034909844935,1,1,1,oligodendrocyte apoptotic process,BP,GAS6
5529,GO:1900141,0.208034909844935,1,1,1,regulation of oligodendrocyte apoptotic process,BP,GAS6
5530,GO:1900142,0.208034909844935,1,1,1,negative regulation of oligodendrocyte apoptotic process,BP,GAS6
5531,GO:1900165,0.208034909844935,1,1,1,negative regulation of interleukin-6 secretion,BP,GAS6
5830,GO:1903556,0.208034909844935,1,1,1,negative regulation of tumor necrosis factor superfamily cytokine production,BP,GAS6
5879,GO:1904035,0.208034909844935,1,1,1,regulation of epithelial cell apoptotic process,BP,GAS6
5880,GO:1904036,0.208034909844935,1,1,1,negative regulation of epithelial cell apoptotic process,BP,GAS6
6076,GO:2000351,0.208034909844935,1,1,1,regulation of endothelial cell apoptotic process,BP,GAS6
6077,GO:2000352,0.208034909844935,1,1,1,negative regulation of endothelial cell apoptotic process,BP,GAS6
6095,GO:2000508,0.208034909844935,1,1,1,regulation of dendritic cell chemotaxis,BP,GAS6
6096,GO:2000510,0.208034909844935,1,1,1,positive regulation of dendritic cell chemotaxis,BP,GAS6
6097,GO:2000532,0.208034909844935,1,1,1,regulation of renal albumin absorption,BP,GAS6
6098,GO:2000533,0.208034909844935,1,1,1,negative regulation of renal albumin absorption,BP,GAS6
6112,GO:2000668,0.208034909844935,1,1,1,regulation of dendritic cell apoptotic process,BP,GAS6
6113,GO:2000669,0.208034909844935,1,1,1,negative regulation of dendritic cell apoptotic process,BP,GAS6
3367,GO:0044763,0.208051692151131,0.885812175635844,50,191,single-organism cellular process,BP,LAMA1;ACTN2;MYO7A;CDKN1A;HMGCS2;NRTN;REEP1;DKK3;RHOB;KITLG;PRND;PHLDA1;SLC52A3;RHOJ;NUAK2;MFGE8;CAMSAP3;PLEKHH2;CLDN11;PIK3R1;GAS6;LAMA5;SDC4;MPZL1;ITGB5;SEMA6C;PRKACB;ITGB8;SERPINA5;HMGN5;ACSL4;CRISPLD2;FHOD3;RAB39B;FOXO4;DHH;GPSM1;MARK4;ESPN;DAAM2;DLL1;PDE4B;UNC119;CLDN1;CTGF;ITGA3;WT1;MSN;PTGES;SH3BP4
4293,GO:0052547,0.208158007429806,0.943318764539125,3,8,regulation of peptidase activity,BP,GAS6;SERPINA5;CTGF
4013,GO:0050865,0.208436793727072,0.920033834163151,5,14,regulation of cell activation,BP,CDKN1A;PIK3R1;GAS6;SDC4;CTGF
1475,GO:0014070,0.208502248695098,0.894839756078241,9,29,response to organic cyclic compound,BP,CDKN1A;PRKACB;DHH;PDE4B;CLDN1;CTGF;WT1;MSN;PTGES
1122,GO:0008305,0.209342529390314,0.956154189290631,3,5,integrin complex,CC,ITGB5;ITGB8;ITGA3
5436,GO:0098636,0.209342529390314,0.956154189290631,3,5,protein complex involved in cell adhesion,CC,ITGB5;ITGB8;ITGA3
5678,GO:1902115,0.210523941602701,0.965787546235347,2,4,regulation of organelle assembly,BP,SDC4;MSN
5679,GO:1902117,0.210523941602701,0.965787546235347,2,4,positive regulation of organelle assembly,BP,SDC4;MSN
1202,GO:0009266,0.211912496978771,0.96540579152809,2,4,response to temperature stimulus,BP,CDKN1A;SLC52A3
1798,GO:0019887,0.211933030953046,0.965400131510991,2,4,protein kinase regulator activity,MF,CDKN1A;GAS6
5660,GO:1901987,0.212151963030851,0.960609910432863,2,5,regulation of cell cycle phase transition,BP,CDKN1A;FOXO4
5662,GO:1901990,0.212151963030851,0.960609910432863,2,5,regulation of mitotic cell cycle phase transition,BP,CDKN1A;FOXO4
3642,GO:0046578,0.213526648306291,0.964959563668341,2,4,regulation of Ras protein signal transduction,BP,KITLG;ITGA3
661,GO:0005775,0.21442757847892,1,1,1,vacuolar lumen,CC,SDC4
727,GO:0006026,0.21442757847892,1,1,1,aminoglycan catabolic process,BP,SDC4
728,GO:0006027,0.21442757847892,1,1,1,glycosaminoglycan catabolic process,BP,SDC4
3073,GO:0043034,0.21442757847892,1,1,1,costamere,CC,SDC4
3109,GO:0043202,0.21442757847892,1,1,1,lysosomal lumen,CC,SDC4
4759,GO:0070053,0.21442757847892,1,1,1,thrombospondin receptor activity,MF,SDC4
5033,GO:0071971,0.21442757847892,1,1,1,extracellular exosome assembly,BP,SDC4
5823,GO:1903541,0.21442757847892,1,1,1,regulation of exosomal secretion,BP,SDC4
5824,GO:1903543,0.21442757847892,1,1,1,positive regulation of exosomal secretion,BP,SDC4
5827,GO:1903551,0.21442757847892,1,1,1,regulation of extracellular exosome assembly,BP,SDC4
5828,GO:1903553,0.21442757847892,1,1,1,positive regulation of extracellular exosome assembly,BP,SDC4
4379,GO:0060119,0.218589903225672,0.973093606338943,2,3,inner ear receptor cell development,BP,MYO7A;SDC4
4381,GO:0060122,0.218589903225672,0.973093606338943,2,3,inner ear receptor stereocilium organization,BP,MYO7A;SDC4
4144,GO:0051249,0.218819197049011,0.924918024593032,4,11,regulation of lymphocyte activation,BP,CDKN1A;PIK3R1;GAS6;SDC4
1120,GO:0008289,0.219828537211833,0.913940609030536,5,14,lipid binding,MF,ACTN2;MFGE8;GAS6;SERPINA5;UNC119
623,GO:0005543,0.220012687367399,0.926395744070483,4,10,phospholipid binding,MF,ACTN2;MFGE8;GAS6;SERPINA5
2594,GO:0034097,0.222558849195281,0.923068260133637,4,11,response to cytokine,BP,GAS6;ACSL4;CLDN1;PTGES
5239,GO:0090004,0.22261257303532,0.972234206596869,2,3,positive regulation of establishment of protein localization to plasma membrane,BP,PIK3R1;ITGA3
5776,GO:1903078,0.22261257303532,0.972234206596869,2,3,positive regulation of protein localization to plasma membrane,BP,PIK3R1;ITGA3
5888,GO:1904377,0.22261257303532,0.972234206596869,2,3,positive regulation of protein localization to cell periphery,BP,PIK3R1;ITGA3
5722,GO:1902612,0.222684097710862,1,1,1,regulation of anti-Mullerian hormone signaling pathway,BP,DKK3
5723,GO:1902613,0.222684097710862,1,1,1,negative regulation of anti-Mullerian hormone signaling pathway,BP,DKK3
5985,GO:1990262,0.222684097710862,1,1,1,anti-Mullerian hormone signaling pathway,BP,DKK3
4247,GO:0051726,0.222814072073134,0.893897739353127,7,25,regulation of cell cycle,BP,CDKN1A;RHOB;GAS6;PRKACB;HMGN5;FOXO4;CTGF
2512,GO:0032970,0.22349628129049,0.900420782578448,7,17,regulation of actin filament-based process,BP,ACTN2;PLEKHH2;PIK3R1;SDC4;FHOD3;PDE4B;CTGF
4031,GO:0050900,0.223982212404467,0.896663360903847,7,20,leukocyte migration,BP,KITLG;PIK3R1;GAS6;SDC4;PDE4B;ITGA3;MSN
829,GO:0006694,0.22443419885862,0.939532206521704,3,7,steroid biosynthetic process,BP,HMGCS2;DKK3;DHH
1101,GO:0008202,0.22443419885862,0.939532206521704,3,7,steroid metabolic process,BP,HMGCS2;DKK3;DHH
2936,GO:0042157,0.22517668505335,0.971679607314042,2,3,lipoprotein metabolic process,BP,PRND;PRKACB
3342,GO:0044451,0.226089430783498,0.938847879228909,3,7,nucleoplasm part,CC,CDKN1A;FOXO4;WT1
1209,GO:0009566,0.226511610583831,0.961273840492552,2,4,fertilization,BP,MFGE8;SERPINA5
8,GO:0000075,0.227745329545436,0.955629114367165,2,5,cell cycle checkpoint,BP,CDKN1A;FOXO4
5626,GO:1901655,0.229000943065642,0.960547678546469,2,4,cellular response to ketone,BP,GAS6;MSN
4206,GO:0051495,0.230342821349145,0.93389012451209,3,8,positive regulation of cytoskeleton organization,BP,ACTN2;SDC4;CTGF
667,GO:0005789,0.232826936952125,0.920122710020795,4,10,endoplasmic reticulum membrane,CC,REEP1;ACSL4;GPSM1;PTGES
1127,GO:0008360,0.232876483152771,0.959404566402573,2,4,regulation of cell shape,BP,RHOJ;MSN
996,GO:0007275,0.233881020513898,0.848418020969988,36,129,multicellular organism development,BP,LAMA1;ACTN2;MYO7A;CDKN1A;NRTN;DKK3;RHOB;KITLG;RHOJ;MFGE8;CAMSAP3;CLDN11;PIK3R1;GAS6;LAMA5;SDC4;ITGB5;SEMA6C;PRKACB;ITGB8;SERPINA5;ACSL4;CRISPLD2;FHOD3;FOXO4;DHH;GPSM1;MARK4;DAAM2;DLL1;UNC119;CLDN1;CTGF;ITGA3;WT1;MSN
403,GO:0003158,0.23424958982573,0.907674633693574,5,13,endothelium development,BP,RHOB;LAMA5;DLL1;CLDN1;MSN
699,GO:0005915,0.2350266194354,1,1,1,zonula adherens,CC,CAMSAP3
845,GO:0006767,0.2350266194354,1,1,1,water-soluble vitamin metabolic process,BP,SLC52A3
846,GO:0006771,0.2350266194354,1,1,1,riboflavin metabolic process,BP,SLC52A3
1427,GO:0010923,0.2350266194354,1,1,1,negative regulation of phosphatase activity,BP,CAMSAP3
2313,GO:0032217,0.2350266194354,1,1,1,riboflavin transporter activity,MF,SLC52A3
2314,GO:0032218,0.2350266194354,1,1,1,riboflavin transport,BP,SLC52A3
2619,GO:0034331,0.2350266194354,1,1,1,cell junction maintenance,BP,CAMSAP3
2636,GO:0034453,0.2350266194354,1,1,1,microtubule anchoring,BP,CAMSAP3
2722,GO:0035305,0.2350266194354,1,1,1,negative regulation of dephosphorylation,BP,CAMSAP3
3035,GO:0042726,0.2350266194354,1,1,1,flavin-containing compound metabolic process,BP,SLC52A3
3445,GO:0045217,0.2350266194354,1,1,1,cell-cell junction maintenance,BP,CAMSAP3
3446,GO:0045218,0.2350266194354,1,1,1,zonula adherens maintenance,BP,CAMSAP3
4057,GO:0051011,0.2350266194354,1,1,1,microtubule minus-end binding,MF,CAMSAP3
532,GO:0004857,0.235537719812321,0.934882106403008,3,7,enzyme inhibitor activity,MF,CDKN1A;GAS6;SERPINA5
2765,GO:0035690,0.236382701409985,0.958357161943083,2,4,cellular response to drug,BP,GAS6;PDE4B
809,GO:0006629,0.236794086233158,0.876850653751703,9,28,lipid metabolic process,BP,HMGCS2;DKK3;KITLG;PIK3R1;SDC4;ITGB8;ACSL4;DHH;PTGES
70,GO:0001077,0.237439654817533,1,1,1,transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,WT1
83,GO:0001228,0.237439654817533,1,1,1,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,MF,WT1
1007,GO:0007354,0.237439654817533,1,1,1,zygotic determination of anterior/posterior axis, embryo,BP,WT1
1008,GO:0007356,0.237439654817533,1,1,1,thorax and anterior abdomen determination,BP,WT1
1298,GO:0010385,0.237439654817533,1,1,1,double-stranded methylated DNA binding,MF,WT1
2476,GO:0032836,0.237439654817533,1,1,1,glomerular basement membrane development,BP,WT1
2741,GO:0035502,0.237439654817533,1,1,1,metanephric part of ureteric bud development,BP,WT1
2779,GO:0035801,0.237439654817533,1,1,1,adrenal cortex development,BP,WT1
2780,GO:0035802,0.237439654817533,1,1,1,adrenal cortex formation,BP,WT1
3364,GO:0044729,0.237439654817533,1,1,1,hemi-methylated DNA-binding,MF,WT1
4639,GO:0061032,0.237439654817533,1,1,1,visceral serous pericardium development,BP,WT1
4866,GO:0070742,0.237439654817533,1,1,1,C2H2 zinc finger domain binding,MF,WT1
5108,GO:0072166,0.237439654817533,1,1,1,posterior mesonephric tubule development,BP,WT1
5147,GO:0072262,0.237439654817533,1,1,1,metanephric glomerular mesangial cell proliferation involved in metanephros development,BP,WT1
5152,GO:0072298,0.237439654817533,1,1,1,regulation of metanephric glomerulus development,BP,WT1
5153,GO:0072299,0.237439654817533,1,1,1,negative regulation of metanephric glomerulus development,BP,WT1
5154,GO:0072301,0.237439654817533,1,1,1,regulation of metanephric glomerular mesangial cell proliferation,BP,WT1
5155,GO:0072302,0.237439654817533,1,1,1,negative regulation of metanephric glomerular mesangial cell proliferation,BP,WT1
5971,GO:1905941,0.237439654817533,1,1,1,positive regulation of gonad development,BP,WT1
6020,GO:2000020,0.237439654817533,1,1,1,positive regulation of male gonad development,BP,WT1
6059,GO:2000194,0.237439654817533,1,1,1,regulation of female gonad development,BP,WT1
6060,GO:2000195,0.237439654817533,1,1,1,negative regulation of female gonad development,BP,WT1
6159,GO:2001074,0.237439654817533,1,1,1,regulation of metanephric ureteric bud development,BP,WT1
6160,GO:2001076,0.237439654817533,1,1,1,positive regulation of metanephric ureteric bud development,BP,WT1
1254,GO:0009897,0.237569192853068,0.934016195165694,3,7,external side of plasma membrane,CC,MFGE8;SERPINA5;ITGA3
4892,GO:0071157,0.238196293843905,0.984138714098918,1,2,negative regulation of cell cycle arrest,BP,HMGN5
2381,GO:0032420,0.238566527201158,0.968696888254746,2,3,stereocilium,CC,MYO7A;ESPN
2382,GO:0032421,0.238566527201158,0.968696888254746,2,3,stereocilium bundle,CC,MYO7A;ESPN
151,GO:0001817,0.238647429415249,0.91721178384962,4,10,regulation of cytokine production,BP,PIK3R1;GAS6;DLL1;PDE4B
2502,GO:0032943,0.238828505207019,0.930132345274055,3,8,mononuclear cell proliferation,BP,CDKN1A;SDC4;MSN
3653,GO:0046651,0.238828505207019,0.930132345274055,3,8,lymphocyte proliferation,BP,CDKN1A;SDC4;MSN
3327,GO:0044430,0.239755139528345,0.869525826451921,11,30,cytoskeletal part,CC,ACTN2;MYO7A;CAMSAP3;PLEKHH2;PRKACB;FHOD3;MARK4;ESPN;PDE4B;UNC119;CGN
5392,GO:0097435,0.240010022553878,0.882787015427602,8,21,supramolecular fiber organization,BP,ACTN2;PLEKHH2;PIK3R1;SDC4;ITGB5;FHOD3;ESPN;CTGF
1576,GO:0016032,0.242538963760626,0.903084057675142,5,13,viral process,BP,MFGE8;PIK3R1;GAS6;ITGB5;CLDN1
4973,GO:0071559,0.242947838944162,0.901128481415706,5,14,response to transforming growth factor beta,BP,DKK3;ITGB5;CGN;CLDN1;ITGA3
4974,GO:0071560,0.242947838944162,0.901128481415706,5,14,cellular response to transforming growth factor beta stimulus,BP,DKK3;ITGB5;CGN;CLDN1;ITGA3
152,GO:0001818,0.244777500887048,0.955798178257128,2,4,negative regulation of cytokine production,BP,GAS6;DLL1
1229,GO:0009725,0.248643093216618,0.869511861688369,9,27,response to hormone,BP,ACTN2;CDKN1A;PIK3R1;PRKACB;FOXO4;CLDN1;CTGF;ITGA3;WT1
3538,GO:0045787,0.24867363448289,0.906255436191061,4,13,positive regulation of cell cycle,BP,CDKN1A;HMGN5;FOXO4;CTGF
3321,GO:0044422,0.250602567874983,0.834598730271597,30,110,organelle part,CC,ACTN2;MYO7A;CDKN1A;HMGCS2;REEP1;RHOB;MRO;PHLDA1;CAMSAP3;PLEKHH2;PIK3R1;SLC25A53;GAS6;SDC4;PRKACB;SERPINA5;HMGN5;ACSL4;CRISPLD2;FHOD3;FOXO4;GPSM1;MARK4;ESPN;TMEM163;PDE4B;UNC119;CGN;WT1;PTGES
942,GO:0007095,0.251576484307592,1,1,1,mitotic G2 DNA damage checkpoint,BP,FOXO4
1299,GO:0010389,0.251576484307592,1,1,1,regulation of G2/M transition of mitotic cell cycle,BP,FOXO4
1439,GO:0010972,0.251576484307592,1,1,1,negative regulation of G2/M transition of mitotic cell cycle,BP,FOXO4
2223,GO:0031572,0.251576484307592,1,1,1,G2 DNA damage checkpoint,BP,FOXO4
2797,GO:0035902,0.251576484307592,1,1,1,response to immobilization stress,BP,FOXO4
3383,GO:0044818,0.251576484307592,1,1,1,mitotic G2/M transition checkpoint,BP,FOXO4
4810,GO:0070317,0.251576484307592,1,1,1,negative regulation of G0 to G1 transition,BP,FOXO4
5738,GO:1902749,0.251576484307592,1,1,1,regulation of cell cycle G2/M phase transition,BP,FOXO4
5739,GO:1902750,0.251576484307592,1,1,1,negative regulation of cell cycle G2/M phase transition,BP,FOXO4
6001,GO:1990785,0.251576484307592,1,1,1,response to water-immersion restraint stress,BP,FOXO4
6003,GO:1990841,0.251576484307592,1,1,1,promoter-specific chromatin binding,MF,FOXO4
3282,GO:0044255,0.252111194809736,0.878139256956061,7,21,cellular lipid metabolic process,BP,HMGCS2;KITLG;PIK3R1;SDC4;ITGB8;ACSL4;PTGES
315,GO:0002576,0.252134202562512,0.953495960489305,2,4,platelet degranulation,BP,ACTN2;GAS6
139,GO:0001757,0.254200498436379,1,1,1,somite specification,BP,DLL1
271,GO:0002313,0.254200498436379,1,1,1,mature B cell differentiation involved in immune response,BP,DLL1
272,GO:0002315,0.254200498436379,1,1,1,marginal zone B cell differentiation,BP,DLL1
277,GO:0002335,0.254200498436379,1,1,1,mature B cell differentiation,BP,DLL1
1011,GO:0007379,0.254200498436379,1,1,1,segment specification,BP,DLL1
1830,GO:0021679,0.254200498436379,1,1,1,cerebellar molecular layer development,BP,DLL1
1831,GO:0021680,0.254200498436379,1,1,1,cerebellar Purkinje cell layer development,BP,DLL1
1835,GO:0021687,0.254200498436379,1,1,1,cerebellar molecular layer morphogenesis,BP,DLL1
1836,GO:0021688,0.254200498436379,1,1,1,cerebellar molecular layer formation,BP,DLL1
1837,GO:0021692,0.254200498436379,1,1,1,cerebellar Purkinje cell layer morphogenesis,BP,DLL1
1838,GO:0021693,0.254200498436379,1,1,1,cerebellar Purkinje cell layer structural organization,BP,DLL1
1842,GO:0021698,0.254200498436379,1,1,1,cerebellar cortex structural organization,BP,DLL1
2126,GO:0030957,0.254200498436379,1,1,1,Tat protein binding,MF,DLL1
2423,GO:0032613,0.254200498436379,1,1,1,interleukin-10 production,BP,DLL1
2435,GO:0032653,0.254200498436379,1,1,1,regulation of interleukin-10 production,BP,DLL1
2444,GO:0032693,0.254200498436379,1,1,1,negative regulation of interleukin-10 production,BP,DLL1
2874,GO:0038084,0.254200498436379,1,1,1,vascular endothelial growth factor signaling pathway,BP,DLL1
3427,GO:0045168,0.254200498436379,1,1,1,cell-cell signaling involved in cell fate commitment,BP,DLL1
3613,GO:0046331,0.254200498436379,1,1,1,lateral inhibition,BP,DLL1
3812,GO:0048532,0.254200498436379,1,1,1,anatomical structure arrangement,BP,DLL1
3859,GO:0048665,0.254200498436379,1,1,1,neuron fate specification,BP,DLL1
4352,GO:0060042,0.254200498436379,1,1,1,retina morphogenesis in camera-type eye,BP,DLL1
4595,GO:0060844,0.254200498436379,1,1,1,arterial endothelial cell fate commitment,BP,DLL1
4596,GO:0060846,0.254200498436379,1,1,1,blood vessel endothelial cell fate commitment,BP,DLL1
4597,GO:0060847,0.254200498436379,1,1,1,endothelial cell fate specification,BP,DLL1
4598,GO:0060853,0.254200498436379,1,1,1,Notch signaling pathway involved in arterial endothelial cell fate commitment,BP,DLL1
5042,GO:0072014,0.254200498436379,1,1,1,proximal tubule development,BP,DLL1
5351,GO:0097101,0.254200498436379,1,1,1,blood vessel endothelial cell fate specification,BP,DLL1
5352,GO:0097102,0.254200498436379,1,1,1,endothelial tip cell fate specification,BP,DLL1
5560,GO:1900746,0.254200498436379,1,1,1,regulation of vascular endothelial growth factor signaling pathway,BP,DLL1
5712,GO:1902547,0.254200498436379,1,1,1,regulation of cellular response to vascular endothelial growth factor stimulus,BP,DLL1
6094,GO:2000505,0.254200498436379,1,1,1,regulation of energy homeostasis,BP,DLL1
3107,GO:0043200,0.255045582820321,0.952569402882331,2,4,response to amino acid,BP,CTGF;SH3BP4
303,GO:0002474,0.257674264834535,1,1,1,antigen processing and presentation of peptide antigen via MHC class I,BP,ITGB5
304,GO:0002478,0.257674264834535,1,1,1,antigen processing and presentation of exogenous peptide antigen,BP,ITGB5
305,GO:0002479,0.257674264834535,1,1,1,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,ITGB5
1797,GO:0019884,0.257674264834535,1,1,1,antigen processing and presentation of exogenous antigen,BP,ITGB5
2657,GO:0034684,0.257674264834535,1,1,1,integrin alphav-beta5 complex,CC,ITGB5
3018,GO:0042590,0.257674264834535,1,1,1,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,ITGB5
3720,GO:0048002,0.257674264834535,1,1,1,antigen processing and presentation of peptide antigen,BP,ITGB5
1222,GO:0009628,0.258600322116089,0.871547330942599,7,24,response to abiotic stimulus,BP,CDKN1A;RHOB;SLC52A3;PIK3R1;UNC119;CLDN1;CTGF
3266,GO:0044089,0.258962540213171,0.889060595664629,5,16,positive regulation of cellular component biogenesis,BP,SDC4;ESPN;CLDN1;CTGF;MSN
1273,GO:0009991,0.259146128908283,0.891799649503755,5,14,response to extracellular stimulus,BP,CDKN1A;NUAK2;GAS6;ACSL4;FOXO4
2242,GO:0031667,0.259146128908283,0.891799649503755,5,14,response to nutrient levels,BP,CDKN1A;NUAK2;GAS6;ACSL4;FOXO4
1146,GO:0008584,0.259323172097998,0.924449925495712,3,7,male gonad development,BP,KITLG;DHH;WT1
3641,GO:0046546,0.259323172097998,0.924449925495712,3,7,development of primary male sexual characteristics,BP,KITLG;DHH;WT1
906,GO:0006970,0.259572307696814,1,1,1,response to osmotic stress,BP,CLDN1
907,GO:0006972,0.259572307696814,1,1,1,hyperosmotic response,BP,CLDN1
1078,GO:0008065,0.259572307696814,1,1,1,establishment of blood-nerve barrier,BP,CLDN1
1224,GO:0009651,0.259572307696814,1,1,1,response to salt stress,BP,CLDN1
1295,GO:0010288,0.259572307696814,1,1,1,response to lead ion,BP,CLDN1
1568,GO:0015893,0.259572307696814,1,1,1,drug transport,BP,CLDN1
2572,GO:0033561,0.259572307696814,1,1,1,regulation of water loss via skin,BP,CLDN1
3006,GO:0042538,0.259572307696814,1,1,1,hyperosmotic salinity response,BP,CLDN1
4721,GO:0061436,0.259572307696814,1,1,1,establishment of skin barrier,BP,CLDN1
4750,GO:0061772,0.259572307696814,1,1,1,drug transport across blood-nerve barrier,BP,CLDN1
4908,GO:0071284,0.259572307696814,1,1,1,cellular response to lead ion,BP,CLDN1
5323,GO:0090557,0.259572307696814,1,1,1,establishment of endothelial intestinal barrier,BP,CLDN1
5390,GO:0097421,0.259572307696814,1,1,1,liver regeneration,BP,CLDN1
5795,GO:1903348,0.259572307696814,1,1,1,positive regulation of bicellular tight junction assembly,BP,CLDN1
5825,GO:1903544,0.259572307696814,1,1,1,response to butyrate,BP,CLDN1
5826,GO:1903545,0.259572307696814,1,1,1,cellular response to butyrate,BP,CLDN1
6132,GO:2000810,0.259572307696814,1,1,1,regulation of bicellular tight junction assembly,BP,CLDN1
5375,GO:0097205,0.260769503688832,0.950722065828022,2,4,renal filtration,BP,GAS6;ITGA3
1802,GO:0019899,0.261152810479881,0.849068391092511,12,37,enzyme binding,MF,CDKN1A;PIK3R1;GAS6;SDC4;PRKACB;SERPINA5;RIN3;FOXO4;DAAM2;ITGA3;MSN;SH3BP4
2641,GO:0034612,0.262899326105806,0.943404834226736,2,5,response to tumor necrosis factor,BP,GAS6;CLDN1
4929,GO:0071356,0.262899326105806,0.943404834226736,2,5,cellular response to tumor necrosis factor,BP,GAS6;CLDN1
4894,GO:0071214,0.263044822581912,0.918948966784405,3,8,cellular response to abiotic stimulus,BP,CDKN1A;RHOB;PIK3R1
1938,GO:0030048,0.264263442667147,0.927797946078622,3,6,actin filament-based movement,BP,ACTN2;MYO7A;PDE4B
4146,GO:0051251,0.264352351996941,0.918325765280091,3,8,positive regulation of lymphocyte activation,BP,CDKN1A;PIK3R1;GAS6
5720,GO:1902589,0.264504428872548,0.843773279320024,13,40,single-organism organelle organization,BP,ACTN2;RHOJ;NUAK2;PLEKHH2;PIK3R1;LAMA5;SDC4;ITGB5;FHOD3;MARK4;ESPN;DAAM2;CTGF
1937,GO:0030046,0.265630487734896,1,1,1,parallel actin filament bundle assembly,BP,ESPN
2260,GO:0031941,0.265630487734896,1,1,1,filamentous actin,CC,ESPN
2383,GO:0032426,0.265630487734896,1,1,1,stereocilium tip,CC,ESPN
3063,GO:0043005,0.272491093640223,0.87390095504737,6,17,neuron projection,CC,ACTN2;NRTN;RAB39B;MARK4;PDE4B;ITGA3
908,GO:0006974,0.273298389974522,0.911085548020685,3,9,cellular response to DNA damage stimulus,BP,CDKN1A;PIK3R1;FOXO4
2507,GO:0032956,0.273327478147493,0.876704655511408,6,15,regulation of actin cytoskeleton organization,BP,ACTN2;PLEKHH2;PIK3R1;SDC4;FHOD3;CTGF
53,GO:0000922,0.273631219333436,0.978592418840684,1,2,spindle pole,CC,UNC119
3113,GO:0043209,0.274604120174771,0.946115629438008,2,4,myelin sheath,CC,CLDN11;MSN
923,GO:0007029,0.276356632989385,1,1,1,endoplasmic reticulum organization,BP,REEP1
2254,GO:0031849,0.276356632989385,1,1,1,olfactory receptor binding,MF,REEP1
5003,GO:0071782,0.276356632989385,1,1,1,endoplasmic reticulum tubular network,CC,REEP1
5004,GO:0071786,0.276356632989385,1,1,1,endoplasmic reticulum tubular network organization,BP,REEP1
5467,GO:0098827,0.276356632989385,1,1,1,endoplasmic reticulum subcompartment,CC,REEP1
1041,GO:0007569,0.278319569286289,0.977785215434319,1,2,cell aging,BP,CDKN1A
1297,GO:0010332,0.278319569286289,0.977785215434319,1,2,response to gamma radiation,BP,CDKN1A
4962,GO:0071480,0.278319569286289,0.977785215434319,1,2,cellular response to gamma radiation,BP,CDKN1A
5314,GO:0090398,0.278319569286289,0.977785215434319,1,2,cellular senescence,BP,CDKN1A
1705,GO:0017112,0.28069913240274,1,1,1,Rab guanyl-nucleotide exchange factor activity,MF,RIN3
1641,GO:0016485,0.281511542025867,0.943740211608897,2,4,protein processing,BP,GAS6;PRKACB
3443,GO:0045214,0.281694060305652,0.943676758439687,2,4,sarcomere organization,BP,ACTN2;FHOD3
538,GO:0004869,0.283324273014553,0.976904021496443,1,2,cysteine-type endopeptidase inhibitor activity,MF,GAS6
164,GO:0001843,0.283844275851,0.942926559629144,2,4,neural tube closure,BP,SDC4;PRKACB
4951,GO:0071417,0.285565926875525,0.857209837577812,7,20,cellular response to organonitrogen compound,BP,ACTN2;PIK3R1;PRKACB;FOXO4;PDE4B;WT1;SH3BP4
2554,GO:0033218,0.286452009335921,0.942010124066184,2,4,amide binding,MF,PIK3R1;PTGES
2948,GO:0042277,0.286452009335921,0.942010124066184,2,4,peptide binding,MF,PIK3R1;PTGES
610,GO:0005507,0.286512498824121,1,1,1,copper ion binding,MF,PRND
796,GO:0006501,0.286512498824121,1,1,1,C-terminal protein lipidation,BP,PRND
872,GO:0006878,0.286512498824121,1,1,1,cellular copper ion homeostasis,BP,PRND
1732,GO:0018410,0.286512498824121,1,1,1,C-terminal protein amino acid modification,BP,PRND
2169,GO:0031225,0.286512498824121,1,1,1,anchored component of membrane,CC,PRND
3241,GO:0043687,0.286512498824121,1,1,1,post-translational protein modification,BP,PRND
4320,GO:0055070,0.286512498824121,1,1,1,copper ion homeostasis,BP,PRND
143,GO:0001771,0.286558023656377,1,1,1,immunological synapse formation,BP,MSN
182,GO:0001931,0.286558023656377,1,1,1,uropod,CC,MSN
491,GO:0003725,0.286558023656377,1,1,1,double-stranded RNA binding,MF,MSN
1272,GO:0009988,0.286558023656377,1,1,1,cell-cell recognition,BP,MSN
1897,GO:0022614,0.286558023656377,1,1,1,membrane to membrane docking,BP,MSN
2176,GO:0031254,0.286558023656377,1,1,1,cell trailing edge,CC,MSN
2218,GO:0031528,0.286558023656377,1,1,1,microvillus membrane,CC,MSN
2820,GO:0036010,0.286558023656377,1,1,1,protein localization to endosome,BP,MSN
3395,GO:0045022,0.286558023656377,1,1,1,early endosome to late endosome transport,BP,MSN
4946,GO:0071394,0.286558023656377,1,1,1,cellular response to testosterone stimulus,BP,MSN
5005,GO:0071800,0.286558023656377,1,1,1,podosome assembly,BP,MSN
5006,GO:0071801,0.286558023656377,1,1,1,regulation of podosome assembly,BP,MSN
5007,GO:0071803,0.286558023656377,1,1,1,positive regulation of podosome assembly,BP,MSN
5479,GO:0098927,0.286558023656377,1,1,1,vesicle-mediated transport between endosomal compartments,BP,MSN
5755,GO:1902946,0.286558023656377,1,1,1,protein localization to early endosome,BP,MSN
5756,GO:1902965,0.286558023656377,1,1,1,regulation of protein localization to early endosome,BP,MSN
5757,GO:1902966,0.286558023656377,1,1,1,positive regulation of protein localization to early endosome,BP,MSN
5836,GO:1903649,0.286558023656377,1,1,1,regulation of cytoplasmic transport,BP,MSN
5837,GO:1903651,0.286558023656377,1,1,1,positive regulation of cytoplasmic transport,BP,MSN
5959,GO:1905666,0.286558023656377,1,1,1,regulation of protein localization to endosome,BP,MSN
5960,GO:1905668,0.286558023656377,1,1,1,positive regulation of protein localization to endosome,BP,MSN
6108,GO:2000641,0.286558023656377,1,1,1,regulation of early endosome to late endosome transport,BP,MSN
6109,GO:2000643,0.286558023656377,1,1,1,positive regulation of early endosome to late endosome transport,BP,MSN
291,GO:0002429,0.28997180127829,0.910057679497953,3,7,immune response-activating cell surface receptor signaling pathway,BP,PIK3R1;PRKACB;PDE4B
353,GO:0002768,0.28997180127829,0.910057679497953,3,7,immune response-regulating cell surface receptor signaling pathway,BP,PIK3R1;PRKACB;PDE4B
5269,GO:0090150,0.290445482988181,0.863996503824439,6,16,establishment of protein localization to membrane,BP,ACTN2;REEP1;PIK3R1;GAS6;LAMA5;ITGA3
1962,GO:0030162,0.29089761844972,0.884156510200297,4,12,regulation of proteolysis,BP,GAS6;PRKACB;SERPINA5;CTGF
910,GO:0006977,0.291334226130679,0.975451200482542,1,2,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,BP,CDKN1A
2222,GO:0031571,0.291334226130679,0.975451200482542,1,2,mitotic G1 DNA damage checkpoint,BP,CDKN1A
3377,GO:0044783,0.291334226130679,0.975451200482542,1,2,G1 DNA damage checkpoint,BP,CDKN1A
3384,GO:0044819,0.291334226130679,0.975451200482542,1,2,mitotic G1/S transition checkpoint,BP,CDKN1A
5013,GO:0071850,0.291334226130679,0.975451200482542,1,2,mitotic cell cycle arrest,BP,CDKN1A
5167,GO:0072395,0.291334226130679,0.975451200482542,1,2,signal transduction involved in cell cycle checkpoint,BP,CDKN1A
5168,GO:0072401,0.291334226130679,0.975451200482542,1,2,signal transduction involved in DNA integrity checkpoint,BP,CDKN1A
5169,GO:0072413,0.291334226130679,0.975451200482542,1,2,signal transduction involved in mitotic cell cycle checkpoint,BP,CDKN1A
5170,GO:0072422,0.291334226130679,0.975451200482542,1,2,signal transduction involved in DNA damage checkpoint,BP,CDKN1A
5171,GO:0072431,0.291334226130679,0.975451200482542,1,2,signal transduction involved in mitotic G1 DNA damage checkpoint,BP,CDKN1A
5700,GO:1902400,0.291334226130679,0.975451200482542,1,2,intracellular signal transduction involved in G1 DNA damage checkpoint,BP,CDKN1A
5701,GO:1902402,0.291334226130679,0.975451200482542,1,2,signal transduction involved in mitotic DNA damage checkpoint,BP,CDKN1A
5702,GO:1902403,0.291334226130679,0.975451200482542,1,2,signal transduction involved in mitotic DNA integrity checkpoint,BP,CDKN1A
5741,GO:1902807,0.291334226130679,0.975451200482542,1,2,negative regulation of cell cycle G1/S phase transition,BP,CDKN1A
6045,GO:2000134,0.291334226130679,0.975451200482542,1,2,negative regulation of G1/S transition of mitotic cell cycle,BP,CDKN1A
1971,GO:0030183,0.291509826408143,0.940211928381567,2,4,B cell differentiation,BP,PIK3R1;DLL1
5843,GO:1903708,0.29240751633301,0.939889907867248,2,4,positive regulation of hemopoiesis,BP,KITLG;GAS6
5372,GO:0097193,0.293339322742918,0.931688662646696,2,5,intrinsic apoptotic signaling pathway,BP,CDKN1A;PIK3R1
2150,GO:0031099,0.293702301971583,0.903813002999359,3,8,regeneration,BP,CDKN1A;GAS6;CLDN1
1458,GO:0014031,0.296458119816823,0.906873768423037,3,7,mesenchymal cell development,BP,NRTN;KITLG;LAMA5
1930,GO:0030031,0.296960641644093,0.88593748022316,4,10,cell projection assembly,BP,ACTN2;LAMA5;MARK4;ESPN
6037,GO:2000106,0.297041779834092,0.938213701297712,2,4,regulation of leukocyte apoptotic process,BP,KITLG;GAS6
1054,GO:0007605,0.297302522094572,0.906455714021711,3,7,sensory perception of sound,BP,MYO7A;SLC52A3;ESPN
4047,GO:0050954,0.297302522094572,0.906455714021711,3,7,sensory perception of mechanical stimulus,BP,MYO7A;SLC52A3;ESPN
3238,GO:0043627,0.297433095576326,0.974309457619921,1,2,response to estrogen,BP,DHH
3368,GO:0044764,0.29855920079392,0.867901852081893,5,14,multi-organism cellular process,BP,MFGE8;PIK3R1;GAS6;ITGB5;CLDN1
2361,GO:0032355,0.298877380906416,0.924509446849567,2,6,response to estradiol,BP,DHH;CTGF
5486,GO:0099080,0.299418084144243,0.855033996768142,6,18,supramolecular complex,CC,ACTN2;CAMSAP3;SDC4;FHOD3;ESPN;PDE4B
5487,GO:0099081,0.299418084144243,0.855033996768142,6,18,supramolecular polymer,CC,ACTN2;CAMSAP3;SDC4;FHOD3;ESPN;PDE4B
5494,GO:0099512,0.299418084144243,0.855033996768142,6,18,supramolecular fiber,CC,ACTN2;CAMSAP3;SDC4;FHOD3;ESPN;PDE4B
498,GO:0004112,0.29959599353442,1,1,1,cyclic-nucleotide phosphodiesterase activity,MF,PDE4B
499,GO:0004114,0.29959599353442,1,1,1,3',5'-cyclic-nucleotide phosphodiesterase activity,MF,PDE4B
500,GO:0004115,0.29959599353442,1,1,1,3',5'-cyclic-AMP phosphodiesterase activity,MF,PDE4B
752,GO:0006195,0.29959599353442,1,1,1,purine nucleotide catabolic process,BP,PDE4B
753,GO:0006198,0.29959599353442,1,1,1,cAMP catabolic process,BP,PDE4B
1186,GO:0009154,0.29959599353442,1,1,1,purine ribonucleotide catabolic process,BP,PDE4B
1189,GO:0009166,0.29959599353442,1,1,1,nucleotide catabolic process,BP,PDE4B
1197,GO:0009214,0.29959599353442,1,1,1,cyclic nucleotide catabolic process,BP,PDE4B
1201,GO:0009261,0.29959599353442,1,1,1,ribonucleotide catabolic process,BP,PDE4B
2424,GO:0032623,0.29959599353442,1,1,1,interleukin-2 production,BP,PDE4B
2436,GO:0032663,0.29959599353442,1,1,1,regulation of interleukin-2 production,BP,PDE4B
2453,GO:0032743,0.29959599353442,1,1,1,positive regulation of interleukin-2 production,BP,PDE4B
3622,GO:0046434,0.29959599353442,1,1,1,organophosphate catabolic process,BP,PDE4B
5015,GO:0071867,0.29959599353442,1,1,1,response to monoamine,BP,PDE4B
5016,GO:0071868,0.29959599353442,1,1,1,cellular response to monoamine stimulus,BP,PDE4B
5017,GO:0071869,0.29959599353442,1,1,1,response to catecholamine,BP,PDE4B
5018,GO:0071870,0.29959599353442,1,1,1,cellular response to catecholamine stimulus,BP,PDE4B
5019,GO:0071871,0.29959599353442,1,1,1,response to epinephrine,BP,PDE4B
5020,GO:0071872,0.29959599353442,1,1,1,cellular response to epinephrine stimulus,BP,PDE4B
5182,GO:0072523,0.29959599353442,1,1,1,purine-containing compound catabolic process,BP,PDE4B
5572,GO:1901078,0.29959599353442,1,1,1,negative regulation of relaxation of muscle,BP,PDE4B
5588,GO:1901292,0.29959599353442,1,1,1,nucleoside phosphate catabolic process,BP,PDE4B
5600,GO:1901385,0.29959599353442,1,1,1,regulation of voltage-gated calcium channel activity,BP,PDE4B
5642,GO:1901841,0.29959599353442,1,1,1,regulation of high voltage-gated calcium channel activity,BP,PDE4B
5652,GO:1901898,0.29959599353442,1,1,1,negative regulation of relaxation of cardiac muscle,BP,PDE4B
1615,GO:0016324,0.300005916003129,0.869188049380735,5,13,apical plasma membrane,CC,MYO7A;SLC52A3;DLL1;CLDN1;MSN
1994,GO:0030260,0.300084706601807,0.905072461494203,3,7,entry into host cell,BP,GAS6;ITGB5;CLDN1
3317,GO:0044409,0.300084706601807,0.905072461494203,3,7,entry into host,BP,GAS6;ITGB5;CLDN1
4242,GO:0051701,0.300084706601807,0.905072461494203,3,7,interaction with host,BP,GAS6;ITGB5;CLDN1
4258,GO:0051806,0.300084706601807,0.905072461494203,3,7,entry into cell of other organism involved in symbiotic interaction,BP,GAS6;ITGB5;CLDN1
4259,GO:0051828,0.300084706601807,0.905072461494203,3,7,entry into other organism involved in symbiotic interaction,BP,GAS6;ITGB5;CLDN1
1270,GO:0009986,0.300151315910787,0.831355057985328,9,30,cell surface,CC,RHOB;MFGE8;SDC4;MPZL1;ITGB5;ITGB8;SERPINA5;ITGA3;MSN
5956,GO:1905477,0.302503689825224,0.936208339753566,2,4,positive regulation of protein localization to membrane,BP,PIK3R1;ITGA3
4152,GO:0051260,0.303062282485139,0.903582154208749,3,7,protein homooligomerization,BP,ACTN2;PRND;CLDN1
1879,GO:0022402,0.303091801069148,0.833439884063863,8,29,cell cycle process,BP,CDKN1A;RHOB;PHLDA1;GAS6;HMGN5;FOXO4;MARK4;CTGF
1306,GO:0010466,0.303535531141714,0.927525120073835,2,5,negative regulation of peptidase activity,BP,GAS6;SERPINA5
1435,GO:0010951,0.303535531141714,0.927525120073835,2,5,negative regulation of endopeptidase activity,BP,GAS6;SERPINA5
3560,GO:0045861,0.303535531141714,0.927525120073835,2,5,negative regulation of proteolysis,BP,GAS6;SERPINA5
1265,GO:0009954,0.304561503273739,0.972935425991641,1,2,proximal/distal pattern formation,BP,DLL1
5252,GO:0090068,0.304656366604564,0.894763135482076,3,9,positive regulation of cell cycle process,BP,CDKN1A;FOXO4;CTGF
1882,GO:0022406,0.306081029621817,0.926466736081393,2,5,membrane docking,BP,MARK4;MSN
885,GO:0006909,0.306858590656029,0.877143894708086,4,11,phagocytosis,BP,MYO7A;MFGE8;PIK3R1;GAS6
933,GO:0007049,0.307429289624913,0.824373969489938,9,33,cell cycle,BP,CDKN1A;RHOB;PHLDA1;GAS6;PRKACB;HMGN5;FOXO4;MARK4;CTGF
3444,GO:0045216,0.307593033801372,0.860313017271078,5,15,cell-cell junction organization,BP,ACTN2;CAMSAP3;LAMA5;SDC4;CLDN1
518,GO:0004690,0.308513643539262,1,1,1,cyclic nucleotide-dependent protein kinase activity,MF,PRKACB
519,GO:0004691,0.308513643539262,1,1,1,cAMP-dependent protein kinase activity,MF,PRKACB
3562,GO:0045879,0.308513643539262,1,1,1,negative regulation of smoothened signaling pathway,BP,PRKACB
4588,GO:0060831,0.308513643539262,1,1,1,smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,PRKACB
4846,GO:0070613,0.308513643539262,1,1,1,regulation of protein processing,BP,PRKACB
5385,GO:0097338,0.308513643539262,1,1,1,response to clozapine,BP,PRKACB
5619,GO:1901620,0.308513643539262,1,1,1,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,PRKACB
5620,GO:1901621,0.308513643539262,1,1,1,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,PRKACB
5792,GO:1903317,0.308513643539262,1,1,1,regulation of protein maturation,BP,PRKACB
1147,GO:0008585,0.310651789751617,0.933156405268214,2,4,female gonad development,BP,KITLG;WT1
3640,GO:0046545,0.310651789751617,0.933156405268214,2,4,development of primary female sexual characteristics,BP,KITLG;WT1
330,GO:0002694,0.310737898816985,0.87234636893142,4,12,regulation of leukocyte activation,BP,CDKN1A;PIK3R1;GAS6;SDC4
1409,GO:0010861,0.31086529925427,1,1,1,thyroid hormone receptor activator activity,MF,ACTN2
1932,GO:0030035,0.31086529925427,1,1,1,microspike assembly,BP,ACTN2
1995,GO:0030274,0.31086529925427,1,1,1,LIM domain binding,MF,ACTN2
2022,GO:0030375,0.31086529925427,1,1,1,thyroid hormone receptor coactivator activity,MF,ACTN2
2095,GO:0030836,0.31086529925427,1,1,1,positive regulation of actin filament depolymerization,BP,ACTN2
2209,GO:0031432,0.31086529925427,1,1,1,titin binding,MF,ACTN2
2376,GO:0032411,0.31086529925427,1,1,1,positive regulation of transporter activity,BP,ACTN2
2379,GO:0032414,0.31086529925427,1,1,1,positive regulation of ion transmembrane transporter activity,BP,ACTN2
2882,GO:0038166,0.31086529925427,1,1,1,angiotensin-activated signaling pathway,BP,ACTN2
3130,GO:0043243,0.31086529925427,1,1,1,positive regulation of protein complex disassembly,BP,ACTN2
4154,GO:0051262,0.31086529925427,1,1,1,protein tetramerization,BP,ACTN2
4164,GO:0051289,0.31086529925427,1,1,1,protein homotetramerization,BP,ACTN2
4183,GO:0051373,0.31086529925427,1,1,1,FATZ binding,MF,ACTN2
4241,GO:0051695,0.31086529925427,1,1,1,actin filament uncapping,BP,ACTN2
4763,GO:0070080,0.31086529925427,1,1,1,titin Z domain binding,MF,ACTN2
5235,GO:0086097,0.31086529925427,1,1,1,phospholipase C-activating angiotensin-activated signaling pathway,BP,ACTN2
5564,GO:1901018,0.31086529925427,1,1,1,positive regulation of potassium ion transmembrane transporter activity,BP,ACTN2
5648,GO:1901881,0.31086529925427,1,1,1,positive regulation of protein depolymerization,BP,ACTN2
5889,GO:1904385,0.31086529925427,1,1,1,cellular response to angiotensin,BP,ACTN2
5998,GO:1990776,0.31086529925427,1,1,1,response to angiotensin,BP,ACTN2
6014,GO:2000008,0.31086529925427,1,1,1,regulation of protein localization to cell surface,BP,ACTN2
6015,GO:2000009,0.31086529925427,1,1,1,negative regulation of protein localization to cell surface,BP,ACTN2
6161,GO:2001135,0.31086529925427,1,1,1,regulation of endocytic recycling,BP,ACTN2
6162,GO:2001137,0.31086529925427,1,1,1,positive regulation of endocytic recycling,BP,ACTN2
6181,GO:2001259,0.31086529925427,1,1,1,positive regulation of cation channel activity,BP,ACTN2
90,GO:0001516,0.311617194107011,0.971532804946126,1,2,prostaglandin biosynthetic process,BP,PTGES
811,GO:0006633,0.311617194107011,0.971532804946126,1,2,fatty acid biosynthetic process,BP,PTGES
813,GO:0006636,0.311617194107011,0.971532804946126,1,2,unsaturated fatty acid biosynthetic process,BP,PTGES
826,GO:0006690,0.311617194107011,0.971532804946126,1,2,icosanoid metabolic process,BP,PTGES
827,GO:0006692,0.311617194107011,0.971532804946126,1,2,prostanoid metabolic process,BP,PTGES
828,GO:0006693,0.311617194107011,0.971532804946126,1,2,prostaglandin metabolic process,BP,PTGES
1584,GO:0016053,0.311617194107011,0.971532804946126,1,2,organic acid biosynthetic process,BP,PTGES
2571,GO:0033559,0.311617194107011,0.971532804946126,1,2,unsaturated fatty acid metabolic process,BP,PTGES
3618,GO:0046394,0.311617194107011,0.971532804946126,1,2,carboxylic acid biosynthetic process,BP,PTGES
3623,GO:0046456,0.311617194107011,0.971532804946126,1,2,icosanoid biosynthetic process,BP,PTGES
3624,GO:0046457,0.311617194107011,0.971532804946126,1,2,prostanoid biosynthetic process,BP,PTGES
5161,GO:0072330,0.311617194107011,0.971532804946126,1,2,monocarboxylic acid biosynthetic process,BP,PTGES
5610,GO:1901568,0.311617194107011,0.971532804946126,1,2,fatty acid derivative metabolic process,BP,PTGES
5611,GO:1901570,0.311617194107011,0.971532804946126,1,2,fatty acid derivative biosynthetic process,BP,PTGES
492,GO:0003774,0.311666791671058,0.949764374392195,2,3,motor activity,MF,MYO7A;CGN
1634,GO:0016459,0.311666791671058,0.949764374392195,2,3,myosin complex,CC,MYO7A;CGN
3531,GO:0045766,0.311702075837786,0.932757727368885,2,4,positive regulation of angiogenesis,BP,RHOB;DLL1
1076,GO:0008047,0.312835482401631,0.893809222474473,3,8,enzyme activator activity,MF,CDKN1A;GAS6;RIN3
5509,GO:0101002,0.313067724957109,1,1,1,ficolin-1-rich granule,CC,CRISPLD2
5907,GO:1904813,0.313067724957109,1,1,1,ficolin-1-rich granule lumen,CC,CRISPLD2
3315,GO:0044403,0.31577745482267,0.856930366639521,5,14,symbiosis, encompassing mutualism through parasitism,BP,MFGE8;PIK3R1;GAS6;ITGB5;CLDN1
3318,GO:0044419,0.31577745482267,0.856930366639521,5,14,interspecies interaction between organisms,BP,MFGE8;PIK3R1;GAS6;ITGB5;CLDN1
988,GO:0007264,0.315893136903728,0.85191268837467,5,17,small GTPase mediated signal transduction,BP,CDKN1A;RHOB;KITLG;RHOJ;ITGA3
1804,GO:0019901,0.316299587636815,0.85466113501584,5,15,protein kinase binding,MF,CDKN1A;PIK3R1;GAS6;SDC4;MSN
3919,GO:0048856,0.316411575008339,0.782849416193153,36,133,anatomical structure development,BP,LAMA1;ACTN2;MYO7A;CDKN1A;NRTN;DKK3;RHOB;KITLG;RHOJ;MFGE8;CAMSAP3;CLDN11;PIK3R1;GAS6;LAMA5;SDC4;ITGB5;SEMA6C;PRKACB;ITGB8;SERPINA5;ACSL4;CRISPLD2;FHOD3;FOXO4;DHH;GPSM1;MARK4;DAAM2;DLL1;UNC119;CLDN1;CTGF;ITGA3;WT1;MSN
1392,GO:0010811,0.31668627849666,0.930849229468719,2,4,positive regulation of cell-substrate adhesion,BP,SDC4;ITGA3
322,GO:0002682,0.316757927619498,0.819081307038183,9,30,regulation of immune system process,BP,CDKN1A;KITLG;PIK3R1;GAS6;SDC4;PRKACB;DLL1;PDE4B;MSN
5176,GO:0072509,0.317175224771972,0.970397626063653,1,2,divalent inorganic cation transmembrane transporter activity,MF,GAS6
2114,GO:0030888,0.318439221558086,0.970135702849896,1,2,regulation of B cell proliferation,BP,CDKN1A
2115,GO:0030890,0.318439221558086,0.970135702849896,1,2,positive regulation of B cell proliferation,BP,CDKN1A
2924,GO:0042100,0.318439221558086,0.970135702849896,1,2,B cell proliferation,BP,CDKN1A
4012,GO:0050864,0.318439221558086,0.970135702849896,1,2,regulation of B cell activation,BP,CDKN1A
4018,GO:0050871,0.318439221558086,0.970135702849896,1,2,positive regulation of B cell activation,BP,CDKN1A
325,GO:0002685,0.318459549270896,0.890786555260861,3,8,regulation of leukocyte migration,BP,KITLG;GAS6;MSN
4535,GO:0060606,0.320001275062727,0.920543827668802,2,5,tube closure,BP,SDC4;PRKACB
3574,GO:0045930,0.320032295385057,0.915049649494162,2,6,negative regulation of mitotic cell cycle,BP,CDKN1A;FOXO4
2006,GO:0030308,0.320113961867776,0.889890251954197,3,8,negative regulation of cell growth,BP,CDKN1A;WT1;SH3BP4
85,GO:0001502,0.321214077101762,0.96955577637828,1,2,cartilage condensation,BP,CTGF
5449,GO:0098743,0.321214077101762,0.96955577637828,1,2,cell aggregation,BP,CTGF
1072,GO:0008021,0.322270499560204,0.914016684486518,2,6,synaptic vesicle,CC,TMEM163;PDE4B
2311,GO:0032182,0.325767952002885,1,1,1,ubiquitin-like protein binding,MF,MARK4
3092,GO:0043130,0.325767952002885,1,1,1,ubiquitin binding,MF,MARK4
3932,GO:0050321,0.325767952002885,1,1,1,tau-protein kinase activity,MF,MARK4
5412,GO:0097711,0.325767952002885,1,1,1,ciliary basal body docking,BP,MARK4
5163,GO:0072332,0.326345679399513,0.968465350253125,1,2,intrinsic apoptotic signaling pathway by p53 class mediator,BP,CDKN1A
404,GO:0003159,0.326485787246476,0.968435249566322,1,2,morphogenesis of an endothelium,BP,RHOB
4674,GO:0061154,0.326485787246476,0.968435249566322,1,2,endothelial tube morphogenesis,BP,RHOB
683,GO:0005865,0.3269468492797,1,1,1,striated muscle thin filament,CC,FHOD3
2850,GO:0036379,0.3269468492797,1,1,1,myofilament,CC,FHOD3
4229,GO:0051639,0.3269468492797,1,1,1,actin filament network formation,BP,FHOD3
4300,GO:0055003,0.3269468492797,1,1,1,cardiac myofibril assembly,BP,FHOD3
2026,GO:0030426,0.327441688059484,1,1,1,growth cone,CC,ITGA3
2027,GO:0030427,0.327441688059484,1,1,1,site of polarized growth,CC,ITGA3
2656,GO:0034667,0.327441688059484,1,1,1,integrin alpha3-beta1 complex,CC,ITGA3
2682,GO:0035023,0.327441688059484,1,1,1,regulation of Rho protein signal transduction,BP,ITGA3
2683,GO:0035024,0.327441688059484,1,1,1,negative regulation of Rho protein signal transduction,BP,ITGA3
2759,GO:0035640,0.327441688059484,1,1,1,exploration behavior,BP,ITGA3
3127,GO:0043236,0.327441688059484,1,1,1,laminin binding,MF,ITGA3
3644,GO:0046580,0.327441688059484,1,1,1,negative regulation of Ras protein signal transduction,BP,ITGA3
4005,GO:0050840,0.327441688059484,1,1,1,extracellular matrix binding,MF,ITGA3
4077,GO:0051058,0.327441688059484,1,1,1,negative regulation of small GTPase mediated signal transduction,BP,ITGA3
4954,GO:0071437,0.327441688059484,1,1,1,invadopodium,CC,ITGA3
4955,GO:0071438,0.327441688059484,1,1,1,invadopodium membrane,CC,ITGA3
5346,GO:0097062,0.327441688059484,1,1,1,dendritic spine maintenance,BP,ITGA3
3926,GO:0048871,0.328343278348008,0.861490883848682,4,12,multicellular organismal homeostasis,BP,PRKACB;DLL1;CLDN1;CTGF
1042,GO:0007584,0.328591838623647,0.926179056856204,2,4,response to nutrient,BP,GAS6;ACSL4
3372,GO:0044770,0.330764307631764,0.880281525840476,3,9,cell cycle phase transition,BP,CDKN1A;PHLDA1;FOXO4
3373,GO:0044772,0.330764307631764,0.880281525840476,3,9,mitotic cell cycle phase transition,BP,CDKN1A;PHLDA1;FOXO4
5635,GO:1901701,0.330821403807098,0.798689522053745,11,37,cellular response to oxygen-containing compound,BP,ACTN2;RHOB;PIK3R1;GAS6;PRKACB;FOXO4;PDE4B;CLDN1;WT1;MSN;SH3BP4
169,GO:0001885,0.332317535809429,0.91511112368736,2,5,endothelial cell development,BP,CLDN1;MSN
4637,GO:0061028,0.332317535809429,0.91511112368736,2,5,establishment of endothelial barrier,BP,CLDN1;MSN
5632,GO:1901698,0.333080615858524,0.80746013985406,9,29,response to nitrogen compound,BP,ACTN2;CDKN1A;PIK3R1;PRKACB;FOXO4;PDE4B;CTGF;WT1;SH3BP4
3083,GO:0043086,0.333270872216502,0.841683573151108,5,16,negative regulation of catalytic activity,BP,CDKN1A;CAMSAP3;GAS6;SERPINA5;SH3BP4
2128,GO:0030971,0.33379775351719,0.924087124630644,2,4,receptor tyrosine kinase binding,MF,PIK3R1;GAS6
6000,GO:1990782,0.33379775351719,0.924087124630644,2,4,protein tyrosine kinase binding,MF,PIK3R1;GAS6
1434,GO:0010950,0.33399613551638,0.966795901295179,1,2,positive regulation of endopeptidase activity,BP,CTGF
3146,GO:0043280,0.33399613551638,0.966795901295179,1,2,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,CTGF
6157,GO:2001056,0.33399613551638,0.966795901295179,1,2,positive regulation of cysteine-type endopeptidase activity,BP,CTGF
3761,GO:0048259,0.334050965761716,0.966783745463684,1,2,regulation of receptor-mediated endocytosis,BP,UNC119
3486,GO:0045619,0.334304784079007,0.966727438464898,1,2,regulation of lymphocyte differentiation,BP,GAS6
4730,GO:0061462,0.334829147102692,1,1,1,protein localization to lysosome,BP,SH3BP4
5202,GO:0072665,0.334829147102692,1,1,1,protein localization to vacuole,BP,SH3BP4
510,GO:0004467,0.335126056587303,1,1,1,long-chain fatty acid-CoA ligase activity,MF,ACSL4
663,GO:0005777,0.335126056587303,1,1,1,peroxisome,CC,ACSL4
664,GO:0005778,0.335126056587303,1,1,1,peroxisomal membrane,CC,ACSL4
676,GO:0005811,0.335126056587303,1,1,1,lipid particle,CC,ACSL4
814,GO:0006637,0.335126056587303,1,1,1,acyl-CoA metabolic process,BP,ACSL4
1173,GO:0009108,0.335126056587303,1,1,1,coenzyme biosynthetic process,BP,ACSL4
1541,GO:0015645,0.335126056587303,1,1,1,fatty acid ligase activity,MF,ACSL4
1687,GO:0016874,0.335126056587303,1,1,1,ligase activity,MF,ACSL4
1688,GO:0016877,0.335126056587303,1,1,1,ligase activity, forming carbon-sulfur bonds,MF,ACSL4
1689,GO:0016878,0.335126056587303,1,1,1,acid-thiol ligase activity,MF,ACSL4
2257,GO:0031903,0.335126056587303,1,1,1,microbody membrane,CC,ACSL4
2269,GO:0031957,0.335126056587303,1,1,1,very long-chain fatty acid-CoA ligase activity,MF,ACSL4
2729,GO:0035336,0.335126056587303,1,1,1,long-chain fatty-acyl-CoA metabolic process,BP,ACSL4
2730,GO:0035337,0.335126056587303,1,1,1,fatty-acyl-CoA metabolic process,BP,ACSL4
2731,GO:0035338,0.335126056587303,1,1,1,long-chain fatty-acyl-CoA biosynthetic process,BP,ACSL4
2732,GO:0035383,0.335126056587303,1,1,1,thioester metabolic process,BP,ACSL4
2733,GO:0035384,0.335126056587303,1,1,1,thioester biosynthetic process,BP,ACSL4
3013,GO:0042579,0.335126056587303,1,1,1,microbody,CC,ACSL4
3332,GO:0044438,0.335126056587303,1,1,1,microbody part,CC,ACSL4
3333,GO:0044439,0.335126056587303,1,1,1,peroxisomal part,CC,ACSL4
3711,GO:0046949,0.335126056587303,1,1,1,fatty-acyl-CoA biosynthetic process,BP,ACSL4
3719,GO:0047676,0.335126056587303,1,1,1,arachidonate-CoA ligase activity,MF,ACSL4
4117,GO:0051188,0.335126056587303,1,1,1,cofactor biosynthetic process,BP,ACSL4
4386,GO:0060136,0.335126056587303,1,1,1,embryonic process involved in female pregnancy,BP,ACSL4
4859,GO:0070672,0.335126056587303,1,1,1,response to interleukin-15,BP,ACSL4
4977,GO:0071616,0.335126056587303,1,1,1,acyl-CoA biosynthetic process,BP,ACSL4
5511,GO:0102391,0.335126056587303,1,1,1,decanoate--CoA ligase activity,MF,ACSL4
3381,GO:0044802,0.335662691570573,0.818762780760367,7,23,single-organism membrane organization,BP,ACTN2;REEP1;PIK3R1;GAS6;LAMA5;SERPINA5;ITGA3
810,GO:0006631,0.337743182886957,0.91265994318136,2,5,fatty acid metabolic process,BP,ACSL4;PTGES
2014,GO:0030325,0.338408437648047,0.912356941522686,2,5,adrenal gland development,BP,DKK3;WT1
1051,GO:0007601,0.339521515022705,0.921751771442399,2,4,visual perception,BP,MYO7A;UNC119
4046,GO:0050953,0.339521515022705,0.921751771442399,2,4,sensory perception of light stimulus,BP,MYO7A;UNC119
5512,GO:0120025,0.339573245361569,0.789009997428524,12,38,plasma membrane bounded cell projection,CC,ACTN2;MYO7A;NRTN;KITLG;PLEKHH2;PRKACB;RAB39B;MARK4;ESPN;PDE4B;ITGA3;MSN
2504,GO:0032945,0.339693291686493,0.965518163000803,1,2,negative regulation of mononuclear cell proliferation,BP,SDC4
2932,GO:0042129,0.339693291686493,0.965518163000803,1,2,regulation of T cell proliferation,BP,SDC4
2933,GO:0042130,0.339693291686493,0.965518163000803,1,2,negative regulation of T cell proliferation,BP,SDC4
3939,GO:0050672,0.339693291686493,0.965518163000803,1,2,negative regulation of lymphocyte proliferation,BP,SDC4
4016,GO:0050868,0.339693291686493,0.965518163000803,1,2,negative regulation of T cell activation,BP,SDC4
4855,GO:0070664,0.339693291686493,0.965518163000803,1,2,negative regulation of leukocyte proliferation,BP,SDC4
5767,GO:1903038,0.339693291686493,0.965518163000803,1,2,negative regulation of leukocyte cell-cell adhesion,BP,SDC4
1929,GO:0030030,0.339747388874663,0.788871672938087,12,38,cell projection organization,BP,ACTN2;MYO7A;NRTN;CAMSAP3;PIK3R1;LAMA5;SDC4;SEMA6C;ACSL4;MARK4;ESPN;ITGA3
3591,GO:0045989,0.340265297210041,0.965388229881224,1,2,positive regulation of striated muscle contraction,BP,CTGF
4485,GO:0060452,0.340265297210041,0.965388229881224,1,2,positive regulation of cardiac muscle contraction,BP,CTGF
614,GO:0005516,0.341263365429028,0.921033693246325,2,4,calmodulin binding,MF,MYO7A;CAMSAP3
5237,GO:0090002,0.341446900871109,0.842508117325643,5,13,establishment of protein localization to plasma membrane,BP,ACTN2;PIK3R1;GAS6;LAMA5;ITGA3
578,GO:0005173,0.342087464520772,1,1,1,stem cell factor receptor binding,MF,KITLG
1342,GO:0010623,0.342087464520772,1,1,1,programmed cell death involved in cell development,BP,KITLG
2522,GO:0033023,0.342087464520772,1,1,1,mast cell homeostasis,BP,KITLG
2523,GO:0033024,0.342087464520772,1,1,1,mast cell apoptotic process,BP,KITLG
2524,GO:0033025,0.342087464520772,1,1,1,regulation of mast cell apoptotic process,BP,KITLG
2525,GO:0033026,0.342087464520772,1,1,1,negative regulation of mast cell apoptotic process,BP,KITLG
2526,GO:0033028,0.342087464520772,1,1,1,myeloid cell apoptotic process,BP,KITLG
2527,GO:0033032,0.342087464520772,1,1,1,regulation of myeloid cell apoptotic process,BP,KITLG
2528,GO:0033033,0.342087464520772,1,1,1,negative regulation of myeloid cell apoptotic process,BP,KITLG
2708,GO:0035234,0.342087464520772,1,1,1,ectopic germ cell programmed cell death,BP,KITLG
3491,GO:0045634,0.342087464520772,1,1,1,regulation of melanocyte differentiation,BP,KITLG
3492,GO:0045636,0.342087464520772,1,1,1,positive regulation of melanocyte differentiation,BP,KITLG
3738,GO:0048070,0.342087464520772,1,1,1,regulation of developmental pigmentation,BP,KITLG
3739,GO:0048087,0.342087464520772,1,1,1,positive regulation of developmental pigmentation,BP,KITLG
4043,GO:0050932,0.342087464520772,1,1,1,regulation of pigment cell differentiation,BP,KITLG
4044,GO:0050942,0.342087464520772,1,1,1,positive regulation of pigment cell differentiation,BP,KITLG
4853,GO:0070662,0.342087464520772,1,1,1,mast cell proliferation,BP,KITLG
4857,GO:0070666,0.342087464520772,1,1,1,regulation of mast cell proliferation,BP,KITLG
4858,GO:0070668,0.342087464520772,1,1,1,positive regulation of mast cell proliferation,BP,KITLG
5667,GO:1902033,0.342087464520772,1,1,1,regulation of hematopoietic stem cell proliferation,BP,KITLG
5668,GO:1902035,0.342087464520772,1,1,1,positive regulation of hematopoietic stem cell proliferation,BP,KITLG
3105,GO:0043197,0.342437986539564,0.920547502272031,2,4,dendritic spine,CC,ACTN2;PDE4B
3300,GO:0044309,0.342437986539564,0.920547502272031,2,4,neuron spine,CC,ACTN2;PDE4B
4512,GO:0060548,0.342830473498933,0.797493142768508,9,33,negative regulation of cell death,BP,CDKN1A;KITLG;NUAK2;PIK3R1;GAS6;HMGN5;DLL1;CTGF;WT1
868,GO:0006869,0.343491732456171,0.910023886533437,2,5,lipid transport,BP,SERPINA5;ACSL4
1414,GO:0010876,0.343491732456171,0.910023886533437,2,5,lipid localization,BP,SERPINA5;ACSL4
5471,GO:0098862,0.344223589272922,0.919805397933382,2,4,cluster of actin-based cell projections,CC,MYO7A;ESPN
5614,GO:1901576,0.344576904601219,0.765538572144338,19,72,organic substance biosynthetic process,BP,ACTN2;CDKN1A;HMGCS2;DKK3;KITLG;PRND;PHLDA1;PIK3R1;GAS6;SDC4;HMGN5;ACSL4;FOXO4;DHH;DLL1;CTGF;ITGA3;WT1;PTGES
5673,GO:1902105,0.347078037913614,0.874821516245955,3,8,regulation of leukocyte differentiation,BP,KITLG;PIK3R1;GAS6
1803,GO:0019900,0.347874463568772,0.83166595402104,5,16,kinase binding,MF,CDKN1A;PIK3R1;GAS6;SDC4;MSN
327,GO:0002687,0.348567761316979,0.907662653120583,2,5,positive regulation of leukocyte migration,BP,KITLG;GAS6
3151,GO:0043297,0.348846905620481,0.963402421318022,1,2,apical junction assembly,BP,CLDN1
4870,GO:0070830,0.348846905620481,0.963402421318022,1,2,bicellular tight junction assembly,BP,CLDN1
4225,GO:0051604,0.348976683555379,0.907471057008519,2,5,protein maturation,BP,GAS6;PRKACB
1203,GO:0009267,0.349185832390433,0.869569797706402,3,9,cellular response to starvation,BP,CDKN1A;NUAK2;GAS6
3021,GO:0042594,0.349185832390433,0.869569797706402,3,9,response to starvation,BP,CDKN1A;NUAK2;GAS6
875,GO:0006886,0.350259070784754,0.831826270770543,5,15,intracellular protein transport,BP,MYO7A;CDKN1A;RHOB;PIK3R1;GAS6
1888,GO:0022412,0.35215389820879,0.864708355192562,3,10,cellular process involved in reproduction in multicellular organism,BP,SERPINA5;DHH;WT1
2235,GO:0031647,0.352324691650677,0.905894637607557,2,5,regulation of protein stability,BP,CDKN1A;PIK3R1
1548,GO:0015711,0.353408770121567,0.905381231263303,2,5,organic anion transport,BP,SLC52A3;ACSL4
3331,GO:0044437,0.354039503713746,0.90508185472626,2,5,vacuolar part,CC,MYO7A;SDC4
1088,GO:0008134,0.355088080881318,0.870176535101576,3,8,transcription factor binding,MF,PIK3R1;FOXO4;DLL1
1148,GO:0008589,0.355280767080655,0.961868214148622,1,2,regulation of smoothened signaling pathway,BP,PRKACB
196,GO:0001953,0.355338933962599,1,1,1,negative regulation of cell-matrix adhesion,BP,PIK3R1
550,GO:0005068,0.355338933962599,1,1,1,transmembrane receptor protein tyrosine kinase adaptor activity,MF,PIK3R1
570,GO:0005158,0.355338933962599,1,1,1,insulin receptor binding,MF,PIK3R1
571,GO:0005159,0.355338933962599,1,1,1,insulin-like growth factor receptor binding,MF,PIK3R1
574,GO:0005165,0.355338933962599,1,1,1,neurotrophin receptor binding,MF,PIK3R1
575,GO:0005167,0.355338933962599,1,1,1,neurotrophin TRK receptor binding,MF,PIK3R1
576,GO:0005168,0.355338933962599,1,1,1,neurotrophin TRKA receptor binding,MF,PIK3R1
913,GO:0006986,0.355338933962599,1,1,1,response to unfolded protein,BP,PIK3R1
2069,GO:0030674,0.355338933962599,1,1,1,protein binding, bridging,MF,PIK3R1
2127,GO:0030968,0.355338933962599,1,1,1,endoplasmic reticulum unfolded protein response,BP,PIK3R1
2456,GO:0032760,0.355338933962599,1,1,1,positive regulation of tumor necrosis factor production,BP,PIK3R1
2543,GO:0033120,0.355338933962599,1,1,1,positive regulation of RNA splicing,BP,PIK3R1
2644,GO:0034620,0.355338933962599,1,1,1,cellular response to unfolded protein,BP,PIK3R1
2751,GO:0035591,0.355338933962599,1,1,1,signaling adaptor activity,MF,PIK3R1
2809,GO:0035966,0.355338933962599,1,1,1,response to topologically incorrect protein,BP,PIK3R1
2810,GO:0035967,0.355338933962599,1,1,1,cellular response to topologically incorrect protein,BP,PIK3R1
2846,GO:0036312,0.355338933962599,1,1,1,phosphatidylinositol 3-kinase regulatory subunit binding,MF,PIK3R1
3091,GO:0043125,0.355338933962599,1,1,1,ErbB-3 class receptor binding,MF,PIK3R1
3189,GO:0043484,0.355338933962599,1,1,1,regulation of RNA splicing,BP,PIK3R1
3219,GO:0043559,0.355338933962599,1,1,1,insulin binding,MF,PIK3R1
3648,GO:0046626,0.355338933962599,1,1,1,regulation of insulin receptor signaling pathway,BP,PIK3R1
4208,GO:0051531,0.355338933962599,1,1,1,NFAT protein import into nucleus,BP,PIK3R1
4451,GO:0060396,0.355338933962599,1,1,1,growth hormone receptor signaling pathway,BP,PIK3R1
4939,GO:0071378,0.355338933962599,1,1,1,cellular response to growth hormone stimulus,BP,PIK3R1
5340,GO:0097038,0.355338933962599,1,1,1,perinuclear endoplasmic reticulum,CC,PIK3R1
5523,GO:1900101,0.355338933962599,1,1,1,regulation of endoplasmic reticulum unfolded protein response,BP,PIK3R1
5524,GO:1900103,0.355338933962599,1,1,1,positive regulation of endoplasmic reticulum unfolded protein response,BP,PIK3R1
5831,GO:1903557,0.355338933962599,1,1,1,positive regulation of tumor necrosis factor superfamily cytokine production,BP,PIK3R1
5994,GO:1990578,0.355338933962599,1,1,1,perinuclear endoplasmic reticulum membrane,CC,PIK3R1
2662,GO:0034698,0.355576707348066,0.915001197538571,2,4,response to gonadotropin,BP,ITGA3;WT1
2993,GO:0042490,0.355932623039282,0.875392218822942,3,7,mechanoreceptor differentiation,BP,MYO7A;SDC4;DLL1
4377,GO:0060113,0.355932623039282,0.875392218822942,3,7,inner ear receptor cell differentiation,BP,MYO7A;SDC4;DLL1
5841,GO:1903706,0.35597134592826,0.846661693168961,4,11,regulation of hemopoiesis,BP,KITLG;PIK3R1;GAS6;DLL1
3429,GO:0045177,0.356043441021338,0.830008711011781,5,14,apical part of cell,CC,MYO7A;SLC52A3;DLL1;CLDN1;MSN
323,GO:0002683,0.357028252724803,0.845975205185753,4,11,negative regulation of immune system process,BP,KITLG;PIK3R1;SDC4;DLL1
2468,GO:0032801,0.357335732349902,1,1,1,receptor catabolic process,BP,GPRASP1
3526,GO:0045744,0.357335732349902,1,1,1,negative regulation of G-protein coupled receptor protein signaling pathway,BP,GPRASP1
5981,GO:1990172,0.357335732349902,1,1,1,G-protein coupled receptor catabolic process,BP,GPRASP1
2630,GO:0034394,0.357476682227567,0.961335555388218,1,2,protein localization to cell surface,BP,ACTN2
533,GO:0004860,0.357757423386342,0.961267123112425,1,2,protein kinase inhibitor activity,MF,CDKN1A
1747,GO:0019210,0.357757423386342,0.961267123112425,1,2,kinase inhibitor activity,MF,CDKN1A
2002,GO:0030291,0.357757423386342,0.961267123112425,1,2,protein serine/threonine kinase inhibitor activity,MF,CDKN1A
221,GO:0002064,0.357773354117566,0.824742996508678,5,16,epithelial cell development,BP,MYO7A;CDKN1A;DLL1;CLDN1;MSN
3441,GO:0045210,0.358323486861638,1,1,1,FasL biosynthetic process,BP,PHLDA1
4658,GO:0061097,0.358396304872099,0.896477768549627,2,6,regulation of protein tyrosine kinase activity,BP,GAS6;UNC119
4659,GO:0061098,0.358396304872099,0.896477768549627,2,6,positive regulation of protein tyrosine kinase activity,BP,GAS6;UNC119
324,GO:0002684,0.35856024169226,0.810988767901241,6,20,positive regulation of immune system process,BP,CDKN1A;KITLG;PIK3R1;GAS6;PRKACB;PDE4B
482,GO:0003682,0.359069986394873,0.913492912783541,2,4,chromatin binding,MF,HMGN5;FOXO4
4696,GO:0061318,0.359089608704304,0.960941361671499,1,2,renal filtration cell differentiation,BP,WT1
5040,GO:0072010,0.359089608704304,0.960941361671499,1,2,glomerular epithelium development,BP,WT1
5054,GO:0072050,0.359089608704304,0.960941361671499,1,2,S-shaped body morphogenesis,BP,WT1
5088,GO:0072112,0.359089608704304,0.960941361671499,1,2,glomerular visceral epithelial cell differentiation,BP,WT1
5137,GO:0072217,0.359089608704304,0.960941361671499,1,2,negative regulation of metanephros development,BP,WT1
5151,GO:0072284,0.359089608704304,0.960941361671499,1,2,metanephric S-shaped body morphogenesis,BP,WT1
5158,GO:0072311,0.359089608704304,0.960941361671499,1,2,glomerular epithelial cell differentiation,BP,WT1
4155,GO:0051270,0.360304900084286,0.775274795056712,11,37,regulation of cellular component movement,BP,LAMA1;RHOB;KITLG;PIK3R1;GAS6;LAMA5;SDC4;FOXO4;PDE4B;ITGA3;MSN
5238,GO:0090003,0.360893225632661,0.912700032955501,2,4,regulation of establishment of protein localization to plasma membrane,BP,PIK3R1;ITGA3
5774,GO:1903076,0.360893225632661,0.912700032955501,2,4,regulation of protein localization to plasma membrane,BP,PIK3R1;ITGA3
5850,GO:1903729,0.360893225632661,0.912700032955501,2,4,regulation of plasma membrane organization,BP,PIK3R1;ITGA3
5886,GO:1904375,0.360893225632661,0.912700032955501,2,4,regulation of protein localization to cell periphery,BP,PIK3R1;ITGA3
3295,GO:0044283,0.361306102074706,0.862296688971299,3,9,small molecule biosynthetic process,BP,HMGCS2;DKK3;PTGES
2505,GO:0032946,0.364578657920884,0.9474579086209,1,3,positive regulation of mononuclear cell proliferation,BP,CDKN1A
3938,GO:0050671,0.364578657920884,0.9474579086209,1,3,positive regulation of lymphocyte proliferation,BP,CDKN1A
865,GO:0006839,0.365318139528848,0.959395494785902,1,2,mitochondrial transport,BP,SLC25A53
2419,GO:0032609,0.366051056240976,0.899286153154953,2,5,interferon-gamma production,BP,GAS6;PDE4B
2431,GO:0032649,0.366051056240976,0.899286153154953,2,5,regulation of interferon-gamma production,BP,GAS6;PDE4B
4845,GO:0070588,0.367252953792294,0.898696289633617,2,5,calcium ion transmembrane transport,BP,GAS6;PDE4B
3078,GO:0043067,0.367264494391203,0.763678241736588,12,45,regulation of programmed cell death,BP,ACTN2;CDKN1A;RHOB;KITLG;NUAK2;PIK3R1;GAS6;HMGN5;MARK4;DLL1;CTGF;WT1
1228,GO:0009719,0.367292625127828,0.75780053342548,14,50,response to endogenous stimulus,BP,ACTN2;CDKN1A;DKK3;PIK3R1;ITGB5;PRKACB;FOXO4;PDE4B;CGN;CLDN1;CTGF;ITGA3;WT1;SH3BP4
1700,GO:0017048,0.367685501279469,1,1,1,Rho GTPase binding,MF,DAAM2
927,GO:0007034,0.36815801412371,0.909501944381964,2,4,vacuolar transport,BP,GPRASP1;RHOB
929,GO:0007041,0.36815801412371,0.909501944381964,2,4,lysosomal transport,BP,GPRASP1;RHOB
3883,GO:0048731,0.368454121409703,0.737767536862127,33,123,system development,BP,ACTN2;MYO7A;CDKN1A;NRTN;DKK3;RHOB;KITLG;RHOJ;MFGE8;CAMSAP3;CLDN11;PIK3R1;GAS6;LAMA5;SDC4;SEMA6C;PRKACB;ITGB8;SERPINA5;ACSL4;CRISPLD2;FHOD3;FOXO4;DHH;GPSM1;MARK4;DLL1;UNC119;CLDN1;CTGF;ITGA3;WT1;MSN
2368,GO:0032388,0.369217267633262,0.861792428252999,3,8,positive regulation of intracellular transport,BP,PIK3R1;GAS6;MSN
1826,GO:0021549,0.369387323581532,0.958365087344006,1,2,cerebellum development,BP,DLL1
1827,GO:0021575,0.369387323581532,0.958365087344006,1,2,hindbrain morphogenesis,BP,DLL1
1828,GO:0021587,0.369387323581532,0.958365087344006,1,2,cerebellum morphogenesis,BP,DLL1
1839,GO:0021695,0.369387323581532,0.958365087344006,1,2,cerebellar cortex development,BP,DLL1
1840,GO:0021696,0.369387323581532,0.958365087344006,1,2,cerebellar cortex morphogenesis,BP,DLL1
1841,GO:0021697,0.369387323581532,0.958365087344006,1,2,cerebellar cortex formation,BP,DLL1
1877,GO:0022037,0.369387323581532,0.958365087344006,1,2,metencephalon development,BP,DLL1
59,GO:0000981,0.370210271796501,0.897237157370534,2,5,RNA polymerase II transcription factor activity, sequence-specific DNA binding,MF,FOXO4;WT1
2620,GO:0034332,0.370589474999039,0.866987628109309,3,7,adherens junction organization,BP,ACTN2;LAMA5;SDC4
1115,GO:0008277,0.370631950183361,0.897028202997174,2,5,regulation of G-protein coupled receptor protein signaling pathway,BP,GPRASP1;GPSM1
3572,GO:0045926,0.371885741164622,0.85580034291503,3,9,negative regulation of growth,BP,CDKN1A;WT1;SH3BP4
3922,GO:0048863,0.372315877654156,0.832820438016087,4,12,stem cell differentiation,BP,NRTN;KITLG;LAMA5;FOXO4
1164,GO:0009058,0.372601377499299,0.741675609542852,19,73,biosynthetic process,BP,ACTN2;CDKN1A;HMGCS2;DKK3;KITLG;PRND;PHLDA1;PIK3R1;GAS6;SDC4;HMGN5;ACSL4;FOXO4;DHH;DLL1;CTGF;ITGA3;WT1;PTGES
126,GO:0001709,0.373215889005667,0.957380669569305,1,2,cell fate determination,BP,DLL1
270,GO:0002312,0.374003524619767,0.957176340063906,1,2,B cell activation involved in immune response,BP,DLL1
4452,GO:0060401,0.374679377472164,0.957000515128498,1,2,cytosolic calcium ion transport,BP,CTGF
1134,GO:0008406,0.374706666039449,0.85404476130502,3,9,gonad development,BP,KITLG;DHH;WT1
3423,GO:0045137,0.374706666039449,0.85404476130502,3,9,development of primary sexual characteristics,BP,KITLG;DHH;WT1
3062,GO:0042995,0.374905599697948,0.759887155868017,12,39,cell projection,CC,ACTN2;MYO7A;NRTN;KITLG;PLEKHH2;PRKACB;RAB39B;MARK4;ESPN;PDE4B;ITGA3;MSN
6073,GO:2000278,0.375819791120903,0.9567027962128,1,2,regulation of DNA biosynthetic process,BP,CDKN1A
4770,GO:0070161,0.377582237378341,0.773565960486944,9,28,anchoring junction,CC,ACTN2;RHOB;CAMSAP3;SDC4;MPZL1;ITGB5;DLL1;ITGA3;MSN
4059,GO:0051015,0.378432719851481,0.862382594894706,3,7,actin filament binding,MF,ACTN2;MYO7A;ESPN
332,GO:0002696,0.379152571738233,0.851257772151893,3,9,positive regulation of leukocyte activation,BP,CDKN1A;PIK3R1;GAS6
931,GO:0007044,0.379989499550553,0.861459567776644,3,7,cell-substrate junction assembly,BP,ACTN2;LAMA5;SDC4
1118,GO:0008285,0.381299293616229,0.782307012230971,7,25,negative regulation of cell proliferation,BP,CDKN1A;SDC4;FOXO4;DLL1;WT1;PTGES;SH3BP4
2718,GO:0035295,0.381388429861786,0.762152593135383,10,35,tube development,BP,CDKN1A;RHOB;LAMA5;SDC4;PRKACB;CRISPLD2;DLL1;CTGF;ITGA3;WT1
3704,GO:0046914,0.381669887350612,0.826431434545019,4,12,transition metal ion binding,MF,PRND;DHH;TMEM163;WT1
5492,GO:0099503,0.3820025693347,0.790154289997776,6,23,secretory vesicle,CC,ACTN2;GAS6;SERPINA5;CRISPLD2;TMEM163;PDE4B
255,GO:0002253,0.382228553186333,0.853854218814016,3,8,activation of immune response,BP,PIK3R1;PRKACB;PDE4B
347,GO:0002757,0.382228553186333,0.853854218814016,3,8,immune response-activating signal transduction,BP,PIK3R1;PRKACB;PDE4B
352,GO:0002764,0.382228553186333,0.853854218814016,3,8,immune response-regulating signaling pathway,BP,PIK3R1;PRKACB;PDE4B
1676,GO:0016788,0.382519646607648,0.8910444811013,2,5,hydrolase activity, acting on ester bonds,MF,PTPN7;PDE4B
3012,GO:0042578,0.382519646607648,0.8910444811013,2,5,phosphoric ester hydrolase activity,MF,PTPN7;PDE4B
3493,GO:0045637,0.382881860404261,0.853450090378947,3,8,regulation of myeloid cell differentiation,BP,KITLG;PIK3R1;DLL1
2398,GO:0032504,0.383425423466676,0.781582754455504,7,24,multicellular organism reproduction,BP,KITLG;CLDN11;SERPINA5;ACSL4;DHH;ITGA3;WT1
3839,GO:0048609,0.383425423466676,0.781582754455504,7,24,multicellular organismal reproductive process,BP,KITLG;CLDN11;SERPINA5;ACSL4;DHH;ITGA3;WT1
2935,GO:0042149,0.385018746609147,0.954253237115797,1,2,cellular response to glucose starvation,BP,NUAK2
245,GO:0002220,0.385487335993494,0.954126148615997,1,2,innate immune response activating cell surface receptor signaling pathway,BP,PRKACB
247,GO:0002223,0.385487335993494,0.954126148615997,1,2,stimulatory C-type lectin receptor signaling pathway,BP,PRKACB
706,GO:0005929,0.385554637967784,0.858135476905119,3,7,cilium,CC,MYO7A;PRKACB;MARK4
3335,GO:0044441,0.385554637967784,0.858135476905119,3,7,ciliary part,CC,MYO7A;PRKACB;MARK4
4243,GO:0051704,0.38563139258393,0.744411663140597,13,50,multi-organism process,BP,MFGE8;CLDN11;PIK3R1;GAS6;ITGB5;SERPINA5;ACSL4;DHH;PDE4B;CLDN1;ITGA3;WT1;PTGES
5199,GO:0072657,0.386140730423424,0.79170630686735,6,19,protein localization to membrane,BP,ACTN2;REEP1;PIK3R1;GAS6;LAMA5;ITGA3
2284,GO:0032006,0.38645820116676,0.88902207777604,2,5,regulation of TOR signaling,BP,GAS6;SH3BP4
2923,GO:0042098,0.38748806032744,0.888489954342658,2,5,T cell proliferation,BP,SDC4;MSN
2270,GO:0031960,0.387673533566341,0.845847158803808,3,9,response to corticosteroid,BP,CDKN1A;CLDN1;CTGF
3186,GO:0043473,0.387800305692118,0.888328347473133,2,5,pigmentation,BP,MYO7A;KITLG
2018,GO:0030334,0.388683009089302,0.756749184512005,10,34,regulation of cell migration,BP,LAMA1;RHOB;KITLG;PIK3R1;GAS6;LAMA5;SDC4;FOXO4;ITGA3;MSN
6049,GO:2000145,0.388683009089302,0.756749184512005,10,34,regulation of cell motility,BP,LAMA1;RHOB;KITLG;PIK3R1;GAS6;LAMA5;SDC4;FOXO4;ITGA3;MSN
3742,GO:0048145,0.388856551509123,0.88038957661793,2,6,regulation of fibroblast proliferation,BP,CDKN1A;GAS6
3743,GO:0048146,0.388856551509123,0.88038957661793,2,6,positive regulation of fibroblast proliferation,BP,CDKN1A;GAS6
808,GO:0006612,0.389367385320066,0.953065122692168,1,2,protein targeting to membrane,BP,GAS6
3094,GO:0043154,0.390514948787873,0.952748325845187,1,2,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,GAS6
6043,GO:2000117,0.390514948787873,0.952748325845187,1,2,negative regulation of cysteine-type endopeptidase activity,BP,GAS6
390,GO:0003104,0.391131852846428,0.95257745671153,1,2,positive regulation of glomerular filtration,BP,GAS6
5417,GO:0097734,0.392595373665531,0.952170504545372,1,2,extracellular exosome biogenesis,BP,SDC4
5982,GO:1990182,0.392595373665531,0.952170504545372,1,2,exosomal secretion,BP,SDC4
3229,GO:0043603,0.393574818789145,0.885316849937864,2,5,cellular amide metabolic process,BP,GAS6;ITGB8
2278,GO:0031982,0.394340793391088,0.716071993829706,26,97,vesicle,CC,ACTN2;MYO7A;FRMPD1;RHOB;PHLDA1;RHOJ;MFGE8;CLDN11;GAS6;LAMA5;SDC4;ITGB5;PRKACB;ITGB8;SERPINA5;RIN3;ACSL4;CRISPLD2;RAB39B;DAAM2;DLL1;TMEM163;PDE4B;ITGA3;MSN;SH3BP4
91,GO:0001523,0.394680532844184,0.951586823476463,1,2,retinoid metabolic process,BP,SDC4
836,GO:0006721,0.394680532844184,0.951586823476463,1,2,terpenoid metabolic process,BP,SDC4
1592,GO:0016101,0.394680532844184,0.951586823476463,1,2,diterpenoid metabolic process,BP,SDC4
5024,GO:0071887,0.394768772794091,0.884688763920816,2,5,leukocyte apoptotic process,BP,KITLG;GAS6
646,GO:0005737,0.395281975605591,0.722837243080379,42,164,cytoplasm,CC,ACTN2;MYO7A;CDKN1A;FRMPD1;HMGCS2;REEP1;GPRASP1;RHOB;KITLG;PHLDA1;RHOJ;NUAK2;CAMSAP3;PLEKHH2;PIK3R1;SLC25A53;GAS6;SDC4;ITGB5;PRKACB;SERPINA5;PTPN7;RIN3;ACSL4;CRISPLD2;FHOD3;RAB39B;FOXO4;GPSM1;MARK4;ESPN;DLL1;TMEM163;PDE4B;UNC119;CLDN1;CTGF;ITGA3;WT1;MSN;PTGES;SH3BP4
551,GO:0005080,0.395453906648873,0.951369177919114,1,2,protein kinase C binding,MF,SDC4
1000,GO:0007286,0.395991232874407,0.95121759060802,1,2,spermatid development,BP,DHH
3803,GO:0048515,0.395991232874407,0.95121759060802,1,2,spermatid differentiation,BP,DHH
18,GO:0000146,0.396090878859614,1,1,1,microfilament motor activity,MF,MYO7A
136,GO:0001754,0.396090878859614,1,1,1,eye photoreceptor cell differentiation,BP,MYO7A
179,GO:0001917,0.396090878859614,1,1,1,photoreceptor inner segment,CC,MYO7A
235,GO:0002093,0.396090878859614,1,1,1,auditory receptor cell morphogenesis,BP,MYO7A
237,GO:0002139,0.396090878859614,1,1,1,stereocilia coupling link,CC,MYO7A
238,GO:0002140,0.396090878859614,1,1,1,stereocilia tip link,CC,MYO7A
1243,GO:0009886,0.396090878859614,1,1,1,post-embryonic animal morphogenesis,BP,MYO7A
1636,GO:0016461,0.396090878859614,1,1,1,unconventional myosin complex,CC,MYO7A
1690,GO:0016887,0.396090878859614,1,1,1,ATPase activity,MF,MYO7A
2116,GO:0030898,0.396090878859614,1,1,1,actin-dependent ATPase activity,MF,MYO7A
2211,GO:0031477,0.396090878859614,1,1,1,myosin VII complex,CC,MYO7A
2982,GO:0042461,0.396090878859614,1,1,1,photoreceptor cell development,BP,MYO7A
2983,GO:0042462,0.396090878859614,1,1,1,eye photoreceptor cell development,BP,MYO7A
3022,GO:0042623,0.396090878859614,1,1,1,ATPase activity, coupled,MF,MYO7A
3204,GO:0043531,0.396090878859614,1,1,1,ADP binding,MF,MYO7A
3822,GO:0048563,0.396090878859614,1,1,1,post-embryonic animal organ morphogenesis,BP,MYO7A
3826,GO:0048569,0.396090878859614,1,1,1,post-embryonic animal organ development,BP,MYO7A
4374,GO:0060088,0.396090878859614,1,1,1,auditory receptor cell stereocilium organization,BP,MYO7A
4378,GO:0060117,0.396090878859614,1,1,1,auditory receptor cell development,BP,MYO7A
5990,GO:1990427,0.396090878859614,1,1,1,stereocilia tip-link density,CC,MYO7A
5992,GO:1990435,0.396090878859614,1,1,1,upper tip-link density,CC,MYO7A
2592,GO:0033993,0.396121499835513,0.768916605183445,7,27,response to lipid,BP,CDKN1A;DHH;PDE4B;CLDN1;CTGF;MSN;PTGES
1230,GO:0009743,0.397561217856592,0.875566906966292,2,6,response to carbohydrate,BP,GAS6;CTGF
1232,GO:0009746,0.397561217856592,0.875566906966292,2,6,response to hexose,BP,GAS6;CTGF
1233,GO:0009749,0.397561217856592,0.875566906966292,2,6,response to glucose,BP,GAS6;CTGF
2615,GO:0034284,0.397561217856592,0.875566906966292,2,6,response to monosaccharide,BP,GAS6;CTGF
2943,GO:0042221,0.398151856954023,0.714504809779595,23,90,response to chemical,BP,ACTN2;CDKN1A;NRTN;DKK3;RHOB;PIK3R1;GAS6;ITGB5;SEMA6C;PRKACB;ACSL4;FOXO4;DHH;DLL1;PDE4B;CGN;CLDN1;CTGF;ITGA3;WT1;MSN;PTGES;SH3BP4
3655,GO:0046661,0.39849947884316,0.835215237549507,3,10,male sex differentiation,BP,KITLG;DHH;WT1
145,GO:0001776,0.398882494202001,0.882510415899391,2,5,leukocyte homeostasis,BP,KITLG;PDE4B
528,GO:0004721,0.399160508811977,0.950317280040746,1,2,phosphoprotein phosphatase activity,MF,PTPN7
529,GO:0004725,0.399160508811977,0.950317280040746,1,2,protein tyrosine phosphatase activity,MF,PTPN7
2728,GO:0035335,0.399160508811977,0.950317280040746,1,2,peptidyl-tyrosine dephosphorylation,BP,PTPN7
4125,GO:0051205,0.399708190361601,0.950160617113038,1,2,protein insertion into membrane,BP,REEP1
1223,GO:0009636,0.400505218598756,0.881645012559749,2,5,response to toxic substance,BP,CDKN1A;CLDN1
3494,GO:0045638,0.402484382987986,0.880584815138579,2,5,negative regulation of myeloid cell differentiation,BP,PIK3R1;DLL1
1048,GO:0007596,0.404440881351624,0.788844628383585,5,17,blood coagulation,BP,RHOB;PIK3R1;GAS6;PRKACB;SERPINA5
1049,GO:0007599,0.404440881351624,0.788844628383585,5,17,hemostasis,BP,RHOB;PIK3R1;GAS6;PRKACB;SERPINA5
3997,GO:0050817,0.404440881351624,0.788844628383585,5,17,coagulation,BP,RHOB;PIK3R1;GAS6;PRKACB;SERPINA5
5633,GO:1901699,0.405002327066753,0.765558870237424,7,23,cellular response to nitrogen compound,BP,ACTN2;PIK3R1;PRKACB;FOXO4;PDE4B;WT1;SH3BP4
162,GO:0001841,0.406869551634459,0.878217282171946,2,5,neural tube formation,BP,SDC4;PRKACB
1456,GO:0014020,0.406869551634459,0.878217282171946,2,5,primary neural tube formation,BP,SDC4;PRKACB
3463,GO:0045446,0.406891884158695,0.808688430106268,4,12,endothelial cell differentiation,BP,LAMA5;DLL1;CLDN1;MSN
3329,GO:0044432,0.407013307295768,0.772794958537339,6,21,endoplasmic reticulum part,CC,REEP1;PIK3R1;GAS6;ACSL4;GPSM1;PTGES
1953,GO:0030133,0.408337258837678,0.823320520755706,3,12,transport vesicle,CC,CRISPLD2;TMEM163;PDE4B
3853,GO:0048646,0.408849142306624,0.725908238396054,13,46,anatomical structure formation involved in morphogenesis,BP,ACTN2;RHOB;MFGE8;LAMA5;SDC4;ITGB5;PRKACB;FHOD3;FOXO4;DLL1;CTGF;ITGA3;WT1
2931,GO:0042127,0.409193865938822,0.727675711984374,12,47,regulation of cell proliferation,BP,CDKN1A;KITLG;GAS6;LAMA5;SDC4;HMGN5;FOXO4;DLL1;CTGF;WT1;PTGES;SH3BP4
4965,GO:0071495,0.409883588220138,0.724644839428968,13,47,cellular response to endogenous stimulus,BP,ACTN2;DKK3;PIK3R1;ITGB5;PRKACB;FOXO4;PDE4B;CGN;CLDN1;CTGF;ITGA3;WT1;SH3BP4
195,GO:0001952,0.410518304870622,0.876227817721004,2,5,regulation of cell-matrix adhesion,BP,PIK3R1;SDC4
4112,GO:0051180,0.41061433167284,0.946973808579873,1,2,vitamin transport,BP,SLC52A3
4114,GO:0051183,0.41061433167284,0.946973808579873,1,2,vitamin transporter activity,MF,SLC52A3
1050,GO:0007600,0.410879322903667,0.803029819289026,4,13,sensory perception,BP,MYO7A;SLC52A3;ESPN;UNC119
859,GO:0006816,0.411342529612206,0.830335776867042,3,9,calcium ion transport,BP,GAS6;PDE4B;CTGF
4635,GO:0061025,0.411459218370855,0.862270597391953,2,7,membrane fusion,BP,GAS6;SERPINA5
2553,GO:0033209,0.411731206560199,0.946640159664013,1,2,tumor necrosis factor-mediated signaling pathway,BP,GAS6
4510,GO:0060539,0.4124807584644,0.946415474421627,1,2,diaphragm development,BP,WT1
4823,GO:0070382,0.413313060859786,0.861158967640203,2,7,exocytic vesicle,CC,TMEM163;PDE4B
54,GO:0000930,0.413508882046326,0.946106278421781,1,2,gamma-tubulin complex,CC,PDE4B
3341,GO:0044450,0.413508882046326,0.946106278421781,1,2,microtubule organizing center part,CC,PDE4B
5138,GO:0072223,0.413825865645172,0.946010714176989,1,2,metanephric glomerular mesangium development,BP,WT1
5139,GO:0072224,0.413825865645172,0.946010714176989,1,2,metanephric glomerulus development,BP,WT1
5142,GO:0072239,0.413825865645172,0.946010714176989,1,2,metanephric glomerulus vasculature development,BP,WT1
2262,GO:0031944,0.414145473413598,0.945914246412387,1,2,negative regulation of glucocorticoid metabolic process,BP,DKK3
2265,GO:0031947,0.414145473413598,0.945914246412387,1,2,negative regulation of glucocorticoid biosynthetic process,BP,DKK3
2351,GO:0032345,0.414145473413598,0.945914246412387,1,2,negative regulation of aldosterone metabolic process,BP,DKK3
2354,GO:0032348,0.414145473413598,0.945914246412387,1,2,negative regulation of aldosterone biosynthetic process,BP,DKK3
2357,GO:0032351,0.414145473413598,0.945914246412387,1,2,negative regulation of hormone metabolic process,BP,DKK3
2359,GO:0032353,0.414145473413598,0.945914246412387,1,2,negative regulation of hormone biosynthetic process,BP,DKK3
5246,GO:0090032,0.414145473413598,0.945914246412387,1,2,negative regulation of steroid hormone biosynthetic process,BP,DKK3
6033,GO:2000065,0.414145473413598,0.945914246412387,1,2,negative regulation of cortisol biosynthetic process,BP,DKK3
2530,GO:0033043,0.41441193578442,0.741741255939654,9,30,regulation of organelle organization,BP,ACTN2;CAMSAP3;PLEKHH2;PIK3R1;SDC4;FHOD3;ESPN;CTGF;MSN
4634,GO:0061024,0.415254137755533,0.738914826210635,9,33,membrane organization,BP,ACTN2;REEP1;MFGE8;PIK3R1;GAS6;LAMA5;SERPINA5;RIN3;ITGA3
1807,GO:0019904,0.415300567367122,0.784538621505783,5,15,protein domain specific binding,MF,ACTN2;MYO7A;ESPN;ITGA3;WT1
2397,GO:0032502,0.415468535119455,0.697884870415709,36,137,developmental process,BP,LAMA1;ACTN2;MYO7A;CDKN1A;NRTN;DKK3;RHOB;KITLG;RHOJ;MFGE8;CAMSAP3;CLDN11;PIK3R1;GAS6;LAMA5;SDC4;ITGB5;SEMA6C;PRKACB;ITGB8;SERPINA5;ACSL4;CRISPLD2;FHOD3;FOXO4;DHH;GPSM1;MARK4;DAAM2;DLL1;UNC119;CLDN1;CTGF;ITGA3;WT1;MSN
3371,GO:0044767,0.415468535119455,0.697884870415709,36,137,single-organism developmental process,BP,LAMA1;ACTN2;MYO7A;CDKN1A;NRTN;DKK3;RHOB;KITLG;RHOJ;MFGE8;CAMSAP3;CLDN11;PIK3R1;GAS6;LAMA5;SDC4;ITGB5;SEMA6C;PRKACB;ITGB8;SERPINA5;ACSL4;CRISPLD2;FHOD3;FOXO4;DHH;GPSM1;MARK4;DAAM2;DLL1;UNC119;CLDN1;CTGF;ITGA3;WT1;MSN
917,GO:0007009,0.415646934980835,0.784274089810253,5,15,plasma membrane organization,BP,ACTN2;PIK3R1;GAS6;LAMA5;ITGA3
5200,GO:0072659,0.415646934980835,0.784274089810253,5,15,protein localization to plasma membrane,BP,ACTN2;PIK3R1;GAS6;LAMA5;ITGA3
5999,GO:1990778,0.415646934980835,0.784274089810253,5,15,protein localization to cell periphery,BP,ACTN2;PIK3R1;GAS6;LAMA5;ITGA3
2575,GO:0033574,0.416423062572451,0.94522352201745,1,2,response to testosterone,BP,MSN
4607,GO:0060911,0.417395425443161,0.944926878148692,1,2,cardiac cell fate commitment,BP,WT1
4610,GO:0060923,0.417395425443161,0.944926878148692,1,2,cardiac muscle cell fate commitment,BP,WT1
4914,GO:0071310,0.418880882533862,0.7072524344469,16,61,cellular response to organic substance,BP,ACTN2;DKK3;PIK3R1;GAS6;ITGB5;PRKACB;FOXO4;DLL1;PDE4B;CGN;CLDN1;CTGF;ITGA3;WT1;MSN;SH3BP4
1862,GO:0021904,0.418985594336317,0.944439483859833,1,2,dorsal/ventral neural tube patterning,BP,PRKACB
4165,GO:0051291,0.421449262580042,0.927163813817111,1,3,protein heterooligomerization,BP,CLDN1
5860,GO:1903828,0.422444098066566,0.869600374247952,2,5,negative regulation of cellular protein localization,BP,ACTN2;GAS6
3272,GO:0044232,0.422553998397854,0.943335427516861,1,2,organelle membrane contact site,CC,ACSL4
3273,GO:0044233,0.422553998397854,0.943335427516861,1,2,ER-mitochondrion membrane contact site,CC,ACSL4
1052,GO:0007602,0.422710157155885,0.943286784631385,1,2,phototransduction,BP,UNC119
1212,GO:0009583,0.422710157155885,0.943286784631385,1,2,detection of light stimulus,BP,UNC119
1242,GO:0009880,0.42299642927329,0.860884868490034,2,6,embryonic pattern specification,BP,DLL1;WT1
101,GO:0001573,0.423024175594941,1,1,1,ganglioside metabolic process,BP,ITGB8
818,GO:0006643,0.423024175594941,1,1,1,membrane lipid metabolic process,BP,ITGB8
822,GO:0006664,0.423024175594941,1,1,1,glycolipid metabolic process,BP,ITGB8
823,GO:0006665,0.423024175594941,1,1,1,sphingolipid metabolic process,BP,ITGB8
824,GO:0006672,0.423024175594941,1,1,1,ceramide metabolic process,BP,ITGB8
825,GO:0006687,0.423024175594941,1,1,1,glycosphingolipid metabolic process,BP,ITGB8
2658,GO:0034686,0.423024175594941,1,1,1,integrin alphav-beta8 complex,CC,ITGB8
5811,GO:1903509,0.423024175594941,1,1,1,liposaccharide metabolic process,BP,ITGB8
5991,GO:1990430,0.423024175594941,1,1,1,extracellular matrix protein binding,MF,ITGB8
1431,GO:0010941,0.423274680168792,0.715471850251034,12,47,regulation of cell death,BP,ACTN2;CDKN1A;RHOB;KITLG;NUAK2;PIK3R1;GAS6;HMGN5;MARK4;DLL1;CTGF;WT1
1425,GO:0010921,0.42348658553923,0.943044520417854,1,2,regulation of phosphatase activity,BP,CAMSAP3
4337,GO:0055119,0.424520725475895,0.942720783055005,1,2,relaxation of cardiac muscle,BP,PDE4B
5571,GO:1901077,0.424520725475895,0.942720783055005,1,2,regulation of relaxation of muscle,BP,PDE4B
5651,GO:1901897,0.424520725475895,0.942720783055005,1,2,regulation of relaxation of cardiac muscle,BP,PDE4B
1515,GO:0014911,0.424735191608749,0.942653492451533,1,2,positive regulation of smooth muscle cell migration,BP,FOXO4
4100,GO:0051151,0.424735191608749,0.942653492451533,1,2,negative regulation of smooth muscle cell differentiation,BP,FOXO4
651,GO:0005759,0.425615804325915,0.942376644149998,1,2,mitochondrial matrix,CC,HMGCS2
1796,GO:0019882,0.426159511442778,0.942205271650837,1,2,antigen processing and presentation,BP,ITGB5
2286,GO:0032008,0.426318714042832,0.942155028332928,1,2,positive regulation of TOR signaling,BP,GAS6
3840,GO:0048630,0.426523460069464,0.942090369267303,1,2,skeletal muscle tissue growth,BP,DLL1
3841,GO:0048631,0.426523460069464,0.942090369267303,1,2,regulation of skeletal muscle tissue growth,BP,DLL1
3842,GO:0048633,0.426523460069464,0.942090369267303,1,2,positive regulation of skeletal muscle tissue growth,BP,DLL1
3849,GO:0048641,0.426523460069464,0.942090369267303,1,2,regulation of skeletal muscle tissue development,BP,DLL1
3850,GO:0048643,0.426523460069464,0.942090369267303,1,2,positive regulation of skeletal muscle tissue development,BP,DLL1
4306,GO:0055013,0.426565668015302,0.867264955208081,2,5,cardiac muscle cell development,BP,ACTN2;FHOD3
2390,GO:0032456,0.427951556887186,0.941638041251978,1,2,endocytic recycling,BP,ACTN2
4683,GO:0061213,0.428245266775661,0.924453141611074,1,3,positive regulation of mesonephros development,BP,WT1
60,GO:0000982,0.429282468633667,0.941214390281765,1,2,transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,WT1
999,GO:0007283,0.429441712857448,0.817987842336339,3,9,spermatogenesis,BP,CLDN11;SERPINA5;DHH
3753,GO:0048232,0.429441712857448,0.817987842336339,3,9,male gamete generation,BP,CLDN11;SERPINA5;DHH
4590,GO:0060839,0.430251815084994,0.940904549089529,1,2,endothelial cell fate commitment,BP,DLL1
5345,GO:0097061,0.431477857003697,0.940511105072042,1,2,dendritic spine organization,BP,ITGA3
102,GO:0001578,0.431548769589129,0.940488295641651,1,2,microtubule bundle formation,BP,MARK4
2952,GO:0042306,0.431734819392834,0.81639280125178,3,9,regulation of protein import into nucleus,BP,CDKN1A;PIK3R1;GAS6
3671,GO:0046822,0.431734819392834,0.81639280125178,3,9,regulation of nucleocytoplasmic transport,BP,CDKN1A;PIK3R1;GAS6
5822,GO:1903533,0.431734819392834,0.81639280125178,3,9,regulation of protein targeting,BP,CDKN1A;PIK3R1;GAS6
5893,GO:1904589,0.431734819392834,0.81639280125178,3,9,regulation of protein import,BP,CDKN1A;PIK3R1;GAS6
5423,GO:0098552,0.432840587364305,0.789636002658745,4,12,side of membrane,CC,MFGE8;SERPINA5;PTPN7;ITGA3
104,GO:0001618,0.433203432001404,0.863454622696935,2,5,virus receptor activity,MF,ITGB5;CLDN1
3269,GO:0044092,0.434248530976807,0.749656059717517,6,22,negative regulation of molecular function,BP,ACTN2;CDKN1A;CAMSAP3;GAS6;SERPINA5;SH3BP4
146,GO:0001779,0.43523821076844,0.939293510179244,1,2,natural killer cell differentiation,BP,GAS6
633,GO:0005606,0.435569776091924,1,1,1,laminin-1 complex,CC,LAMA1
634,GO:0005608,0.435569776091924,1,1,1,laminin-3 complex,CC,LAMA1
694,GO:0005903,0.437139474556425,0.938671602923374,1,2,brush border,CC,ESPN
197,GO:0001954,0.437648618252995,0.938504340795309,1,2,positive regulation of cell-matrix adhesion,BP,SDC4
4264,GO:0051893,0.437648618252995,0.938504340795309,1,2,regulation of focal adhesion assembly,BP,SDC4
4265,GO:0051894,0.437648618252995,0.938504340795309,1,2,positive regulation of focal adhesion assembly,BP,SDC4
5261,GO:0090109,0.437648618252995,0.938504340795309,1,2,regulation of cell-substrate junction assembly,BP,SDC4
5798,GO:1903391,0.437648618252995,0.938504340795309,1,2,regulation of adherens junction organization,BP,SDC4
5799,GO:1903393,0.437648618252995,0.938504340795309,1,2,positive regulation of adherens junction organization,BP,SDC4
2367,GO:0032387,0.437756166571855,0.93846897038353,1,2,negative regulation of intracellular transport,BP,GAS6
2954,GO:0042308,0.437756166571855,0.93846897038353,1,2,negative regulation of protein import into nucleus,BP,GAS6
3177,GO:0043433,0.437756166571855,0.93846897038353,1,2,negative regulation of sequence-specific DNA binding transcription factor activity,BP,GAS6
3672,GO:0046823,0.437756166571855,0.93846897038353,1,2,negative regulation of nucleocytoplasmic transport,BP,GAS6
5307,GO:0090317,0.437756166571855,0.93846897038353,1,2,negative regulation of intracellular protein transport,BP,GAS6
5894,GO:1904590,0.437756166571855,0.93846897038353,1,2,negative regulation of protein import,BP,GAS6
4627,GO:0060996,0.437991281187818,0.938391598639972,1,2,dendritic spine development,BP,ACSL4
132,GO:0001738,0.438381510669252,0.875250003988585,2,4,morphogenesis of a polarized epithelium,BP,LAMA5;MSN
581,GO:0005198,0.43867175513315,0.737973440695601,7,23,structural molecule activity,MF,LAMA1;ACTN2;CLDN11;LAMA5;MPZL1;CLDN1;MSN
1436,GO:0010952,0.439447413852843,0.919844136324414,1,3,positive regulation of peptidase activity,BP,CTGF
5355,GO:0097110,0.439808147539542,0.937791503757877,1,2,scaffold protein binding,MF,DLL1
96,GO:0001558,0.440035624481302,0.77873031554283,4,14,regulation of cell growth,BP,CDKN1A;CTGF;WT1;SH3BP4
1580,GO:0016049,0.440035624481302,0.77873031554283,4,14,cell growth,BP,CDKN1A;CTGF;WT1;SH3BP4
1449,GO:0014002,0.44060765480675,0.93752619671229,1,2,astrocyte development,BP,DLL1
2021,GO:0030374,0.440962882539344,0.937408075386549,1,2,ligand-dependent nuclear receptor transcription coactivator activity,MF,ACTN2
3652,GO:0046649,0.442007223373631,0.744500081400745,6,21,lymphocyte activation,BP,CDKN1A;PIK3R1;GAS6;SDC4;DLL1;MSN
1349,GO:0010638,0.442059707994461,0.775079898409723,4,15,positive regulation of organelle organization,BP,ACTN2;SDC4;CTGF;MSN
4800,GO:0070293,0.443165713608543,0.936672232712062,1,2,renal absorption,BP,GAS6
4792,GO:0070252,0.443664231337461,0.857325149449479,2,5,actin-mediated cell contraction,BP,ACTN2;PDE4B
947,GO:0007155,0.444671626535647,0.680780424882526,18,64,cell adhesion,BP,LAMA1;ACTN2;RHOB;KITLG;MFGE8;CAMSAP3;CLDN11;PIK3R1;GAS6;LAMA5;SDC4;ITGB5;ITGB8;DLL1;CLDN1;CTGF;ITGA3;MSN
1895,GO:0022610,0.444671626535647,0.680780424882526,18,64,biological adhesion,BP,LAMA1;ACTN2;RHOB;KITLG;MFGE8;CAMSAP3;CLDN11;PIK3R1;GAS6;LAMA5;SDC4;ITGB5;ITGB8;DLL1;CLDN1;CTGF;ITGA3;MSN
3077,GO:0043066,0.445474000893809,0.719182699300408,8,31,negative regulation of apoptotic process,BP,CDKN1A;KITLG;NUAK2;PIK3R1;GAS6;HMGN5;DLL1;WT1
3080,GO:0043069,0.445474000893809,0.719182699300408,8,31,negative regulation of programmed cell death,BP,CDKN1A;KITLG;NUAK2;PIK3R1;GAS6;HMGN5;DLL1;WT1
4151,GO:0051259,0.445696312936228,0.802362103586157,3,10,protein oligomerization,BP,ACTN2;PRND;CLDN1
1652,GO:0016579,0.445951861899655,0.935733229770251,1,2,protein deubiquitination,BP,FOXO4
4850,GO:0070646,0.445951861899655,0.935733229770251,1,2,protein modification by small protein removal,BP,FOXO4
2217,GO:0031527,0.445986828169987,0.935721386026646,1,2,filopodium membrane,CC,ITGA3
2051,GO:0030551,0.446181388988675,0.935655457677951,1,2,cyclic nucleotide binding,MF,PDE4B
2052,GO:0030552,0.446181388988675,0.935655457677951,1,2,cAMP binding,MF,PDE4B
5461,GO:0098802,0.446349939886916,0.811591578347463,3,8,plasma membrane receptor complex,CC,ITGB5;ITGB8;ITGA3
553,GO:0005088,0.44655567480949,0.773667623515326,4,14,Ras guanyl-nucleotide exchange factor activity,MF,ACTN2;NRTN;KITLG;RIN3
638,GO:0005623,0.446853495954031,0.778830499410612,56,225,cell,CC,ACTN2;MYO7A;CDKN1A;FRMPD1;HMGCS2;NRTN;REEP1;GPRASP1;RHOB;KITLG;MRO;PRND;PHLDA1;SLC52A3;RHOJ;NUAK2;MFGE8;CAMSAP3;PLEKHH2;CLDN11;PIK3R1;SLC25A53;GAS6;LAMA5;SDC4;MPZL1;ITGB5;SEMA6C;PRKACB;ITGB8;SERPINA5;HMGN5;PTPN7;RIN3;ACSL4;CRISPLD2;FHOD3;RAB39B;FOXO4;DHH;GPSM1;MARK4;ESPN;DLL1;TMEM163;PDE4B;UNC119;CGN;CLDN1;SLC18B1;CTGF;ITGA3;WT1;MSN;PTGES;SH3BP4
3347,GO:0044464,0.446853495954031,0.778830499410612,56,225,cell part,CC,ACTN2;MYO7A;CDKN1A;FRMPD1;HMGCS2;NRTN;REEP1;GPRASP1;RHOB;KITLG;MRO;PRND;PHLDA1;SLC52A3;RHOJ;NUAK2;MFGE8;CAMSAP3;PLEKHH2;CLDN11;PIK3R1;SLC25A53;GAS6;LAMA5;SDC4;MPZL1;ITGB5;SEMA6C;PRKACB;ITGB8;SERPINA5;HMGN5;PTPN7;RIN3;ACSL4;CRISPLD2;FHOD3;RAB39B;FOXO4;DHH;GPSM1;MARK4;ESPN;DLL1;TMEM163;PDE4B;UNC119;CGN;CLDN1;SLC18B1;CTGF;ITGA3;WT1;MSN;PTGES;SH3BP4
1736,GO:0019058,0.447547543401302,0.81075101377582,3,8,viral life cycle,BP,GAS6;ITGB5;CLDN1
1296,GO:0010324,0.448290181708123,0.934937947570799,1,2,membrane invagination,BP,MFGE8
5483,GO:0099024,0.448290181708123,0.934937947570799,1,2,plasma membrane invagination,BP,MFGE8
5184,GO:0072562,0.448551372225564,0.934848703990261,1,2,blood microparticle,CC,MSN
2726,GO:0035315,0.448980709041478,0.869527374552949,2,4,hair cell differentiation,BP,MYO7A;DLL1
2994,GO:0042491,0.448980709041478,0.869527374552949,2,4,auditory receptor cell differentiation,BP,MYO7A;DLL1
3376,GO:0044782,0.44905270417781,0.869487982743983,2,4,cilium organization,BP,LAMA5;MARK4
4409,GO:0060271,0.44905270417781,0.869487982743983,2,4,cilium assembly,BP,LAMA5;MARK4
2243,GO:0031668,0.449394877613064,0.799663338828019,3,10,cellular response to extracellular stimulus,BP,CDKN1A;NUAK2;GAS6
2244,GO:0031669,0.449394877613064,0.799663338828019,3,10,cellular response to nutrient levels,BP,CDKN1A;NUAK2;GAS6
1428,GO:0010927,0.449472520362413,0.853855123701492,2,5,cellular component assembly involved in morphogenesis,BP,ACTN2;FHOD3
1990,GO:0030239,0.449472520362413,0.853855123701492,2,5,myofibril assembly,BP,ACTN2;FHOD3
1706,GO:0017124,0.451287289461795,0.933908913862379,1,2,SH3 domain binding,MF,ESPN
2562,GO:0033293,0.451929189078846,0.933687098995621,1,2,monocarboxylic acid binding,MF,SERPINA5
385,GO:0003091,0.453257824066553,0.933226372851644,1,2,renal water homeostasis,BP,PRKACB
711,GO:0005952,0.453257824066553,0.933226372851644,1,2,cAMP-dependent protein kinase complex,CC,PRKACB
2606,GO:0034199,0.453257824066553,0.933226372851644,1,2,activation of protein kinase A activity,BP,PRKACB
5403,GO:0097546,0.453257824066553,0.933226372851644,1,2,ciliary base,CC,PRKACB
1613,GO:0016311,0.453418361189902,0.842132570555243,2,6,dephosphorylation,BP,CAMSAP3;PTPN7
5969,GO:1905939,0.454200391419451,0.932898207800649,1,2,regulation of gonad development,BP,WT1
5970,GO:1905940,0.454200391419451,0.932898207800649,1,2,negative regulation of gonad development,BP,WT1
6018,GO:2000018,0.454200391419451,0.932898207800649,1,2,regulation of male gonad development,BP,WT1
1293,GO:0010256,0.454466748054323,0.737197056849062,6,19,endomembrane system organization,BP,ACTN2;REEP1;PIK3R1;GAS6;LAMA5;ITGA3
1152,GO:0008610,0.454486559153554,0.746065146007128,5,19,lipid biosynthetic process,BP,HMGCS2;DKK3;PIK3R1;DHH;PTGES
691,GO:0005891,0.454589960942339,0.932762255560556,1,2,voltage-gated calcium channel complex,CC,PDE4B
2665,GO:0034704,0.454589960942339,0.932762255560556,1,2,calcium channel complex,CC,PDE4B
5565,GO:1901019,0.454589960942339,0.932762255560556,1,2,regulation of calcium ion transmembrane transporter activity,BP,PDE4B
690,GO:0005887,0.455034754523922,0.704669995878198,9,33,integral component of plasma membrane,CC,SLC52A3;SDC4;MPZL1;ITGB5;ITGB8;DLL1;CLDN1;SLC18B1;ITGA3
3643,GO:0046579,0.455088748606308,0.913107251071024,1,3,positive regulation of Ras protein signal transduction,BP,KITLG
4076,GO:0051057,0.455088748606308,0.913107251071024,1,3,positive regulation of small GTPase mediated signal transduction,BP,KITLG
950,GO:0007159,0.455437523365489,0.79949524623365,3,9,leukocyte cell-cell adhesion,BP,PIK3R1;SDC4;MSN
730,GO:0006066,0.456098307520087,0.932234105271786,1,2,alcohol metabolic process,BP,HMGCS2
3601,GO:0046165,0.456098307520087,0.932234105271786,1,2,alcohol biosynthetic process,BP,HMGCS2
44,GO:0000785,0.456333532827451,0.932151487125266,1,2,chromatin,CC,HMGN5
644,GO:0005694,0.456333532827451,0.932151487125266,1,2,chromosome,CC,HMGN5
3324,GO:0044427,0.456333532827451,0.932151487125266,1,2,chromosomal part,CC,HMGN5
5204,GO:0072676,0.456800619573828,0.839965044110278,2,6,lymphocyte migration,BP,GAS6;MSN
3032,GO:0042693,0.456965100512765,0.91227493315299,1,3,muscle cell fate commitment,BP,WT1
2067,GO:0030672,0.458062198208551,0.911785845072358,1,3,synaptic vesicle membrane,CC,TMEM163
5491,GO:0099501,0.458062198208551,0.911785845072358,1,3,exocytic vesicle membrane,CC,TMEM163
5130,GO:0072203,0.458732972858062,0.931304808423525,1,2,cell proliferation involved in metanephros development,BP,WT1
3178,GO:0043434,0.458901870573453,0.745707342569852,5,17,response to peptide hormone,BP,ACTN2;PIK3R1;PRKACB;FOXO4;CTGF
1640,GO:0016482,0.45955240589158,0.931014016649073,1,2,cytosolic transport,BP,MSN
914,GO:0006996,0.459856787376269,0.666486729125216,18,66,organelle organization,BP,ACTN2;MYO7A;REEP1;RHOJ;NUAK2;CAMSAP3;PLEKHH2;PIK3R1;LAMA5;SDC4;ITGB5;HMGN5;FHOD3;MARK4;ESPN;DAAM2;CTGF;MSN
5333,GO:0097009,0.459912306954659,0.930886033562451,1,2,energy homeostasis,BP,DLL1
1082,GO:0008081,0.460223395698889,0.930775277846791,1,2,phosphoric diester hydrolase activity,MF,PDE4B
2245,GO:0031670,0.460478981490556,0.930684191936669,1,2,cellular response to nutrient,BP,GAS6
4910,GO:0071295,0.460478981490556,0.930684191936669,1,2,cellular response to vitamin,BP,GAS6
3545,GO:0045823,0.460557913102737,0.910666529820462,1,3,positive regulation of heart contraction,BP,CTGF
3577,GO:0045933,0.460557913102737,0.910666529820462,1,3,positive regulation of muscle contraction,BP,CTGF
2565,GO:0033365,0.461270994969725,0.743753141196913,5,17,protein localization to organelle,BP,CDKN1A;PIK3R1;GAS6;MSN;SH3BP4
2618,GO:0034330,0.461417151878092,0.743632366131925,5,17,cell junction organization,BP,ACTN2;CAMSAP3;LAMA5;SDC4;CLDN1
635,GO:0005610,0.461674893907858,1,1,1,laminin-5 complex,CC,LAMA5
3081,GO:0043083,0.461674893907858,1,1,1,synaptic cleft,CC,LAMA5
3135,GO:0043259,0.461674893907858,1,1,1,laminin-10 complex,CC,LAMA5
3136,GO:0043260,0.461674893907858,1,1,1,laminin-11 complex,CC,LAMA5
4175,GO:0051336,0.462794124760855,0.696557401502139,9,35,regulation of hydrolase activity,BP,ACTN2;NRTN;KITLG;CAMSAP3;GAS6;SERPINA5;RIN3;CTGF;SH3BP4
1753,GO:0019218,0.463270628642272,0.83577160663396,2,6,regulation of steroid metabolic process,BP,DKK3;DHH
3996,GO:0050810,0.463270628642272,0.83577160663396,2,6,regulation of steroid biosynthetic process,BP,DKK3;DHH
2375,GO:0032410,0.463398361940708,0.929637957052259,1,2,negative regulation of transporter activity,BP,ACTN2
2378,GO:0032413,0.463398361940708,0.929637957052259,1,2,negative regulation of ion transmembrane transporter activity,BP,ACTN2
5562,GO:1901016,0.463398361940708,0.929637957052259,1,2,regulation of potassium ion transmembrane transporter activity,BP,ACTN2
5563,GO:1901017,0.463398361940708,0.929637957052259,1,2,negative regulation of potassium ion transmembrane transporter activity,BP,ACTN2
4937,GO:0071375,0.464276746886195,0.762260178086736,4,13,cellular response to peptide hormone stimulus,BP,ACTN2;PIK3R1;PRKACB;FOXO4
5624,GO:1901653,0.464276746886195,0.762260178086736,4,13,cellular response to peptide,BP,ACTN2;PIK3R1;PRKACB;FOXO4
375,GO:0003014,0.464710704217512,0.78829037512142,3,10,renal system process,BP,GAS6;PRKACB;ITGA3
5861,GO:1903829,0.465225475916952,0.761503724319784,4,13,positive regulation of cellular protein localization,BP,PIK3R1;GAS6;ITGA3;MSN
1153,GO:0008625,0.465411680118127,0.928910162927121,1,2,extrinsic apoptotic signaling pathway via death domain receptors,BP,PIK3R1
5967,GO:1905897,0.465411680118127,0.928910162927121,1,2,regulation of response to endoplasmic reticulum stress,BP,PIK3R1
5968,GO:1905898,0.465411680118127,0.928910162927121,1,2,positive regulation of response to endoplasmic reticulum stress,BP,PIK3R1
3440,GO:0045202,0.465916671570777,0.725883846304803,6,20,synapse,CC,ACTN2;MYO7A;LAMA5;TMEM163;PDE4B;ITGA3
4872,GO:0070848,0.466055443718344,0.701207300705386,8,31,response to growth factor,BP,DKK3;GAS6;ITGB5;DLL1;CGN;CLDN1;CTGF;ITGA3
4933,GO:0071363,0.466055443718344,0.701207300705386,8,31,cellular response to growth factor stimulus,BP,DKK3;GAS6;ITGB5;DLL1;CGN;CLDN1;CTGF;ITGA3
5059,GO:0072070,0.466530739608766,0.928503408507183,1,2,loop of Henle development,BP,DLL1
3056,GO:0042981,0.466544945217406,0.681112653796248,11,44,regulation of apoptotic process,BP,ACTN2;CDKN1A;RHOB;KITLG;NUAK2;PIK3R1;GAS6;HMGN5;DLL1;CTGF;WT1
2035,GO:0030507,0.466819494572697,0.859548023004884,2,4,spectrin binding,MF,MYO7A;CAMSAP3
3097,GO:0043168,0.467080952967646,0.662890439809182,16,65,anion binding,MF,ACTN2;MYO7A;RHOB;RHOJ;NUAK2;MFGE8;GAS6;PRKACB;SERPINA5;ACSL4;CRISPLD2;RAB39B;MARK4;PDE4B;CTGF;PTGES
3351,GO:0044699,0.468101256479012,0.710587081967863,53,211,single-organism process,BP,LAMA1;ACTN2;MYO7A;CDKN1A;HMGCS2;NRTN;REEP1;DKK3;GPRASP1;RHOB;KITLG;PRND;PHLDA1;SLC52A3;RHOJ;NUAK2;MFGE8;CAMSAP3;PLEKHH2;CLDN11;PIK3R1;GAS6;LAMA5;SDC4;MPZL1;ITGB5;SEMA6C;PRKACB;ITGB8;SERPINA5;HMGN5;RIN3;ACSL4;CRISPLD2;FHOD3;RAB39B;FOXO4;DHH;GPSM1;MARK4;ESPN;DAAM2;DLL1;PDE4B;UNC119;CGN;CLDN1;CTGF;ITGA3;WT1;MSN;PTGES;SH3BP4
153,GO:0001819,0.468285864634074,0.832478116824619,2,6,positive regulation of cytokine production,BP,PIK3R1;PDE4B
2275,GO:0031974,0.468316147157953,0.675679302524196,12,46,membrane-enclosed lumen,CC,ACTN2;CDKN1A;HMGCS2;MRO;PHLDA1;GAS6;SDC4;PRKACB;CRISPLD2;FOXO4;WT1;PTGES
3124,GO:0043233,0.468316147157953,0.675679302524196,12,46,organelle lumen,CC,ACTN2;CDKN1A;HMGCS2;MRO;PHLDA1;GAS6;SDC4;PRKACB;CRISPLD2;FOXO4;WT1;PTGES
4756,GO:0070013,0.468316147157953,0.675679302524196,12,46,intracellular organelle lumen,CC,ACTN2;CDKN1A;HMGCS2;MRO;PHLDA1;GAS6;SDC4;PRKACB;CRISPLD2;FOXO4;WT1;PTGES
110,GO:0001657,0.470155988355155,0.780691655927398,3,11,ureteric bud development,BP,LAMA5;SDC4;WT1
5106,GO:0072163,0.470155988355155,0.780691655927398,3,11,mesonephric epithelium development,BP,LAMA5;SDC4;WT1
5107,GO:0072164,0.470155988355155,0.780691655927398,3,11,mesonephric tubule development,BP,LAMA5;SDC4;WT1
1939,GO:0030049,0.470260409024144,0.927136194727363,1,2,muscle filament sliding,BP,ACTN2
2559,GO:0033275,0.470260409024144,0.927136194727363,1,2,actin-myosin filament sliding,BP,ACTN2
556,GO:0005102,0.47052712147351,0.663024654031646,15,58,receptor binding,MF,LAMA1;ACTN2;NRTN;REEP1;KITLG;MFGE8;PIK3R1;GAS6;LAMA5;ITGB8;DHH;DLL1;CTGF;ITGA3;MSN
480,GO:0003676,0.471258888304798,0.756666285130754,4,13,nucleic acid binding,MF,HMGN5;FOXO4;WT1;MSN
3322,GO:0044424,0.471555529878013,0.665117503092915,46,182,intracellular part,CC,ACTN2;MYO7A;CDKN1A;FRMPD1;HMGCS2;REEP1;GPRASP1;RHOB;KITLG;MRO;PHLDA1;RHOJ;NUAK2;CAMSAP3;PLEKHH2;PIK3R1;SLC25A53;GAS6;LAMA5;SDC4;ITGB5;PRKACB;SERPINA5;HMGN5;PTPN7;RIN3;ACSL4;CRISPLD2;FHOD3;RAB39B;FOXO4;GPSM1;MARK4;ESPN;DLL1;TMEM163;PDE4B;UNC119;CGN;CLDN1;CTGF;ITGA3;WT1;MSN;PTGES;SH3BP4
636,GO:0005615,0.472029704669872,0.680185783677967,10,43,extracellular space,CC,LAMA1;DKK3;KITLG;MFGE8;GAS6;LAMA5;SERPINA5;DHH;CTGF;MSN
3805,GO:0048519,0.473079108764557,0.643836696423431,27,104,negative regulation of biological process,BP,ACTN2;CDKN1A;DKK3;GPRASP1;RHOB;KITLG;NUAK2;CAMSAP3;PLEKHH2;PIK3R1;GAS6;SDC4;PRKACB;ITGB8;SERPINA5;HMGN5;FHOD3;FOXO4;ESPN;DLL1;PDE4B;UNC119;CTGF;ITGA3;WT1;PTGES;SH3BP4
3718,GO:0047485,0.473181041103263,0.9260530498738,1,2,protein N-terminus binding,MF,MYO7A
4511,GO:0060541,0.474302044720016,0.73288603732793,5,17,respiratory system development,BP,LAMA5;CRISPLD2;CTGF;ITGA3;WT1
3085,GO:0043112,0.474490992336087,0.925563646081922,1,2,receptor metabolic process,BP,GPRASP1
688,GO:0005884,0.47591244047414,0.837442108042026,2,5,actin filament,CC,ACTN2;ESPN
2256,GO:0031902,0.475943275825921,0.903556735026446,1,3,late endosome membrane,CC,RHOB
3344,GO:0044456,0.476182738647227,0.731301024817714,5,17,synapse part,CC,ACTN2;LAMA5;TMEM163;PDE4B;ITGA3
5453,GO:0098772,0.476281730539933,0.678607480434427,10,38,molecular function regulator,MF,ACTN2;CDKN1A;NRTN;KITLG;PIK3R1;GAS6;SERPINA5;RIN3;GPSM1;SH3BP4
4205,GO:0051494,0.476525158748297,0.798152576902918,3,7,negative regulation of cytoskeleton organization,BP,PLEKHH2;FHOD3;ESPN
5840,GO:1903672,0.47855853668818,0.924029687233918,1,2,positive regulation of sprouting angiogenesis,BP,DLL1
1820,GO:0021532,0.478879582484849,0.902158119131452,1,3,neural tube patterning,BP,PRKACB
844,GO:0006766,0.478965735391916,0.923874925409622,1,2,vitamin metabolic process,BP,SLC52A3
288,GO:0002407,0.479376095315587,0.923718740416199,1,2,dendritic cell chemotaxis,BP,GAS6
2847,GO:0036336,0.479376095315587,0.923718740416199,1,2,dendritic cell migration,BP,GAS6
2812,GO:0035987,0.48099974932656,0.923098582176856,1,2,endodermal cell differentiation,BP,ITGB5
3530,GO:0045765,0.481226319906736,0.78630956360128,3,8,regulation of angiogenesis,BP,RHOB;FOXO4;DLL1
2829,GO:0036064,0.481448937726166,0.922926395424612,1,2,ciliary basal body,CC,MARK4
616,GO:0005520,0.481756451389598,0.922808361777855,1,2,insulin-like growth factor binding,MF,CTGF
2672,GO:0034764,0.482544022911093,0.922505491592169,1,2,positive regulation of transmembrane transport,BP,ACTN2
2675,GO:0034767,0.482544022911093,0.922505491592169,1,2,positive regulation of ion transmembrane transport,BP,ACTN2
5599,GO:1901381,0.482544022911093,0.922505491592169,1,2,positive regulation of potassium ion transmembrane transport,BP,ACTN2
5883,GO:1904064,0.482544022911093,0.922505491592169,1,2,positive regulation of cation transmembrane transport,BP,ACTN2
848,GO:0006790,0.483951034334107,0.92196234503885,1,2,sulfur compound metabolic process,BP,ACSL4
3292,GO:0044272,0.483951034334107,0.92196234503885,1,2,sulfur compound biosynthetic process,BP,ACSL4
4185,GO:0051384,0.484170321695049,0.814946804393272,2,7,response to glucocorticoid,BP,CDKN1A;CLDN1
4171,GO:0051302,0.485866459278929,0.898775212968041,1,3,regulation of cell division,BP,DLL1
4011,GO:0050863,0.487413340642471,0.819566667556342,2,6,regulation of T cell activation,BP,PIK3R1;SDC4
5766,GO:1903037,0.487413340642471,0.819566667556342,2,6,regulation of leukocyte cell-cell adhesion,BP,PIK3R1;SDC4
3264,GO:0044087,0.488481589640801,0.69371218254207,7,24,regulation of cellular component biogenesis,BP,PIK3R1;SDC4;FHOD3;ESPN;CLDN1;CTGF;MSN
2617,GO:0034329,0.489760171464079,0.738771487749017,4,14,cell junction assembly,BP,ACTN2;LAMA5;SDC4;CLDN1
1077,GO:0008064,0.490227414139687,0.788147537975712,3,7,regulation of actin polymerization or depolymerization,BP,ACTN2;PLEKHH2;FHOD3
1092,GO:0008154,0.490227414139687,0.788147537975712,3,7,actin polymerization or depolymerization,BP,ACTN2;PLEKHH2;FHOD3
2091,GO:0030832,0.490227414139687,0.788147537975712,3,7,regulation of actin filament length,BP,ACTN2;PLEKHH2;FHOD3
2896,GO:0040012,0.490296839773955,0.666362024811876,10,37,regulation of locomotion,BP,LAMA1;RHOB;KITLG;PIK3R1;GAS6;LAMA5;SDC4;FOXO4;ITGA3;MSN
5427,GO:0098589,0.490738377873798,0.772903980791742,3,9,membrane region,CC,SDC4;DLL1;SH3BP4
1429,GO:0010934,0.490979235654626,0.919209283904922,1,2,macrophage cytokine production,BP,GAS6
2426,GO:0032635,0.490979235654626,0.919209283904922,1,2,interleukin-6 production,BP,GAS6
2438,GO:0032675,0.490979235654626,0.919209283904922,1,2,regulation of interleukin-6 production,BP,GAS6
3947,GO:0050701,0.490979235654626,0.919209283904922,1,2,interleukin-1 secretion,BP,GAS6
3949,GO:0050704,0.490979235654626,0.919209283904922,1,2,regulation of interleukin-1 secretion,BP,GAS6
3951,GO:0050707,0.490979235654626,0.919209283904922,1,2,regulation of cytokine secretion,BP,GAS6
147,GO:0001780,0.491104448613923,0.919159626852475,1,2,neutrophil homeostasis,BP,PDE4B
2011,GO:0030318,0.49165135944729,0.918942480645421,1,2,melanocyte differentiation,BP,KITLG
144,GO:0001775,0.491944470530967,0.670237753620167,9,35,cell activation,BP,CDKN1A;RHOB;PIK3R1;GAS6;SDC4;CRISPLD2;DLL1;CTGF;MSN
5740,GO:1902806,0.492046118475068,0.884840567165521,1,4,regulation of cell cycle G1/S phase transition,BP,CDKN1A
6025,GO:2000045,0.492046118475068,0.884840567165521,1,4,regulation of G1/S transition of mitotic cell cycle,BP,CDKN1A
156,GO:0001823,0.492684599949363,0.760054329983795,3,12,mesonephros development,BP,LAMA5;SDC4;WT1
1596,GO:0016192,0.493111198235002,0.649059841262131,13,49,vesicle-mediated transport,BP,ACTN2;MYO7A;MFGE8;PIK3R1;GAS6;SDC4;RIN3;CRISPLD2;RAB39B;DLL1;UNC119;MSN;SH3BP4
3570,GO:0045921,0.49406456820062,0.894705646058475,1,3,positive regulation of exocytosis,BP,SDC4
2642,GO:0034613,0.49406793183917,0.657718438082072,11,40,cellular protein localization,BP,ACTN2;MYO7A;CDKN1A;REEP1;RHOB;PIK3R1;GAS6;LAMA5;ITGA3;MSN;SH3BP4
4864,GO:0070727,0.49406793183917,0.657718438082072,11,40,cellular macromolecule localization,BP,ACTN2;MYO7A;CDKN1A;REEP1;RHOB;PIK3R1;GAS6;LAMA5;ITGA3;MSN;SH3BP4
4434,GO:0060341,0.494206244714935,0.687422625119351,7,25,regulation of cellular localization,BP,ACTN2;CDKN1A;REEP1;PIK3R1;GAS6;ITGA3;MSN
3118,GO:0043227,0.49434333682257,0.628884240136669,39,156,membrane-bounded organelle,CC,ACTN2;MYO7A;CDKN1A;FRMPD1;HMGCS2;REEP1;RHOB;MRO;PHLDA1;RHOJ;NUAK2;MFGE8;CLDN11;PIK3R1;SLC25A53;GAS6;LAMA5;SDC4;ITGB5;PRKACB;ITGB8;SERPINA5;HMGN5;RIN3;ACSL4;CRISPLD2;RAB39B;FOXO4;GPSM1;DAAM2;DLL1;TMEM163;PDE4B;CTGF;ITGA3;WT1;MSN;PTGES;SH3BP4
4202,GO:0051491,0.494754463929643,0.91770262940556,1,2,positive regulation of filopodium assembly,BP,ESPN
640,GO:0005635,0.495059440723954,0.894204320608543,1,3,nuclear envelope,CC,PTGES
3788,GO:0048468,0.495662506310468,0.632667006033615,18,68,cell development,BP,ACTN2;MYO7A;CDKN1A;NRTN;KITLG;CAMSAP3;PIK3R1;LAMA5;SDC4;SEMA6C;ACSL4;FHOD3;DHH;DLL1;CLDN1;ITGA3;WT1;MSN
3789,GO:0048469,0.495954398624554,0.893751949662983,1,3,cell maturation,BP,CDKN1A
257,GO:0002262,0.496252325074689,0.813408768132192,2,6,myeloid cell homeostasis,BP,KITLG;PDE4B
1965,GO:0030168,0.496958139975418,0.763281239527282,3,10,platelet activation,BP,RHOB;PIK3R1;GAS6
150,GO:0001816,0.497066096349677,0.735445009211992,4,13,cytokine production,BP,PIK3R1;GAS6;DLL1;PDE4B
118,GO:0001678,0.497984952504916,0.812187244306069,2,6,cellular glucose homeostasis,BP,PIK3R1;GAS6
552,GO:0005085,0.498185892074727,0.729327864677985,4,15,guanyl-nucleotide exchange factor activity,MF,ACTN2;NRTN;KITLG;RIN3
1330,GO:0010564,0.498405939373265,0.725412170160872,4,17,regulation of cell cycle process,BP,CDKN1A;HMGN5;FOXO4;CTGF
3658,GO:0046683,0.49881853672998,0.916058631134269,1,2,response to organophosphorus,BP,WT1
4220,GO:0051591,0.49881853672998,0.916058631134269,1,2,response to cAMP,BP,WT1
4917,GO:0071320,0.49881853672998,0.916058631134269,1,2,cellular response to cAMP,BP,WT1
3741,GO:0048144,0.499540272861966,0.80391942074978,2,7,fibroblast proliferation,BP,CDKN1A;GAS6
30,GO:0000226,0.499628904486197,0.798748009099887,2,8,microtubule cytoskeleton organization,BP,CAMSAP3;MARK4
921,GO:0007017,0.499628904486197,0.798748009099887,2,8,microtubule-based process,BP,CAMSAP3;MARK4
3982,GO:0050790,0.500552286385567,0.634232967671052,15,61,regulation of catalytic activity,BP,ACTN2;CDKN1A;NRTN;KITLG;CAMSAP3;PIK3R1;GAS6;SDC4;PRKACB;SERPINA5;RIN3;GPSM1;UNC119;CTGF;SH3BP4
976,GO:0007220,0.50110106864724,0.915125164248827,1,2,Notch receptor processing,BP,DLL1
806,GO:0006606,0.501166575483521,0.75990843121322,3,10,protein import into nucleus,BP,CDKN1A;PIK3R1;GAS6
888,GO:0006913,0.501166575483521,0.75990843121322,3,10,nucleocytoplasmic transport,BP,CDKN1A;PIK3R1;GAS6
1698,GO:0017038,0.501166575483521,0.75990843121322,3,10,protein import,BP,CDKN1A;PIK3R1;GAS6
3365,GO:0044744,0.501166575483521,0.75990843121322,3,10,protein targeting to nucleus,BP,CDKN1A;PIK3R1;GAS6
4105,GO:0051169,0.501166575483521,0.75990843121322,3,10,nuclear transport,BP,CDKN1A;PIK3R1;GAS6
4106,GO:0051170,0.501166575483521,0.75990843121322,3,10,nuclear import,BP,CDKN1A;PIK3R1;GAS6
5721,GO:1902593,0.501166575483521,0.75990843121322,3,10,single-organism nuclear import,BP,CDKN1A;PIK3R1;GAS6
995,GO:0007272,0.502370881341924,0.801847557520444,2,7,ensheathment of neurons,BP,CLDN11;DHH
1129,GO:0008366,0.502370881341924,0.801847557520444,2,7,axon ensheathment,BP,CLDN11;DHH
3673,GO:0046824,0.503073647475396,0.808572000673048,2,6,positive regulation of nucleocytoplasmic transport,BP,PIK3R1;GAS6
4458,GO:0060416,0.504279498284761,0.913813045846023,1,2,response to growth hormone,BP,PIK3R1
2130,GO:0031012,0.505076758878465,0.702813453132443,5,19,extracellular matrix,CC,LAMA1;MFGE8;LAMA5;CRISPLD2;CTGF
5495,GO:0099513,0.505815352605457,0.756152854299408,3,10,polymeric cytoskeletal fiber,CC,ACTN2;CAMSAP3;ESPN
4008,GO:0050851,0.506281512338754,0.806271646909633,2,6,antigen receptor-mediated signaling pathway,BP,PIK3R1;PDE4B
4009,GO:0050852,0.506281512338754,0.806271646909633,2,6,T cell receptor signaling pathway,BP,PIK3R1;PDE4B
94,GO:0001541,0.50633263023752,0.912957824832583,1,2,ovarian follicle development,BP,KITLG
1891,GO:0022602,0.50633263023752,0.912957824832583,1,2,ovulation cycle process,BP,KITLG
4822,GO:0070374,0.506983077266259,0.78629835746451,2,10,positive regulation of ERK1 and ERK2 cascade,BP,GAS6;CTGF
5881,GO:1904062,0.507311091850269,0.805529818073219,2,6,regulation of cation transmembrane transport,BP,ACTN2;PDE4B
4509,GO:0060538,0.507708960543478,0.805242687649714,2,6,skeletal muscle organ development,BP,DLL1;WT1
3966,GO:0050730,0.507853098786925,0.74763472600516,3,12,regulation of peptidyl-tyrosine phosphorylation,BP,KITLG;GAS6;UNC119
3967,GO:0050731,0.507853098786925,0.74763472600516,3,12,positive regulation of peptidyl-tyrosine phosphorylation,BP,KITLG;GAS6;UNC119
2704,GO:0035162,0.507914590293982,0.91229474485981,1,2,embryonic hemopoiesis,BP,KITLG
639,GO:0005634,0.508154299582479,0.630910006946854,14,54,nucleus,CC,CDKN1A;RHOB;MRO;PHLDA1;NUAK2;PIK3R1;LAMA5;PRKACB;HMGN5;FOXO4;WT1;MSN;PTGES;SH3BP4
1114,GO:0008270,0.508692541908622,0.753812677855815,3,10,zinc ion binding,MF,DHH;TMEM163;WT1
3336,GO:0044444,0.508889926590615,0.612594931618092,37,147,cytoplasmic part,CC,ACTN2;MYO7A;CDKN1A;FRMPD1;HMGCS2;REEP1;GPRASP1;RHOB;PHLDA1;RHOJ;PLEKHH2;PIK3R1;SLC25A53;GAS6;SDC4;ITGB5;PRKACB;SERPINA5;PTPN7;RIN3;ACSL4;CRISPLD2;FHOD3;RAB39B;FOXO4;GPSM1;MARK4;DLL1;TMEM163;PDE4B;UNC119;CTGF;ITGA3;WT1;MSN;PTGES;SH3BP4
3430,GO:0045178,0.50912731510865,0.886938724672368,1,3,basal part of cell,CC,CLDN11
1271,GO:0009987,0.509974142476999,0.688104556132573,54,216,cellular process,BP,LAMA1;ACTN2;MYO7A;CDKN1A;HMGCS2;NRTN;REEP1;DKK3;GPRASP1;RHOB;KITLG;PRND;PHLDA1;SLC52A3;RHOJ;NUAK2;MFGE8;CAMSAP3;PLEKHH2;CLDN11;PIK3R1;GAS6;LAMA5;SDC4;MPZL1;ITGB5;SEMA6C;PRKACB;ITGB8;SERPINA5;HMGN5;PTPN7;RIN3;ACSL4;CRISPLD2;FHOD3;RAB39B;FOXO4;DHH;GPSM1;MARK4;ESPN;DAAM2;DLL1;PDE4B;UNC119;CGN;CLDN1;CTGF;ITGA3;WT1;MSN;PTGES;SH3BP4
1005,GO:0007350,0.509993651001305,0.911417815233303,1,2,blastoderm segmentation,BP,WT1
1006,GO:0007351,0.509993651001305,0.911417815233303,1,2,tripartite regional subdivision,BP,WT1
1150,GO:0008595,0.509993651001305,0.911417815233303,1,2,anterior/posterior axis specification, embryo,BP,WT1
2019,GO:0030335,0.51085102353772,0.681106922736233,6,24,positive regulation of cell migration,BP,RHOB;KITLG;PIK3R1;GAS6;FOXO4;ITGA3
4157,GO:0051272,0.51085102353772,0.681106922736233,6,24,positive regulation of cellular component movement,BP,RHOB;KITLG;PIK3R1;GAS6;FOXO4;ITGA3
6051,GO:2000147,0.51085102353772,0.681106922736233,6,24,positive regulation of cell motility,BP,RHOB;KITLG;PIK3R1;GAS6;FOXO4;ITGA3
2285,GO:0032007,0.510877115325027,0.91104328122752,1,2,negative regulation of TOR signaling,BP,SH3BP4
4900,GO:0071230,0.510877115325027,0.91104328122752,1,2,cellular response to amino acid stimulus,BP,SH3BP4
2396,GO:0032501,0.510938714286499,0.612735677629113,39,152,multicellular organismal process,BP,LAMA1;ACTN2;MYO7A;CDKN1A;NRTN;DKK3;RHOB;KITLG;SLC52A3;RHOJ;MFGE8;CAMSAP3;CLDN11;PIK3R1;GAS6;LAMA5;SDC4;ITGB5;SEMA6C;PRKACB;ITGB8;SERPINA5;ACSL4;CRISPLD2;FHOD3;FOXO4;DHH;GPSM1;MARK4;ESPN;DAAM2;DLL1;PDE4B;UNC119;CLDN1;CTGF;ITGA3;WT1;MSN
4299,GO:0055002,0.511445452167159,0.802533626406193,2,6,striated muscle cell development,BP,ACTN2;FHOD3
2490,GO:0032886,0.511551026068392,0.885653100428882,1,3,regulation of microtubule-based process,BP,CAMSAP3
4836,GO:0070507,0.511551026068392,0.885653100428882,1,3,regulation of microtubule cytoskeleton organization,BP,CAMSAP3
4971,GO:0071548,0.514251522645058,0.884208730397804,1,3,response to dexamethasone,BP,CLDN1
3809,GO:0048523,0.514537404038648,0.605276771685894,25,99,negative regulation of cellular process,BP,ACTN2;CDKN1A;DKK3;GPRASP1;RHOB;KITLG;NUAK2;CAMSAP3;PLEKHH2;PIK3R1;GAS6;SDC4;PRKACB;SERPINA5;HMGN5;FHOD3;FOXO4;ESPN;DLL1;UNC119;CTGF;ITGA3;WT1;PTGES;SH3BP4
2548,GO:0033157,0.515232848704927,0.748447803768999,3,10,regulation of intracellular protein transport,BP,CDKN1A;PIK3R1;GAS6
1237,GO:0009791,0.516373003412109,0.88306517132598,1,3,post-embryonic development,BP,MYO7A
1165,GO:0009059,0.51670409856715,0.619056745724694,15,60,macromolecule biosynthetic process,BP,ACTN2;CDKN1A;DKK3;KITLG;PRND;PHLDA1;PIK3R1;GAS6;SDC4;HMGN5;FOXO4;DLL1;CTGF;ITGA3;WT1
4099,GO:0051150,0.516945525432795,0.882755214867221,1,3,regulation of smooth muscle cell differentiation,BP,FOXO4
1369,GO:0010712,0.517498829736833,0.882455117690013,1,3,regulation of collagen metabolic process,BP,CTGF
1370,GO:0010714,0.517498829736833,0.882455117690013,1,3,positive regulation of collagen metabolic process,BP,CTGF
2508,GO:0032963,0.517498829736833,0.882455117690013,1,3,collagen metabolic process,BP,CTGF
2509,GO:0032964,0.517498829736833,0.882455117690013,1,3,collagen biosynthetic process,BP,CTGF
2510,GO:0032965,0.517498829736833,0.882455117690013,1,3,regulation of collagen biosynthetic process,BP,CTGF
2511,GO:0032967,0.517498829736833,0.882455117690013,1,3,positive regulation of collagen biosynthetic process,BP,CTGF
3274,GO:0044236,0.517498829736833,0.882455117690013,1,3,multicellular organism metabolic process,BP,CTGF
3278,GO:0044246,0.517498829736833,0.882455117690013,1,3,regulation of multicellular organismal metabolic process,BP,CTGF
3281,GO:0044253,0.517498829736833,0.882455117690013,1,3,positive regulation of multicellular organismal metabolic process,BP,CTGF
3284,GO:0044259,0.517498829736833,0.882455117690013,1,3,multicellular organismal macromolecule metabolic process,BP,CTGF
680,GO:0005829,0.518000589707117,0.60783581702915,20,75,cytosol,CC,ACTN2;MYO7A;CDKN1A;FRMPD1;GPRASP1;RHOB;PHLDA1;RHOJ;PIK3R1;PRKACB;PTPN7;RIN3;FOXO4;GPSM1;MARK4;PDE4B;UNC119;CTGF;WT1;MSN
2047,GO:0030539,0.518222543687371,0.869941949497057,1,4,male genitalia development,BP,WT1
637,GO:0005622,0.518629436047904,0.626574096479831,47,191,intracellular,CC,ACTN2;MYO7A;CDKN1A;FRMPD1;HMGCS2;NRTN;REEP1;GPRASP1;RHOB;KITLG;MRO;PHLDA1;RHOJ;NUAK2;CAMSAP3;PLEKHH2;PIK3R1;SLC25A53;GAS6;LAMA5;SDC4;ITGB5;PRKACB;SERPINA5;HMGN5;PTPN7;RIN3;ACSL4;CRISPLD2;FHOD3;RAB39B;FOXO4;GPSM1;MARK4;ESPN;DLL1;TMEM163;PDE4B;UNC119;CGN;CLDN1;CTGF;ITGA3;WT1;MSN;PTGES;SH3BP4
4685,GO:0061217,0.519956384911725,0.868911089774941,1,4,regulation of mesonephros development,BP,WT1
4871,GO:0070838,0.521604359598881,0.739234654024298,3,11,divalent metal ion transport,BP,GAS6;PDE4B;CTGF
5178,GO:0072511,0.521604359598881,0.739234654024298,3,11,divalent inorganic cation transport,BP,GAS6;PDE4B;CTGF
1814,GO:0019953,0.52178359697178,0.686339381485903,5,20,sexual reproduction,BP,MFGE8;CLDN11;SERPINA5;DHH;WT1
793,GO:0006497,0.522098445260104,0.906186244511657,1,2,protein lipidation,BP,PRND
2937,GO:0042158,0.522098445260104,0.906186244511657,1,2,lipoprotein biosynthetic process,BP,PRND
2212,GO:0031489,0.5253397046083,0.878144374045672,1,3,myosin V binding,MF,RAB39B
2894,GO:0040008,0.526125588773579,0.667066832352252,6,24,regulation of growth,BP,CDKN1A;GAS6;DLL1;CTGF;WT1;SH3BP4
754,GO:0006259,0.526358115607927,0.727246942447606,3,14,DNA metabolic process,BP,CDKN1A;KITLG;CTGF
4196,GO:0051447,0.528772474708596,0.876222585229336,1,3,negative regulation of meiotic cell cycle,BP,PRKACB
5370,GO:0097191,0.528898364043757,0.776259820870083,2,8,extrinsic apoptotic signaling pathway,BP,KITLG;PIK3R1
4918,GO:0071322,0.529173833387489,0.875996501954088,1,3,cellular response to carbohydrate stimulus,BP,GAS6
4919,GO:0071326,0.529173833387489,0.875996501954088,1,3,cellular response to monosaccharide stimulus,BP,GAS6
4920,GO:0071331,0.529173833387489,0.875996501954088,1,3,cellular response to hexose stimulus,BP,GAS6
4921,GO:0071333,0.529173833387489,0.875996501954088,1,3,cellular response to glucose stimulus,BP,GAS6
331,GO:0002695,0.529646997776997,0.875729596078461,1,3,negative regulation of leukocyte activation,BP,SDC4
4145,GO:0051250,0.529646997776997,0.875729596078461,1,3,negative regulation of lymphocyte activation,BP,SDC4
351,GO:0002763,0.529865372831694,0.902713659122895,1,2,positive regulation of myeloid leukocyte differentiation,BP,KITLG
5454,GO:0098773,0.529983600593218,0.800545083741305,2,5,skin epidermis development,BP,LAMA5;DLL1
1060,GO:0007613,0.530016622982735,0.902645117545259,1,2,memory,BP,ITGA3
2170,GO:0031226,0.53007757133723,0.635219809941111,9,34,intrinsic component of plasma membrane,CC,SLC52A3;SDC4;MPZL1;ITGB5;ITGB8;DLL1;CLDN1;SLC18B1;ITGA3
583,GO:0005201,0.530473366055164,0.902437921927214,1,2,extracellular matrix structural constituent,MF,LAMA1
207,GO:0001977,0.531102861042236,0.874905813012828,1,3,renal system process involved in regulation of blood volume,BP,GAS6
382,GO:0003071,0.531102861042236,0.874905813012828,1,3,renal system process involved in regulation of systemic arterial blood pressure,BP,GAS6
386,GO:0003093,0.531102861042236,0.874905813012828,1,3,regulation of glomerular filtration,BP,GAS6
387,GO:0003094,0.531102861042236,0.874905813012828,1,3,glomerular filtration,BP,GAS6
725,GO:0006023,0.531498999200448,0.874680995391741,1,3,aminoglycan biosynthetic process,BP,SDC4
726,GO:0006024,0.531498999200448,0.874680995391741,1,3,glycosaminoglycan biosynthetic process,BP,SDC4
679,GO:0005819,0.532562626458939,0.861245646426176,1,4,spindle,CC,UNC119
5456,GO:0098793,0.532636198086209,0.769107328058064,2,9,presynapse,CC,TMEM163;PDE4B
709,GO:0005943,0.533473725205484,0.901068795690158,1,2,phosphatidylinositol 3-kinase complex, class IA,CC,PIK3R1
3220,GO:0043560,0.533473725205484,0.901068795690158,1,2,insulin receptor substrate binding,MF,PIK3R1
647,GO:0005739,0.534082133074282,0.695775734615893,4,16,mitochondrion,CC,HMGCS2;REEP1;SLC25A53;ACSL4
4302,GO:0055007,0.53419049892605,0.732536266627692,3,10,cardiac muscle cell differentiation,BP,ACTN2;FHOD3;WT1
4948,GO:0071398,0.534415692955343,0.873016871851959,1,3,cellular response to fatty acid,BP,CLDN1
2422,GO:0032612,0.534931102684911,0.872721181259107,1,3,interleukin-1 production,BP,GAS6
2434,GO:0032652,0.534931102684911,0.872721181259107,1,3,regulation of interleukin-1 production,BP,GAS6
5216,GO:0086004,0.536400107207869,0.899719869640547,1,2,regulation of cardiac muscle cell contraction,BP,PDE4B
5777,GO:1903115,0.536400107207869,0.899719869640547,1,2,regulation of actin filament-based movement,BP,PDE4B
2213,GO:0031490,0.536755192809184,0.899555274649107,1,2,chromatin DNA binding,MF,HMGN5
860,GO:0006820,0.537105510815395,0.775349863018101,2,7,anion transport,BP,SLC52A3;ACSL4
971,GO:0007200,0.537269204258667,0.871373657022015,1,3,phospholipase C-activating G-protein coupled receptor signaling pathway,BP,ACTN2
786,GO:0006470,0.537309913316519,0.87135010547067,1,3,protein dephosphorylation,BP,PTPN7
3465,GO:0045471,0.539363989249434,0.856983176978716,1,4,response to ethanol,BP,CLDN1
4020,GO:0050877,0.539805414962197,0.671322326467403,5,19,neurological system process,BP,MYO7A;SLC52A3;ESPN;UNC119;ITGA3
148,GO:0001784,0.540331698383159,0.897886285339014,1,2,phosphotyrosine binding,MF,PIK3R1
2680,GO:0035014,0.540331698383159,0.897886285339014,1,2,phosphatidylinositol 3-kinase regulator activity,MF,PIK3R1
3312,GO:0044381,0.540331698383159,0.897886285339014,1,2,glucose import in response to insulin stimulus,BP,PIK3R1
3450,GO:0045309,0.540331698383159,0.897886285339014,1,2,protein phosphorylated amino acid binding,MF,PIK3R1
3708,GO:0046935,0.540331698383159,0.897886285339014,1,2,1-phosphatidylinositol-3-kinase regulator activity,MF,PIK3R1
4129,GO:0051219,0.540331698383159,0.897886285339014,1,2,phosphoprotein binding,MF,PIK3R1
5521,GO:1900076,0.540331698383159,0.897886285339014,1,2,regulation of cellular response to insulin stimulus,BP,PIK3R1
5522,GO:1900078,0.540331698383159,0.897886285339014,1,2,positive regulation of cellular response to insulin stimulus,BP,PIK3R1
6182,GO:2001273,0.540331698383159,0.897886285339014,1,2,regulation of glucose import in response to insulin stimulus,BP,PIK3R1
6183,GO:2001275,0.540331698383159,0.897886285339014,1,2,positive regulation of glucose import in response to insulin stimulus,BP,PIK3R1
3213,GO:0043548,0.540745928851135,0.897691666111713,1,2,phosphatidylinositol 3-kinase binding,MF,PIK3R1
483,GO:0003690,0.541319834991595,0.869015110403087,1,3,double-stranded DNA binding,MF,WT1
2049,GO:0030545,0.541457075353313,0.771886358582691,2,7,receptor regulator activity,MF,ACTN2;GAS6
2050,GO:0030546,0.541457075353313,0.771886358582691,2,7,receptor activator activity,MF,ACTN2;GAS6
2105,GO:0030859,0.541745675746246,0.897220819340784,1,2,polarized epithelial cell differentiation,BP,MSN
2690,GO:0035089,0.541745675746246,0.897220819340784,1,2,establishment of apical/basal cell polarity,BP,MSN
3438,GO:0045198,0.541745675746246,0.897220819340784,1,2,establishment of epithelial cell apical/basal polarity,BP,MSN
4677,GO:0061162,0.541745675746246,0.897220819340784,1,2,establishment of monopolar cell polarity,BP,MSN
4702,GO:0061339,0.541745675746246,0.897220819340784,1,2,establishment or maintenance of monopolar cell polarity,BP,MSN
5270,GO:0090162,0.541745675746246,0.897220819340784,1,2,establishment of epithelial cell polarity,BP,MSN
1391,GO:0010810,0.542765666974917,0.730426577336525,3,9,regulation of cell-substrate adhesion,BP,PIK3R1;SDC4;ITGA3
2899,GO:0040017,0.543140856989648,0.650036521172253,6,25,positive regulation of locomotion,BP,RHOB;KITLG;PIK3R1;GAS6;FOXO4;ITGA3
3978,GO:0050776,0.543218104650522,0.72476679489857,3,10,regulation of immune response,BP,PIK3R1;PRKACB;PDE4B
3980,GO:0050778,0.543218104650522,0.72476679489857,3,10,positive regulation of immune response,BP,PIK3R1;PRKACB;PDE4B
116,GO:0001669,0.5438483487092,0.896225285521738,1,2,acrosomal vesicle,CC,SERPINA5
5376,GO:0097223,0.5438483487092,0.896225285521738,1,2,sperm part,CC,SERPINA5
5713,GO:1902554,0.544045114448854,0.867410966187316,1,3,serine/threonine protein kinase complex,CC,CDKN1A
5752,GO:1902911,0.544045114448854,0.867410966187316,1,3,protein kinase complex,CC,CDKN1A
5369,GO:0097190,0.544200194436461,0.713794372025013,3,13,apoptotic signaling pathway,BP,CDKN1A;KITLG;PIK3R1
194,GO:0001948,0.54503759621832,0.895659059549767,1,2,glycoprotein binding,MF,ITGA3
5090,GO:0072125,0.545572111946814,0.866506015494834,1,3,negative regulation of glomerular mesangial cell proliferation,BP,WT1
5278,GO:0090185,0.545572111946814,0.866506015494834,1,3,negative regulation of kidney development,BP,WT1
5286,GO:0090194,0.545572111946814,0.866506015494834,1,3,negative regulation of glomerulus development,BP,WT1
5637,GO:1901723,0.545572111946814,0.866506015494834,1,3,negative regulation of cell proliferation involved in kidney development,BP,WT1
1514,GO:0014910,0.546029260976847,0.866234232421932,1,3,regulation of smooth muscle cell migration,BP,FOXO4
349,GO:0002761,0.548202539508056,0.774640690761215,2,6,regulation of myeloid leukocyte differentiation,BP,KITLG;PIK3R1
4092,GO:0051129,0.548271837610939,0.669673854921542,5,16,negative regulation of cellular component organization,BP,PLEKHH2;FHOD3;ESPN;UNC119;ITGA3
5954,GO:1905475,0.550133651392664,0.773110980914169,2,6,regulation of protein localization to membrane,BP,PIK3R1;ITGA3
684,GO:0005874,0.550367254481923,0.849893884640148,1,4,microtubule,CC,CAMSAP3
250,GO:0002237,0.550688998576163,0.710727862974782,3,12,response to molecule of bacterial origin,BP,PDE4B;CLDN1;PTGES
2395,GO:0032496,0.550688998576163,0.710727862974782,3,12,response to lipopolysaccharide,BP,PDE4B;CLDN1;PTGES
3280,GO:0044249,0.55095092570915,0.580095917398174,17,70,cellular biosynthetic process,BP,ACTN2;CDKN1A;HMGCS2;DKK3;KITLG;PRND;PHLDA1;PIK3R1;GAS6;HMGN5;ACSL4;FOXO4;DLL1;CTGF;ITGA3;WT1;PTGES
1739,GO:0019079,0.550980539857544,0.892794891909028,1,2,viral genome replication,BP,GAS6
3597,GO:0046058,0.551602202108171,0.849083030592752,1,4,cAMP metabolic process,BP,PDE4B
2119,GO:0030902,0.552909499130739,0.862095465603217,1,3,hindbrain development,BP,DLL1
1884,GO:0022408,0.553482795612917,0.861746477808087,1,3,negative regulation of cell-cell adhesion,BP,SDC4
1210,GO:0009581,0.555514565242089,0.860504502866441,1,3,detection of external stimulus,BP,UNC119
1211,GO:0009582,0.555514565242089,0.860504502866441,1,3,detection of abiotic stimulus,BP,UNC119
2720,GO:0035303,0.556114721525613,0.86013609655788,1,3,regulation of dephosphorylation,BP,CAMSAP3
1581,GO:0016050,0.556175462683757,0.753992848743834,2,8,vesicle organization,BP,MYO7A;SDC4
5253,GO:0090075,0.556914076387968,0.859644314529211,1,3,relaxation of muscle,BP,PDE4B
4880,GO:0070887,0.557480859262809,0.573602400679794,17,70,cellular response to chemical stimulus,BP,ACTN2;DKK3;RHOB;PIK3R1;GAS6;ITGB5;PRKACB;FOXO4;DLL1;PDE4B;CGN;CLDN1;CTGF;ITGA3;WT1;MSN;SH3BP4
4069,GO:0051050,0.558225486294125,0.624453113554589,7,28,positive regulation of transport,BP,ACTN2;MFGE8;PIK3R1;GAS6;SDC4;DLL1;MSN
1707,GO:0017137,0.558807568879512,0.888933209229664,1,2,Rab GTPase binding,MF,RIN3
3737,GO:0048066,0.558823134094757,0.858464727212095,1,3,developmental pigmentation,BP,KITLG
4042,GO:0050931,0.558823134094757,0.858464727212095,1,3,pigment cell differentiation,BP,KITLG
630,GO:0005578,0.559830909886307,0.674299317073377,4,15,proteinaceous extracellular matrix,CC,LAMA1;LAMA5;CRISPLD2;CTGF
5623,GO:1901652,0.561377159100593,0.652818660435134,5,18,response to peptide,BP,ACTN2;PIK3R1;PRKACB;FOXO4;CTGF
2591,GO:0033762,0.561702331764528,0.856672051399362,1,3,response to glucagon,BP,PRKACB
4938,GO:0071377,0.561702331764528,0.856672051399362,1,3,cellular response to glucagon stimulus,BP,PRKACB
244,GO:0002218,0.562421594165595,0.85622163988025,1,3,activation of innate immune response,BP,PRKACB
348,GO:0002758,0.562421594165595,0.85622163988025,1,3,innate immune response-activating signal transduction,BP,PRKACB
4860,GO:0070673,0.562676293514442,0.856061895855067,1,3,response to interleukin-18,BP,CLDN1
5438,GO:0098655,0.562685606058372,0.699887210847704,3,12,cation transmembrane transport,BP,ACTN2;GAS6;PDE4B
5442,GO:0098660,0.562685606058372,0.699887210847704,3,12,inorganic ion transmembrane transport,BP,ACTN2;GAS6;PDE4B
5444,GO:0098662,0.562685606058372,0.699887210847704,3,12,inorganic cation transmembrane transport,BP,ACTN2;GAS6;PDE4B
2865,GO:0038034,0.562847199386597,0.84155547721445,1,4,signal transduction in absence of ligand,BP,KITLG
5371,GO:0097192,0.562847199386597,0.84155547721445,1,4,extrinsic apoptotic signaling pathway in absence of ligand,BP,KITLG
815,GO:0006638,0.563376426703289,0.886631019975372,1,2,neutral lipid metabolic process,BP,ACSL4
816,GO:0006639,0.563376426703289,0.886631019975372,1,2,acylglycerol metabolic process,BP,ACSL4
817,GO:0006641,0.563376426703289,0.886631019975372,1,2,triglyceride metabolic process,BP,ACSL4
1379,GO:0010761,0.563917609619397,0.855281498504987,1,3,fibroblast migration,BP,SDC4
1380,GO:0010762,0.563917609619397,0.855281498504987,1,3,regulation of fibroblast migration,BP,SDC4
1950,GO:0030101,0.563957209001009,0.855256552052058,1,3,natural killer cell activation,BP,GAS6
4429,GO:0060325,0.564291460922536,0.855045857510163,1,3,face morphogenesis,BP,CRISPLD2
1638,GO:0016477,0.564626940935285,0.579204706429652,13,51,cell migration,BP,LAMA1;NRTN;RHOB;KITLG;PIK3R1;GAS6;LAMA5;SDC4;FOXO4;PDE4B;CTGF;ITGA3;MSN
890,GO:0006915,0.565425665147508,0.581544899730276,12,50,apoptotic process,BP,ACTN2;CDKN1A;RHOB;KITLG;PHLDA1;NUAK2;PIK3R1;GAS6;HMGN5;DLL1;CTGF;WT1
3702,GO:0046907,0.566867361441699,0.608691909597422,8,29,intracellular transport,BP,MYO7A;CDKN1A;REEP1;GPRASP1;RHOB;PIK3R1;GAS6;MSN
3098,GO:0043169,0.567117351912024,0.577846142502311,13,48,cation binding,MF,ACTN2;CDKN1A;PRND;NUAK2;GAS6;PRKACB;SERPINA5;DHH;DLL1;TMEM163;PDE4B;ITGA3;WT1
4935,GO:0071371,0.567779601650193,0.884378169290521,1,2,cellular response to gonadotropin stimulus,BP,WT1
2016,GO:0030330,0.568212970043508,0.837870392188164,1,4,DNA damage response, signal transduction by p53 class mediator,BP,CDKN1A
3045,GO:0042770,0.568212970043508,0.837870392188164,1,4,signal transduction in response to DNA damage,BP,CDKN1A
3418,GO:0045121,0.569288458595994,0.757574914290754,2,6,membrane raft,CC,SDC4;DLL1
5469,GO:0098857,0.569288458595994,0.757574914290754,2,6,membrane microdomain,CC,SDC4;DLL1
4328,GO:0055085,0.569632235063838,0.639988796858754,5,21,transmembrane transport,BP,ACTN2;SLC25A53;GAS6;PDE4B;SLC18B1
1614,GO:0016323,0.569687499629237,0.748601958347361,2,7,basolateral plasma membrane,CC,ITGA3;MSN
4025,GO:0050885,0.570164250492142,0.883143904883938,1,2,neuromuscular process controlling balance,BP,MYO7A
4048,GO:0050957,0.570164250492142,0.883143904883938,1,2,equilibrioception,BP,MYO7A
3275,GO:0044237,0.571002546658691,0.548719478982411,33,133,cellular metabolic process,BP,ACTN2;CDKN1A;HMGCS2;NRTN;DKK3;GPRASP1;KITLG;PRND;PHLDA1;SLC52A3;NUAK2;MFGE8;CAMSAP3;PIK3R1;GAS6;SDC4;PRKACB;ITGB8;SERPINA5;HMGN5;PTPN7;ACSL4;FOXO4;MARK4;DLL1;PDE4B;UNC119;CTGF;ITGA3;WT1;MSN;PTGES;SH3BP4
4021,GO:0050878,0.571334329593395,0.623895112584066,6,24,regulation of body fluid levels,BP,RHOB;PIK3R1;GAS6;PRKACB;SERPINA5;CLDN1
52,GO:0000910,0.571749910956737,0.850285551649117,1,3,cytokinesis,BP,RHOB
649,GO:0005741,0.572038262237993,0.850099230571058,1,3,mitochondrial outer membrane,CC,ACSL4
1794,GO:0019867,0.572038262237993,0.850099230571058,1,3,outer membrane,CC,ACSL4
2273,GO:0031968,0.572038262237993,0.850099230571058,1,3,organelle outer membrane,CC,ACSL4
488,GO:0003713,0.572335149029032,0.849907215125692,1,3,transcription coactivator activity,MF,ACTN2
5166,GO:0072359,0.57288500970644,0.57603653907553,12,45,circulatory system development,BP,ACTN2;RHOB;RHOJ;MFGE8;LAMA5;ITGB8;FHOD3;FOXO4;DLL1;CTGF;ITGA3;WT1
1675,GO:0016787,0.574459220544062,0.59660673205153,8,35,hydrolase activity,MF,MYO7A;RHOB;RHOJ;PTPN7;RAB39B;DHH;PDE4B;CGN
2280,GO:0031984,0.575029576170573,0.848156223736968,1,3,organelle subcompartment,CC,REEP1
1948,GO:0030099,0.576198696624725,0.690907187539414,3,11,myeloid cell differentiation,BP,KITLG;PIK3R1;DLL1
5859,GO:1903827,0.576309984824237,0.6216040647687,6,22,regulation of cellular protein localization,BP,ACTN2;CDKN1A;PIK3R1;GAS6;ITGA3;MSN
2258,GO:0031929,0.576384347446138,0.742865030036036,2,7,TOR signaling,BP,GAS6;SH3BP4
1117,GO:0008284,0.576934095751366,0.615331755176857,6,27,positive regulation of cell proliferation,BP,CDKN1A;KITLG;GAS6;HMGN5;DLL1;CTGF
231,GO:0002085,0.577352932830781,0.879361856420074,1,2,inhibition of neuroepithelial cell differentiation,BP,DLL1
1012,GO:0007386,0.577352932830781,0.879361856420074,1,2,compartment pattern specification,BP,DLL1
1487,GO:0014807,0.577352932830781,0.879361856420074,1,2,regulation of somitogenesis,BP,DLL1
2103,GO:0030857,0.577352932830781,0.879361856420074,1,2,negative regulation of epithelial cell differentiation,BP,DLL1
2904,GO:0040034,0.577352932830781,0.879361856420074,1,2,regulation of development, heterochronic,BP,DLL1
3480,GO:0045605,0.577352932830781,0.879361856420074,1,2,negative regulation of epidermal cell differentiation,BP,DLL1
3482,GO:0045607,0.577352932830781,0.879361856420074,1,2,regulation of auditory receptor cell differentiation,BP,DLL1
3483,GO:0045608,0.577352932830781,0.879361856420074,1,2,negative regulation of auditory receptor cell differentiation,BP,DLL1
3489,GO:0045631,0.577352932830781,0.879361856420074,1,2,regulation of mechanoreceptor differentiation,BP,DLL1
3490,GO:0045632,0.577352932830781,0.879361856420074,1,2,negative regulation of mechanoreceptor differentiation,BP,DLL1
3512,GO:0045683,0.577352932830781,0.879361856420074,1,2,negative regulation of epidermis development,BP,DLL1
3798,GO:0048505,0.577352932830781,0.879361856420074,1,2,regulation of timing of cell differentiation,BP,DLL1
4618,GO:0060972,0.577352932830781,0.879361856420074,1,2,left/right pattern formation,BP,DLL1
4886,GO:0070986,0.577352932830781,0.879361856420074,1,2,left/right axis specification,BP,DLL1
6146,GO:2000980,0.577352932830781,0.879361856420074,1,2,regulation of inner ear receptor cell differentiation,BP,DLL1
6147,GO:2000981,0.577352932830781,0.879361856420074,1,2,negative regulation of inner ear receptor cell differentiation,BP,DLL1
2567,GO:0033500,0.578228116594929,0.74127077465021,2,7,carbohydrate homeostasis,BP,PIK3R1;GAS6
3020,GO:0042593,0.578228116594929,0.74127077465021,2,7,glucose homeostasis,BP,PIK3R1;GAS6
3354,GO:0044703,0.579895929198478,0.602180167800242,7,29,multi-organism reproductive process,BP,MFGE8;CLDN11;SERPINA5;ACSL4;DHH;ITGA3;WT1
2058,GO:0030658,0.579958907730893,0.820751959583179,1,5,transport vesicle membrane,CC,TMEM163
4201,GO:0051489,0.581035968957418,0.844198365127159,1,3,regulation of filopodium assembly,BP,ESPN
107,GO:0001654,0.581245577162165,0.649635617183635,4,17,eye development,BP,MYO7A;RHOJ;DLL1;WT1
833,GO:0006704,0.581303081311031,0.844020587433666,1,3,glucocorticoid biosynthetic process,BP,DKK3
1105,GO:0008211,0.581303081311031,0.844020587433666,1,3,glucocorticoid metabolic process,BP,DKK3
1419,GO:0010894,0.581303081311031,0.844020587433666,1,3,negative regulation of steroid biosynthetic process,BP,DKK3
2261,GO:0031943,0.581303081311031,0.844020587433666,1,3,regulation of glucocorticoid metabolic process,BP,DKK3
2264,GO:0031946,0.581303081311031,0.844020587433666,1,3,regulation of glucocorticoid biosynthetic process,BP,DKK3
2651,GO:0034650,0.581303081311031,0.844020587433666,1,3,cortisol metabolic process,BP,DKK3
2652,GO:0034651,0.581303081311031,0.844020587433666,1,3,cortisol biosynthetic process,BP,DKK3
3582,GO:0045939,0.581303081311031,0.844020587433666,1,3,negative regulation of steroid metabolic process,BP,DKK3
6032,GO:2000064,0.581303081311031,0.844020587433666,1,3,regulation of cortisol biosynthetic process,BP,DKK3
6083,GO:2000401,0.58139178724167,0.843961515348845,1,3,regulation of lymphocyte migration,BP,MSN
92,GO:0001525,0.581493513755959,0.615092233337936,6,23,angiogenesis,BP,RHOB;MFGE8;LAMA5;FOXO4;DLL1;CTGF
281,GO:0002367,0.582236983834623,0.843397833392129,1,3,cytokine production involved in immune response,BP,GAS6
4657,GO:0061082,0.582236983834623,0.843397833392129,1,3,myeloid leukocyte cytokine production,BP,GAS6
1549,GO:0015718,0.582244497005499,0.843392815862504,1,3,monocarboxylic acid transport,BP,ACSL4
1569,GO:0015908,0.582244497005499,0.843392815862504,1,3,fatty acid transport,BP,ACSL4
4335,GO:0055117,0.582327841605531,0.737702774575944,2,7,regulation of cardiac muscle contraction,BP,PDE4B;CTGF
5533,GO:1900181,0.583074330303733,0.842837886817637,1,3,negative regulation of protein localization to nucleus,BP,GAS6
1677,GO:0016791,0.58355494672118,0.842515815155493,1,3,phosphatase activity,MF,PTPN7
3706,GO:0046916,0.583761376525923,0.84237733038162,1,3,cellular transition metal ion homeostasis,BP,PRND
4266,GO:0051896,0.583771967253488,0.842370223064537,1,3,regulation of protein kinase B signaling,BP,GAS6
4267,GO:0051897,0.583771967253488,0.842370223064537,1,3,positive regulation of protein kinase B signaling,BP,GAS6
199,GO:0001959,0.584133538651683,0.842127432559628,1,3,regulation of cytokine-mediated signaling pathway,BP,GAS6
201,GO:0001961,0.584133538651683,0.842127432559628,1,3,positive regulation of cytokine-mediated signaling pathway,BP,GAS6
329,GO:0002690,0.584133538651683,0.842127432559628,1,3,positive regulation of leukocyte chemotaxis,BP,GAS6
4575,GO:0060759,0.584133538651683,0.842127432559628,1,3,regulation of response to cytokine stimulus,BP,GAS6
4576,GO:0060760,0.584133538651683,0.842127432559628,1,3,positive regulation of response to cytokine stimulus,BP,GAS6
2714,GO:0035265,0.584842456659851,0.724412510293728,2,9,organ growth,BP,DLL1;WT1
43,GO:0000578,0.586197491042342,0.840736142274705,1,3,embryonic axis specification,BP,WT1
3356,GO:0044707,0.586360054885527,0.536019762981507,37,146,single-multicellular organism process,BP,LAMA1;ACTN2;MYO7A;CDKN1A;NRTN;DKK3;RHOB;KITLG;RHOJ;MFGE8;CAMSAP3;CLDN11;PIK3R1;GAS6;LAMA5;SDC4;ITGB5;SEMA6C;PRKACB;ITGB8;SERPINA5;ACSL4;CRISPLD2;FHOD3;FOXO4;DHH;GPSM1;MARK4;DAAM2;DLL1;PDE4B;UNC119;CLDN1;CTGF;ITGA3;WT1;MSN
2196,GO:0031346,0.586688021682849,0.733872868836344,2,7,positive regulation of cell projection organization,BP,ESPN;ITGA3
4517,GO:0060562,0.588388854656038,0.606957997294816,6,24,epithelial tube morphogenesis,BP,RHOB;LAMA5;SDC4;PRKACB;DLL1;WT1
997,GO:0007276,0.58878003667829,0.642261672874532,4,17,gamete generation,BP,CLDN11;SERPINA5;DHH;WT1
2175,GO:0031253,0.5894299393243,0.740504080743003,2,6,cell projection membrane,CC,ITGA3;MSN
1116,GO:0008283,0.589941388116861,0.552061782173506,13,56,cell proliferation,BP,CDKN1A;KITLG;GAS6;LAMA5;SDC4;HMGN5;FOXO4;DLL1;CTGF;WT1;MSN;PTGES;SH3BP4
2529,GO:0033036,0.59056712348616,0.545768588008742,15,60,macromolecule localization,BP,ACTN2;MYO7A;CDKN1A;REEP1;RHOB;PIK3R1;GAS6;LAMA5;SERPINA5;ACSL4;RAB39B;UNC119;ITGA3;MSN;SH3BP4
73,GO:0001101,0.590584690719527,0.640482907885324,4,17,response to acid chemical,BP,CLDN1;CTGF;PTGES;SH3BP4
123,GO:0001706,0.590648263758109,0.837704565013808,1,3,endoderm formation,BP,ITGB5
2717,GO:0035282,0.591025918236955,0.739118133756618,2,6,segmentation,BP,DLL1;WT1
1245,GO:0009888,0.593005966744749,0.533989527501063,19,76,tissue development,BP,ACTN2;MYO7A;CDKN1A;NRTN;RHOB;KITLG;GAS6;LAMA5;SDC4;ITGB5;PRKACB;ITGB8;FHOD3;DLL1;CLDN1;CTGF;ITGA3;WT1;MSN
695,GO:0005905,0.593436319563638,0.835783474712873,1,3,clathrin-coated pit,CC,SH3BP4
2012,GO:0030323,0.593693799120622,0.641779070329842,4,15,respiratory tube development,BP,LAMA5;CRISPLD2;CTGF;ITGA3
2013,GO:0030324,0.593693799120622,0.641779070329842,4,15,lung development,BP,LAMA5;CRISPLD2;CTGF;ITGA3
657,GO:0005770,0.595555316633428,0.818116036970765,1,4,late endosome,CC,RHOB
4301,GO:0055006,0.595984262978555,0.734780425903844,2,6,cardiac cell development,BP,ACTN2;FHOD3
159,GO:0001838,0.596350005783785,0.718737923884879,2,8,embryonic epithelial tube formation,BP,SDC4;PRKACB
1447,GO:0012505,0.59706474481613,0.532965095524493,17,73,endomembrane system,CC,ACTN2;REEP1;RHOB;PIK3R1;GAS6;SDC4;SERPINA5;RIN3;ACSL4;CRISPLD2;RAB39B;GPSM1;TMEM163;PDE4B;CTGF;PTGES;SH3BP4
1220,GO:0009617,0.597530027707209,0.66410166654116,3,13,response to bacterium,BP,PDE4B;CLDN1;PTGES
3138,GO:0043267,0.597579906648945,0.832896591470279,1,3,negative regulation of potassium ion transport,BP,ACTN2
5597,GO:1901379,0.597579906648945,0.832896591470279,1,3,regulation of potassium ion transmembrane transport,BP,ACTN2
5598,GO:1901380,0.597579906648945,0.832896591470279,1,3,negative regulation of potassium ion transmembrane transport,BP,ACTN2
5882,GO:1904063,0.597579906648945,0.832896591470279,1,3,negative regulation of cation transmembrane transport,BP,ACTN2
5306,GO:0090316,0.598946781486433,0.72290710989785,2,7,positive regulation of intracellular protein transport,BP,PIK3R1;GAS6
3139,GO:0043268,0.601754872490785,0.829948947640514,1,3,positive regulation of potassium ion transport,BP,ACTN2
1172,GO:0009101,0.601939215229451,0.82981788776293,1,3,glycoprotein biosynthetic process,BP,PHLDA1
998,GO:0007281,0.602071013108553,0.708548721378233,2,9,germ cell development,BP,DHH;WT1
4819,GO:0070371,0.603299003896907,0.700540361241943,2,11,ERK1 and ERK2 cascade,BP,GAS6;CTGF
4820,GO:0070372,0.603299003896907,0.700540361241943,2,11,regulation of ERK1 and ERK2 cascade,BP,GAS6;CTGF
166,GO:0001845,0.603565755227631,0.828658133489236,1,3,phagolysosome assembly,BP,MYO7A
928,GO:0007040,0.603565755227631,0.828658133489236,1,3,lysosome organization,BP,MYO7A
5211,GO:0080171,0.603565755227631,0.828658133489236,1,3,lytic vacuole organization,BP,MYO7A
4097,GO:0051148,0.60442462239206,0.717910939009651,2,7,negative regulation of muscle cell differentiation,BP,FOXO4;DLL1
2229,GO:0031625,0.605514234872642,0.710261380709165,2,8,ubiquitin protein ligase binding,MF,CDKN1A;PRKACB
3313,GO:0044389,0.605514234872642,0.710261380709165,2,8,ubiquitin-like protein ligase binding,MF,CDKN1A;PRKACB
4030,GO:0050896,0.605676036334584,0.518042860631951,38,157,response to stimulus,BP,LAMA1;ACTN2;CDKN1A;NRTN;DKK3;GPRASP1;RHOB;KITLG;SLC52A3;RHOJ;NUAK2;PIK3R1;GAS6;LAMA5;SDC4;MPZL1;ITGB5;SEMA6C;PRKACB;ITGB8;SERPINA5;RIN3;ACSL4;CRISPLD2;FOXO4;DHH;GPSM1;DLL1;PDE4B;UNC119;CGN;CLDN1;CTGF;ITGA3;WT1;MSN;PTGES;SH3BP4
3683,GO:0046872,0.606185473692113,0.54202782812584,12,45,metal ion binding,MF,ACTN2;CDKN1A;PRND;NUAK2;GAS6;PRKACB;DHH;DLL1;TMEM163;PDE4B;ITGA3;WT1
5192,GO:0072594,0.606416194453702,0.658384813303919,3,12,establishment of protein localization to organelle,BP,CDKN1A;PIK3R1;GAS6
1922,GO:0030010,0.607229910450859,0.715328935354892,2,7,establishment of cell polarity,BP,MARK4;MSN
4170,GO:0051301,0.608098131106119,0.656723900209109,3,12,cell division,BP,RHOB;MARK4;DLL1
5923,GO:1904951,0.608268967376489,0.660258090074235,3,11,positive regulation of establishment of protein localization,BP,PIK3R1;GAS6;ITGA3
3065,GO:0043010,0.609904556593384,0.649368814372145,3,14,camera-type eye development,BP,RHOJ;DLL1;WT1
2345,GO:0032330,0.610086729827729,0.806920297808392,1,4,regulation of chondrocyte differentiation,BP,CTGF
1476,GO:0014074,0.610283722317331,0.823803651063789,1,3,response to purine-containing compound,BP,WT1
3818,GO:0048545,0.611270307326314,0.653577882142358,3,12,response to steroid hormone,BP,CDKN1A;CLDN1;CTGF
1648,GO:0016569,0.611948545226624,0.82258440198686,1,3,covalent chromatin modification,BP,HMGN5
5136,GO:0072216,0.612006130985426,0.805403633273967,1,4,positive regulation of metanephros development,BP,WT1
481,GO:0003677,0.612672029168472,0.655911271049229,3,11,DNA binding,MF,HMGN5;FOXO4;WT1
4260,GO:0051875,0.613284687521211,0.821601150156623,1,3,pigment granule localization,BP,MYO7A
4269,GO:0051904,0.613284687521211,0.821601150156623,1,3,pigment granule transport,BP,MYO7A
4270,GO:0051905,0.613284687521211,0.821601150156623,1,3,establishment of pigment granule localization,BP,MYO7A
5062,GO:0072075,0.61331772437845,0.821576785332104,1,3,metanephric mesenchyme development,BP,WT1
3630,GO:0046486,0.613926824719826,0.650929626558049,3,12,glycerolipid metabolic process,BP,KITLG;PIK3R1;ACSL4
2482,GO:0032870,0.613941993818504,0.598820975917812,5,19,cellular response to hormone stimulus,BP,ACTN2;PIK3R1;PRKACB;FOXO4;WT1
3925,GO:0048870,0.615018483706447,0.527309668907355,13,52,cell motility,BP,LAMA1;NRTN;RHOB;KITLG;PIK3R1;GAS6;LAMA5;SDC4;FOXO4;PDE4B;CTGF;ITGA3;MSN
4239,GO:0051674,0.615018483706447,0.527309668907355,13,52,localization of cell,BP,LAMA1;NRTN;RHOB;KITLG;PIK3R1;GAS6;LAMA5;SDC4;FOXO4;PDE4B;CTGF;ITGA3;MSN
1863,GO:0021915,0.615100049896022,0.707999466892908,2,7,neural tube development,BP,SDC4;PRKACB
1668,GO:0016746,0.615464812293909,0.819987752178457,1,3,transferase activity, transferring acyl groups,MF,HMGCS2
1108,GO:0008217,0.615479408664589,0.695795241957334,2,9,regulation of blood pressure,BP,GAS6;DLL1
1432,GO:0010942,0.616656611253108,0.616311407594319,4,16,positive regulation of cell death,BP,CDKN1A;RHOB;MARK4;CTGF
3079,GO:0043068,0.616656611253108,0.616311407594319,4,16,positive regulation of programmed cell death,BP,CDKN1A;RHOB;MARK4;CTGF
4966,GO:0071496,0.616880478705748,0.64490116630275,3,13,cellular response to external stimulus,BP,CDKN1A;NUAK2;GAS6
5387,GO:0097367,0.616985164437666,0.523502317372144,13,58,carbohydrate derivative binding,MF,MYO7A;RHOB;RHOJ;NUAK2;PRKACB;SERPINA5;ACSL4;CRISPLD2;RAB39B;MARK4;PDE4B;CTGF;ITGA3
2558,GO:0033273,0.617787910559625,0.818256085774095,1,3,response to vitamin,BP,GAS6
1225,GO:0009653,0.618272874401897,0.504811957227206,21,83,anatomical structure morphogenesis,BP,ACTN2;MYO7A;NRTN;DKK3;RHOB;RHOJ;MFGE8;PIK3R1;LAMA5;SDC4;ITGB5;SEMA6C;PRKACB;CRISPLD2;FHOD3;FOXO4;DLL1;CTGF;ITGA3;WT1;MSN
2193,GO:0031334,0.618476391928046,0.800224271045463,1,4,positive regulation of protein complex assembly,BP,MSN
3150,GO:0043296,0.618618671177423,0.612212771097253,4,17,apical junction complex,CC,CAMSAP3;CLDN11;CGN;CLDN1
613,GO:0005515,0.61966403419156,0.518764667429781,45,183,protein binding,MF,LAMA1;ACTN2;MYO7A;CDKN1A;FRMPD1;NRTN;REEP1;GPRASP1;RHOB;KITLG;PHLDA1;RHOJ;NUAK2;MFGE8;CAMSAP3;PLEKHH2;CLDN11;PIK3R1;GAS6;LAMA5;SDC4;MPZL1;ITGB5;PRKACB;ITGB8;SERPINA5;PTPN7;RIN3;FHOD3;RAB39B;FOXO4;DHH;MARK4;ESPN;DAAM2;DLL1;PDE4B;UNC119;CGN;CLDN1;CTGF;ITGA3;WT1;MSN;SH3BP4
555,GO:0005096,0.620819375303905,0.815976887188132,1,3,GTPase activator activity,MF,RIN3
3698,GO:0046890,0.620995199264936,0.695555877257809,2,8,regulation of lipid biosynthetic process,BP,DKK3;DHH
3359,GO:0044711,0.621378585208266,0.569955318616631,6,27,single-organism biosynthetic process,BP,HMGCS2;DKK3;PIK3R1;DHH;CTGF;PTGES
1894,GO:0022607,0.621528550098937,0.517102316072384,14,55,cellular component assembly,BP,ACTN2;MYO7A;PRND;PIK3R1;GAS6;LAMA5;SDC4;ITGB5;FHOD3;MARK4;ESPN;CLDN1;CTGF;MSN
1893,GO:0022604,0.621909846540667,0.69467153198369,2,8,regulation of cell morphogenesis,BP,RHOJ;MSN
4135,GO:0051234,0.622012949103544,0.495822796080483,27,111,establishment of localization,BP,ACTN2;MYO7A;CDKN1A;REEP1;GPRASP1;RHOB;SLC52A3;MFGE8;PIK3R1;SLC25A53;GAS6;LAMA5;SDC4;SERPINA5;RIN3;ACSL4;CRISPLD2;RAB39B;DLL1;PDE4B;UNC119;CLDN1;SLC18B1;CTGF;ITGA3;MSN;SH3BP4
2010,GO:0030316,0.62234304044551,0.814822914840864,1,3,osteoclast differentiation,BP,PIK3R1
3509,GO:0045670,0.62234304044551,0.814822914840864,1,3,regulation of osteoclast differentiation,BP,PIK3R1
3510,GO:0045671,0.62234304044551,0.814822914840864,1,3,negative regulation of osteoclast differentiation,BP,PIK3R1
2586,GO:0033674,0.623009914134747,0.567364281605804,6,28,positive regulation of kinase activity,BP,CDKN1A;KITLG;GAS6;SDC4;PRKACB;UNC119
3559,GO:0045860,0.623009914134747,0.567364281605804,6,28,positive regulation of protein kinase activity,BP,CDKN1A;KITLG;GAS6;SDC4;PRKACB;UNC119
5878,GO:1904031,0.623616542063829,0.785814847308142,1,5,positive regulation of cyclin-dependent protein kinase activity,BP,CDKN1A
3310,GO:0044346,0.623694025182377,0.813794986419032,1,3,fibroblast apoptotic process,BP,GAS6
6069,GO:2000269,0.623694025182377,0.813794986419032,1,3,regulation of fibroblast apoptotic process,BP,GAS6
6070,GO:2000270,0.623694025182377,0.813794986419032,1,3,negative regulation of fibroblast apoptotic process,BP,GAS6
3049,GO:0042802,0.623793115802357,0.554760881818081,7,32,identical protein binding,MF,ACTN2;MYO7A;PLEKHH2;CLDN11;FOXO4;CLDN1;SH3BP4
5593,GO:1901360,0.624163789499624,0.507022765707951,16,69,organic cyclic compound metabolic process,BP,ACTN2;CDKN1A;HMGCS2;DKK3;KITLG;SLC52A3;PIK3R1;GAS6;HMGN5;FOXO4;DHH;DLL1;PDE4B;CTGF;ITGA3;WT1
799,GO:0006518,0.624196373505389,0.795558453376988,1,4,peptide metabolic process,BP,GAS6
805,GO:0006605,0.624229590624979,0.640539804538235,3,12,protein targeting,BP,CDKN1A;PIK3R1;GAS6
1287,GO:0010171,0.625072692490261,0.794836314067807,1,4,body morphogenesis,BP,CRISPLD2
4427,GO:0060323,0.625072692490261,0.794836314067807,1,4,head morphogenesis,BP,CRISPLD2
3221,GO:0043565,0.625118771178219,0.698482739775906,2,7,sequence-specific DNA binding,MF,FOXO4;WT1
111,GO:0001658,0.625920809482068,0.685608535091786,2,9,branching involved in ureteric bud morphogenesis,BP,LAMA5;WT1
4548,GO:0060675,0.625920809482068,0.685608535091786,2,9,ureteric bud morphogenesis,BP,LAMA5;WT1
5110,GO:0072171,0.625920809482068,0.685608535091786,2,9,mesonephric tubule morphogenesis,BP,LAMA5;WT1
5595,GO:1901362,0.626737416821501,0.513472922395084,13,57,organic cyclic compound biosynthetic process,BP,ACTN2;CDKN1A;HMGCS2;DKK3;PIK3R1;GAS6;HMGN5;FOXO4;DHH;DLL1;CTGF;ITGA3;WT1
1091,GO:0008152,0.626870268290656,0.491892861250612,34,140,metabolic process,BP,ACTN2;CDKN1A;HMGCS2;NRTN;DKK3;GPRASP1;KITLG;PRND;PHLDA1;SLC52A3;NUAK2;MFGE8;CAMSAP3;PIK3R1;GAS6;SDC4;PRKACB;ITGB8;SERPINA5;HMGN5;PTPN7;ACSL4;FOXO4;DHH;MARK4;DLL1;PDE4B;UNC119;CTGF;ITGA3;WT1;MSN;PTGES;SH3BP4
3722,GO:0048009,0.627154999959645,0.811141148409239,1,3,insulin-like growth factor receptor signaling pathway,BP,PIK3R1
5770,GO:1903047,0.627499524096072,0.599573423267202,4,19,mitotic cell cycle process,BP,CDKN1A;PHLDA1;FOXO4;MARK4
5842,GO:1903707,0.627513042113635,0.696176977609541,2,7,negative regulation of hemopoiesis,BP,PIK3R1;DLL1
5071,GO:0072091,0.627523566992633,0.850206888750181,1,2,regulation of stem cell proliferation,BP,KITLG
6110,GO:2000648,0.627523566992633,0.850206888750181,1,2,positive regulation of stem cell proliferation,BP,KITLG
4493,GO:0060491,0.628128055965108,0.79230313047723,1,4,regulation of cell projection assembly,BP,ESPN
2195,GO:0031345,0.628376519165935,0.810197417757582,1,3,negative regulation of cell projection organization,BP,ITGA3
4746,GO:0061695,0.629291204601564,0.694456592887782,2,7,transferase complex, transferring phosphorus-containing groups,CC,CDKN1A;PIK3R1
615,GO:0005518,0.629305834615112,0.809476948121894,1,3,collagen binding,MF,ITGA3
191,GO:0001944,0.62938120559971,0.533885920487652,9,36,vasculature development,BP,RHOB;RHOJ;MFGE8;LAMA5;ITGB8;FOXO4;DLL1;CTGF;WT1
3985,GO:0050794,0.629575706349982,0.498347218437225,41,170,regulation of cellular process,BP,LAMA1;ACTN2;CDKN1A;NRTN;DKK3;GPRASP1;RHOB;KITLG;RHOJ;NUAK2;MFGE8;CAMSAP3;PLEKHH2;PIK3R1;GAS6;LAMA5;SDC4;MPZL1;ITGB5;PRKACB;ITGB8;SERPINA5;HMGN5;RIN3;FHOD3;FOXO4;DHH;GPSM1;MARK4;ESPN;DLL1;PDE4B;UNC119;CGN;CLDN1;CTGF;ITGA3;WT1;MSN;PTGES;SH3BP4
4838,GO:0070527,0.629579290912896,0.809264534611432,1,3,platelet aggregation,BP,GAS6
2709,GO:0035239,0.630609804159384,0.562232608469135,6,25,tube morphogenesis,BP,RHOB;LAMA5;SDC4;PRKACB;DLL1;WT1
4925,GO:0071345,0.630678801307713,0.680890639158452,2,9,cellular response to cytokine stimulus,BP,GAS6;CLDN1
1119,GO:0008286,0.632386288218307,0.691445795306132,2,7,insulin receptor signaling pathway,BP,PIK3R1;FOXO4
3451,GO:0045321,0.632675667723435,0.547689981026444,7,29,leukocyte activation,BP,CDKN1A;PIK3R1;GAS6;SDC4;CRISPLD2;DLL1;MSN
665,GO:0005783,0.635402317670366,0.556067703044823,6,26,endoplasmic reticulum,CC,REEP1;PIK3R1;GAS6;ACSL4;GPSM1;PTGES
2614,GO:0034260,0.635579014041037,0.804556632715011,1,3,negative regulation of GTPase activity,BP,SH3BP4
4286,GO:0051961,0.635771038278419,0.68812935931032,2,7,negative regulation of nervous system development,BP,PRKACB;DLL1
356,GO:0002792,0.635805322225884,0.804377260116316,1,3,negative regulation of peptide secretion,BP,GAS6
3953,GO:0050709,0.635805322225884,0.804377260116316,1,3,negative regulation of protein secretion,BP,GAS6
3778,GO:0048333,0.636028403416805,0.80420031675589,1,3,mesodermal cell differentiation,BP,ITGA3
3802,GO:0048514,0.636255123187864,0.544797431230332,7,28,blood vessel morphogenesis,BP,RHOB;MFGE8;LAMA5;FOXO4;DLL1;CTGF;WT1
854,GO:0006810,0.636455155697875,0.481435332340218,25,104,transport,BP,ACTN2;MYO7A;CDKN1A;REEP1;GPRASP1;RHOB;SLC52A3;MFGE8;PIK3R1;SLC25A53;GAS6;SDC4;SERPINA5;RIN3;ACSL4;CRISPLD2;RAB39B;DLL1;PDE4B;UNC119;CLDN1;SLC18B1;CTGF;MSN;SH3BP4
1786,GO:0019752,0.636505682753495,0.680318585750169,2,8,carboxylic acid metabolic process,BP,ACSL4;PTGES
2464,GO:0032787,0.636505682753495,0.680318585750169,2,8,monocarboxylic acid metabolic process,BP,ACSL4;PTGES
6065,GO:2000242,0.63828756894028,0.678534840094366,2,8,negative regulation of reproductive process,BP,PRKACB;WT1
5618,GO:1901617,0.63889269297866,0.677927500502658,2,8,organic hydroxy compound biosynthetic process,BP,HMGCS2;DKK3
263,GO:0002285,0.638969996395646,0.783117933137428,1,4,lymphocyte activation involved in immune response,BP,DLL1
4014,GO:0050866,0.639257485874425,0.782870139446038,1,4,negative regulation of cell activation,BP,SDC4
1239,GO:0009798,0.639341364273625,0.672176376047432,2,9,axis specification,BP,DLL1;WT1
724,GO:0006022,0.640316587499348,0.781955361144605,1,4,aminoglycan metabolic process,BP,SDC4
1976,GO:0030203,0.640316587499348,0.781955361144605,1,4,glycosaminoglycan metabolic process,BP,SDC4
3495,GO:0045639,0.640366245958974,0.800734121856048,1,3,positive regulation of myeloid cell differentiation,BP,KITLG
2569,GO:0033554,0.640425895421084,0.528176903395001,8,35,cellular response to stress,BP,CDKN1A;RHOB;SLC52A3;NUAK2;PIK3R1;GAS6;FOXO4;CTGF
2053,GO:0030554,0.640802017536432,0.553839729517753,6,23,adenyl nucleotide binding,MF,MYO7A;NUAK2;PRKACB;ACSL4;MARK4;PDE4B
2409,GO:0032559,0.640802017536432,0.553839729517753,6,23,adenyl ribonucleotide binding,MF,MYO7A;NUAK2;PRKACB;ACSL4;MARK4;PDE4B
516,GO:0004674,0.64088026305541,0.623338732029401,3,12,protein serine/threonine kinase activity,MF,NUAK2;PRKACB;MARK4
1015,GO:0007399,0.642020756436648,0.486212953298522,17,70,nervous system development,BP,MYO7A;NRTN;CAMSAP3;CLDN11;PIK3R1;GAS6;SDC4;SEMA6C;PRKACB;ACSL4;DHH;GPSM1;MARK4;DLL1;UNC119;CLDN1;ITGA3
5577,GO:1901137,0.642963077373766,0.668484590444578,2,9,carbohydrate derivative biosynthetic process,BP,PHLDA1;SDC4
2623,GO:0034341,0.645184179751942,0.777712059706342,1,4,response to interferon-gamma,BP,CLDN1
4926,GO:0071346,0.645184179751942,0.777712059706342,1,4,cellular response to interferon-gamma,BP,CLDN1
3501,GO:0045661,0.645409861497555,0.796642229545525,1,3,regulation of myoblast differentiation,BP,DLL1
3502,GO:0045662,0.645409861497555,0.796642229545525,1,3,negative regulation of myoblast differentiation,BP,DLL1
3249,GO:0043933,0.645877212696114,0.547059361454718,6,24,macromolecular complex subunit organization,BP,ACTN2;PRND;PLEKHH2;FHOD3;CLDN1;MSN
5010,GO:0071822,0.645877212696114,0.547059361454718,6,24,protein complex subunit organization,BP,ACTN2;PRND;PLEKHH2;FHOD3;CLDN1;MSN
838,GO:0006732,0.646111988600214,0.796067261512134,1,3,coenzyme metabolic process,BP,ACSL4
4116,GO:0051186,0.646111988600214,0.796067261512134,1,3,cofactor metabolic process,BP,ACSL4
1261,GO:0009948,0.646148983863016,0.776863323913081,1,4,anterior/posterior axis specification,BP,WT1
3215,GO:0043550,0.647423598452681,0.7949896696184,1,3,regulation of lipid kinase activity,BP,PIK3R1
3216,GO:0043551,0.647423598452681,0.7949896696184,1,3,regulation of phosphatidylinositol 3-kinase activity,BP,PIK3R1
5847,GO:1903725,0.647423598452681,0.7949896696184,1,3,regulation of phospholipid metabolic process,BP,PIK3R1
1947,GO:0030098,0.647520882807877,0.616333527717539,3,12,lymphocyte differentiation,BP,PIK3R1;GAS6;DLL1
5114,GO:0072175,0.648405184212554,0.658718153301276,2,10,epithelial tube formation,BP,SDC4;PRKACB
115,GO:0001667,0.648839761389838,0.5426624077832,6,25,ameboidal-type cell migration,BP,NRTN;RHOB;KITLG;LAMA5;SDC4;ITGA3
3034,GO:0042698,0.648850600368689,0.793812040177859,1,3,ovulation cycle,BP,KITLG
1957,GO:0030141,0.649230349253236,0.576409000863298,4,19,secretory granule,CC,ACTN2;GAS6;SERPINA5;CRISPLD2
2477,GO:0032844,0.649511905704011,0.667137082421644,2,8,regulation of homeostatic process,BP,KITLG;DLL1
295,GO:0002440,0.650003847132647,0.773446584704829,1,4,production of molecular mediator of immune response,BP,GAS6
3353,GO:0044702,0.650326196847004,0.503079854502936,10,43,single organism reproductive process,BP,KITLG;MFGE8;CLDN11;PRKACB;ITGB8;SERPINA5;ACSL4;DHH;ITGA3;WT1
5086,GO:0072110,0.651519129052056,0.772092212787102,1,4,glomerular mesangial cell proliferation,BP,WT1
5089,GO:0072124,0.651519129052056,0.772092212787102,1,4,regulation of glomerular mesangial cell proliferation,BP,WT1
5284,GO:0090192,0.651519129052056,0.772092212787102,1,4,regulation of glomerulus development,BP,WT1
5636,GO:1901722,0.651519129052056,0.772092212787102,1,4,regulation of cell proliferation involved in kidney development,BP,WT1
3214,GO:0043549,0.651762948751442,0.524733522849744,7,32,regulation of kinase activity,BP,CDKN1A;KITLG;PIK3R1;GAS6;SDC4;PRKACB;UNC119
4754,GO:0065009,0.65196678733589,0.477130840020539,16,70,regulation of molecular function,BP,ACTN2;CDKN1A;NRTN;KITLG;CAMSAP3;PIK3R1;GAS6;SDC4;PRKACB;SERPINA5;RIN3;GPSM1;PDE4B;UNC119;CTGF;SH3BP4
4081,GO:0051093,0.652185675903192,0.537942529512669,6,26,negative regulation of developmental process,BP,PIK3R1;GAS6;PRKACB;FOXO4;DLL1;WT1
900,GO:0006942,0.652415419546226,0.66414257855167,2,8,regulation of striated muscle contraction,BP,PDE4B;CTGF
5873,GO:1904019,0.652535300738533,0.790745817745538,1,3,epithelial cell apoptotic process,BP,GAS6
5215,GO:0086003,0.652543463156066,0.79073898442048,1,3,cardiac muscle cell contraction,BP,PDE4B
1036,GO:0007548,0.65254788438002,0.60506131866723,3,14,sex differentiation,BP,KITLG;DHH;WT1
5591,GO:1901342,0.652676028589639,0.580871072805502,4,15,regulation of vasculature development,BP,RHOB;FOXO4;DLL1;WT1
1538,GO:0015629,0.652748129554138,0.545921892755875,6,20,actin cytoskeleton,CC,ACTN2;MYO7A;PLEKHH2;FHOD3;ESPN;CGN
2402,GO:0032535,0.652990044143396,0.583514185910607,4,14,regulation of cellular component size,BP,ACTN2;PLEKHH2;FHOD3;MSN
584,GO:0005215,0.653217550855451,0.572073843760839,4,19,transporter activity,MF,SLC52A3;SLC25A53;GAS6;SLC18B1
4180,GO:0051347,0.653460962269613,0.53385337683075,6,29,positive regulation of transferase activity,BP,CDKN1A;KITLG;GAS6;SDC4;PRKACB;UNC119
1637,GO:0016462,0.653820776580011,0.548466929013374,5,25,pyrophosphatase activity,MF,MYO7A;RHOB;RHOJ;RAB39B;CGN
1681,GO:0016817,0.653820776580011,0.548466929013374,5,25,hydrolase activity, acting on acid anhydrides,MF,MYO7A;RHOB;RHOJ;RAB39B;CGN
1682,GO:0016818,0.653820776580011,0.548466929013374,5,25,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,MYO7A;RHOB;RHOJ;RAB39B;CGN
1704,GO:0017111,0.653820776580011,0.548466929013374,5,25,nucleoside-triphosphatase activity,MF,MYO7A;RHOB;RHOJ;RAB39B;CGN
5718,GO:1902582,0.654488197707457,0.574210741034767,4,17,single-organism intracellular transport,BP,MYO7A;CDKN1A;PIK3R1;GAS6
4226,GO:0051606,0.654584675729416,0.769332484296694,1,4,detection of stimulus,BP,UNC119
1699,GO:0017046,0.655150956514315,0.788546724732014,1,3,peptide hormone binding,MF,PIK3R1
3011,GO:0042562,0.655150956514315,0.788546724732014,1,3,hormone binding,MF,PIK3R1
2685,GO:0035051,0.655160266858521,0.612134851155232,3,11,cardiocyte differentiation,BP,ACTN2;FHOD3;WT1
4071,GO:0051052,0.655224535430159,0.648200551459798,2,11,regulation of DNA metabolic process,BP,CDKN1A;KITLG
3678,GO:0046847,0.655473226359019,0.768527609302355,1,4,filopodium assembly,BP,ESPN
5311,GO:0090382,0.65618884655747,0.767877747852299,1,4,phagosome maturation,BP,MYO7A
855,GO:0006811,0.65619456747759,0.532572290640669,6,27,ion transport,BP,ACTN2;SLC52A3;GAS6;ACSL4;PDE4B;CTGF
4221,GO:0051592,0.656574150911578,0.767527244866734,1,4,response to calcium ion,BP,PTGES
3380,GO:0044801,0.657093631784581,0.755719722013765,1,5,single-organism membrane fusion,BP,SERPINA5
952,GO:0007162,0.657357329807341,0.66637625645731,2,7,negative regulation of cell adhesion,BP,PIK3R1;SDC4
5818,GO:1903524,0.657520018988576,0.755316280893174,1,5,positive regulation of blood circulation,BP,CTGF
957,GO:0007167,0.657945411832525,0.48887131130758,11,48,enzyme linked receptor protein signaling pathway,BP,NRTN;DKK3;PIK3R1;GAS6;MPZL1;ITGB5;FOXO4;DLL1;CGN;CTGF;ITGA3
904,GO:0006955,0.657988066424427,0.520298943012146,7,29,immune response,BP,PIK3R1;GAS6;PRKACB;CRISPLD2;DLL1;PDE4B;CLDN1
3635,GO:0046530,0.658326451767959,0.829623102799414,1,2,photoreceptor cell differentiation,BP,MYO7A
3293,GO:0044281,0.658620598200505,0.530887045266318,6,26,small molecule metabolic process,BP,HMGCS2;DKK3;SLC52A3;ACSL4;PDE4B;PTGES
3536,GO:0045785,0.658735966375357,0.608292912946196,3,11,positive regulation of cell adhesion,BP,PIK3R1;SDC4;ITGA3
4952,GO:0071425,0.659317596832621,0.785004582867956,1,3,hematopoietic stem cell proliferation,BP,KITLG
4589,GO:0060837,0.660668133671863,0.783846053168657,1,3,blood vessel endothelial cell differentiation,BP,DLL1
4593,GO:0060842,0.660668133671863,0.783846053168657,1,3,arterial endothelial cell differentiation,BP,DLL1
2715,GO:0035270,0.660748605197092,0.596151338197177,3,14,endocrine system development,BP,DKK3;DLL1;WT1
2854,GO:0036477,0.661032375544883,0.605812046547869,3,11,somatodendritic compartment,CC,ACTN2;ACSL4;PDE4B
5191,GO:0072593,0.662468906825368,0.643826874039487,2,10,reactive oxygen species metabolic process,BP,CDKN1A;CTGF
3654,GO:0046660,0.66267369077343,0.653407364809193,2,8,female sex differentiation,BP,KITLG;WT1
3884,GO:0048732,0.663092238561881,0.527032562537054,6,25,gland development,BP,DKK3;LAMA5;SERPINA5;CLDN1;WT1;MSN
707,GO:0005938,0.664629525954189,0.57083293205314,4,14,cell cortex,CC,ACTN2;MYO7A;PLEKHH2;CTGF
5500,GO:0099568,0.664629525954189,0.57083293205314,4,14,cytoplasmic region,CC,ACTN2;MYO7A;PLEKHH2;CTGF
2532,GO:0033059,0.664637851556728,0.760093678025692,1,4,cellular pigmentation,BP,MYO7A
5302,GO:0090287,0.666666292427843,0.595656961039962,3,12,regulation of cellular response to growth factor stimulus,BP,DKK3;DLL1;ITGA3
5716,GO:1902580,0.667184721807988,0.510133121522861,7,29,single-organism cellular localization,BP,ACTN2;MYO7A;CDKN1A;PIK3R1;GAS6;LAMA5;ITGA3
3431,GO:0045184,0.667396805848937,0.479255298264914,11,46,establishment of protein localization,BP,ACTN2;MYO7A;CDKN1A;REEP1;RHOB;PIK3R1;GAS6;LAMA5;RAB39B;UNC119;ITGA3
292,GO:0002431,0.667948042082901,0.777511835524716,1,3,Fc receptor mediated stimulatory signaling pathway,BP,PIK3R1
293,GO:0002433,0.667948042082901,0.777511835524716,1,3,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP,PIK3R1
2876,GO:0038094,0.667948042082901,0.777511835524716,1,3,Fc-gamma receptor signaling pathway,BP,PIK3R1
2878,GO:0038096,0.667948042082901,0.777511835524716,1,3,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,PIK3R1
5607,GO:1901564,0.668223271109304,0.535941967917869,5,22,organonitrogen compound metabolic process,BP,SLC52A3;GAS6;SDC4;ITGB8;PDE4B
5162,GO:0072331,0.668667865035583,0.744579061066668,1,5,signal transduction by p53 class mediator,BP,CDKN1A
2880,GO:0038128,0.669152732509049,0.755848421766489,1,4,ERBB2 signaling pathway,BP,PIK3R1
4032,GO:0050905,0.669631405890212,0.776025403293586,1,3,neuromuscular process,BP,MYO7A
283,GO:0002376,0.670071953303633,0.467156089738193,13,55,immune system process,BP,CDKN1A;KITLG;PIK3R1;GAS6;SDC4;ITGB5;PRKACB;CRISPLD2;DLL1;PDE4B;CLDN1;ITGA3;MSN
1090,GO:0008150,0.670481837766593,0.590952558035721,56,228,biological_process,BP,LAMA1;ACTN2;MYO7A;CDKN1A;HMGCS2;NRTN;REEP1;DKK3;GPRASP1;RHOB;KITLG;PRND;PHLDA1;SLC52A3;RHOJ;NUAK2;MFGE8;CAMSAP3;PLEKHH2;CLDN11;PIK3R1;SLC25A53;GAS6;LAMA5;SDC4;MPZL1;ITGB5;SEMA6C;PRKACB;ITGB8;SERPINA5;HMGN5;PTPN7;RIN3;ACSL4;CRISPLD2;FHOD3;RAB39B;FOXO4;DHH;GPSM1;MARK4;ESPN;DAAM2;DLL1;PDE4B;UNC119;CGN;CLDN1;SLC18B1;CTGF;ITGA3;WT1;MSN;PTGES;SH3BP4
2650,GO:0034645,0.670963437667644,0.465886361692233,13,56,cellular macromolecule biosynthetic process,BP,CDKN1A;DKK3;KITLG;PRND;PHLDA1;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;CTGF;ITGA3;WT1
1846,GO:0021782,0.671576223131907,0.753544558396312,1,4,glial cell development,BP,DLL1
10,GO:0000079,0.672149440538058,0.733500941541505,1,6,regulation of cyclin-dependent protein serine/threonine kinase activity,BP,CDKN1A
5876,GO:1904029,0.672149440538058,0.733500941541505,1,6,regulation of cyclin-dependent protein kinase activity,BP,CDKN1A
6072,GO:2000273,0.672406740336734,0.75275096230483,1,4,positive regulation of receptor activity,BP,ACTN2
3263,GO:0044085,0.673581719635795,0.460308441859255,14,57,cellular component biogenesis,BP,ACTN2;MYO7A;PRND;PIK3R1;GAS6;LAMA5;SDC4;ITGB5;FHOD3;MARK4;ESPN;CLDN1;CTGF;MSN
2643,GO:0034614,0.674015539559508,0.751207729352766,1,4,cellular response to reactive oxygen species,BP,RHOB
1489,GO:0014812,0.674604192646586,0.750641096528166,1,4,muscle cell migration,BP,FOXO4
1513,GO:0014909,0.674604192646586,0.750641096528166,1,4,smooth muscle cell migration,BP,FOXO4
5135,GO:0072215,0.674638193521858,0.73867548415652,1,5,regulation of metanephros development,BP,WT1
5872,GO:1904018,0.674783481100541,0.648022625620037,2,7,positive regulation of vasculature development,BP,RHOB;DLL1
314,GO:0002573,0.674793622089228,0.640403595269616,2,8,myeloid leukocyte differentiation,BP,KITLG;PIK3R1
309,GO:0002526,0.675545032487057,0.749733250841935,1,4,acute inflammatory response,BP,PTGES
1818,GO:0021510,0.67559671256602,0.770690859953664,1,3,spinal cord development,BP,DLL1
2803,GO:0035924,0.67559671256602,0.770690859953664,1,3,cellular response to vascular endothelial growth factor stimulus,BP,DLL1
5061,GO:0072074,0.675703068447047,0.749580490855213,1,4,kidney mesenchyme development,BP,WT1
1123,GO:0008307,0.676399122068813,0.769965216724283,1,3,structural constituent of muscle,MF,ACTN2
2986,GO:0042472,0.676586208588675,0.748725421104863,1,4,inner ear morphogenesis,BP,MYO7A
34,GO:0000278,0.676651088384656,0.544563888355102,4,20,mitotic cell cycle,BP,CDKN1A;PHLDA1;FOXO4;MARK4
2608,GO:0034220,0.677343461917123,0.577714783977233,3,14,ion transmembrane transport,BP,ACTN2;GAS6;PDE4B
2369,GO:0032391,0.678580971647084,0.81480878647616,1,2,photoreceptor connecting cilium,CC,MYO7A
2792,GO:0035869,0.678580971647084,0.81480878647616,1,2,ciliary transition zone,CC,MYO7A
1560,GO:0015849,0.678811959817582,0.746559736543361,1,4,organic acid transport,BP,ACSL4
3710,GO:0046942,0.678811959817582,0.746559736543361,1,4,carboxylic acid transport,BP,ACSL4
4074,GO:0051055,0.679024183606046,0.7463524381475,1,4,negative regulation of lipid biosynthetic process,BP,DKK3
4176,GO:0051338,0.679335237420639,0.493431960466426,7,33,regulation of transferase activity,BP,CDKN1A;KITLG;PIK3R1;GAS6;SDC4;PRKACB;UNC119
3801,GO:0048513,0.679500513017526,0.436311382274421,23,96,animal organ development,BP,ACTN2;MYO7A;CDKN1A;NRTN;DKK3;KITLG;RHOJ;PIK3R1;GAS6;LAMA5;SDC4;ITGB8;SERPINA5;CRISPLD2;FHOD3;FOXO4;DHH;DLL1;CLDN1;CTGF;ITGA3;WT1;MSN
5060,GO:0072073,0.68019392703029,0.545624612277571,4,17,kidney epithelium development,BP,LAMA5;SDC4;DLL1;WT1
926,GO:0007033,0.680767000166273,0.744644759612673,1,4,vacuole organization,BP,MYO7A
2327,GO:0032269,0.680982035291396,0.57125319987588,3,15,negative regulation of cellular protein metabolic process,BP,CDKN1A;GAS6;SERPINA5
1009,GO:0007368,0.681621239557653,0.632920615660964,2,8,determination of left/right symmetry,BP,DAAM2;DLL1
1241,GO:0009855,0.681621239557653,0.632920615660964,2,8,determination of bilateral symmetry,BP,DAAM2;DLL1
1024,GO:0007431,0.681655832602868,0.74377018838458,1,4,salivary gland development,BP,LAMA5
1025,GO:0007435,0.681655832602868,0.74377018838458,1,4,salivary gland morphogenesis,BP,LAMA5
2716,GO:0035272,0.681655832602868,0.74377018838458,1,4,exocrine system development,BP,LAMA5
4482,GO:0060445,0.681655832602868,0.74377018838458,1,4,branching involved in salivary gland morphogenesis,BP,LAMA5
605,GO:0005488,0.682074519127548,0.485958050019014,51,208,binding,MF,LAMA1;ACTN2;MYO7A;CDKN1A;FRMPD1;NRTN;REEP1;GPRASP1;RHOB;KITLG;PRND;PHLDA1;RHOJ;NUAK2;MFGE8;CAMSAP3;PLEKHH2;CLDN11;PIK3R1;GAS6;LAMA5;SDC4;MPZL1;ITGB5;PRKACB;ITGB8;SERPINA5;HMGN5;PTPN7;RIN3;ACSL4;CRISPLD2;FHOD3;RAB39B;FOXO4;DHH;MARK4;ESPN;DAAM2;DLL1;TMEM163;PDE4B;UNC119;CGN;CLDN1;CTGF;ITGA3;WT1;MSN;PTGES;SH3BP4
5165,GO:0072358,0.682321076438841,0.475324497974257,9,37,cardiovascular system development,BP,RHOB;RHOJ;MFGE8;LAMA5;ITGB8;FOXO4;DLL1;CTGF;WT1
4245,GO:0051716,0.682574536862842,0.432107265680463,34,143,cellular response to stimulus,BP,LAMA1;ACTN2;CDKN1A;NRTN;DKK3;GPRASP1;RHOB;KITLG;SLC52A3;RHOJ;NUAK2;PIK3R1;GAS6;LAMA5;SDC4;MPZL1;ITGB5;PRKACB;ITGB8;RIN3;FOXO4;DHH;GPSM1;DLL1;PDE4B;UNC119;CGN;CLDN1;CTGF;ITGA3;WT1;MSN;PTGES;SH3BP4
373,GO:0003012,0.682664296656314,0.540889452733104,4,18,muscle system process,BP,ACTN2;ITGB5;PDE4B;CTGF
895,GO:0006936,0.682664296656314,0.540889452733104,4,18,muscle contraction,BP,ACTN2;ITGB5;PDE4B;CTGF
4324,GO:0055076,0.683737430341534,0.741712256415351,1,4,transition metal ion homeostasis,BP,PRND
831,GO:0006700,0.684405579913454,0.741048796969465,1,4,C21-steroid hormone biosynthetic process,BP,DKK3
834,GO:0006705,0.684405579913454,0.741048796969465,1,4,mineralocorticoid biosynthetic process,BP,DKK3
1103,GO:0008207,0.684405579913454,0.741048796969465,1,4,C21-steroid hormone metabolic process,BP,DKK3
1106,GO:0008212,0.684405579913454,0.741048796969465,1,4,mineralocorticoid metabolic process,BP,DKK3
1332,GO:0010566,0.684405579913454,0.741048796969465,1,4,regulation of ketone biosynthetic process,BP,DKK3
2348,GO:0032341,0.684405579913454,0.741048796969465,1,4,aldosterone metabolic process,BP,DKK3
2349,GO:0032342,0.684405579913454,0.741048796969465,1,4,aldosterone biosynthetic process,BP,DKK3
2350,GO:0032344,0.684405579913454,0.741048796969465,1,4,regulation of aldosterone metabolic process,BP,DKK3
2353,GO:0032347,0.684405579913454,0.741048796969465,1,4,regulation of aldosterone biosynthetic process,BP,DKK3
2356,GO:0032350,0.684405579913454,0.741048796969465,1,4,regulation of hormone metabolic process,BP,DKK3
2668,GO:0034754,0.684405579913454,0.741048796969465,1,4,cellular hormone metabolic process,BP,DKK3
2942,GO:0042181,0.684405579913454,0.741048796969465,1,4,ketone biosynthetic process,BP,DKK3
2980,GO:0042445,0.684405579913454,0.741048796969465,1,4,hormone metabolic process,BP,DKK3
2981,GO:0042446,0.684405579913454,0.741048796969465,1,4,hormone biosynthetic process,BP,DKK3
3602,GO:0046184,0.684405579913454,0.741048796969465,1,4,aldehyde biosynthetic process,BP,DKK3
3693,GO:0046885,0.684405579913454,0.741048796969465,1,4,regulation of hormone biosynthetic process,BP,DKK3
5244,GO:0090030,0.684405579913454,0.741048796969465,1,4,regulation of steroid hormone biosynthetic process,BP,DKK3
1063,GO:0007626,0.685209862761674,0.740248277722409,1,4,locomotory behavior,BP,ESPN
11,GO:0000082,0.686391599339622,0.71877450529308,1,6,G1/S transition of mitotic cell cycle,BP,CDKN1A
3386,GO:0044843,0.686391599339622,0.71877450529308,1,6,cell cycle G1/S phase transition,BP,CDKN1A
653,GO:0005765,0.687964560142789,0.737490800806331,1,4,lysosomal membrane,CC,MYO7A
660,GO:0005774,0.687964560142789,0.737490800806331,1,4,vacuolar membrane,CC,MYO7A
5468,GO:0098852,0.687964560142789,0.737490800806331,1,4,lytic vacuole membrane,CC,MYO7A
2055,GO:0030595,0.688464129534885,0.619530236743817,2,9,leukocyte chemotaxis,BP,GAS6;PDE4B
3909,GO:0048839,0.689036930442082,0.567185679420916,3,13,inner ear development,BP,MYO7A;SDC4;DLL1
3061,GO:0042993,0.689786962544185,0.757567449054255,1,3,positive regulation of transcription factor import into nucleus,BP,PIK3R1
1621,GO:0016338,0.689971054691735,0.609815122644375,2,11,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,BP,CLDN11;CLDN1
3137,GO:0043266,0.690648086326997,0.734781043839524,1,4,regulation of potassium ion transport,BP,ACTN2
766,GO:0006352,0.69098219562973,0.756433342924104,1,3,DNA-templated transcription, initiation,BP,CTGF
772,GO:0006367,0.69098219562973,0.756433342924104,1,3,transcription initiation from RNA polymerase II promoter,BP,CTGF
2671,GO:0034763,0.691235175695279,0.734185095403098,1,4,negative regulation of transmembrane transport,BP,ACTN2
2674,GO:0034766,0.691235175695279,0.734185095403098,1,4,negative regulation of ion transmembrane transport,BP,ACTN2
5408,GO:0097651,0.694358923187355,0.753204529360554,1,3,phosphatidylinositol 3-kinase complex, class I,CC,PIK3R1
3860,GO:0048666,0.694704578883577,0.469995743010611,8,32,neuron development,BP,MYO7A;NRTN;CAMSAP3;PIK3R1;SDC4;SEMA6C;ACSL4;ITGA3
3125,GO:0043234,0.694999281757745,0.445200123195252,12,46,protein complex,CC,LAMA1;MYO7A;CDKN1A;PIK3R1;LAMA5;ITGB5;ITGB8;SERPINA5;ESPN;PDE4B;CGN;ITGA3
966,GO:0007186,0.69534872508931,0.526265118430594,4,18,G-protein coupled receptor signaling pathway,BP,ACTN2;GPRASP1;PRKACB;GPSM1
3758,GO:0048247,0.695402284796892,0.729922580725133,1,4,lymphocyte chemotaxis,BP,GAS6
1111,GO:0008233,0.695757738973816,0.72955633064641,1,4,peptidase activity,MF,DHH
1246,GO:0009889,0.696505517194571,0.436520029160024,13,59,regulation of biosynthetic process,BP,ACTN2;CDKN1A;DKK3;KITLG;PIK3R1;GAS6;HMGN5;FOXO4;DHH;DLL1;CTGF;ITGA3;WT1
672,GO:0005796,0.69669081288265,0.605632391019908,2,10,Golgi lumen,CC,GAS6;SDC4
225,GO:0002068,0.696925602213908,0.728350032386181,1,4,glandular epithelial cell development,BP,DLL1
462,GO:0003309,0.696925602213908,0.728350032386181,1,4,type B pancreatic cell differentiation,BP,DLL1
463,GO:0003323,0.696925602213908,0.728350032386181,1,4,type B pancreatic cell development,BP,DLL1
2794,GO:0035883,0.696925602213908,0.728350032386181,1,4,enteroendocrine cell differentiation,BP,DLL1
1790,GO:0019838,0.697061231296517,0.72820964439524,1,4,growth factor binding,MF,CTGF
733,GO:0006082,0.697081545060408,0.609689768568989,2,9,organic acid metabolic process,BP,ACSL4;PTGES
3179,GO:0043436,0.697081545060408,0.609689768568989,2,9,oxoacid metabolic process,BP,ACSL4;PTGES
5148,GO:0072273,0.69725032732091,0.715298148153483,1,5,metanephric nephron morphogenesis,BP,WT1
125,GO:0001708,0.697315023892898,0.750347536156037,1,3,cell fate specification,BP,DLL1
1446,GO:0012501,0.697742882353207,0.435887302136638,13,56,programmed cell death,BP,ACTN2;CDKN1A;RHOB;KITLG;PHLDA1;NUAK2;PIK3R1;GAS6;HMGN5;MARK4;DLL1;CTGF;WT1
328,GO:0002688,0.698701871909189,0.726506550113513,1,4,regulation of leukocyte chemotaxis,BP,GAS6
1280,GO:0010035,0.698950705018255,0.552858605090623,3,14,response to inorganic substance,BP,RHOB;CLDN1;PTGES
5029,GO:0071901,0.699065086602081,0.71334936679299,1,5,negative regulation of protein serine/threonine kinase activity,BP,CDKN1A
1940,GO:0030054,0.700047870661179,0.43063697504156,14,57,cell junction,CC,ACTN2;RHOB;CAMSAP3;CLDN11;PIK3R1;SDC4;MPZL1;ITGB5;DLL1;TMEM163;CGN;CLDN1;ITGA3;MSN
1171,GO:0009100,0.70094041060281,0.724168152276415,1,4,glycoprotein metabolic process,BP,PHLDA1
1735,GO:0019003,0.701042873167395,0.702940300287775,1,6,GDP binding,MF,RHOB
307,GO:0002521,0.701083987572883,0.521502622826047,4,17,leukocyte differentiation,BP,KITLG;PIK3R1;GAS6;DLL1
2481,GO:0032869,0.701107290441553,0.610913599853374,2,8,cellular response to insulin stimulus,BP,PIK3R1;FOXO4
383,GO:0003073,0.70130466488379,0.710928989750134,1,5,regulation of systemic arterial blood pressure,BP,GAS6
3981,GO:0050789,0.701993712697492,0.422465065605885,42,177,regulation of biological process,BP,LAMA1;ACTN2;CDKN1A;NRTN;REEP1;DKK3;GPRASP1;RHOB;KITLG;RHOJ;NUAK2;MFGE8;CAMSAP3;PLEKHH2;PIK3R1;GAS6;LAMA5;SDC4;MPZL1;ITGB5;PRKACB;ITGB8;SERPINA5;HMGN5;RIN3;FHOD3;FOXO4;DHH;GPSM1;MARK4;ESPN;DLL1;PDE4B;UNC119;CGN;CLDN1;CTGF;ITGA3;WT1;MSN;PTGES;SH3BP4
2449,GO:0032729,0.702052697561591,0.722999917043092,1,4,positive regulation of interferon-gamma production,BP,PDE4B
3462,GO:0045445,0.70211633152874,0.722932954568972,1,4,myoblast differentiation,BP,DLL1
1609,GO:0016301,0.702627970307233,0.479975686474226,6,27,kinase activity,MF,CDKN1A;KITLG;NUAK2;PIK3R1;PRKACB;MARK4
1672,GO:0016772,0.702627970307233,0.479975686474226,6,27,transferase activity, transferring phosphorus-containing groups,MF,CDKN1A;KITLG;NUAK2;PIK3R1;PRKACB;MARK4
1673,GO:0016773,0.702627970307233,0.479975686474226,6,27,phosphotransferase activity, alcohol group as acceptor,MF,CDKN1A;KITLG;NUAK2;PIK3R1;PRKACB;MARK4
5781,GO:1903169,0.70318747316327,0.721803703607869,1,4,regulation of calcium ion transmembrane transport,BP,PDE4B
2689,GO:0035088,0.703871497430663,0.743907704191024,1,3,establishment or maintenance of apical/basal cell polarity,BP,MSN
3437,GO:0045197,0.703871497430663,0.743907704191024,1,3,establishment or maintenance of epithelial cell apical/basal polarity,BP,MSN
4688,GO:0061245,0.703871497430663,0.743907704191024,1,3,establishment or maintenance of bipolar cell polarity,BP,MSN
222,GO:0002065,0.703934532756955,0.553241462194927,3,12,columnar/cuboidal epithelial cell differentiation,BP,MYO7A;CDKN1A;DLL1
4131,GO:0051222,0.704736637119863,0.606704644979094,2,8,positive regulation of protein transport,BP,PIK3R1;GAS6
3924,GO:0048869,0.704848915864481,0.406176050672966,26,108,cellular developmental process,BP,ACTN2;MYO7A;CDKN1A;NRTN;RHOB;KITLG;RHOJ;CAMSAP3;PIK3R1;GAS6;LAMA5;SDC4;ITGB5;SEMA6C;ACSL4;FHOD3;FOXO4;DHH;GPSM1;DLL1;UNC119;CLDN1;CTGF;ITGA3;WT1;MSN
1718,GO:0018108,0.705049444419577,0.541209621907891,3,16,peptidyl-tyrosine phosphorylation,BP,KITLG;GAS6;UNC119
1728,GO:0018212,0.705049444419577,0.541209621907891,3,16,peptidyl-tyrosine modification,BP,KITLG;GAS6;UNC119
2637,GO:0034504,0.705318670846903,0.548185168865063,3,13,protein localization to nucleus,BP,CDKN1A;PIK3R1;GAS6
5532,GO:1900180,0.705318670846903,0.548185168865063,3,13,regulation of protein localization to nucleus,BP,CDKN1A;PIK3R1;GAS6
2875,GO:0038093,0.705417277602958,0.719440270327209,1,4,Fc receptor signaling pathway,BP,PIK3R1
2877,GO:0038095,0.705417277602958,0.719440270327209,1,4,Fc-epsilon receptor signaling pathway,BP,PIK3R1
5838,GO:1903670,0.705430031532525,0.742355624495161,1,3,regulation of sprouting angiogenesis,BP,DLL1
1004,GO:0007346,0.706442154746128,0.585180733739996,2,13,regulation of mitotic cell cycle,BP,CDKN1A;FOXO4
5358,GO:0097150,0.70731888172609,0.740463477400823,1,3,neuronal stem cell population maintenance,BP,DLL1
4700,GO:0061333,0.707994704721871,0.592367540792308,2,10,renal tubule morphogenesis,BP,LAMA5;WT1
5065,GO:0072078,0.707994704721871,0.592367540792308,2,10,nephron tubule morphogenesis,BP,LAMA5;WT1
2478,GO:0032845,0.70821088442609,0.716454893725635,1,4,negative regulation of homeostatic process,BP,KITLG
3096,GO:0043167,0.710234807808392,0.401911211207414,23,97,ion binding,MF,ACTN2;MYO7A;CDKN1A;RHOB;PRND;RHOJ;NUAK2;MFGE8;GAS6;PRKACB;SERPINA5;ACSL4;CRISPLD2;RAB39B;DHH;MARK4;DLL1;TMEM163;PDE4B;CTGF;ITGA3;WT1;PTGES
764,GO:0006325,0.710525131712096,0.713961051368833,1,4,chromatin organization,BP,HMGN5
2893,GO:0040007,0.710862816845307,0.468545153886402,6,29,growth,BP,CDKN1A;GAS6;DLL1;CTGF;WT1;SH3BP4
3031,GO:0042692,0.710971586009744,0.486709327457754,5,22,muscle cell differentiation,BP,ACTN2;FHOD3;FOXO4;DLL1;WT1
2206,GO:0031406,0.711433098311248,0.7129774468827,1,4,carboxylic acid binding,MF,SERPINA5
3100,GO:0043177,0.711433098311248,0.7129774468827,1,4,organic acid binding,MF,SERPINA5
1936,GO:0030042,0.711473488497389,0.618368960839746,2,6,actin filament depolymerization,BP,ACTN2;PLEKHH2
2093,GO:0030834,0.711473488497389,0.618368960839746,2,6,regulation of actin filament depolymerization,BP,ACTN2;PLEKHH2
3131,GO:0043244,0.711473488497389,0.618368960839746,2,6,regulation of protein complex disassembly,BP,ACTN2;PLEKHH2
3237,GO:0043624,0.711473488497389,0.618368960839746,2,6,cellular protein complex disassembly,BP,ACTN2;PLEKHH2
4153,GO:0051261,0.711473488497389,0.618368960839746,2,6,protein depolymerization,BP,ACTN2;PLEKHH2
5646,GO:1901879,0.711473488497389,0.618368960839746,2,6,regulation of protein depolymerization,BP,ACTN2;PLEKHH2
3936,GO:0050663,0.712501034034383,0.735208871731425,1,3,cytokine secretion,BP,GAS6
2024,GO:0030424,0.712880496771729,0.698141487439884,1,5,axon,CC,NRTN
3927,GO:0048872,0.713607705751415,0.590271270743445,2,9,homeostasis of number of cells,BP,KITLG;PDE4B
2515,GO:0032989,0.715421682240182,0.437906192287106,9,36,cellular component morphogenesis,BP,ACTN2;MYO7A;NRTN;RHOJ;PIK3R1;LAMA5;SEMA6C;FHOD3;MSN
3558,GO:0045859,0.71551875224325,0.462252320646261,6,30,regulation of protein kinase activity,BP,CDKN1A;KITLG;GAS6;SDC4;PRKACB;UNC119
4992,GO:0071704,0.715646414276874,0.394070814602904,32,136,organic substance metabolic process,BP,ACTN2;CDKN1A;HMGCS2;NRTN;DKK3;GPRASP1;KITLG;PRND;PHLDA1;SLC52A3;NUAK2;MFGE8;PIK3R1;GAS6;SDC4;PRKACB;ITGB8;SERPINA5;HMGN5;PTPN7;ACSL4;FOXO4;DHH;MARK4;DLL1;PDE4B;UNC119;CTGF;ITGA3;WT1;MSN;PTGES
5750,GO:1902904,0.715970593032888,0.613154952663651,2,6,negative regulation of supramolecular fiber organization,BP,PLEKHH2;FHOD3
98,GO:0001568,0.716221787726413,0.443499066227424,8,34,blood vessel development,BP,RHOB;MFGE8;LAMA5;ITGB8;FOXO4;DLL1;CTGF;WT1
5036,GO:0072006,0.716361592823525,0.50135935069451,4,18,nephron development,BP,LAMA5;DLL1;ITGA3;WT1
1751,GO:0019216,0.716605476878786,0.534665584834714,3,13,regulation of lipid metabolic process,BP,DKK3;PIK3R1;DHH
1236,GO:0009790,0.716668493579979,0.423785732819826,11,45,embryo development,BP,LAMA1;MYO7A;KITLG;LAMA5;SDC4;ITGB5;PRKACB;ACSL4;DLL1;ITGA3;WT1
562,GO:0005112,0.718262326667471,0.729255725074264,1,3,Notch binding,MF,DLL1
350,GO:0002762,0.718312186015909,0.705429112113887,1,4,negative regulation of myeloid leukocyte differentiation,BP,PIK3R1
930,GO:0007043,0.718475979442201,0.683138955135581,1,6,cell-cell junction assembly,BP,CLDN1
3410,GO:0045088,0.719952002010155,0.703604326551467,1,4,regulation of innate immune response,BP,PRKACB
3411,GO:0045089,0.719952002010155,0.703604326551467,1,4,positive regulation of innate immune response,BP,PRKACB
479,GO:0003674,0.720220119912385,0.536930607112525,56,228,molecular_function,MF,LAMA1;ACTN2;MYO7A;CDKN1A;FRMPD1;HMGCS2;NRTN;REEP1;GPRASP1;RHOB;KITLG;PRND;PHLDA1;SLC52A3;RHOJ;NUAK2;MFGE8;CAMSAP3;PLEKHH2;CLDN11;PIK3R1;SLC25A53;GAS6;LAMA5;SDC4;MPZL1;ITGB5;PRKACB;ITGB8;SERPINA5;HMGN5;PTPN7;RIN3;ACSL4;CRISPLD2;FHOD3;RAB39B;FOXO4;DHH;GPSM1;MARK4;ESPN;DAAM2;DLL1;TMEM163;PDE4B;UNC119;CGN;CLDN1;SLC18B1;CTGF;ITGA3;WT1;MSN;PTGES;SH3BP4
2677,GO:0034976,0.720838204458464,0.702614027655871,1,4,response to endoplasmic reticulum stress,BP,PIK3R1
2207,GO:0031410,0.720922326786008,0.408732512060325,13,58,cytoplasmic vesicle,CC,ACTN2;MYO7A;RHOB;PHLDA1;GAS6;ITGB5;SERPINA5;RIN3;CRISPLD2;DLL1;TMEM163;PDE4B;SH3BP4
5411,GO:0097708,0.720922326786008,0.408732512060325,13,58,intracellular vesicle,CC,ACTN2;MYO7A;RHOB;PHLDA1;GAS6;ITGB5;SERPINA5;RIN3;CRISPLD2;DLL1;TMEM163;PDE4B;SH3BP4
5459,GO:0098797,0.721033638637684,0.532750256336126,3,12,plasma membrane protein complex,CC,ITGB5;ITGB8;ITGA3
4428,GO:0060324,0.721156181627952,0.70225798967227,1,4,face development,BP,CRISPLD2
1240,GO:0009799,0.721394168700126,0.580863239711202,2,9,specification of symmetry,BP,DAAM2;DLL1
2,GO:0000003,0.721418684782777,0.421522789105707,10,46,reproduction,BP,KITLG;MFGE8;CLDN11;PRKACB;ITGB8;SERPINA5;ACSL4;DHH;ITGA3;WT1
1889,GO:0022414,0.721418684782777,0.421522789105707,10,46,reproductive process,BP,KITLG;MFGE8;CLDN11;PRKACB;ITGB8;SERPINA5;ACSL4;DHH;ITGA3;WT1
5132,GO:0072207,0.722334253182559,0.700935626536212,1,4,metanephric epithelium development,BP,WT1
42,GO:0000323,0.725280817088358,0.571414837551333,2,10,lytic vacuole,CC,MYO7A;SDC4
652,GO:0005764,0.725280817088358,0.571414837551333,2,10,lysosome,CC,MYO7A;SDC4
893,GO:0006928,0.725634562525939,0.395575695573009,16,65,movement of cell or subcellular component,BP,LAMA1;ACTN2;MYO7A;NRTN;RHOB;KITLG;PIK3R1;GAS6;LAMA5;SDC4;SEMA6C;FOXO4;PDE4B;CTGF;ITGA3;MSN
2634,GO:0034446,0.725723501064397,0.721366773355843,1,3,substrate adhesion-dependent cell spreading,BP,LAMA5
5205,GO:0072678,0.726004028149794,0.69678299951917,1,4,T cell migration,BP,MSN
5212,GO:0085029,0.726019261877101,0.721049793997549,1,3,extracellular matrix assembly,BP,GAS6
589,GO:0005244,0.72619463957116,0.682837081854648,1,5,voltage-gated ion channel activity,MF,GAS6
597,GO:0005261,0.72619463957116,0.682837081854648,1,5,cation channel activity,MF,GAS6
1902,GO:0022832,0.72619463957116,0.682837081854648,1,5,voltage-gated channel activity,MF,GAS6
1904,GO:0022836,0.72619463957116,0.682837081854648,1,5,gated channel activity,MF,GAS6
1906,GO:0022843,0.72619463957116,0.682837081854648,1,5,voltage-gated cation channel activity,MF,GAS6
2025,GO:0030425,0.726218675285116,0.581045999598495,2,8,dendrite,CC,ACTN2;PDE4B
1907,GO:0022857,0.726263967805245,0.515443071675188,3,16,transmembrane transporter activity,MF,SLC25A53;GAS6;SLC18B1
4547,GO:0060674,0.727040964958825,0.695600388961028,1,4,placenta blood vessel development,BP,ITGB8
4233,GO:0051649,0.727303174242892,0.429691750662559,8,35,establishment of localization in cell,BP,MYO7A;CDKN1A;REEP1;GPRASP1;RHOB;PIK3R1;GAS6;MSN
4234,GO:0051650,0.727588336326879,0.68119673039345,1,5,establishment of vesicle localization,BP,MYO7A
174,GO:0001894,0.728073467176828,0.68062399957878,1,5,tissue homeostasis,BP,CTGF
703,GO:0005923,0.7287905521141,0.514394250443581,3,15,bicellular tight junction,CC,CLDN11;CGN;CLDN1
4769,GO:0070160,0.7287905521141,0.514394250443581,3,15,occluding junction,CC,CLDN11;CGN;CLDN1
4356,GO:0060048,0.728950764952567,0.571568239974826,2,9,cardiac muscle contraction,BP,PDE4B;CTGF
1144,GO:0008543,0.729049156041781,0.670590561609086,1,6,fibroblast growth factor receptor signaling pathway,BP,CTGF
3309,GO:0044344,0.729049156041781,0.670590561609086,1,6,cellular response to fibroblast growth factor stimulus,BP,CTGF
5002,GO:0071774,0.729049156041781,0.670590561609086,1,6,response to fibroblast growth factor,BP,CTGF
4459,GO:0060419,0.729486426702957,0.692795078613533,1,4,heart growth,BP,WT1
4460,GO:0060420,0.729486426702957,0.692795078613533,1,4,regulation of heart growth,BP,WT1
4461,GO:0060421,0.729486426702957,0.692795078613533,1,4,positive regulation of heart growth,BP,WT1
1323,GO:0010556,0.729493079655562,0.402212528829296,12,55,regulation of macromolecule biosynthetic process,BP,ACTN2;CDKN1A;DKK3;KITLG;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;CTGF;ITGA3;WT1
4298,GO:0055001,0.729786044126289,0.576657040471402,2,8,muscle cell development,BP,ACTN2;FHOD3
3799,GO:0048511,0.730206499676262,0.691964656161257,1,4,rhythmic process,BP,KITLG
4491,GO:0060485,0.730215211341629,0.4827247852453,4,19,mesenchyme development,BP,NRTN;KITLG;LAMA5;WT1
967,GO:0007187,0.730649542885579,0.677567589520386,1,5,G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,BP,PRKACB
968,GO:0007188,0.730649542885579,0.677567589520386,1,5,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,BP,PRKACB
959,GO:0007169,0.730716848872397,0.444743182508786,6,29,transmembrane receptor protein tyrosine kinase signaling pathway,BP,NRTN;PIK3R1;MPZL1;FOXO4;DLL1;CTGF
582,GO:0005200,0.730977331197117,0.715686619922003,1,3,structural constituent of cytoskeleton,MF,MSN
1801,GO:0019898,0.731135967297841,0.520317462072209,3,12,extrinsic component of membrane,CC,MFGE8;PIK3R1;MSN
1350,GO:0010639,0.731182128350827,0.524552425769522,3,11,negative regulation of organelle organization,BP,PLEKHH2;FHOD3;ESPN
3593,GO:0045995,0.731483650965672,0.489822242042302,4,15,regulation of embryonic development,BP,LAMA1;LAMA5;PRKACB;DLL1
5460,GO:0098801,0.732171379339287,0.675749909923008,1,5,regulation of renal system process,BP,GAS6
4991,GO:0071702,0.732302164823358,0.408289143653487,10,47,organic substance transport,BP,MYO7A;CDKN1A;RHOB;SLC52A3;PIK3R1;GAS6;SERPINA5;ACSL4;RAB39B;UNC119
5428,GO:0098590,0.732837292997287,0.447240507390265,6,24,plasma membrane region,CC,MYO7A;SLC52A3;DLL1;CLDN1;ITGA3;MSN
2678,GO:0035004,0.73303837077463,0.561737688225759,2,10,phosphatidylinositol 3-kinase activity,MF,KITLG;PIK3R1
3632,GO:0046488,0.73303837077463,0.561737688225759,2,10,phosphatidylinositol metabolic process,BP,KITLG;PIK3R1
3676,GO:0046834,0.73303837077463,0.561737688225759,2,10,lipid phosphorylation,BP,KITLG;PIK3R1
3682,GO:0046854,0.73303837077463,0.561737688225759,2,10,phosphatidylinositol phosphorylation,BP,KITLG;PIK3R1
3707,GO:0046934,0.73303837077463,0.561737688225759,2,10,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,KITLG;PIK3R1
4297,GO:0052813,0.73303837077463,0.561737688225759,2,10,phosphatidylinositol bisphosphate kinase activity,MF,KITLG;PIK3R1
1348,GO:0010634,0.733332317898153,0.557611900777434,2,11,positive regulation of epithelial cell migration,BP,RHOB;ITGA3
1216,GO:0009607,0.733576879186106,0.504508367083785,3,17,response to biotic stimulus,BP,PDE4B;CLDN1;PTGES
3112,GO:0043207,0.733576879186106,0.504508367083785,3,17,response to external biotic stimulus,BP,PDE4B;CLDN1;PTGES
4244,GO:0051707,0.733576879186106,0.504508367083785,3,17,response to other organism,BP,PDE4B;CLDN1;PTGES
3409,GO:0045087,0.734126954215723,0.560365705367013,2,10,innate immune response,BP,PRKACB;CLDN1
3019,GO:0042592,0.734360509324815,0.412697725332949,9,41,homeostatic process,BP,KITLG;PRND;PIK3R1;GAS6;PRKACB;DLL1;PDE4B;CLDN1;CTGF
3449,GO:0045296,0.73508500407309,0.686285249905042,1,4,cadherin binding,MF,CGN
755,GO:0006260,0.73592231311711,0.662204171737825,1,6,DNA replication,BP,KITLG
757,GO:0006275,0.73592231311711,0.662204171737825,1,6,regulation of DNA replication,BP,KITLG
3523,GO:0045740,0.73592231311711,0.662204171737825,1,6,positive regulation of DNA replication,BP,KITLG
619,GO:0005524,0.73693676348847,0.456666993223473,5,21,ATP binding,MF,MYO7A;NUAK2;PRKACB;ACSL4;MARK4
3325,GO:0044428,0.736984575725309,0.427265418154793,7,31,nuclear part,CC,CDKN1A;MRO;PHLDA1;PRKACB;FOXO4;WT1;PTGES
6080,GO:2000379,0.737044769584744,0.66081696138251,1,6,positive regulation of reactive oxygen species metabolic process,BP,CDKN1A
1441,GO:0010976,0.7372790935872,0.683700309384332,1,4,positive regulation of neuron projection development,BP,ITGA3
1022,GO:0007422,0.737421931660123,0.660349713247005,1,6,peripheral nervous system development,BP,CLDN1
3529,GO:0045747,0.737700777242123,0.683201303161627,1,4,positive regulation of Notch signaling pathway,BP,DLL1
6066,GO:2000243,0.738261354114803,0.682536829213866,1,4,positive regulation of reproductive process,BP,WT1
5087,GO:0072111,0.738386002259222,0.66823255693789,1,5,cell proliferation involved in kidney development,BP,WT1
2648,GO:0034641,0.738793973236264,0.38153515114562,15,67,cellular nitrogen compound metabolic process,BP,ACTN2;CDKN1A;DKK3;KITLG;SLC52A3;PIK3R1;GAS6;ITGB8;HMGN5;FOXO4;DLL1;PDE4B;CTGF;ITGA3;WT1
1393,GO:0010812,0.738845742491677,0.706979661128571,1,3,negative regulation of cell-substrate adhesion,BP,PIK3R1
1034,GO:0007519,0.739279877974165,0.681326291107711,1,4,skeletal muscle tissue development,BP,DLL1
5797,GO:1903364,0.739305661572308,0.681295592324281,1,4,positive regulation of cellular protein catabolic process,BP,MSN
4699,GO:0061326,0.739685044228134,0.503163910023561,3,14,renal tubule development,BP,LAMA5;DLL1;WT1
5039,GO:0072009,0.739685044228134,0.503163910023561,3,14,nephron epithelium development,BP,LAMA5;DLL1;WT1
5067,GO:0072080,0.739685044228134,0.503163910023561,3,14,nephron tubule development,BP,LAMA5;DLL1;WT1
1314,GO:0010508,0.74044372518618,0.665709482394569,1,5,positive regulation of autophagy,BP,SH3BP4
1109,GO:0008219,0.740811051029413,0.385363575401449,13,58,cell death,BP,ACTN2;CDKN1A;RHOB;KITLG;PHLDA1;NUAK2;PIK3R1;GAS6;HMGN5;MARK4;DLL1;CTGF;WT1
1958,GO:0030154,0.740908178786047,0.365379827970425,25,105,cell differentiation,BP,ACTN2;MYO7A;CDKN1A;NRTN;RHOB;KITLG;CAMSAP3;PIK3R1;GAS6;LAMA5;SDC4;ITGB5;SEMA6C;ACSL4;FHOD3;FOXO4;DHH;GPSM1;DLL1;UNC119;CLDN1;CTGF;ITGA3;WT1;MSN
1068,GO:0008013,0.741028703880536,0.679237966464117,1,4,beta-catenin binding,MF,FOXO4
3454,GO:0045335,0.741485487199829,0.664425583239559,1,5,phagocytic vesicle,CC,ITGB5
3833,GO:0048592,0.742072092191604,0.555028767431427,2,9,eye morphogenesis,BP,MYO7A;DLL1
1032,GO:0007507,0.742474457795583,0.44834065561469,5,22,heart development,BP,ACTN2;FHOD3;DLL1;ITGA3;WT1
4133,GO:0051224,0.742556925185348,0.67740285347879,1,4,negative regulation of protein transport,BP,GAS6
1083,GO:0008083,0.742882468363241,0.491113901126671,3,18,growth factor activity,MF,NRTN;KITLG;CTGF
1217,GO:0009611,0.742904185260965,0.418606875539406,7,33,response to wounding,BP,RHOB;PIK3R1;GAS6;SDC4;PRKACB;SERPINA5;CTGF
155,GO:0001822,0.744090510480272,0.443867455832901,5,24,kidney development,BP,LAMA5;SDC4;DLL1;ITGA3;WT1
1771,GO:0019439,0.745464398302164,0.673884929457317,1,4,aromatic compound catabolic process,BP,PDE4B
2654,GO:0034655,0.745464398302164,0.673884929457317,1,4,nucleobase-containing compound catabolic process,BP,PDE4B
3290,GO:0044270,0.745464398302164,0.673884929457317,1,4,cellular nitrogen compound catabolic process,BP,PDE4B
3662,GO:0046700,0.745464398302164,0.673884929457317,1,4,heterocycle catabolic process,BP,PDE4B
5594,GO:1901361,0.745464398302164,0.673884929457317,1,4,organic cyclic compound catabolic process,BP,PDE4B
2460,GO:0032774,0.747350363852854,0.38524165241921,11,51,RNA biosynthetic process,BP,ACTN2;CDKN1A;DKK3;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;CTGF;ITGA3;WT1
5409,GO:0097659,0.747350363852854,0.38524165241921,11,51,nucleic acid-templated transcription,BP,ACTN2;CDKN1A;DKK3;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;CTGF;ITGA3;WT1
1618,GO:0016331,0.747473460002643,0.490735225915228,3,15,morphogenesis of embryonic epithelium,BP,LAMA5;SDC4;PRKACB
852,GO:0006807,0.747602666772832,0.368557169460589,16,72,nitrogen compound metabolic process,BP,ACTN2;CDKN1A;DKK3;KITLG;SLC52A3;PIK3R1;GAS6;SDC4;ITGB8;HMGN5;FOXO4;DLL1;PDE4B;CTGF;ITGA3;WT1
3847,GO:0048639,0.747696691996121,0.542964933055196,2,10,positive regulation of developmental growth,BP,DLL1;WT1
1697,GO:0017022,0.748097748327975,0.670668254891277,1,4,myosin binding,MF,RAB39B
2277,GO:0031981,0.748420022197444,0.424693995956088,6,27,nuclear lumen,CC,CDKN1A;MRO;PHLDA1;PRKACB;FOXO4;WT1
4518,GO:0060563,0.748887875661343,0.552499145574249,2,8,neuroepithelial cell differentiation,BP,MYO7A;DLL1
2020,GO:0030336,0.75092127002783,0.667186700624452,1,4,negative regulation of cell migration,BP,RHOB
6050,GO:2000146,0.75092127002783,0.667186700624452,1,4,negative regulation of cell motility,BP,RHOB
2179,GO:0031294,0.751280066387481,0.666741847145271,1,4,lymphocyte costimulation,BP,PIK3R1
2180,GO:0031295,0.751280066387481,0.666741847145271,1,4,T cell costimulation,BP,PIK3R1
4017,GO:0050870,0.751280066387481,0.666741847145271,1,4,positive regulation of T cell activation,BP,PIK3R1
5768,GO:1903039,0.751280066387481,0.666741847145271,1,4,positive regulation of leukocyte cell-cell adhesion,BP,PIK3R1
4037,GO:0050921,0.751513971009812,0.642476476161829,1,6,positive regulation of chemotaxis,BP,GAS6
2054,GO:0030593,0.751681112650956,0.651623047832361,1,5,neutrophil chemotaxis,BP,PDE4B
4979,GO:0071621,0.751681112650956,0.651623047832361,1,5,granulocyte chemotaxis,BP,PDE4B
5401,GO:0097530,0.751681112650956,0.651623047832361,1,5,granulocyte migration,BP,PDE4B
5986,GO:1990266,0.751681112650956,0.651623047832361,1,5,neutrophil migration,BP,PDE4B
3082,GO:0043085,0.751834367363068,0.3838100002611,10,50,positive regulation of catalytic activity,BP,ACTN2;CDKN1A;NRTN;KITLG;GAS6;SDC4;PRKACB;RIN3;UNC119;CTGF
135,GO:0001750,0.75238309519451,0.691411853971497,1,3,photoreceptor outer segment,CC,MYO7A
5414,GO:0097730,0.75238309519451,0.691411853971497,1,3,non-motile cilium,CC,MYO7A
5415,GO:0097731,0.75238309519451,0.691411853971497,1,3,9+0 non-motile cilium,CC,MYO7A
5416,GO:0097733,0.75238309519451,0.691411853971497,1,3,photoreceptor cell cilium,CC,MYO7A
1128,GO:0008361,0.753253141087084,0.649609986606404,1,5,regulation of cell size,BP,MSN
1086,GO:0008104,0.753331460928347,0.370641495173071,13,57,protein localization,BP,ACTN2;MYO7A;CDKN1A;REEP1;RHOB;PIK3R1;GAS6;LAMA5;RAB39B;UNC119;ITGA3;MSN;SH3BP4
1773,GO:0019538,0.754301319756461,0.352517426261566,21,94,protein metabolic process,BP,ACTN2;CDKN1A;NRTN;KITLG;PRND;PHLDA1;NUAK2;MFGE8;PIK3R1;GAS6;SDC4;PRKACB;SERPINA5;PTPN7;FOXO4;DHH;MARK4;DLL1;UNC119;CTGF;MSN
494,GO:0003824,0.754489011200399,0.358178536755558,17,77,catalytic activity,MF,MYO7A;CDKN1A;HMGCS2;RHOB;KITLG;RHOJ;NUAK2;PIK3R1;PRKACB;PTPN7;ACSL4;RAB39B;DHH;MARK4;PDE4B;CGN;PTGES
1278,GO:0010008,0.755275086241563,0.529154853421514,2,11,endosome membrane,CC,RHOB;TMEM163
3334,GO:0044440,0.755275086241563,0.529154853421514,2,11,endosomal part,CC,RHOB;TMEM163
2599,GO:0034109,0.755860735739683,0.661013548574191,1,4,homotypic cell-cell adhesion,BP,GAS6
1806,GO:0019903,0.75588322508449,0.660985198896487,1,4,protein phosphatase binding,MF,PIK3R1
1057,GO:0007610,0.756324423031361,0.531605115169358,2,10,behavior,BP,ESPN;ITGA3
5432,GO:0098602,0.756502263078539,0.404837521559327,7,29,single organism cell adhesion,BP,CAMSAP3;PIK3R1;GAS6;LAMA5;SDC4;ITGB5;MSN
4158,GO:0051276,0.756600222520078,0.645288233115178,1,5,chromosome organization,BP,HMGN5
781,GO:0006461,0.756772641629615,0.428996283266669,5,23,protein complex assembly,BP,ACTN2;PRND;FHOD3;CLDN1;MSN
4751,GO:0065003,0.756772641629615,0.428996283266669,5,23,macromolecular complex assembly,BP,ACTN2;PRND;FHOD3;CLDN1;MSN
4797,GO:0070271,0.756772641629615,0.428996283266669,5,23,protein complex biogenesis,BP,ACTN2;PRND;FHOD3;CLDN1;MSN
5457,GO:0098794,0.75731414289134,0.541475405850444,2,8,postsynapse,CC,ACTN2;PDE4B
3276,GO:0044238,0.757485736717454,0.345152673408619,30,129,primary metabolic process,BP,ACTN2;CDKN1A;HMGCS2;NRTN;DKK3;KITLG;PRND;PHLDA1;NUAK2;MFGE8;PIK3R1;GAS6;SDC4;PRKACB;ITGB8;SERPINA5;HMGN5;PTPN7;ACSL4;FOXO4;DHH;MARK4;DLL1;PDE4B;UNC119;CTGF;ITGA3;WT1;MSN;PTGES
6022,GO:2000026,0.757547454975212,0.369233548208922,12,53,regulation of multicellular organismal development,BP,LAMA1;RHOB;KITLG;PIK3R1;GAS6;LAMA5;PRKACB;FOXO4;DLL1;CTGF;ITGA3;WT1
193,GO:0001947,0.757765174657671,0.658604936873786,1,4,heart looping,BP,DLL1
4714,GO:0061371,0.757765174657671,0.658604936873786,1,4,determination of heart left/right asymmetry,BP,DLL1
1331,GO:0010565,0.75812989731256,0.643296791448736,1,5,regulation of cellular ketone metabolic process,BP,DKK3
2941,GO:0042180,0.75812989731256,0.643296791448736,1,5,cellular ketone metabolic process,BP,DKK3
1402,GO:0010827,0.758250979119292,0.657987949685724,1,4,regulation of glucose transport,BP,PIK3R1
1403,GO:0010828,0.758250979119292,0.657987949685724,1,4,positive regulation of glucose transport,BP,PIK3R1
3608,GO:0046324,0.758250979119292,0.657987949685724,1,4,regulation of glucose import,BP,PIK3R1
3609,GO:0046326,0.758250979119292,0.657987949685724,1,4,positive regulation of glucose import,BP,PIK3R1
3479,GO:0045604,0.759622348860934,0.656240585793848,1,4,regulation of epidermal cell differentiation,BP,DLL1
2307,GO:0032148,0.759679547060605,0.641268790005084,1,5,activation of protein kinase B activity,BP,GAS6
209,GO:0002009,0.759796992422107,0.398309423550472,7,32,morphogenesis of an epithelium,BP,RHOB;LAMA5;SDC4;PRKACB;DLL1;WT1;MSN
2895,GO:0040011,0.760951403793201,0.358721367847238,14,59,locomotion,BP,LAMA1;NRTN;RHOB;KITLG;PIK3R1;GAS6;LAMA5;SDC4;SEMA6C;FOXO4;PDE4B;CTGF;ITGA3;MSN
5382,GO:0097305,0.761929009245804,0.628726343887036,1,6,response to alcohol,BP,CLDN1
371,GO:0003008,0.762521414408429,0.362620896651552,12,55,system process,BP,ACTN2;MYO7A;SLC52A3;GAS6;ITGB5;PRKACB;ESPN;DLL1;PDE4B;UNC119;CTGF;ITGA3
2487,GO:0032880,0.762569034552373,0.406852940242734,6,27,regulation of protein localization,BP,ACTN2;CDKN1A;PIK3R1;GAS6;ITGA3;MSN
1163,GO:0009057,0.762641886841089,0.473361023135356,3,14,macromolecule catabolic process,BP,GPRASP1;SDC4;MSN
4895,GO:0071216,0.762671869431604,0.637322415074028,1,5,cellular response to biotic stimulus,BP,PDE4B
4896,GO:0071219,0.762671869431604,0.637322415074028,1,5,cellular response to molecule of bacterial origin,BP,PDE4B
4897,GO:0071222,0.762671869431604,0.637322415074028,1,5,cellular response to lipopolysaccharide,BP,PDE4B
5458,GO:0098796,0.763306629316175,0.475430164877415,3,13,membrane protein complex,CC,ITGB5;ITGB8;ITGA3
5674,GO:1902106,0.763999491235397,0.635558558391846,1,5,negative regulation of leukocyte differentiation,BP,PIK3R1
2670,GO:0034762,0.764068162547737,0.521204843307173,2,10,regulation of transmembrane transport,BP,ACTN2;PDE4B
2673,GO:0034765,0.764068162547737,0.521204843307173,2,10,regulation of ion transmembrane transport,BP,ACTN2;PDE4B
628,GO:0005575,0.764973380564603,0.999999999999999,59,240,cellular_component,CC,LAMA1;ACTN2;MYO7A;CDKN1A;FRMPD1;HMGCS2;NRTN;REEP1;DKK3;GPRASP1;RHOB;KITLG;MRO;PRND;PHLDA1;SLC52A3;RHOJ;NUAK2;MFGE8;CAMSAP3;PLEKHH2;CLDN11;PIK3R1;SLC25A53;GAS6;LAMA5;SDC4;MPZL1;ITGB5;SEMA6C;PRKACB;ITGB8;SERPINA5;HMGN5;PTPN7;RIN3;ACSL4;CRISPLD2;FHOD3;RAB39B;FOXO4;DHH;GPSM1;MARK4;ESPN;DAAM2;DLL1;TMEM163;PDE4B;UNC119;CGN;CLDN1;SLC18B1;CTGF;ITGA3;WT1;MSN;PTGES;SH3BP4
1264,GO:0009953,0.765020011350807,0.617858953871203,1,7,dorsal/ventral pattern formation,BP,PRKACB
2702,GO:0035148,0.765108561614631,0.515912849717557,2,11,tube formation,BP,SDC4;PRKACB
3323,GO:0044425,0.765308443754493,0.336031858691225,27,110,membrane part,CC,MYO7A;REEP1;KITLG;PRND;SLC52A3;MFGE8;CLDN11;PIK3R1;SLC25A53;SDC4;MPZL1;ITGB5;SEMA6C;ITGB8;SERPINA5;PTPN7;ACSL4;GPSM1;DLL1;TMEM163;PDE4B;CLDN1;SLC18B1;ITGA3;MSN;PTGES;SH3BP4
1472,GO:0014066,0.765742901368175,0.515047761991507,2,11,regulation of phosphatidylinositol 3-kinase signaling,BP,KITLG;PIK3R1
1058,GO:0007611,0.765818966234196,0.633128173320023,1,5,learning or memory,BP,ITGA3
5575,GO:1901135,0.766233210498967,0.436806337449853,4,19,carbohydrate derivative metabolic process,BP,PHLDA1;SDC4;ITGB8;PDE4B
659,GO:0005773,0.766637622916182,0.513825299411355,2,11,vacuole,CC,MYO7A;SDC4
3228,GO:0043588,0.766660616322443,0.444972199155997,4,15,skin development,BP,LAMA5;DLL1;CLDN1;ITGA3
4752,GO:0065007,0.767761317112568,0.34900176528565,43,183,biological regulation,BP,LAMA1;ACTN2;CDKN1A;NRTN;REEP1;DKK3;GPRASP1;RHOB;KITLG;PRND;RHOJ;NUAK2;MFGE8;CAMSAP3;PLEKHH2;PIK3R1;GAS6;LAMA5;SDC4;MPZL1;ITGB5;PRKACB;ITGB8;SERPINA5;HMGN5;RIN3;FHOD3;FOXO4;DHH;GPSM1;MARK4;ESPN;DLL1;PDE4B;UNC119;CGN;CLDN1;CTGF;ITGA3;WT1;MSN;PTGES;SH3BP4
2132,GO:0031018,0.767762632515177,0.630515068307186,1,5,endocrine pancreas development,BP,DLL1
5134,GO:0072210,0.76829168329877,0.620088671948672,1,6,metanephric nephron development,BP,WT1
1516,GO:0015031,0.769241191835814,0.385059597729421,7,34,protein transport,BP,MYO7A;CDKN1A;RHOB;PIK3R1;GAS6;RAB39B;UNC119
5617,GO:1901615,0.769757091139667,0.513437153277132,2,10,organic hydroxy compound metabolic process,BP,HMGCS2;DKK3
2514,GO:0032984,0.771799398342482,0.530671856712115,2,7,macromolecular complex disassembly,BP,ACTN2;PLEKHH2
3128,GO:0043241,0.771799398342482,0.530671856712115,2,7,protein complex disassembly,BP,ACTN2;PLEKHH2
5069,GO:0072088,0.772157409463368,0.506224060247566,2,11,nephron epithelium morphogenesis,BP,LAMA5;WT1
4271,GO:0051924,0.772813344884557,0.623642239829649,1,5,regulation of calcium ion transport,BP,PDE4B
3122,GO:0043231,0.773729146796635,0.326501516139725,25,109,intracellular membrane-bounded organelle,CC,MYO7A;CDKN1A;HMGCS2;REEP1;RHOB;MRO;PHLDA1;NUAK2;PIK3R1;SLC25A53;GAS6;LAMA5;SDC4;PRKACB;SERPINA5;HMGN5;ACSL4;RAB39B;FOXO4;GPSM1;CTGF;WT1;MSN;PTGES;SH3BP4
514,GO:0004672,0.773843488761976,0.423831361577431,4,21,protein kinase activity,MF,CDKN1A;NUAK2;PRKACB;MARK4
5984,GO:1990234,0.774077010949676,0.512401671434517,2,9,transferase complex,CC,CDKN1A;PIK3R1
1215,GO:0009605,0.774796251142483,0.347026505429023,12,57,response to external stimulus,BP,CDKN1A;NRTN;NUAK2;PIK3R1;GAS6;SEMA6C;ACSL4;FOXO4;PDE4B;UNC119;CLDN1;PTGES
585,GO:0005216,0.775197806864668,0.610501089362753,1,6,ion channel activity,MF,GAS6
1905,GO:0022838,0.775197806864668,0.610501089362753,1,6,substrate-specific channel activity,MF,GAS6
4833,GO:0070482,0.776072311351979,0.497594331644198,2,12,response to oxygen levels,BP,CDKN1A;CTGF
3084,GO:0043087,0.77660769111653,0.402090527169728,5,24,regulation of GTPase activity,BP,ACTN2;NRTN;KITLG;RIN3;SH3BP4
962,GO:0007178,0.776963410155323,0.42101425348906,4,20,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,DKK3;ITGB5;CGN;ITGA3
2915,GO:0042060,0.777028756885991,0.385728395879474,6,30,wound healing,BP,RHOB;PIK3R1;GAS6;SDC4;PRKACB;SERPINA5
3270,GO:0044093,0.777571823927934,0.351703438937608,10,51,positive regulation of molecular function,BP,ACTN2;CDKN1A;NRTN;KITLG;GAS6;SDC4;PRKACB;RIN3;UNC119;CTGF
899,GO:0006941,0.778078640633014,0.501874522290999,2,10,striated muscle contraction,BP,PDE4B;CTGF
1757,GO:0019222,0.78013055360578,0.321470660043384,21,96,regulation of metabolic process,BP,ACTN2;CDKN1A;DKK3;KITLG;CAMSAP3;PIK3R1;GAS6;SDC4;PRKACB;ITGB8;SERPINA5;HMGN5;FOXO4;DHH;DLL1;UNC119;CTGF;ITGA3;WT1;MSN;SH3BP4
3126,GO:0043235,0.780783283655996,0.455343861217589,3,12,receptor complex,CC,ITGB5;ITGB8;ITGA3
3058,GO:0042990,0.780891759700897,0.628019792622669,1,4,regulation of transcription factor import into nucleus,BP,PIK3R1
3059,GO:0042991,0.780891759700897,0.628019792622669,1,4,transcription factor import into nucleus,BP,PIK3R1
2191,GO:0031331,0.781189571388739,0.497489208910267,2,10,positive regulation of cellular catabolic process,BP,MSN;SH3BP4
708,GO:0005942,0.782959700103325,0.625158550759453,1,4,phosphatidylinositol 3-kinase complex,CC,PIK3R1
4402,GO:0060231,0.783673802556111,0.598420650592602,1,6,mesenchymal to epithelial transition,BP,WT1
2131,GO:0031016,0.783872795407102,0.598132769243842,1,6,pancreas development,BP,DLL1
2985,GO:0042471,0.784130085250473,0.597760255276358,1,6,ear morphogenesis,BP,MYO7A
1959,GO:0030155,0.784604376614403,0.381554617642128,6,24,regulation of cell adhesion,BP,LAMA1;PIK3R1;LAMA5;SDC4;DLL1;ITGA3
4194,GO:0051445,0.785157740443424,0.606324960148881,1,5,regulation of meiotic cell cycle,BP,PRKACB
1624,GO:0016358,0.785267982358067,0.606166878697639,1,5,dendrite development,BP,ACSL4
771,GO:0006366,0.785368118324249,0.355438365042341,8,39,transcription from RNA polymerase II promoter,BP,CDKN1A;PIK3R1;HMGN5;FOXO4;DLL1;CTGF;ITGA3;WT1
5101,GO:0072148,0.785690415914701,0.621346790874498,1,4,epithelial cell fate commitment,BP,DLL1
2927,GO:0042110,0.785782465353454,0.441858063011598,3,14,T cell activation,BP,PIK3R1;SDC4;MSN
1281,GO:0010038,0.785840662100386,0.486925608962828,2,11,response to metal ion,BP,CLDN1;PTGES
3573,GO:0045927,0.787524389389574,0.484504619644085,2,11,positive regulation of growth,BP,DLL1;WT1
4779,GO:0070201,0.788844885594274,0.406416138242923,4,19,regulation of establishment of protein localization,BP,CDKN1A;PIK3R1;GAS6;ITGA3
5592,GO:1901343,0.789048173413955,0.49124742291621,2,9,negative regulation of vasculature development,BP,FOXO4;WT1
1843,GO:0021700,0.79014684389934,0.588953022490554,1,6,developmental maturation,BP,CDKN1A
1927,GO:0030027,0.790287324499981,0.489459143888866,2,9,lamellipodium,CC,KITLG;PLEKHH2
1018,GO:0007411,0.790481891640585,0.432766277068274,3,15,axon guidance,BP,NRTN;PIK3R1;SEMA6C
5399,GO:0097485,0.790481891640585,0.432766277068274,3,15,neuron projection guidance,BP,NRTN;PIK3R1;SEMA6C
1557,GO:0015833,0.791207391974986,0.356068138031061,7,35,peptide transport,BP,MYO7A;CDKN1A;RHOB;PIK3R1;GAS6;RAB39B;UNC119
3053,GO:0042886,0.791207391974986,0.356068138031061,7,35,amide transport,BP,MYO7A;CDKN1A;RHOB;PIK3R1;GAS6;RAB39B;UNC119
819,GO:0006644,0.791506054280319,0.47873784891661,2,11,phospholipid metabolic process,BP,KITLG;PIK3R1
820,GO:0006650,0.791506054280319,0.47873784891661,2,11,glycerophospholipid metabolic process,BP,KITLG;PIK3R1
956,GO:0007166,0.791517502606311,0.311432860506192,18,82,cell surface receptor signaling pathway,BP,LAMA1;NRTN;DKK3;KITLG;PIK3R1;GAS6;LAMA5;MPZL1;ITGB5;PRKACB;ITGB8;FOXO4;DHH;DLL1;PDE4B;CGN;CTGF;ITGA3
626,GO:0005546,0.791658472380556,0.596895760705203,1,5,phosphatidylinositol-4,5-bisphosphate binding,MF,ACTN2
901,GO:0006950,0.791673878952446,0.321983088869522,13,64,response to stress,BP,CDKN1A;RHOB;SLC52A3;NUAK2;PIK3R1;GAS6;SDC4;PRKACB;SERPINA5;FOXO4;CLDN1;CTGF;PTGES
896,GO:0006937,0.791898687236538,0.478165984771904,2,11,regulation of muscle contraction,BP,PDE4B;CTGF
5295,GO:0090257,0.791898687236538,0.478165984771904,2,11,regulation of muscle system process,BP,PDE4B;CTGF
5796,GO:1903362,0.794362442630278,0.592908173390704,1,5,regulation of cellular protein catabolic process,BP,MSN
3009,GO:0042552,0.79454990868263,0.582388938336963,1,6,myelination,BP,DHH
1037,GO:0007565,0.79468425267257,0.47805521093878,2,10,female pregnancy,BP,ACSL4;ITGA3
2984,GO:0042470,0.795910744208429,0.590607170189565,1,5,melanosome,CC,MYO7A
3895,GO:0048770,0.795910744208429,0.590607170189565,1,5,pigment granule,CC,MYO7A
3561,GO:0045862,0.796164556515467,0.579956053238748,1,6,positive regulation of proteolysis,BP,CTGF
1620,GO:0016337,0.79735697192417,0.361285055600759,6,27,single organismal cell-cell adhesion,BP,CAMSAP3;PIK3R1;GAS6;SDC4;ITGB5;MSN
2168,GO:0031224,0.797506123661684,0.302864645179096,19,83,intrinsic component of membrane,CC,REEP1;KITLG;PRND;SLC52A3;CLDN11;SLC25A53;SDC4;MPZL1;ITGB5;SEMA6C;ITGB8;ACSL4;DLL1;TMEM163;PDE4B;CLDN1;SLC18B1;ITGA3;PTGES
3629,GO:0046483,0.797825073262949,0.311738914468841,14,66,heterocycle metabolic process,BP,ACTN2;CDKN1A;DKK3;KITLG;SLC52A3;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;PDE4B;CTGF;ITGA3;WT1
955,GO:0007165,0.797971822127099,0.296561676262838,30,132,signal transduction,BP,LAMA1;ACTN2;CDKN1A;NRTN;DKK3;GPRASP1;RHOB;KITLG;RHOJ;NUAK2;PIK3R1;GAS6;LAMA5;SDC4;MPZL1;ITGB5;PRKACB;ITGB8;RIN3;FOXO4;DHH;GPSM1;DLL1;PDE4B;UNC119;CGN;CTGF;ITGA3;PTGES;SH3BP4
3730,GO:0048018,0.798215978906108,0.576844796711778,1,6,receptor agonist activity,MF,GAS6
4993,GO:0071705,0.799316212861845,0.336398728615829,8,41,nitrogen compound transport,BP,MYO7A;CDKN1A;RHOB;SLC52A3;PIK3R1;GAS6;RAB39B;UNC119
785,GO:0006469,0.799431387433846,0.567838918092422,1,7,negative regulation of protein kinase activity,BP,CDKN1A
2585,GO:0033673,0.799431387433846,0.567838918092422,1,7,negative regulation of kinase activity,BP,CDKN1A
4181,GO:0051348,0.799431387433846,0.567838918092422,1,7,negative regulation of transferase activity,BP,CDKN1A
465,GO:0003338,0.799561901144474,0.567637699483073,1,7,metanephros morphogenesis,BP,WT1
1309,GO:0010469,0.80005649661251,0.574033903037184,1,6,regulation of receptor activity,BP,ACTN2
68,GO:0001071,0.800139858947743,0.475028184474537,2,9,nucleic acid binding transcription factor activity,MF,FOXO4;WT1
485,GO:0003700,0.800139858947743,0.475028184474537,2,9,transcription factor activity, sequence-specific DNA binding,MF,FOXO4;WT1
1479,GO:0014706,0.800588749697771,0.390109607276608,4,19,striated muscle tissue development,BP,ACTN2;FHOD3;DLL1;WT1
258,GO:0002263,0.800754725561946,0.465111209950108,2,11,cell activation involved in immune response,BP,CRISPLD2;DLL1
280,GO:0002366,0.800754725561946,0.465111209950108,2,11,leukocyte activation involved in immune response,BP,CRISPLD2;DLL1
2480,GO:0032868,0.801249821034608,0.468348822496522,2,10,response to insulin,BP,PIK3R1;FOXO4
4095,GO:0051146,0.802568158950565,0.418002137160885,3,14,striated muscle cell differentiation,BP,ACTN2;FHOD3;WT1
4753,GO:0065008,0.802700240921532,0.297431875479966,18,83,regulation of biological quality,BP,ACTN2;CDKN1A;DKK3;RHOB;KITLG;PRND;RHOJ;PLEKHH2;PIK3R1;GAS6;PRKACB;SERPINA5;FHOD3;DLL1;PDE4B;CLDN1;CTGF;MSN
3132,GO:0043254,0.802714974575902,0.471192763447289,2,9,regulation of protein complex assembly,BP,FHOD3;MSN
5596,GO:1901363,0.803210144143715,0.3077375667804,13,62,heterocyclic compound binding,MF,MYO7A;RHOB;RHOJ;NUAK2;PRKACB;HMGN5;ACSL4;RAB39B;FOXO4;MARK4;PDE4B;WT1;MSN
953,GO:0007163,0.803232230823332,0.465384525095767,2,10,establishment or maintenance of cell polarity,BP,MARK4;MSN
50,GO:0000902,0.803954213631871,0.341683131505009,7,31,cell morphogenesis,BP,MYO7A;NRTN;RHOJ;PIK3R1;LAMA5;SEMA6C;MSN
2953,GO:0042307,0.804451463819738,0.577676776050393,1,5,positive regulation of protein import into nucleus,BP,PIK3R1
5895,GO:1904591,0.804451463819738,0.577676776050393,1,5,positive regulation of protein import,BP,PIK3R1
38,GO:0000302,0.805459233293429,0.565674164961394,1,6,response to reactive oxygen species,BP,RHOB
3289,GO:0044267,0.805512863125911,0.292449478823134,19,88,cellular protein metabolic process,BP,ACTN2;CDKN1A;NRTN;KITLG;PRND;NUAK2;MFGE8;PIK3R1;GAS6;SDC4;PRKACB;SERPINA5;PTPN7;FOXO4;MARK4;DLL1;UNC119;CTGF;MSN
24,GO:0000166,0.805554782051996,0.321436993679576,9,46,nucleotide binding,MF,MYO7A;RHOB;RHOJ;NUAK2;PRKACB;ACSL4;RAB39B;MARK4;PDE4B
1702,GO:0017076,0.805554782051996,0.321436993679576,9,46,purine nucleotide binding,MF,MYO7A;RHOB;RHOJ;NUAK2;PRKACB;ACSL4;RAB39B;MARK4;PDE4B
2407,GO:0032553,0.805554782051996,0.321436993679576,9,46,ribonucleotide binding,MF,MYO7A;RHOB;RHOJ;NUAK2;PRKACB;ACSL4;RAB39B;MARK4;PDE4B
2408,GO:0032555,0.805554782051996,0.321436993679576,9,46,purine ribonucleotide binding,MF,MYO7A;RHOB;RHOJ;NUAK2;PRKACB;ACSL4;RAB39B;MARK4;PDE4B
5587,GO:1901265,0.805554782051996,0.321436993679576,9,46,nucleoside phosphate binding,MF,MYO7A;RHOB;RHOJ;NUAK2;PRKACB;ACSL4;RAB39B;MARK4;PDE4B
6064,GO:2000241,0.80588166066854,0.461398054750685,2,10,regulation of reproductive process,BP,PRKACB;WT1
1343,GO:0010628,0.806043811028946,0.315832724519531,10,49,positive regulation of gene expression,BP,PIK3R1;GAS6;ITGB8;HMGN5;FOXO4;DLL1;CTGF;ITGA3;WT1;MSN
4405,GO:0060249,0.807275324876339,0.562827079790115,1,6,anatomical structure homeostasis,BP,CTGF
4132,GO:0051223,0.807682433816957,0.408055610890221,3,15,regulation of protein transport,BP,CDKN1A;PIK3R1;GAS6
1308,GO:0010468,0.807706528446811,0.302177278346514,13,61,regulation of gene expression,BP,CDKN1A;DKK3;PIK3R1;GAS6;PRKACB;ITGB8;HMGN5;FOXO4;DLL1;CTGF;ITGA3;WT1;MSN
4143,GO:0051248,0.80803627391261,0.401965825649217,3,18,negative regulation of protein metabolic process,BP,CDKN1A;GAS6;SERPINA5
4949,GO:0071407,0.808170856388895,0.405209407780146,3,16,cellular response to organic cyclic compound,BP,PDE4B;WT1;MSN
1712,GO:0017157,0.80844672695625,0.560980623202885,1,6,regulation of exocytosis,BP,SDC4
2194,GO:0031344,0.808567611191132,0.453338597802258,2,11,regulation of cell projection organization,BP,ESPN;ITGA3
849,GO:0006793,0.809570838147198,0.292068549079915,16,76,phosphorus metabolic process,BP,ACTN2;CDKN1A;NRTN;KITLG;NUAK2;CAMSAP3;PIK3R1;GAS6;SDC4;PRKACB;PTPN7;ACSL4;MARK4;PDE4B;UNC119;CTGF
3808,GO:0048522,0.809709149118918,0.284832097737304,21,100,positive regulation of cellular process,BP,ACTN2;CDKN1A;RHOB;KITLG;MFGE8;PIK3R1;GAS6;SDC4;PRKACB;HMGN5;FOXO4;MARK4;ESPN;DLL1;UNC119;CLDN1;CTGF;ITGA3;WT1;MSN;SH3BP4
1013,GO:0007389,0.811429294996947,0.370675472010415,4,22,pattern specification process,BP,PRKACB;DAAM2;DLL1;WT1
1720,GO:0018130,0.811445596992014,0.304097650020204,11,54,heterocycle biosynthetic process,BP,ACTN2;CDKN1A;DKK3;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;CTGF;ITGA3;WT1
2653,GO:0034654,0.811445596992014,0.304097650020204,11,54,nucleobase-containing compound biosynthetic process,BP,ACTN2;CDKN1A;DKK3;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;CTGF;ITGA3;WT1
3291,GO:0044271,0.811445596992014,0.304097650020204,11,54,cellular nitrogen compound biosynthetic process,BP,ACTN2;CDKN1A;DKK3;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;CTGF;ITGA3;WT1
3592,GO:0045992,0.811859903759828,0.56612286738412,1,5,negative regulation of embryonic development,BP,PRKACB
2664,GO:0034703,0.812691749168811,0.554222257419992,1,6,cation channel complex,CC,PDE4B
4641,GO:0061035,0.813153125852804,0.553481306494647,1,6,regulation of cartilage development,BP,CTGF
5277,GO:0090184,0.813590047247575,0.545454889820888,1,7,positive regulation of kidney development,BP,WT1
3225,GO:0043583,0.813639378522494,0.39714547854139,3,16,ear development,BP,MYO7A;SDC4;DLL1
6079,GO:2000377,0.814552138181056,0.543891989729784,1,7,regulation of reactive oxygen species metabolic process,BP,CDKN1A
3646,GO:0046620,0.814593416467023,0.551160075072402,1,6,regulation of organ growth,BP,WT1
3647,GO:0046622,0.814593416467023,0.551160075072402,1,6,positive regulation of organ growth,BP,WT1
5008,GO:0071804,0.815765038140014,0.549262634324367,1,6,cellular potassium ion transport,BP,ACTN2
5009,GO:0071805,0.815765038140014,0.549262634324367,1,6,potassium ion transmembrane transport,BP,ACTN2
397,GO:0003143,0.815885762929584,0.559707090530885,1,5,embryonic heart tube morphogenesis,BP,DLL1
2684,GO:0035050,0.815885762929584,0.559707090530885,1,5,embryonic heart tube development,BP,DLL1
2199,GO:0031349,0.817188630510251,0.557609518209526,1,5,positive regulation of defense response,BP,PRKACB
3836,GO:0048598,0.81737345043764,0.322117683108453,7,33,embryonic morphogenesis,BP,MYO7A;LAMA5;SDC4;ITGB5;PRKACB;DLL1;ITGA3
1643,GO:0016525,0.817830201879159,0.573392707151071,1,4,negative regulation of angiogenesis,BP,FOXO4
698,GO:0005913,0.818226457372448,0.555931105879451,1,5,cell-cell adherens junction,CC,CAMSAP3
1344,GO:0010629,0.81892263628854,0.330032582860856,6,29,negative regulation of gene expression,BP,CDKN1A;DKK3;GAS6;ITGB8;CTGF;WT1
4231,GO:0051641,0.819068461155658,0.291369837865483,12,54,cellular localization,BP,ACTN2;MYO7A;CDKN1A;REEP1;GPRASP1;RHOB;PIK3R1;GAS6;LAMA5;ITGA3;MSN;SH3BP4
190,GO:0001942,0.819153371899156,0.571286606008253,1,4,hair follicle development,BP,LAMA5
1880,GO:0022404,0.819153371899156,0.571286606008253,1,4,molting cycle process,BP,LAMA5
1881,GO:0022405,0.819153371899156,0.571286606008253,1,4,hair cycle process,BP,LAMA5
2951,GO:0042303,0.819153371899156,0.571286606008253,1,4,molting cycle,BP,LAMA5
3024,GO:0042633,0.819153371899156,0.571286606008253,1,4,hair cycle,BP,LAMA5
3984,GO:0050793,0.819423306491699,0.284292725071728,14,65,regulation of developmental process,BP,LAMA1;RHOB;KITLG;RHOJ;PIK3R1;GAS6;LAMA5;PRKACB;FOXO4;DLL1;CTGF;ITGA3;WT1;MSN
1023,GO:0007423,0.820145464627852,0.339634242665778,5,27,sensory organ development,BP,MYO7A;RHOJ;SDC4;DLL1;WT1
4027,GO:0050890,0.820426493499469,0.541630313768941,1,6,cognition,BP,ITGA3
732,GO:0006081,0.820892377198362,0.540860110136538,1,6,cellular aldehyde metabolic process,BP,DKK3
3861,GO:0048667,0.821288600714165,0.360421501687578,4,19,cell morphogenesis involved in neuron differentiation,BP,MYO7A;NRTN;PIK3R1;SEMA6C
1145,GO:0008544,0.821581505902452,0.363649103359732,4,17,epidermis development,BP,MYO7A;LAMA5;DLL1;CTGF
2163,GO:0031175,0.821737252791572,0.326888433065176,6,28,neuron projection development,BP,NRTN;CAMSAP3;PIK3R1;SEMA6C;ACSL4;ITGA3
5710,GO:1902532,0.821831953944998,0.432772815212455,2,11,negative regulation of intracellular signal transduction,BP,ITGA3;SH3BP4
876,GO:0006887,0.821988910998541,0.355384537070863,4,22,exocytosis,BP,ACTN2;GAS6;SDC4;CRISPLD2
1770,GO:0019438,0.822319545782846,0.289571250333601,11,55,aromatic compound biosynthetic process,BP,ACTN2;CDKN1A;DKK3;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;CTGF;ITGA3;WT1
1575,GO:0016021,0.822902710699206,0.272041581331037,18,81,integral component of membrane,CC,REEP1;KITLG;SLC52A3;CLDN11;SLC25A53;SDC4;MPZL1;ITGB5;SEMA6C;ITGB8;ACSL4;DLL1;TMEM163;PDE4B;CLDN1;SLC18B1;ITGA3;PTGES
3607,GO:0046323,0.823154608602764,0.547868282421666,1,5,glucose import,BP,PIK3R1
1329,GO:0010563,0.823300425297085,0.424530204047473,2,13,negative regulation of phosphorus metabolic process,BP,CDKN1A;CAMSAP3
3580,GO:0045936,0.823300425297085,0.424530204047473,2,13,negative regulation of phosphate metabolic process,BP,CDKN1A;CAMSAP3
3141,GO:0043270,0.823616181638301,0.528892555866209,1,7,positive regulation of ion transport,BP,ACTN2
1033,GO:0007517,0.823820178093815,0.353881724230472,4,21,muscle organ development,BP,LAMA5;FOXO4;DLL1;WT1
5922,GO:1904950,0.824004775211574,0.546461594701773,1,5,negative regulation of establishment of protein localization,BP,GAS6
3870,GO:0048699,0.824335621043865,0.287901521529686,11,51,generation of neurons,BP,MYO7A;NRTN;CAMSAP3;PIK3R1;GAS6;SDC4;SEMA6C;ACSL4;DLL1;UNC119;ITGA3
170,GO:0001889,0.824625800202723,0.545431072746285,1,5,liver development,BP,CLDN1
4631,GO:0061008,0.824625800202723,0.545431072746285,1,5,hepaticobiliary system development,BP,CLDN1
5045,GO:0072028,0.824963156508643,0.424564658897695,2,12,nephron morphogenesis,BP,LAMA5;WT1
765,GO:0006351,0.825143845858057,0.290290060703417,10,50,transcription, DNA-templated,BP,CDKN1A;DKK3;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;CTGF;ITGA3;WT1
3355,GO:0044706,0.825340730505051,0.427205041522764,2,11,multi-multicellular organism process,BP,ACSL4;ITGA3
497,GO:0003924,0.825425433005561,0.371272445169123,3,22,GTPase activity,MF,RHOB;RHOJ;RAB39B
1346,GO:0010632,0.825477260822759,0.423744986734816,2,12,regulation of epithelial cell migration,BP,RHOB;ITGA3
5305,GO:0090304,0.825770358941924,0.281422370553046,12,59,nucleic acid metabolic process,BP,ACTN2;CDKN1A;DKK3;KITLG;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;CTGF;ITGA3;WT1
2834,GO:0036094,0.825780266927293,0.289171093567444,10,51,small molecule binding,MF,MYO7A;RHOB;RHOJ;NUAK2;PRKACB;SERPINA5;ACSL4;RAB39B;MARK4;PDE4B
138,GO:0001756,0.825809152458152,0.560519676283748,1,4,somitogenesis,BP,DLL1
4096,GO:0051147,0.825950549134099,0.426231743425521,2,11,regulation of muscle cell differentiation,BP,FOXO4;DLL1
3858,GO:0048663,0.826238770891353,0.542742720001585,1,5,neuron fate commitment,BP,DLL1
4174,GO:0051321,0.82634803350055,0.531738322182408,1,6,meiotic cell cycle,BP,PRKACB
1028,GO:0007492,0.827145692746942,0.530388589669466,1,6,endoderm development,BP,ITGB5
4068,GO:0051049,0.827173836940623,0.283353012861916,11,54,regulation of transport,BP,ACTN2;CDKN1A;REEP1;MFGE8;PIK3R1;GAS6;SDC4;DLL1;PDE4B;UNC119;MSN
262,GO:0002283,0.82734239774786,0.530055103025968,1,6,neutrophil activation involved in immune response,BP,CRISPLD2
298,GO:0002446,0.82734239774786,0.530055103025968,1,6,neutrophil mediated immunity,BP,CRISPLD2
2840,GO:0036230,0.82734239774786,0.530055103025968,1,6,granulocyte activation,BP,CRISPLD2
2930,GO:0042119,0.82734239774786,0.530055103025968,1,6,neutrophil activation,BP,CRISPLD2
3154,GO:0043312,0.82734239774786,0.530055103025968,1,6,neutrophil degranulation,BP,CRISPLD2
1993,GO:0030258,0.82754717474711,0.420432817984485,2,12,lipid modification,BP,KITLG;PIK3R1
4078,GO:0051090,0.827622469683406,0.529579841662377,1,6,regulation of sequence-specific DNA binding transcription factor activity,BP,GAS6
4178,GO:0051345,0.828229733426488,0.32728420062442,5,28,positive regulation of hydrolase activity,BP,ACTN2;NRTN;KITLG;RIN3;CTGF
215,GO:0002040,0.828980214625291,0.538133960026321,1,5,sprouting angiogenesis,BP,DLL1
3212,GO:0043547,0.829441271258571,0.344391572979487,4,22,positive regulation of GTPase activity,BP,ACTN2;NRTN;KITLG;RIN3
4508,GO:0060537,0.830378300937117,0.345489618229703,4,20,muscle tissue development,BP,ACTN2;FHOD3;DLL1;WT1
4073,GO:0051054,0.83105837184911,0.510696573981583,1,8,positive regulation of DNA metabolic process,BP,KITLG
1574,GO:0016020,0.83162375462068,0.261142814371146,39,166,membrane,CC,LAMA1;ACTN2;MYO7A;FRMPD1;HMGCS2;REEP1;RHOB;KITLG;PRND;SLC52A3;RHOJ;MFGE8;PLEKHH2;CLDN11;PIK3R1;SLC25A53;SDC4;MPZL1;ITGB5;SEMA6C;PRKACB;ITGB8;SERPINA5;PTPN7;ACSL4;RAB39B;DHH;GPSM1;DLL1;TMEM163;PDE4B;CGN;CLDN1;SLC18B1;CTGF;ITGA3;MSN;PTGES;SH3BP4
4140,GO:0051241,0.83180141529874,0.301509577945006,7,34,negative regulation of multicellular organismal process,BP,PIK3R1;GAS6;PRKACB;FOXO4;DLL1;PDE4B;WT1
3900,GO:0048806,0.832449981869142,0.513775617512069,1,7,genitalia development,BP,WT1
2475,GO:0032835,0.83292701811634,0.520480076895586,1,6,glomerulus development,BP,WT1
4722,GO:0061437,0.83292701811634,0.520480076895586,1,6,renal system vasculature development,BP,WT1
4725,GO:0061440,0.83292701811634,0.520480076895586,1,6,kidney vasculature development,BP,WT1
5041,GO:0072012,0.83292701811634,0.520480076895586,1,6,glomerulus vasculature development,BP,WT1
5085,GO:0072109,0.83292701811634,0.520480076895586,1,6,glomerular mesangium development,BP,WT1
1589,GO:0016070,0.833387378872165,0.275030011187911,11,54,RNA metabolic process,BP,ACTN2;CDKN1A;DKK3;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;CTGF;ITGA3;WT1
3519,GO:0045732,0.833747086028508,0.52999893639194,1,5,positive regulation of protein catabolic process,BP,MSN
3142,GO:0043271,0.834494999158948,0.517753888846377,1,6,negative regulation of ion transport,BP,ACTN2
3873,GO:0048705,0.834696944036379,0.504328835645084,1,8,skeletal system morphogenesis,BP,CTGF
5808,GO:1903506,0.835795231264842,0.275900794231901,10,50,regulation of nucleic acid-templated transcription,BP,ACTN2;CDKN1A;DKK3;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;ITGA3;WT1
6163,GO:2001141,0.835795231264842,0.275900794231901,10,50,regulation of RNA biosynthetic process,BP,ACTN2;CDKN1A;DKK3;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;ITGA3;WT1
3504,GO:0045665,0.836060693841663,0.525993782331335,1,5,negative regulation of neuron differentiation,BP,DLL1
254,GO:0002252,0.837066662772422,0.36141217575372,3,16,immune effector process,BP,PIK3R1;CRISPLD2;DLL1
566,GO:0005126,0.837131190163412,0.404840949907234,2,12,cytokine receptor binding,MF,KITLG;PIK3R1
5327,GO:0090596,0.838722592622317,0.399535402343512,2,13,sensory organ morphogenesis,BP,MYO7A;DLL1
5254,GO:0090087,0.839335277491333,0.35784352030187,3,16,regulation of peptide transport,BP,CDKN1A;PIK3R1;GAS6
108,GO:0001655,0.839838208938617,0.311889822832686,5,26,urogenital system development,BP,LAMA5;SDC4;DLL1;ITGA3;WT1
5035,GO:0072001,0.839838208938617,0.311889822832686,5,26,renal system development,BP,LAMA5;SDC4;DLL1;ITGA3;WT1
5360,GO:0097159,0.83988998083371,0.259471816107084,13,64,organic cyclic compound binding,MF,MYO7A;RHOB;RHOJ;NUAK2;PRKACB;HMGN5;ACSL4;RAB39B;FOXO4;MARK4;PDE4B;WT1;MSN
2692,GO:0035091,0.840620867323814,0.506939010519487,1,6,phosphatidylinositol binding,MF,ACTN2
5657,GO:1901981,0.840620867323814,0.506939010519487,1,6,phosphatidylinositol phosphate binding,MF,ACTN2
5754,GO:1902936,0.840620867323814,0.506939010519487,1,6,phosphatidylinositol bisphosphate binding,MF,ACTN2
1610,GO:0016303,0.840928769048913,0.498775107356155,1,7,1-phosphatidylinositol-3-kinase activity,MF,PIK3R1
2833,GO:0036092,0.840928769048913,0.498775107356155,1,7,phosphatidylinositol-3-phosphate biosynthetic process,BP,PIK3R1
4296,GO:0052742,0.840928769048913,0.498775107356155,1,7,phosphatidylinositol kinase activity,MF,PIK3R1
1919,GO:0030001,0.841101735601343,0.326838213794948,4,22,metal ion transport,BP,ACTN2;GAS6;PDE4B;CTGF
877,GO:0006888,0.841924511994487,0.533183108442073,1,4,ER to Golgi vesicle-mediated transport,BP,GAS6
1805,GO:0019902,0.842329164436176,0.514949462258681,1,5,phosphatase binding,MF,PIK3R1
1437,GO:0010959,0.84305128395993,0.398229007638202,2,11,regulation of metal ion transport,BP,ACTN2;PDE4B
992,GO:0007268,0.843420391748997,0.484446436227995,1,9,chemical synaptic transmission,BP,UNC119
5478,GO:0098916,0.843420391748997,0.484446436227995,1,9,anterograde trans-synaptic signaling,BP,UNC119
5497,GO:0099536,0.843420391748997,0.484446436227995,1,9,synaptic signaling,BP,UNC119
5498,GO:0099537,0.843420391748997,0.484446436227995,1,9,trans-synaptic signaling,BP,UNC119
2789,GO:0035850,0.844199818316171,0.492853101249134,1,7,epithelial cell differentiation involved in kidney development,BP,WT1
5400,GO:0097529,0.844711108908277,0.49192045253949,1,7,myeloid leukocyte migration,BP,PDE4B
2663,GO:0034702,0.846417456011932,0.488794022841864,1,7,ion channel complex,CC,PDE4B
5708,GO:1902495,0.846417456011932,0.488794022841864,1,7,transmembrane transporter complex,CC,PDE4B
5988,GO:1990351,0.846417456011932,0.488794022841864,1,7,transporter complex,CC,PDE4B
2183,GO:0031323,0.846718485961893,0.239385843518868,19,91,regulation of cellular metabolic process,BP,ACTN2;CDKN1A;DKK3;KITLG;CAMSAP3;PIK3R1;GAS6;SDC4;PRKACB;SERPINA5;HMGN5;FOXO4;DLL1;UNC119;CTGF;ITGA3;WT1;MSN;SH3BP4
3285,GO:0044260,0.846950386009843,0.235054706218342,25,113,cellular macromolecule metabolic process,BP,ACTN2;CDKN1A;NRTN;DKK3;GPRASP1;KITLG;PRND;PHLDA1;NUAK2;MFGE8;PIK3R1;GAS6;SDC4;PRKACB;SERPINA5;HMGN5;PTPN7;FOXO4;MARK4;DLL1;UNC119;CTGF;ITGA3;WT1;MSN
3358,GO:0044710,0.847125402084571,0.245013227633265,15,73,single-organism metabolic process,BP,ACTN2;HMGCS2;NRTN;DKK3;KITLG;SLC52A3;PIK3R1;GAS6;SDC4;ITGB8;ACSL4;DHH;PDE4B;CTGF;PTGES
2486,GO:0032879,0.847377262064366,0.241419624443841,17,79,regulation of localization,BP,LAMA1;ACTN2;CDKN1A;REEP1;RHOB;KITLG;MFGE8;PIK3R1;GAS6;LAMA5;SDC4;FOXO4;DLL1;PDE4B;UNC119;ITGA3;MSN
220,GO:0002062,0.847464493037218,0.476999241507177,1,9,chondrocyte differentiation,BP,CTGF
5462,GO:0098805,0.847700122488482,0.269964336150736,8,42,whole membrane,CC,MYO7A;RHOB;SDC4;SERPINA5;ACSL4;DLL1;TMEM163;SH3BP4
3894,GO:0048762,0.848045951332272,0.342157371353461,3,17,mesenchymal cell differentiation,BP,NRTN;KITLG;LAMA5
1800,GO:0019897,0.849334675821039,0.491086558643956,1,6,extrinsic component of plasma membrane,CC,MFGE8
2186,GO:0031326,0.850195690085987,0.251700893632111,11,56,regulation of cellular biosynthetic process,BP,ACTN2;CDKN1A;DKK3;KITLG;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;ITGA3;WT1
1255,GO:0009898,0.850593285052558,0.499939745129977,1,5,cytoplasmic side of plasma membrane,CC,PTPN7
5424,GO:0098562,0.850593285052558,0.499939745129977,1,5,cytoplasmic side of membrane,CC,PTPN7
3345,GO:0044459,0.850694374208623,0.241019932689978,15,67,plasma membrane part,CC,MYO7A;SLC52A3;MFGE8;SDC4;MPZL1;ITGB5;ITGB8;SERPINA5;PTPN7;DLL1;PDE4B;CLDN1;SLC18B1;ITGA3;MSN
3399,GO:0045055,0.850979106908188,0.33920270838858,3,16,regulated exocytosis,BP,ACTN2;GAS6;CRISPLD2
1193,GO:0009187,0.851198092200211,0.479919073710748,1,7,cyclic nucleotide metabolic process,BP,PDE4B
1908,GO:0022890,0.851652004951717,0.473444411769996,1,8,inorganic cation transmembrane transporter activity,MF,GAS6
3684,GO:0046873,0.851652004951717,0.473444411769996,1,8,metal ion transmembrane transporter activity,MF,GAS6
1149,GO:0008593,0.851897491273923,0.486314745468394,1,6,regulation of Notch signaling pathway,BP,DLL1
1263,GO:0009952,0.852041981426453,0.379697309629967,2,12,anterior/posterior pattern specification,BP,DLL1;WT1
1474,GO:0014069,0.852215184716532,0.49693140205707,1,5,postsynaptic density,CC,PDE4B
2336,GO:0032279,0.852215184716532,0.49693140205707,1,5,asymmetric synapse,CC,PDE4B
5480,GO:0098984,0.852215184716532,0.49693140205707,1,5,neuron to neuron synapse,CC,PDE4B
5501,GO:0099572,0.852215184716532,0.49693140205707,1,5,postsynaptic specialization,CC,PDE4B
2064,GO:0030667,0.852225213858608,0.472363583395942,1,8,secretory granule membrane,CC,SERPINA5
51,GO:0000904,0.852966631259271,0.294041655111541,5,24,cell morphogenesis involved in differentiation,BP,MYO7A;NRTN;PIK3R1;LAMA5;SEMA6C
4350,GO:0060039,0.853737382312116,0.494088734091058,1,5,pericardium development,BP,WT1
4111,GO:0051179,0.854296510234488,0.225414581074138,31,136,localization,BP,LAMA1;ACTN2;MYO7A;CDKN1A;NRTN;REEP1;GPRASP1;RHOB;KITLG;SLC52A3;MFGE8;PIK3R1;SLC25A53;GAS6;LAMA5;SDC4;SERPINA5;RIN3;ACSL4;CRISPLD2;RAB39B;FOXO4;DLL1;PDE4B;UNC119;CLDN1;SLC18B1;CTGF;ITGA3;MSN;SH3BP4
1883,GO:0022407,0.855432564980555,0.377041936671319,2,11,regulation of cell-cell adhesion,BP,PIK3R1;SDC4
6040,GO:2000112,0.855458794087951,0.248460927444561,10,51,regulation of cellular macromolecule biosynthetic process,BP,CDKN1A;DKK3;KITLG;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;ITGA3;WT1
3099,GO:0043170,0.856500373588705,0.222147298926062,27,122,macromolecule metabolic process,BP,ACTN2;CDKN1A;NRTN;DKK3;GPRASP1;KITLG;PRND;PHLDA1;NUAK2;MFGE8;PIK3R1;GAS6;SDC4;PRKACB;ITGB8;SERPINA5;HMGN5;PTPN7;FOXO4;DHH;MARK4;DLL1;UNC119;CTGF;ITGA3;WT1;MSN
368,GO:0003002,0.857024936651211,0.324622994519927,3,19,regionalization,BP,PRKACB;DLL1;WT1
4385,GO:0060135,0.85788099011724,0.474971183489088,1,6,maternal process involved in female pregnancy,BP,ITGA3
1617,GO:0016328,0.858226064275732,0.460895662302681,1,8,lateral plasma membrane,CC,CLDN1
1970,GO:0030182,0.85882315852968,0.24450404185668,10,48,neuron differentiation,BP,MYO7A;NRTN;CAMSAP3;PIK3R1;SDC4;SEMA6C;ACSL4;DLL1;UNC119;ITGA3
857,GO:0006813,0.858885988814983,0.465275983609151,1,7,potassium ion transport,BP,ACTN2
3875,GO:0048708,0.859130602269218,0.472565381027071,1,6,astrocyte differentiation,BP,DLL1
5344,GO:0097060,0.859797264484723,0.482582400616871,1,5,synaptic membrane,CC,ITGA3
2197,GO:0031347,0.859955668190462,0.470969810532282,1,6,regulation of defense response,BP,PRKACB
2758,GO:0035639,0.860043629105404,0.251613165117266,8,44,purine ribonucleoside triphosphate binding,MF,MYO7A;RHOB;RHOJ;NUAK2;PRKACB;ACSL4;RAB39B;MARK4
4070,GO:0051051,0.860640306448276,0.321535191825637,3,17,negative regulation of transport,BP,ACTN2;GAS6;UNC119
5251,GO:0090066,0.861078965303199,0.29680921761222,4,21,regulation of anatomical structure size,BP,ACTN2;PLEKHH2;FHOD3;MSN
5208,GO:0080090,0.862014276289035,0.220102658990278,18,88,regulation of primary metabolic process,BP,ACTN2;CDKN1A;DKK3;KITLG;PIK3R1;GAS6;SDC4;PRKACB;SERPINA5;HMGN5;FOXO4;DHH;DLL1;UNC119;CTGF;ITGA3;WT1;MSN
3972,GO:0050768,0.862023964497538,0.466944806541208,1,6,negative regulation of neurogenesis,BP,DLL1
3852,GO:0048645,0.862068001885707,0.449086122455685,1,9,animal organ formation,BP,WT1
2145,GO:0031090,0.862609150494558,0.242551424639315,9,48,organelle membrane,CC,MYO7A;HMGCS2;REEP1;RHOB;SLC25A53;SERPINA5;ACSL4;GPSM1;TMEM163
1756,GO:0019221,0.862632866330537,0.452291069838602,1,8,cytokine-mediated signaling pathway,BP,GAS6
5821,GO:1903532,0.86283067803716,0.451901089616618,1,8,positive regulation of secretion by cell,BP,SDC4
2639,GO:0034599,0.863245087227432,0.456760675496459,1,7,cellular response to oxidative stress,BP,RHOB
4430,GO:0060326,0.86341701957932,0.359729676303913,2,12,cell chemotaxis,BP,GAS6;PDE4B
1307,GO:0010467,0.863542561194492,0.227253925686444,13,64,gene expression,BP,CDKN1A;DKK3;PIK3R1;GAS6;PRKACB;ITGB8;HMGN5;FOXO4;DLL1;CTGF;ITGA3;WT1;MSN
655,GO:0005768,0.863593181114877,0.312534326093102,3,20,endosome,CC,RHOB;RIN3;TMEM163
2897,GO:0040013,0.863730773144693,0.463595799239817,1,6,negative regulation of locomotion,BP,RHOB
4156,GO:0051271,0.863730773144693,0.463595799239817,1,6,negative regulation of cellular component movement,BP,RHOB
4947,GO:0071396,0.864186897223021,0.312729319510738,3,19,cellular response to lipid,BP,PDE4B;CLDN1;MSN
850,GO:0006796,0.864358621696862,0.221468895367038,15,75,phosphate-containing compound metabolic process,BP,ACTN2;CDKN1A;NRTN;KITLG;NUAK2;CAMSAP3;PIK3R1;GAS6;SDC4;PRKACB;PTPN7;MARK4;PDE4B;UNC119;CTGF
2106,GO:0030863,0.864699036610372,0.369639092562249,2,9,cortical cytoskeleton,CC,ACTN2;PLEKHH2
2107,GO:0030864,0.864699036610372,0.369639092562249,2,9,cortical actin cytoskeleton,CC,ACTN2;PLEKHH2
745,GO:0006139,0.865283189043109,0.224691073283456,13,65,nucleobase-containing compound metabolic process,BP,ACTN2;CDKN1A;DKK3;KITLG;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;PDE4B;CTGF;ITGA3;WT1
3834,GO:0048593,0.865927047898985,0.451441992153501,1,7,camera-type eye morphogenesis,BP,DLL1
3723,GO:0048010,0.866176780882194,0.450943588646176,1,7,vascular endothelial growth factor receptor signaling pathway,BP,PIK3R1
3838,GO:0048608,0.867038769678426,0.268998371241598,5,28,reproductive structure development,BP,KITLG;ITGB8;SERPINA5;DHH;WT1
4729,GO:0061458,0.867038769678426,0.268998371241598,5,28,reproductive system development,BP,KITLG;ITGB8;SERPINA5;DHH;WT1
3886,GO:0048738,0.867320269794053,0.312062505092822,3,16,cardiac muscle tissue development,BP,ACTN2;FHOD3;WT1
1874,GO:0022008,0.867914637151155,0.227324723087304,11,54,neurogenesis,BP,MYO7A;NRTN;CAMSAP3;PIK3R1;GAS6;SDC4;SEMA6C;ACSL4;DLL1;UNC119;ITGA3
856,GO:0006812,0.868635246408368,0.281619697620131,4,24,cation transport,BP,ACTN2;GAS6;PDE4B;CTGF
4899,GO:0071229,0.868733595439437,0.347513786525555,2,13,cellular response to acid chemical,BP,CLDN1;SH3BP4
5276,GO:0090183,0.868793958086157,0.439989337122547,1,8,regulation of kidney development,BP,WT1
2940,GO:0042176,0.869093268552183,0.45290781661293,1,6,regulation of protein catabolic process,BP,MSN
6055,GO:2000181,0.870607886964558,0.461261579091999,1,5,negative regulation of blood vessel morphogenesis,BP,FOXO4
1335,GO:0010595,0.870693051103162,0.43613128170275,1,8,positive regulation of endothelial cell migration,BP,RHOB
1887,GO:0022411,0.871759503168983,0.356753402749624,2,9,cellular component disassembly,BP,ACTN2;PLEKHH2
100,GO:0001570,0.872588460273253,0.445801691193243,1,6,vasculogenesis,BP,WT1
3881,GO:0048729,0.872872730869263,0.233765728906377,8,41,tissue morphogenesis,BP,RHOB;LAMA5;SDC4;PRKACB;DLL1;ITGA3;WT1;MSN
1017,GO:0007409,0.872954759886592,0.30068410640179,3,17,axonogenesis,BP,NRTN;PIK3R1;SEMA6C
837,GO:0006725,0.873480383030871,0.213086283659532,13,66,cellular aromatic compound metabolic process,BP,ACTN2;CDKN1A;DKK3;KITLG;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;PDE4B;CTGF;ITGA3;WT1
5707,GO:1902494,0.873564288397567,0.344467821903819,2,11,catalytic complex,CC,CDKN1A;PIK3R1
3174,GO:0043412,0.873639816815375,0.207017210349105,16,79,macromolecule modification,BP,ACTN2;CDKN1A;NRTN;KITLG;PRND;NUAK2;PIK3R1;GAS6;SDC4;PRKACB;HMGN5;PTPN7;FOXO4;MARK4;UNC119;CTGF
769,GO:0006357,0.87413023217998,0.237951183209216,7,38,regulation of transcription from RNA polymerase II promoter,BP,CDKN1A;PIK3R1;HMGN5;FOXO4;DLL1;ITGA3;WT1
1337,GO:0010604,0.874228978901646,0.207743130672961,15,76,positive regulation of macromolecule metabolic process,BP,CDKN1A;KITLG;PIK3R1;GAS6;SDC4;PRKACB;ITGB8;HMGN5;FOXO4;DLL1;UNC119;CTGF;ITGA3;WT1;MSN
4625,GO:0060993,0.874344173502466,0.335037110784681,2,14,kidney morphogenesis,BP,LAMA5;WT1
1253,GO:0009896,0.874495551275653,0.339565994348502,2,12,positive regulation of catabolic process,BP,MSN;SH3BP4
3952,GO:0050708,0.87513757181942,0.432692449690175,1,7,regulation of protein secretion,BP,GAS6
4327,GO:0055082,0.875183389412364,0.294012486361127,3,19,cellular chemical homeostasis,BP,PRND;PIK3R1;GAS6
4652,GO:0061053,0.876302602856181,0.44959257017345,1,5,somite development,BP,DLL1
3548,GO:0045833,0.877192829305408,0.428402017283652,1,7,negative regulation of lipid metabolic process,BP,DKK3
4232,GO:0051648,0.877592566870921,0.427562867022389,1,7,vesicle localization,BP,MYO7A
2166,GO:0031214,0.878433064180337,0.420069419622022,1,8,biomineral tissue development,BP,GAS6
4774,GO:0070167,0.878433064180337,0.420069419622022,1,8,regulation of biomineral tissue development,BP,GAS6
2305,GO:0032103,0.878472044794555,0.419987114375978,1,8,positive regulation of response to external stimulus,BP,GAS6
821,GO:0006661,0.878613896785774,0.419687479810877,1,8,phosphatidylinositol biosynthetic process,BP,PIK3R1
3394,GO:0045017,0.878613896785774,0.419687479810877,1,8,glycerolipid biosynthetic process,BP,PIK3R1
3628,GO:0046474,0.878613896785774,0.419687479810877,1,8,glycerophospholipid biosynthetic process,BP,PIK3R1
55,GO:0000975,0.878989674845102,0.432487430083318,1,6,regulatory region DNA binding,MF,WT1
67,GO:0001067,0.878989674845102,0.432487430083318,1,6,regulatory region nucleic acid binding,MF,WT1
3271,GO:0044212,0.878989674845102,0.432487430083318,1,6,transcription regulatory region DNA binding,MF,WT1
4128,GO:0051216,0.879270396186832,0.325860070983904,2,14,cartilage development,BP,ITGB8;CTGF
3330,GO:0044433,0.880028942000038,0.235997580494347,6,36,cytoplasmic vesicle part,CC,ACTN2;RHOB;GAS6;SERPINA5;CRISPLD2;TMEM163
3194,GO:0043491,0.880997600598372,0.420351874397858,1,7,protein kinase B signaling,BP,GAS6
3511,GO:0045682,0.881532367817196,0.427086770745292,1,6,regulation of epidermis development,BP,DLL1
3556,GO:0045844,0.88291833471169,0.416233610416403,1,7,positive regulation of striated muscle tissue development,BP,DLL1
3845,GO:0048636,0.88291833471169,0.416233610416403,1,7,positive regulation of muscle organ development,BP,DLL1
5645,GO:1901863,0.88291833471169,0.416233610416403,1,7,positive regulation of muscle tissue development,BP,DLL1
2545,GO:0033138,0.883879625745945,0.414158499753673,1,7,positive regulation of peptidyl-serine phosphorylation,BP,GAS6
3369,GO:0044765,0.883880161466482,0.196105125057759,14,71,single-organism transport,BP,ACTN2;MYO7A;CDKN1A;SLC52A3;MFGE8;PIK3R1;GAS6;SDC4;SERPINA5;ACSL4;CRISPLD2;UNC119;CLDN1;CTGF
1158,GO:0008645,0.883980938610861,0.413939249366293,1,7,hexose transport,BP,PIK3R1
1552,GO:0015749,0.883980938610861,0.413939249366293,1,7,monosaccharide transport,BP,PIK3R1
1553,GO:0015758,0.883980938610861,0.413939249366293,1,7,glucose transport,BP,PIK3R1
487,GO:0003712,0.884349766736941,0.413140182318381,1,7,transcription cofactor activity,MF,ACTN2
374,GO:0003013,0.884900801831372,0.253910377026364,4,25,circulatory system process,BP,GAS6;DLL1;PDE4B;CTGF
1069,GO:0008015,0.884900801831372,0.253910377026364,4,25,blood circulation,BP,GAS6;DLL1;PDE4B;CTGF
16,GO:0000139,0.884916184482254,0.406177081887642,1,8,Golgi membrane,CC,GPSM1
3846,GO:0048638,0.884924813670261,0.315134643698691,2,14,regulation of developmental growth,BP,DLL1;WT1
784,GO:0006468,0.885136416488338,0.198793767664467,12,63,protein phosphorylation,BP,ACTN2;CDKN1A;NRTN;KITLG;NUAK2;PIK3R1;GAS6;SDC4;PRKACB;MARK4;UNC119;CTGF
4728,GO:0061448,0.885258065974654,0.276344374818468,3,19,connective tissue development,BP,ITGB8;CTGF;WT1
3472,GO:0045596,0.885651778506819,0.275643212908139,3,19,negative regulation of cell differentiation,BP,PIK3R1;FOXO4;DLL1
5613,GO:1901575,0.886149974075324,0.254390948242389,4,22,organic substance catabolic process,BP,GPRASP1;SDC4;PDE4B;MSN
4237,GO:0051656,0.886680176950257,0.397969889554041,1,9,establishment of organelle localization,BP,MYO7A
3283,GO:0044257,0.886983491283964,0.401658605132278,1,8,cellular protein catabolic process,BP,MSN
1666,GO:0016740,0.887135195770792,0.21836568857337,7,37,transferase activity,MF,CDKN1A;HMGCS2;KITLG;NUAK2;PIK3R1;PRKACB;MARK4
3328,GO:0044431,0.887336657688706,0.271496938540482,3,20,Golgi apparatus part,CC,GAS6;SDC4;GPSM1
4408,GO:0060255,0.887440395734162,0.185115042937124,18,89,regulation of macromolecule metabolic process,BP,ACTN2;CDKN1A;DKK3;KITLG;PIK3R1;GAS6;SDC4;PRKACB;ITGB8;SERPINA5;HMGN5;FOXO4;DLL1;UNC119;CTGF;ITGA3;WT1;MSN
3339,GO:0044448,0.887515922708571,0.321868991658867,2,10,cell cortex part,CC,ACTN2;PLEKHH2
3804,GO:0048518,0.888036159942474,0.180666338369719,23,111,positive regulation of biological process,BP,ACTN2;CDKN1A;RHOB;KITLG;MFGE8;PIK3R1;GAS6;SDC4;PRKACB;ITGB8;HMGN5;FOXO4;MARK4;ESPN;DLL1;PDE4B;UNC119;CLDN1;CTGF;ITGA3;WT1;MSN;SH3BP4
620,GO:0005525,0.888643595331909,0.26569209755175,3,24,GTP binding,MF,RHOB;RHOJ;RAB39B
1734,GO:0019001,0.888643595331909,0.26569209755175,3,24,guanyl nucleotide binding,MF,RHOB;RHOJ;RAB39B
2405,GO:0032549,0.888643595331909,0.26569209755175,3,24,ribonucleoside binding,MF,RHOB;RHOJ;RAB39B
2406,GO:0032550,0.888643595331909,0.26569209755175,3,24,purine ribonucleoside binding,MF,RHOB;RHOJ;RAB39B
2410,GO:0032561,0.888643595331909,0.26569209755175,3,24,guanyl ribonucleotide binding,MF,RHOB;RHOJ;RAB39B
1250,GO:0009893,0.889332058275546,0.184813851991447,16,82,positive regulation of metabolic process,BP,CDKN1A;KITLG;PIK3R1;GAS6;SDC4;PRKACB;ITGB8;HMGN5;FOXO4;DLL1;UNC119;CTGF;ITGA3;WT1;MSN;SH3BP4
4630,GO:0061005,0.889498688658247,0.396101296146572,1,8,cell differentiation involved in kidney development,BP,WT1
3928,GO:0048878,0.889926589479142,0.231611859010009,5,29,chemical homeostasis,BP,PRND;PIK3R1;GAS6;PRKACB;CLDN1
689,GO:0005886,0.890165699344879,0.177184234746954,31,137,plasma membrane,CC,ACTN2;MYO7A;FRMPD1;RHOB;KITLG;PRND;SLC52A3;RHOJ;MFGE8;PLEKHH2;CLDN11;PIK3R1;SDC4;MPZL1;ITGB5;SEMA6C;PRKACB;ITGB8;SERPINA5;PTPN7;RAB39B;DHH;GPSM1;DLL1;PDE4B;CGN;CLDN1;SLC18B1;CTGF;ITGA3;MSN
1471,GO:0014065,0.890334387106837,0.30467246494332,2,14,phosphatidylinositol 3-kinase signaling,BP,KITLG;PIK3R1
3727,GO:0048015,0.890334387106837,0.30467246494332,2,14,phosphatidylinositol-mediated signaling,BP,KITLG;PIK3R1
3729,GO:0048017,0.890334387106837,0.30467246494332,2,14,inositol lipid-mediated signaling,BP,KITLG;PIK3R1
4094,GO:0051145,0.89052170284306,0.393821786760676,1,8,smooth muscle cell differentiation,BP,FOXO4
1124,GO:0008324,0.890966471525989,0.388474168639483,1,9,cation transmembrane transporter activity,MF,GAS6
5433,GO:0098609,0.891580958959849,0.205423333859502,8,41,cell-cell adhesion,BP,CAMSAP3;CLDN11;PIK3R1;GAS6;SDC4;ITGB5;CLDN1;MSN
1954,GO:0030135,0.891951507060259,0.396351710415662,1,7,coated vesicle,CC,SH3BP4
1955,GO:0030136,0.891951507060259,0.396351710415662,1,7,clathrin-coated vesicle,CC,SH3BP4
1896,GO:0022612,0.892945068708661,0.304231330347796,2,12,gland morphogenesis,BP,LAMA5;MSN
3357,GO:0044708,0.892992513932839,0.388269582806734,1,8,single-organism behavior,BP,ITGA3
1324,GO:0010557,0.893561781290004,0.207224000037663,7,40,positive regulation of macromolecule biosynthetic process,BP,KITLG;PIK3R1;HMGN5;FOXO4;DLL1;CTGF;WT1
611,GO:0005509,0.894262091278542,0.241472364453531,4,21,calcium ion binding,MF,ACTN2;GAS6;DHH;DLL1
1338,GO:0010605,0.895093281442025,0.205131913003533,7,39,negative regulation of macromolecule metabolic process,BP,CDKN1A;DKK3;GAS6;ITGB8;SERPINA5;CTGF;WT1
4654,GO:0061061,0.895119056393788,0.213245697294072,6,33,muscle structure development,BP,ACTN2;LAMA5;FHOD3;FOXO4;DLL1;WT1
768,GO:0006355,0.895460195158656,0.193669939823478,9,49,regulation of transcription, DNA-templated,BP,CDKN1A;DKK3;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;ITGA3;WT1
5714,GO:1902578,0.896784924198989,0.174391433861534,16,79,single-organism localization,BP,ACTN2;MYO7A;CDKN1A;SLC52A3;MFGE8;PIK3R1;GAS6;LAMA5;SDC4;SERPINA5;ACSL4;CRISPLD2;UNC119;CLDN1;CTGF;ITGA3
2037,GO:0030510,0.897040154745151,0.39265139034735,1,6,regulation of BMP signaling pathway,BP,ITGA3
185,GO:0001934,0.897918731025308,0.199460523239087,7,43,positive regulation of protein phosphorylation,BP,CDKN1A;KITLG;GAS6;SDC4;PRKACB;UNC119;CTGF
2962,GO:0042327,0.897918731025308,0.199460523239087,7,43,positive regulation of phosphorylation,BP,CDKN1A;KITLG;GAS6;SDC4;PRKACB;UNC119;CTGF
1935,GO:0030041,0.898163469929286,0.401611480741765,1,5,actin filament polymerization,BP,FHOD3
2092,GO:0030833,0.898163469929286,0.401611480741765,1,5,regulation of actin filament polymerization,BP,FHOD3
2096,GO:0030837,0.898163469929286,0.401611480741765,1,5,negative regulation of actin filament polymerization,BP,FHOD3
2192,GO:0031333,0.898163469929286,0.401611480741765,1,5,negative regulation of protein complex assembly,BP,FHOD3
2330,GO:0032272,0.898163469929286,0.401611480741765,1,5,negative regulation of protein polymerization,BP,FHOD3
184,GO:0001933,0.898197444833359,0.372006494534832,1,9,negative regulation of protein phosphorylation,BP,CDKN1A
2204,GO:0031400,0.898197444833359,0.372006494534832,1,9,negative regulation of protein modification process,BP,CDKN1A
938,GO:0007067,0.898628625278054,0.371005980113397,1,9,mitotic nuclear division,BP,MARK4
2328,GO:0032270,0.899015690754381,0.192024084741659,8,48,positive regulation of cellular protein metabolic process,BP,CDKN1A;KITLG;GAS6;SDC4;PRKACB;UNC119;CTGF;MSN
1755,GO:0019220,0.899054222296316,0.18755580768595,9,52,regulation of phosphate metabolic process,BP,CDKN1A;KITLG;CAMSAP3;PIK3R1;GAS6;SDC4;PRKACB;UNC119;CTGF
4110,GO:0051174,0.899054222296316,0.18755580768595,9,52,regulation of phosphorus metabolic process,BP,CDKN1A;KITLG;CAMSAP3;PIK3R1;GAS6;SDC4;PRKACB;UNC119;CTGF
4147,GO:0051252,0.899121645567843,0.184329989265014,10,53,regulation of RNA metabolic process,BP,ACTN2;CDKN1A;DKK3;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;ITGA3;WT1
1268,GO:0009968,0.899359855995409,0.205880720910446,6,34,negative regulation of signal transduction,BP,DKK3;GPRASP1;GAS6;PRKACB;ITGA3;SH3BP4
1531,GO:0015267,0.900121927534446,0.367524226682708,1,9,channel activity,MF,GAS6
1899,GO:0022803,0.900121927534446,0.367524226682708,1,9,passive transmembrane transporter activity,MF,GAS6
912,GO:0006979,0.900660302004078,0.366262555146363,1,9,response to oxidative stress,BP,RHOB
4139,GO:0051240,0.900988801381094,0.184959684204896,9,50,positive regulation of multicellular organismal process,BP,RHOB;KITLG;PIK3R1;GAS6;DLL1;PDE4B;CTGF;ITGA3;WT1
2185,GO:0031325,0.901543966288256,0.170221117134632,14,75,positive regulation of cellular metabolic process,BP,CDKN1A;KITLG;PIK3R1;GAS6;SDC4;PRKACB;HMGN5;FOXO4;DLL1;UNC119;CTGF;WT1;MSN;SH3BP4
1783,GO:0019725,0.902257441502863,0.244185407572999,3,20,cellular homeostasis,BP,PRND;PIK3R1;GAS6
5070,GO:0072089,0.902509642375067,0.371954647533365,1,7,stem cell proliferation,BP,KITLG
2102,GO:0030856,0.902828988735474,0.365479034262955,1,8,regulation of epithelial cell differentiation,BP,DLL1
1375,GO:0010721,0.903343863542046,0.36425439178927,1,8,negative regulation of cell development,BP,DLL1
109,GO:0001656,0.903853016476779,0.355314576522516,1,10,metanephros development,BP,WT1
355,GO:0002791,0.904528193443924,0.361424924242393,1,8,regulation of peptide secretion,BP,GAS6
642,GO:0005654,0.904891599702546,0.219935396242293,4,24,nucleoplasm,CC,CDKN1A;PRKACB;FOXO4;WT1
3752,GO:0048193,0.905966702034337,0.371543074827976,1,6,Golgi vesicle transport,BP,GAS6
3067,GO:0043025,0.906241224424325,0.363006340949231,1,7,neuronal cell body,CC,ACSL4
1892,GO:0022603,0.90676433497124,0.193228412355626,6,35,regulation of anatomical structure morphogenesis,BP,RHOB;RHOJ;FOXO4;DLL1;WT1;MSN
2094,GO:0030835,0.907455381784897,0.379465988272505,1,5,negative regulation of actin filament depolymerization,BP,PLEKHH2
3129,GO:0043242,0.907455381784897,0.379465988272505,1,5,negative regulation of protein complex disassembly,BP,PLEKHH2
5647,GO:1901880,0.907455381784897,0.379465988272505,1,5,negative regulation of protein depolymerization,BP,PLEKHH2
167,GO:0001882,0.908088206812358,0.229250464211478,3,25,nucleoside binding,MF,RHOB;RHOJ;RAB39B
168,GO:0001883,0.908088206812358,0.229250464211478,3,25,purine nucleoside binding,MF,RHOB;RHOJ;RAB39B
260,GO:0002275,0.908319196817797,0.35224803498187,1,8,myeloid cell activation involved in immune response,BP,CRISPLD2
297,GO:0002444,0.908319196817797,0.35224803498187,1,8,myeloid leukocyte mediated immunity,BP,CRISPLD2
3152,GO:0043299,0.908319196817797,0.35224803498187,1,8,leukocyte degranulation,BP,CRISPLD2
2205,GO:0031401,0.908984988426147,0.181399871303256,7,44,positive regulation of protein modification process,BP,CDKN1A;KITLG;GAS6;SDC4;PRKACB;UNC119;CTGF
3050,GO:0042803,0.909219767493683,0.263204359138313,2,16,protein homodimerization activity,MF,ACTN2;MYO7A
4903,GO:0071248,0.909255153583695,0.349953567577894,1,8,cellular response to metal ion,BP,CLDN1
1440,GO:0010975,0.909458993742966,0.34945231698511,1,8,regulation of neuron projection development,BP,ITGA3
2174,GO:0031252,0.910670741289831,0.267889121198639,2,12,cell leading edge,CC,KITLG;PLEKHH2
3076,GO:0043065,0.910678029237041,0.263377244444929,2,14,positive regulation of apoptotic process,BP,RHOB;CTGF
2973,GO:0042391,0.910701661519394,0.34207846791416,1,9,regulation of membrane potential,BP,ACTN2
369,GO:0003006,0.911574394014564,0.193860556278318,5,31,developmental process involved in reproduction,BP,KITLG;ITGB8;SERPINA5;DHH;WT1
1885,GO:0022409,0.912449653370471,0.347709732607947,1,7,positive regulation of cell-cell adhesion,BP,PIK3R1
5210,GO:0080135,0.913255402160323,0.254696413733454,2,16,regulation of cellular response to stress,BP,PIK3R1;CTGF
1159,GO:0008654,0.913507728443352,0.335086599692911,1,9,phospholipid biosynthetic process,BP,PIK3R1
121,GO:0001704,0.913773236671535,0.258825126153298,2,13,formation of primary germ layer,BP,ITGB5;ITGA3
4142,GO:0051247,0.914091513537252,0.167865674837853,8,49,positive regulation of protein metabolic process,BP,CDKN1A;KITLG;GAS6;SDC4;PRKACB;UNC119;CTGF;MSN
3821,GO:0048562,0.914528461872136,0.255176595650936,2,14,embryonic organ morphogenesis,BP,MYO7A;DLL1
2329,GO:0032271,0.914635546822847,0.35001969310094,1,6,regulation of protein polymerization,BP,FHOD3
1157,GO:0008643,0.914804540807971,0.336104870920772,1,8,carbohydrate transport,BP,PIK3R1
1946,GO:0030097,0.917017937565366,0.198583415541065,4,23,hemopoiesis,BP,KITLG;PIK3R1;GAS6;DLL1
3823,GO:0048565,0.917220220733547,0.3299405529489,1,8,digestive tract development,BP,CDKN1A
4338,GO:0055123,0.917220220733547,0.3299405529489,1,8,digestive system development,BP,CDKN1A
1517,GO:0015075,0.917705034623599,0.321081451006275,1,10,ion transmembrane transporter activity,MF,GAS6
5256,GO:0090092,0.918317066162144,0.24697478420384,2,14,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,DKK3;ITGA3
1788,GO:0019827,0.918407598591484,0.326879137331538,1,8,stem cell population maintenance,BP,DLL1
5446,GO:0098727,0.918407598591484,0.326879137331538,1,8,maintenance of cell number,BP,DLL1
224,GO:0002067,0.919306009913154,0.324548691118842,1,8,glandular epithelial cell differentiation,BP,DLL1
2960,GO:0042325,0.919838911499846,0.158685626341878,8,48,regulation of phosphorylation,BP,CDKN1A;KITLG;PIK3R1;GAS6;SDC4;PRKACB;UNC119;CTGF
782,GO:0006464,0.921703380865749,0.138721426364648,15,78,cellular protein modification process,BP,ACTN2;CDKN1A;NRTN;KITLG;PRND;NUAK2;PIK3R1;GAS6;SDC4;PRKACB;PTPN7;FOXO4;MARK4;UNC119;CTGF
2839,GO:0036211,0.921703380865749,0.138721426364648,15,78,protein modification process,BP,ACTN2;CDKN1A;NRTN;KITLG;PRND;NUAK2;PIK3R1;GAS6;SDC4;PRKACB;PTPN7;FOXO4;MARK4;UNC119;CTGF
5609,GO:1901566,0.922044334442671,0.307144820102191,1,11,organonitrogen compound biosynthetic process,BP,SDC4
4230,GO:0051640,0.922207782162494,0.309380835800634,1,10,organelle localization,BP,MYO7A
2961,GO:0042326,0.922451549461441,0.308738691599366,1,10,negative regulation of phosphorylation,BP,CDKN1A
5534,GO:1900182,0.922817747047804,0.315319946144595,1,8,positive regulation of protein localization to nucleus,BP,PIK3R1
1754,GO:0019219,0.923343462365861,0.143454684798316,11,60,regulation of nucleobase-containing compound metabolic process,BP,ACTN2;CDKN1A;DKK3;KITLG;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;ITGA3;WT1
4107,GO:0051171,0.923343462365861,0.143454684798316,11,60,regulation of nitrogen compound metabolic process,BP,ACTN2;CDKN1A;DKK3;KITLG;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;ITGA3;WT1
296,GO:0002443,0.923574380125671,0.309077242772211,1,9,leukocyte mediated immunity,BP,CRISPLD2
3612,GO:0046330,0.923957801442083,0.304750425249709,1,10,positive regulation of JNK cascade,BP,CTGF
5031,GO:0071944,0.924338842644561,0.128603646381177,31,140,cell periphery,CC,ACTN2;MYO7A;FRMPD1;RHOB;KITLG;PRND;SLC52A3;RHOJ;MFGE8;PLEKHH2;CLDN11;PIK3R1;SDC4;MPZL1;ITGB5;SEMA6C;PRKACB;ITGB8;SERPINA5;PTPN7;RAB39B;DHH;GPSM1;DLL1;PDE4B;CGN;CLDN1;SLC18B1;CTGF;ITGA3;MSN
1952,GO:0030111,0.924631141230594,0.231337387663656,2,15,regulation of Wnt signaling pathway,BP,DKK3;ITGA3
3505,GO:0045666,0.924638364985657,0.306237971129853,1,9,positive regulation of neuron differentiation,BP,ITGA3
2544,GO:0033135,0.925407938546512,0.308386912095064,1,8,regulation of peptidyl-serine phosphorylation,BP,GAS6
2326,GO:0032268,0.925660998147394,0.145060969882508,9,54,regulation of cellular protein metabolic process,BP,CDKN1A;KITLG;GAS6;SDC4;PRKACB;SERPINA5;UNC119;CTGF;MSN
1249,GO:0009892,0.925914155973457,0.14922015965999,8,45,negative regulation of metabolic process,BP,CDKN1A;DKK3;CAMSAP3;GAS6;ITGB8;SERPINA5;CTGF;WT1
2101,GO:0030855,0.925934480285224,0.154369510276368,7,39,epithelial cell differentiation,BP,MYO7A;CDKN1A;LAMA5;DLL1;CLDN1;WT1;MSN
902,GO:0006952,0.926330661842275,0.196207456239536,3,21,defense response,BP,PRKACB;CLDN1;PTGES
2401,GO:0032526,0.926407844387575,0.298186530885725,1,10,response to retinoic acid,BP,PTGES
4285,GO:0051960,0.927811143009962,0.194048576062644,3,20,regulation of nervous system development,BP,PRKACB;DLL1;ITGA3
1334,GO:0010594,0.927917598619009,0.297370947572441,1,9,regulation of endothelial cell migration,BP,RHOB
1248,GO:0009891,0.928375947073648,0.149164392883063,7,43,positive regulation of biosynthetic process,BP,KITLG;PIK3R1;HMGN5;FOXO4;DLL1;CTGF;WT1
1963,GO:0030163,0.928392481633606,0.296071949042597,1,9,protein catabolic process,BP,MSN
2988,GO:0042475,0.928921913069655,0.294619189559687,1,9,odontogenesis of dentin-containing tooth,BP,LAMA5
1266,GO:0009966,0.929789390710845,0.127558120507764,14,75,regulation of signal transduction,BP,ACTN2;DKK3;GPRASP1;RHOB;KITLG;RHOJ;PIK3R1;GAS6;PRKACB;GPSM1;DLL1;CTGF;ITGA3;SH3BP4
2306,GO:0032147,0.930081306256854,0.216377498859275,2,17,activation of protein kinase activity,BP,GAS6;PRKACB
960,GO:0007173,0.930869992556881,0.285977546994887,1,10,epidermal growth factor receptor signaling pathway,BP,PIK3R1
2879,GO:0038127,0.930869992556881,0.285977546994887,1,10,ERBB signaling pathway,BP,PIK3R1
894,GO:0006935,0.930973089362967,0.158970646701009,5,31,chemotaxis,BP,NRTN;PIK3R1;GAS6;SEMA6C;PDE4B
2963,GO:0042330,0.930973089362967,0.158970646701009,5,31,taxis,BP,NRTN;PIK3R1;GAS6;SEMA6C;PDE4B
306,GO:0002520,0.931491158785184,0.169556055632676,4,25,immune system development,BP,KITLG;PIK3R1;GAS6;DLL1
3813,GO:0048534,0.931491158785184,0.169556055632676,4,25,hematopoietic or lymphoid organ development,BP,KITLG;PIK3R1;GAS6;DLL1
1070,GO:0008016,0.932333447023126,0.212393275600377,2,16,regulation of heart contraction,BP,PDE4B;CTGF
4902,GO:0071241,0.932860999442705,0.283655721436261,1,9,cellular response to inorganic substance,BP,CLDN1
3503,GO:0045664,0.932958867578478,0.212312950785374,2,15,regulation of neuron differentiation,BP,DLL1;ITGA3
4467,GO:0060429,0.933190535348536,0.130324985244308,10,54,epithelium development,BP,MYO7A;CDKN1A;RHOB;LAMA5;SDC4;PRKACB;DLL1;CLDN1;WT1;MSN
183,GO:0001932,0.93342637289936,0.140002662014693,7,45,regulation of protein phosphorylation,BP,CDKN1A;KITLG;GAS6;SDC4;PRKACB;UNC119;CTGF
3563,GO:0045892,0.933712240961434,0.181748203348855,3,20,negative regulation of transcription, DNA-templated,BP,DKK3;GAS6;WT1
5731,GO:1902679,0.933712240961434,0.181748203348855,3,20,negative regulation of RNA biosynthetic process,BP,DKK3;GAS6;WT1
5809,GO:1903507,0.933712240961434,0.181748203348855,3,20,negative regulation of nucleic acid-templated transcription,BP,DKK3;GAS6;WT1
1909,GO:0022891,0.933830890646137,0.275094296251617,1,11,substrate-specific transmembrane transporter activity,MF,GAS6
1910,GO:0022892,0.933830890646137,0.275094296251617,1,11,substrate-specific transporter activity,MF,GAS6
3279,GO:0044248,0.934775621917921,0.16372215810007,4,24,cellular catabolic process,BP,GPRASP1;PDE4B;MSN;SH3BP4
1312,GO:0010506,0.934831177699568,0.278066285798522,1,9,regulation of autophagy,BP,SH3BP4
3715,GO:0046982,0.936116373266152,0.20489287796446,2,15,protein heterodimerization activity,MF,PIK3R1;ITGA3
696,GO:0005911,0.936691850073056,0.148654778220423,5,30,cell-cell junction,CC,CAMSAP3;CLDN11;PIK3R1;CGN;CLDN1
4733,GO:0061564,0.936892550341041,0.174987992671958,3,20,axon development,BP,NRTN;PIK3R1;SEMA6C
4141,GO:0051246,0.937025980061523,0.126037984673835,9,55,regulation of protein metabolic process,BP,CDKN1A;KITLG;GAS6;SDC4;PRKACB;SERPINA5;UNC119;CTGF;MSN
671,GO:0005794,0.937616309943558,0.146116354411723,5,32,Golgi apparatus,CC,GAS6;SDC4;RAB39B;GPSM1;CTGF
1612,GO:0016310,0.93770132478573,0.118100940603923,12,67,phosphorylation,BP,ACTN2;CDKN1A;NRTN;KITLG;NUAK2;PIK3R1;GAS6;SDC4;PRKACB;MARK4;UNC119;CTGF
2842,GO:0036293,0.93812073320333,0.262827562903887,1,11,response to decreased oxygen levels,BP,CTGF
1238,GO:0009792,0.938159021058819,0.1569616086893,4,24,embryo development ending in birth or egg hatching,BP,SDC4;PRKACB;ACSL4;DLL1
3828,GO:0048583,0.938494282393582,0.112599872868702,15,80,regulation of response to stimulus,BP,ACTN2;DKK3;GPRASP1;RHOB;KITLG;RHOJ;PIK3R1;GAS6;PRKACB;GPSM1;DLL1;PDE4B;CTGF;ITGA3;SH3BP4
5255,GO:0090090,0.938980283603846,0.270117700996137,1,8,negative regulation of canonical Wnt signaling pathway,BP,DKK3
666,GO:0005788,0.939224641872071,0.259613899050897,1,11,endoplasmic reticulum lumen,CC,GAS6
3995,GO:0050808,0.939303055498745,0.265101395676847,1,9,synapse organization,BP,RAB39B
1328,GO:0010562,0.939640305012568,0.128709603487914,7,47,positive regulation of phosphorus metabolic process,BP,CDKN1A;KITLG;GAS6;SDC4;PRKACB;UNC119;CTGF
3581,GO:0045937,0.939640305012568,0.128709603487914,7,47,positive regulation of phosphate metabolic process,BP,CDKN1A;KITLG;GAS6;SDC4;PRKACB;UNC119;CTGF
1774,GO:0019637,0.939989359238698,0.166774992467996,3,22,organophosphate metabolic process,BP,KITLG;PIK3R1;PDE4B
4036,GO:0050920,0.940835487908914,0.25741085778341,1,10,regulation of chemotaxis,BP,GAS6
2203,GO:0031399,0.941149115977074,0.126185232134021,7,46,regulation of protein modification process,BP,CDKN1A;KITLG;GAS6;SDC4;PRKACB;UNC119;CTGF
3360,GO:0044712,0.941381111621775,0.258938443777617,1,9,single-organism catabolic process,BP,PDE4B
871,GO:0006875,0.941575975028127,0.25521006471913,1,10,cellular metal ion homeostasis,BP,PRND
86,GO:0001503,0.941663614560203,0.189115769571374,2,17,ossification,BP,DHH;CTGF
3830,GO:0048585,0.941666133429725,0.131064252073426,6,38,negative regulation of response to stimulus,BP,DKK3;GPRASP1;GAS6;PRKACB;ITGA3;SH3BP4
259,GO:0002274,0.941988514752198,0.257119737793837,1,9,myeloid leukocyte activation,BP,CRISPLD2
983,GO:0007254,0.942118362867761,0.251073318545791,1,11,JNK cascade,BP,CTGF
3610,GO:0046328,0.942118362867761,0.251073318545791,1,11,regulation of JNK cascade,BP,CTGF
2989,GO:0042476,0.942353574584808,0.252886503179391,1,10,odontogenesis,BP,LAMA5
401,GO:0003156,0.942709800745441,0.249306385726733,1,11,regulation of animal organ formation,BP,WT1
4082,GO:0051094,0.943012635964077,0.123193439917665,7,44,positive regulation of developmental process,BP,RHOB;KITLG;GAS6;DLL1;CTGF;ITGA3;WT1
2485,GO:0032874,0.943351844763761,0.247379845521738,1,11,positive regulation of stress-activated MAPK cascade,BP,CTGF
4806,GO:0070304,0.943351844763761,0.247379845521738,1,11,positive regulation of stress-activated protein kinase signaling cascade,BP,CTGF
2516,GO:0032990,0.943539304314185,0.160537171187931,3,20,cell part morphogenesis,BP,NRTN;PIK3R1;SEMA6C
3903,GO:0048812,0.943539304314185,0.160537171187931,3,20,neuron projection morphogenesis,BP,NRTN;PIK3R1;SEMA6C
3920,GO:0048858,0.943539304314185,0.160537171187931,3,20,cell projection morphogenesis,BP,NRTN;PIK3R1;SEMA6C
1598,GO:0016202,0.944625899359581,0.246021514274935,1,10,regulation of striated muscle tissue development,BP,DLL1
3843,GO:0048634,0.944625899359581,0.246021514274935,1,10,regulation of muscle organ development,BP,DLL1
5643,GO:1901861,0.944625899359581,0.246021514274935,1,10,regulation of muscle tissue development,BP,DLL1
4066,GO:0051047,0.94481964458238,0.24294200181013,1,11,positive regulation of secretion,BP,SDC4
975,GO:0007219,0.944843543749186,0.248462372921108,1,9,Notch signaling pathway,BP,DLL1
4150,GO:0051258,0.94524979627003,0.251188020743386,1,8,protein polymerization,BP,FHOD3
3140,GO:0043269,0.945715973912444,0.179175045224757,2,17,regulation of ion transport,BP,ACTN2;PDE4B
946,GO:0007154,0.946641114180858,0.0948842984537208,30,142,cell communication,BP,LAMA1;ACTN2;CDKN1A;NRTN;DKK3;GPRASP1;RHOB;KITLG;RHOJ;NUAK2;PIK3R1;GAS6;LAMA5;SDC4;MPZL1;ITGB5;PRKACB;ITGB8;RIN3;FOXO4;DHH;GPSM1;DLL1;PDE4B;UNC119;CGN;CTGF;ITGA3;PTGES;SH3BP4
747,GO:0006163,0.94715659047218,0.238239442993262,1,10,purine nucleotide metabolic process,BP,PDE4B
842,GO:0006753,0.94715659047218,0.238239442993262,1,10,nucleoside phosphate metabolic process,BP,PDE4B
1176,GO:0009117,0.94715659047218,0.238239442993262,1,10,nucleotide metabolic process,BP,PDE4B
1184,GO:0009150,0.94715659047218,0.238239442993262,1,10,purine ribonucleotide metabolic process,BP,PDE4B
1199,GO:0009259,0.94715659047218,0.238239442993262,1,10,ribonucleotide metabolic process,BP,PDE4B
1780,GO:0019693,0.94715659047218,0.238239442993262,1,10,ribose phosphate metabolic process,BP,PDE4B
4329,GO:0055086,0.94715659047218,0.238239442993262,1,10,nucleobase-containing small molecule metabolic process,BP,PDE4B
5180,GO:0072521,0.94715659047218,0.238239442993262,1,10,purine-containing compound metabolic process,BP,PDE4B
3716,GO:0046983,0.947530011376737,0.135732801938851,4,28,protein dimerization activity,MF,ACTN2;MYO7A;PIK3R1;ITGA3
1010,GO:0007369,0.948248802941804,0.175177202812931,2,15,gastrulation,BP,ITGB5;ITGA3
1345,GO:0010631,0.948255329558985,0.173910636935232,2,16,epithelial cell migration,BP,RHOB;ITGA3
1162,GO:0009056,0.948287299624344,0.12613946230173,5,30,catabolic process,BP,GPRASP1;SDC4;PDE4B;MSN;SH3BP4
376,GO:0003015,0.948860631418445,0.171300304859102,2,17,heart process,BP,PDE4B;CTGF
4355,GO:0060047,0.948860631418445,0.171300304859102,2,17,heart contraction,BP,PDE4B;CTGF
1204,GO:0009306,0.9495150949601,0.230850805704181,1,10,protein secretion,BP,GAS6
124,GO:0001707,0.950082139503021,0.232082306022383,1,9,mesoderm formation,BP,ITGA3
3777,GO:0048332,0.950082139503021,0.232082306022383,1,9,mesoderm morphogenesis,BP,ITGA3
2500,GO:0032940,0.95017174692259,0.120558790233634,5,36,secretion by cell,BP,ACTN2;GAS6;SDC4;CRISPLD2;CTGF
540,GO:0004872,0.950206221726822,0.131518815315396,4,25,receptor activity,MF,SDC4;ITGB5;ITGB8;CLDN1
4375,GO:0060089,0.950206221726822,0.131518815315396,4,25,molecular transducer activity,MF,SDC4;ITGB5;ITGB8;CLDN1
1542,GO:0015672,0.952073628541225,0.222678919169138,1,10,monovalent inorganic cation transport,BP,ACTN2
5264,GO:0090132,0.953278037205695,0.159982215973641,2,17,epithelium migration,BP,RHOB;ITGA3
63,GO:0000989,0.954552570548803,0.217549256271144,1,9,transcription factor activity, transcription factor binding,MF,ACTN2
1969,GO:0030178,0.955015618792732,0.216012362468586,1,9,negative regulation of Wnt signaling pathway,BP,DKK3
5820,GO:1903531,0.955185899578137,0.212504891750465,1,10,negative regulation of secretion by cell,BP,GAS6
3173,GO:0043410,0.955423652635128,0.130131202580357,3,26,positive regulation of MAPK cascade,BP,KITLG;GAS6;CTGF
1030,GO:0007498,0.955476170281626,0.211542299046163,1,10,mesoderm development,BP,ITGA3
3584,GO:0045944,0.95604475865003,0.117304601974546,4,29,positive regulation of transcription from RNA polymerase II promoter,BP,PIK3R1;FOXO4;DLL1;WT1
5709,GO:1902531,0.956361642914275,0.0950056876959114,8,50,regulation of intracellular signal transduction,BP,RHOB;KITLG;RHOJ;PIK3R1;GAS6;CTGF;ITGA3;SH3BP4
6041,GO:2000113,0.956497911505529,0.129593613855796,3,22,negative regulation of cellular macromolecule biosynthetic process,BP,DKK3;GAS6;WT1
2149,GO:0031098,0.956940757948592,0.202418201578704,1,12,stress-activated protein kinase signaling cascade,BP,CTGF
2483,GO:0032872,0.956940757948592,0.202418201578704,1,12,regulation of stress-activated MAPK cascade,BP,CTGF
4188,GO:0051403,0.956940757948592,0.202418201578704,1,12,stress-activated MAPK cascade,BP,CTGF
4804,GO:0070302,0.956940757948592,0.202418201578704,1,12,regulation of stress-activated protein kinase signaling cascade,BP,CTGF
1915,GO:0023052,0.957664827850767,0.0775009217621921,30,143,signaling,BP,LAMA1;ACTN2;CDKN1A;NRTN;DKK3;GPRASP1;RHOB;KITLG;RHOJ;NUAK2;PIK3R1;GAS6;LAMA5;SDC4;MPZL1;ITGB5;PRKACB;ITGB8;RIN3;FOXO4;DHH;GPSM1;DLL1;PDE4B;UNC119;CGN;CTGF;ITGA3;PTGES;SH3BP4
3352,GO:0044700,0.957664827850767,0.0775009217621921,30,143,single organism signaling,BP,LAMA1;ACTN2;CDKN1A;NRTN;DKK3;GPRASP1;RHOB;KITLG;RHOJ;NUAK2;PIK3R1;GAS6;LAMA5;SDC4;MPZL1;ITGB5;PRKACB;ITGB8;RIN3;FOXO4;DHH;GPSM1;DLL1;PDE4B;UNC119;CGN;CTGF;ITGA3;PTGES;SH3BP4
1257,GO:0009913,0.958254963873102,0.151900338299623,2,13,epidermal cell differentiation,BP,MYO7A;DLL1
3297,GO:0044297,0.959201219036271,0.198969174138717,1,10,cell body,CC,ACSL4
5262,GO:0090130,0.959525178017154,0.142554140142469,2,18,tissue migration,BP,RHOB;ITGA3
2188,GO:0031328,0.959858665302004,0.0955446285525749,6,41,positive regulation of cellular biosynthetic process,BP,KITLG;PIK3R1;HMGN5;FOXO4;DLL1;WT1
1276,GO:0010001,0.960019957062691,0.193874183943935,1,11,glial cell differentiation,BP,DLL1
2916,GO:0042063,0.960019957062691,0.193874183943935,1,11,gliogenesis,BP,DLL1
1354,GO:0010646,0.960066459796412,0.0781734467459278,14,78,regulation of cell communication,BP,ACTN2;DKK3;GPRASP1;RHOB;KITLG;RHOJ;PIK3R1;GAS6;PRKACB;GPSM1;DLL1;CTGF;ITGA3;SH3BP4
3288,GO:0044265,0.960222568051367,0.19317648318631,1,11,cellular macromolecule catabolic process,BP,MSN
171,GO:0001890,0.960685831971849,0.193838689545127,1,10,placenta development,BP,ITGB8
4148,GO:0051253,0.961214409621214,0.118329263194402,3,22,negative regulation of RNA metabolic process,BP,DKK3;GAS6;WT1
3471,GO:0045595,0.96140935289673,0.0885286555296952,7,46,regulation of cell differentiation,BP,KITLG;PIK3R1;GAS6;FOXO4;DLL1;CTGF;ITGA3
5819,GO:1903530,0.961541448824447,0.136329934776898,2,19,regulation of secretion by cell,BP,GAS6;SDC4
3825,GO:0048568,0.962627020301347,0.114365266334544,3,23,embryonic organ development,BP,MYO7A;KITLG;DLL1
141,GO:0001763,0.963026112366322,0.132976310026561,2,18,morphogenesis of a branching structure,BP,LAMA5;WT1
3892,GO:0048754,0.963026112366322,0.132976310026561,2,18,branching morphogenesis of an epithelial tube,BP,LAMA5;WT1
4667,GO:0061138,0.963026112366322,0.132976310026561,2,18,morphogenesis of a branching epithelium,BP,LAMA5;WT1
4851,GO:0070647,0.963389524488169,0.182096282555065,1,11,protein modification by small protein conjugation or removal,BP,FOXO4
62,GO:0000988,0.963829673721968,0.182731462746684,1,10,transcription factor activity, protein binding,MF,ACTN2
5816,GO:1903522,0.964963384904187,0.12685855145876,2,19,regulation of blood circulation,BP,PDE4B;CTGF
1716,GO:0018105,0.965408215571123,0.174852895468156,1,11,peptidyl-serine phosphorylation,BP,GAS6
1726,GO:0018209,0.965408215571123,0.174852895468156,1,11,peptidyl-serine modification,BP,GAS6
1247,GO:0009890,0.965553746178474,0.10715588758251,3,23,negative regulation of biosynthetic process,BP,DKK3;GAS6;WT1
1325,GO:0010558,0.965553746178474,0.10715588758251,3,23,negative regulation of macromolecule biosynthetic process,BP,DKK3;GAS6;WT1
2187,GO:0031327,0.965553746178474,0.10715588758251,3,23,negative regulation of cellular biosynthetic process,BP,DKK3;GAS6;WT1
5317,GO:0090407,0.965967367352121,0.169590602588989,1,13,organophosphate biosynthetic process,BP,PIK3R1
5209,GO:0080134,0.966002724919655,0.105175139636619,3,25,regulation of response to stress,BP,PIK3R1;PRKACB;CTGF
1356,GO:0010648,0.967062598690792,0.0810819021439348,6,40,negative regulation of cell communication,BP,DKK3;GPRASP1;GAS6;PRKACB;ITGA3;SH3BP4
1917,GO:0023057,0.967062598690792,0.0810819021439348,6,40,negative regulation of signaling,BP,DKK3;GPRASP1;GAS6;PRKACB;ITGA3;SH3BP4
1394,GO:0010817,0.967102772249039,0.166914267707192,1,12,regulation of hormone levels,BP,DKK3
869,GO:0006873,0.967561163092568,0.16378556678809,1,13,cellular ion homeostasis,BP,PRND
1920,GO:0030003,0.967561163092568,0.16378556678809,1,13,cellular cation homeostasis,BP,PRND
1914,GO:0023051,0.968766954156295,0.0630032000524305,14,80,regulation of signaling,BP,ACTN2;DKK3;GPRASP1;RHOB;KITLG;RHOJ;PIK3R1;GAS6;PRKACB;GPSM1;DLL1;CTGF;ITGA3;SH3BP4
3832,GO:0048589,0.968786321229243,0.115373791648,2,20,developmental growth,BP,DLL1;WT1
889,GO:0006914,0.968853805438638,0.162134221870245,1,11,autophagy,BP,SH3BP4
354,GO:0002790,0.968897167044012,0.160264042129013,1,12,peptide secretion,BP,GAS6
4067,GO:0051048,0.969022639578207,0.161498751882134,1,11,negative regulation of secretion,BP,GAS6
3578,GO:0045934,0.97032532479563,0.0946536404543539,3,24,negative regulation of nucleobase-containing compound metabolic process,BP,DKK3;GAS6;WT1
370,GO:0003007,0.970461044183949,0.154360576808139,1,12,heart morphogenesis,BP,DLL1
105,GO:0001649,0.970511424979745,0.152776589805256,1,13,osteoblast differentiation,BP,DHH
565,GO:0005125,0.971022331376327,0.150833293035501,1,13,cytokine activity,MF,KITLG
4587,GO:0060828,0.971178245384756,0.151618044956565,1,12,regulation of canonical Wnt signaling pathway,BP,DKK3
2189,GO:0031329,0.971405963281326,0.109674509482176,2,17,regulation of cellular catabolic process,BP,MSN;SH3BP4
2517,GO:0032991,0.971733451755177,0.0589469830818909,13,66,macromolecular complex,CC,LAMA1;MYO7A;CDKN1A;PIK3R1;LAMA5;ITGB5;PRKACB;ITGB8;SERPINA5;ESPN;PDE4B;CGN;ITGA3
3564,GO:0045893,0.972314968785635,0.0738733766635879,5,37,positive regulation of transcription, DNA-templated,BP,PIK3R1;HMGN5;FOXO4;DLL1;WT1
5732,GO:1902680,0.972314968785635,0.0738733766635879,5,37,positive regulation of RNA biosynthetic process,BP,PIK3R1;HMGN5;FOXO4;DLL1;WT1
5810,GO:1903508,0.972314968785635,0.0738733766635879,5,37,positive regulation of nucleic acid-templated transcription,BP,PIK3R1;HMGN5;FOXO4;DLL1;WT1
3473,GO:0045597,0.973946574128523,0.0757530298382304,4,32,positive regulation of cell differentiation,BP,KITLG;GAS6;CTGF;ITGA3
2184,GO:0031324,0.97419476744763,0.0658467239889003,6,41,negative regulation of cellular metabolic process,BP,CDKN1A;DKK3;CAMSAP3;GAS6;SERPINA5;WT1
35,GO:0000280,0.974445529702571,0.137506883377456,1,13,nuclear division,BP,MARK4
3768,GO:0048285,0.974445529702571,0.137506883377456,1,13,organelle fission,BP,MARK4
1586,GO:0016055,0.97481777070123,0.0974892944941456,2,20,Wnt signaling pathway,BP,DKK3;ITGA3
5513,GO:0198738,0.97481777070123,0.0974892944941456,2,20,cell-cell signaling by wnt,BP,DKK3;ITGA3
5448,GO:0098742,0.97493453553467,0.0976679784024608,2,19,cell-cell adhesion via plasma-membrane adhesion molecules,BP,CLDN11;CLDN1
3064,GO:0043009,0.97520600441664,0.0822353140324973,3,23,chordate embryonic development,BP,SDC4;PRKACB;DLL1
3971,GO:0050767,0.975742395891602,0.0951808768479104,2,19,regulation of neurogenesis,BP,DLL1;ITGA3
539,GO:0004871,0.976228042909494,0.0784552794447981,3,26,signal transducer activity,MF,PIK3R1;GAS6;SDC4
4108,GO:0051172,0.977036908057585,0.0765751585642261,3,25,negative regulation of nitrogen compound metabolic process,BP,DKK3;GAS6;WT1
3426,GO:0045165,0.977342115747701,0.0892303108264311,2,21,cell fate commitment,BP,DLL1;WT1
5426,GO:0098588,0.977714158516299,0.0578078578554625,6,44,bounding membrane of organelle,CC,MYO7A;RHOB;SERPINA5;ACSL4;GPSM1;TMEM163
3257,GO:0044057,0.978193324393561,0.0728531086513047,3,27,regulation of system process,BP,GAS6;PDE4B;CTGF
4149,GO:0051254,0.978271040972659,0.0601222022502486,5,38,positive regulation of RNA metabolic process,BP,PIK3R1;HMGN5;FOXO4;DLL1;WT1
3579,GO:0045935,0.978283704609777,0.0565459399153937,6,44,positive regulation of nucleobase-containing compound metabolic process,BP,KITLG;PIK3R1;HMGN5;FOXO4;DLL1;WT1
4109,GO:0051173,0.978283704609777,0.0565459399153937,6,44,positive regulation of nitrogen compound metabolic process,BP,KITLG;PIK3R1;HMGN5;FOXO4;DLL1;WT1
2036,GO:0030509,0.97836672696415,0.122741200101392,1,12,BMP signaling pathway,BP,ITGA3
5000,GO:0071772,0.97836672696415,0.122741200101392,1,12,response to BMP,BP,ITGA3
5001,GO:0071773,0.97836672696415,0.122741200101392,1,12,cellular response to BMP stimulus,BP,ITGA3
3210,GO:0043542,0.978685018046932,0.121396807842346,1,12,endothelial cell migration,BP,RHOB
23,GO:0000165,0.978821643895077,0.0585878831129502,5,40,MAPK cascade,BP,ACTN2;NRTN;KITLG;GAS6;CTGF
1722,GO:0018193,0.980477134540532,0.0663072705034798,3,28,peptidyl-amino acid modification,BP,KITLG;GAS6;UNC119
3169,GO:0043406,0.980864208260277,0.109868412437611,1,14,positive regulation of MAP kinase activity,BP,KITLG
2861,GO:0038023,0.981055804893834,0.109038005342631,1,14,signaling receptor activity,MF,SDC4
991,GO:0007267,0.981210963512297,0.0497187620030479,6,47,cell-cell signaling,BP,DKK3;MPZL1;DHH;DLL1;UNC119;ITGA3
3973,GO:0050769,0.981511177589158,0.108022329308313,1,13,positive regulation of neurogenesis,BP,ITGA3
84,GO:0001501,0.982969146618295,0.0707080987831067,2,22,skeletal system development,BP,ITGB8;CTGF
4318,GO:0055065,0.982981697125789,0.100546400602646,1,14,metal ion homeostasis,BP,PRND
3171,GO:0043408,0.983173527283027,0.0582903609359375,3,30,regulation of MAPK cascade,BP,KITLG;GAS6;CTGF
903,GO:0006954,0.983420261342143,0.0994953116479966,1,13,inflammatory response,BP,PTGES
4287,GO:0051962,0.984551579391275,0.0934145993546783,1,14,positive regulation of nervous system development,BP,ITGA3
4065,GO:0051046,0.985285936766863,0.0625614588394611,2,23,regulation of secretion,BP,GAS6;SDC4
2645,GO:0034622,0.985411986998258,0.0913159049685645,1,12,cellular macromolecular complex assembly,BP,FHOD3
3236,GO:0043623,0.985411986998258,0.0913159049685645,1,12,cellular protein complex assembly,BP,FHOD3
113,GO:0001664,0.985529015326647,0.0874947780047878,1,16,G-protein coupled receptor binding,MF,REEP1
4138,GO:0051239,0.985801809127833,0.0318848369853364,13,76,regulation of multicellular organismal process,BP,LAMA1;RHOB;KITLG;PIK3R1;GAS6;LAMA5;PRKACB;FOXO4;DLL1;PDE4B;CTGF;ITGA3;WT1
3700,GO:0046903,0.986343213519435,0.0402593562698379,5,41,secretion,BP,ACTN2;GAS6;SDC4;CRISPLD2;CTGF
5934,GO:1905114,0.986914570173529,0.0568892592458867,2,23,cell surface receptor signaling pathway involved in cell-cell signaling,BP,DKK3;ITGA3
14,GO:0000122,0.986975628980894,0.0819789402066816,1,14,negative regulation of transcription from RNA polymerase II promoter,BP,WT1
1244,GO:0009887,0.987802146470415,0.0343975877228532,6,45,animal organ morphogenesis,BP,MYO7A;LAMA5;DLL1;CTGF;WT1;MSN
1374,GO:0010720,0.98787099636865,0.0769314346250155,1,15,positive regulation of cell development,BP,ITGA3
4415,GO:0060284,0.988011950497321,0.0529792043356754,2,23,regulation of cell development,BP,DLL1;ITGA3
1251,GO:0009894,0.988342499811312,0.0526391258227344,2,20,regulation of catabolic process,BP,MSN;SH3BP4
5028,GO:0071900,0.988984341789377,0.0490224495547207,2,25,regulation of protein serine/threonine kinase activity,BP,CDKN1A;KITLG
1912,GO:0023014,0.989467159506307,0.0320901120612961,5,43,signal transduction by protein phosphorylation,BP,ACTN2;NRTN;KITLG;GAS6;CTGF
1956,GO:0030139,0.990158310599105,0.0644292031733915,1,17,endocytic vesicle,CC,ITGB5
4326,GO:0055080,0.99067705248328,0.0617497697361604,1,17,cation homeostasis,BP,PRND
5452,GO:0098771,0.99067705248328,0.0617497697361604,1,17,inorganic ion homeostasis,BP,PRND
2742,GO:0035556,0.990787651150155,0.0219933094139512,12,78,intracellular signal transduction,BP,ACTN2;CDKN1A;NRTN;RHOB;KITLG;RHOJ;NUAK2;PIK3R1;GAS6;CTGF;ITGA3;SH3BP4
1448,GO:0012506,0.991217782304055,0.0405386335249818,2,26,vesicle membrane,CC,SERPINA5;TMEM163
2059,GO:0030659,0.991217782304055,0.0405386335249818,2,26,cytoplasmic vesicle membrane,CC,SERPINA5;TMEM163
5030,GO:0071902,0.991753935197566,0.0556979252731969,1,18,positive regulation of protein serine/threonine kinase activity,BP,KITLG
4367,GO:0060070,0.992069044458317,0.0543643836010406,1,17,canonical Wnt signaling pathway,BP,DKK3
4426,GO:0060322,0.99294861467725,0.0341048550897573,2,24,head development,BP,CRISPLD2;DLL1
3988,GO:0050801,0.993621322638906,0.0454216356550353,1,18,ion homeostasis,BP,PRND
5711,GO:1902533,0.993668438474084,0.0253717520727164,3,34,positive regulation of intracellular signal transduction,BP,KITLG;GAS6;CTGF
3829,GO:0048584,0.993899137954966,0.0177116537952853,7,55,positive regulation of response to stimulus,BP,KITLG;PIK3R1;GAS6;PRKACB;DLL1;PDE4B;CTGF
3168,GO:0043405,0.994427940993691,0.0405079815996335,1,19,regulation of MAP kinase activity,BP,KITLG
6023,GO:2000027,0.994632540831523,0.0393086367172363,1,19,regulation of organ morphogenesis,BP,WT1
2303,GO:0032101,0.994678785833913,0.0395736530901227,1,17,regulation of response to external stimulus,BP,GAS6
1267,GO:0009967,0.997737479298452,0.00828584384258945,5,49,positive regulation of signal transduction,BP,KITLG;PIK3R1;GAS6;DLL1;CTGF
1355,GO:0010647,0.997737479298452,0.00828584384258945,5,49,positive regulation of cell communication,BP,KITLG;PIK3R1;GAS6;DLL1;CTGF
1916,GO:0023056,0.997737479298452,0.00828584384258945,5,49,positive regulation of signaling,BP,KITLG;PIK3R1;GAS6;DLL1;CTGF
1021,GO:0007420,0.998236256580772,0.015624950453349,1,21,brain development,BP,DLL1
1020,GO:0007417,0.999785884219284,0.00251766546742801,1,27,central nervous system development,BP,DLL1
2694,GO:0035107,1,0.129784863920821,0,8,appendage morphogenesis,BP,
2695,GO:0035108,1,0.129784863920821,0,8,limb morphogenesis,BP,
1,GO:0000002,1,0.736825336349041,0,1,mitochondrial genome maintenance,BP,
3,GO:0000018,1,0.84015341765014,0,1,regulation of DNA recombination,BP,
4,GO:0000041,1,0.485624424753243,0,3,transition metal ion transport,BP,
5,GO:0000045,1,0.808086260451893,0,1,autophagosome assembly,BP,
7,GO:0000070,1,0.84412233261981,0,1,mitotic sister chromatid segregation,BP,
13,GO:0000118,1,0.66650505420776,0,1,histone deacetylase complex,CC,
15,GO:0000132,1,0.932928362009675,0,1,establishment of mitotic spindle orientation,BP,
17,GO:0000145,1,0.808086260451893,0,1,exocyst,CC,
19,GO:0000149,1,0.651448669347724,0,2,SNARE binding,MF,
20,GO:0000151,1,0.508318019266931,0,2,ubiquitin ligase complex,CC,
21,GO:0000155,1,0.752197563702773,0,1,phosphorelay sensor kinase activity,MF,
22,GO:0000160,1,0.752197563702773,0,1,phosphorelay signal transduction system,BP,
25,GO:0000185,1,0.873454651059782,0,1,activation of MAPKKK activity,BP,
26,GO:0000186,1,0.513578975674719,0,3,activation of MAPKK activity,BP,
27,GO:0000187,1,0.114147014591413,0,8,activation of MAPK activity,BP,
28,GO:0000188,1,0.790836093256502,0,1,inactivation of MAPK activity,BP,
29,GO:0000209,1,0.298279142054991,0,3,protein polyubiquitination,BP,
31,GO:0000228,1,0.66650505420776,0,1,nuclear chromosome,CC,
32,GO:0000242,1,0.838308471778822,0,1,pericentriolar material,CC,
33,GO:0000271,1,0.459393675927699,0,3,polysaccharide biosynthetic process,BP,
36,GO:0000281,1,0.664021257488237,0,1,mitotic cytokinesis,BP,
39,GO:0000303,1,0.710907860107323,0,1,response to superoxide,BP,
40,GO:0000305,1,0.710907860107323,0,1,response to oxygen radical,BP,
45,GO:0000790,1,0.66650505420776,0,1,nuclear chromatin,CC,
46,GO:0000803,1,0.66650505420776,0,1,sex chromosome,CC,
47,GO:0000805,1,0.66650505420776,0,1,X chromosome,CC,
48,GO:0000806,1,0.66650505420776,0,1,Y chromosome,CC,
49,GO:0000819,1,0.84412233261981,0,1,sister chromatid segregation,BP,
56,GO:0000976,1,0.749427895517118,0,1,transcription regulatory region sequence-specific DNA binding,MF,
57,GO:0000977,1,0.749427895517118,0,1,RNA polymerase II regulatory region sequence-specific DNA binding,MF,
58,GO:0000979,1,0.749427895517118,0,1,RNA polymerase II core promoter sequence-specific DNA binding,MF,
61,GO:0000983,1,0.805434907231345,0,1,transcription factor activity, RNA polymerase II core promoter sequence-specific,MF,
64,GO:0001012,1,0.749427895517118,0,1,RNA polymerase II regulatory region DNA binding,MF,
65,GO:0001046,1,0.749427895517118,0,1,core promoter sequence-specific DNA binding,MF,
66,GO:0001047,1,0.370163002271559,0,3,core promoter binding,MF,
69,GO:0001076,1,0.152104987432436,0,5,transcription factor activity, RNA polymerase II transcription factor binding,MF,
71,GO:0001078,1,0.749427895517118,0,1,transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,
72,GO:0001085,1,0.749427895517118,0,1,RNA polymerase II transcription factor binding,MF,
74,GO:0001102,1,0.749427895517118,0,1,RNA polymerase II activating transcription factor binding,MF,
75,GO:0001104,1,0.38020659848273,0,3,RNA polymerase II transcription cofactor activity,MF,
76,GO:0001105,1,0.767040292899237,0,1,RNA polymerase II transcription coactivator activity,MF,
77,GO:0001106,1,0.497233785608133,0,2,RNA polymerase II transcription corepressor activity,MF,
78,GO:0001134,1,0.716190498729619,0,1,transcription factor activity, transcription factor recruiting,MF,
79,GO:0001135,1,0.716190498729619,0,1,transcription factor activity, RNA polymerase II transcription factor recruiting,MF,
80,GO:0001190,1,0.434779495991242,0,2,transcriptional activator activity, RNA polymerase II transcription factor binding,MF,
81,GO:0001191,1,0.214173308317289,0,4,transcriptional repressor activity, RNA polymerase II transcription factor binding,MF,
82,GO:0001227,1,0.749427895517118,0,1,transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,MF,
87,GO:0001504,1,0.928417537918174,0,1,neurotransmitter uptake,BP,
88,GO:0001505,1,0.657543965312316,0,3,regulation of neurotransmitter levels,BP,
89,GO:0001508,1,0.498089368524584,0,2,action potential,BP,
93,GO:0001533,1,0.131529739959322,0,5,cornified envelope,CC,
95,GO:0001556,1,0.954312251553925,0,1,oocyte maturation,BP,
97,GO:0001562,1,0.889443009650413,0,1,response to protozoan,BP,
99,GO:0001569,1,0.561432099114171,0,3,branching involved in blood vessel morphogenesis,BP,
103,GO:0001609,1,0.77186369485247,0,1,G-protein coupled adenosine receptor activity,MF,
106,GO:0001653,1,0.703483707209344,0,1,peptide receptor activity,MF,
112,GO:0001659,1,0.77186369485247,0,1,temperature homeostasis,BP,
114,GO:0001666,1,0.0779004098792864,0,10,response to hypoxia,BP,
119,GO:0001701,1,0.00598832153846962,0,15,in utero embryonic development,BP,
120,GO:0001702,1,0.19504908470494,0,4,gastrulation with mouth forming second,BP,
122,GO:0001705,1,0.719441160584566,0,1,ectoderm formation,BP,
127,GO:0001710,1,0.841205940583945,0,1,mesodermal cell fate commitment,BP,
128,GO:0001712,1,0.719441160584566,0,1,ectodermal cell fate commitment,BP,
129,GO:0001715,1,0.719441160584566,0,1,ectodermal cell fate specification,BP,
130,GO:0001726,1,0.322313834941749,0,3,ruffle,CC,
131,GO:0001736,1,0.462131730838942,0,2,establishment of planar polarity,BP,
133,GO:0001741,1,0.66650505420776,0,1,XY body,CC,
134,GO:0001743,1,0.741374927768024,0,1,optic placode formation,BP,
140,GO:0001759,1,0.303987543605939,0,7,organ induction,BP,
154,GO:0001821,1,0.818949769337691,0,1,histamine secretion,BP,
157,GO:0001836,1,0.639212907528369,0,2,release of cytochrome c from mitochondria,BP,
158,GO:0001837,1,0.0359560625271154,0,10,epithelial to mesenchymal transition,BP,
160,GO:0001839,1,0.89801195405569,0,1,neural plate morphogenesis,BP,
161,GO:0001840,1,0.89801195405569,0,1,neural plate development,BP,
163,GO:0001842,1,0.710907860107323,0,1,neural fold formation,BP,
165,GO:0001844,1,0.830438737450604,0,1,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
172,GO:0001892,1,0.130198446832575,0,7,embryonic placenta development,BP,
173,GO:0001893,1,0.299782437319141,0,4,maternal placenta development,BP,
175,GO:0001895,1,0.551625323982002,0,2,retina homeostasis,BP,
176,GO:0001906,1,0.636185085189838,0,2,cell killing,BP,
177,GO:0001909,1,0.774047742304058,0,1,leukocyte mediated cytotoxicity,BP,
178,GO:0001913,1,0.774047742304058,0,1,T cell mediated cytotoxicity,BP,
180,GO:0001927,1,0.808086260451893,0,1,exocyst assembly,BP,
181,GO:0001928,1,0.808086260451893,0,1,regulation of exocyst assembly,BP,
186,GO:0001935,1,0.137287373147441,0,7,endothelial cell proliferation,BP,
187,GO:0001936,1,0.137287373147441,0,7,regulation of endothelial cell proliferation,BP,
188,GO:0001938,1,0.137287373147441,0,7,positive regulation of endothelial cell proliferation,BP,
189,GO:0001941,1,0.645729544403573,0,2,postsynaptic membrane organization,BP,
192,GO:0001945,1,0.698511067066285,0,1,lymph vessel development,BP,
198,GO:0001958,1,0.494801655974952,0,3,endochondral ossification,BP,
202,GO:0001963,1,0.928417537918174,0,1,synaptic transmission, dopaminergic,BP,
205,GO:0001973,1,0.77186369485247,0,1,adenosine receptor signaling pathway,BP,
206,GO:0001974,1,0.59911569251198,0,3,blood vessel remodeling,BP,
208,GO:0001990,1,0.818949769337691,0,1,regulation of systemic arterial blood pressure by hormone,BP,
210,GO:0002011,1,0.0853833397115063,0,7,morphogenesis of an epithelial sheet,BP,
212,GO:0002026,1,0.822648168832337,0,1,regulation of the force of heart contraction,BP,
213,GO:0002027,1,0.204491855668776,0,5,regulation of heart rate,BP,
214,GO:0002028,1,0.35172028360273,0,3,regulation of sodium ion transport,BP,
216,GO:0002042,1,0.395646254351599,0,2,cell migration involved in sprouting angiogenesis,BP,
217,GO:0002043,1,0.841205940583945,0,1,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
218,GO:0002052,1,0.568202356117225,0,1,positive regulation of neuroblast proliferation,BP,
219,GO:0002053,1,0.494826506536024,0,2,positive regulation of mesenchymal cell proliferation,BP,
228,GO:0002072,1,0.643840742286014,0,1,optic cup morphogenesis involved in camera-type eye development,BP,
230,GO:0002082,1,0.76995755234939,0,1,regulation of oxidative phosphorylation,BP,
232,GO:0002087,1,0.77186369485247,0,1,regulation of respiratory gaseous exchange by neurological system process,BP,
233,GO:0002088,1,0.16211271145875,0,7,lens development in camera-type eye,BP,
234,GO:0002089,1,0.841205940583945,0,1,lens morphogenesis in camera-type eye,BP,
236,GO:0002102,1,0.767524119009516,0,1,podosome,CC,
239,GO:0002159,1,0.773259263118995,0,1,desmosome assembly,BP,
240,GO:0002193,1,0.568202356117225,0,1,MAML1-RBP-Jkappa- ICN1 complex,CC,
241,GO:0002200,1,0.84015341765014,0,1,somatic diversification of immune receptors,BP,
242,GO:0002204,1,0.84015341765014,0,1,somatic recombination of immunoglobulin genes involved in immune response,BP,
243,GO:0002208,1,0.84015341765014,0,1,somatic diversification of immunoglobulins involved in immune response,BP,
246,GO:0002221,1,0.714080197774154,0,1,pattern recognition receptor signaling pathway,BP,
248,GO:0002224,1,0.714080197774154,0,1,toll-like receptor signaling pathway,BP,
249,GO:0002228,1,0.774047742304058,0,1,natural killer cell mediated immunity,BP,
251,GO:0002244,1,0.272765792679677,0,4,hematopoietic progenitor cell differentiation,BP,
252,GO:0002250,1,0.274124637852626,0,5,adaptive immune response,BP,
253,GO:0002251,1,0.831112644014506,0,1,organ or tissue specific immune response,BP,
256,GO:0002260,1,0.639212907528369,0,2,lymphocyte homeostasis,BP,
261,GO:0002279,1,0.540916071183739,0,2,mast cell activation involved in immune response,BP,
264,GO:0002286,1,0.579352036412511,0,2,T cell activation involved in immune response,BP,
265,GO:0002287,1,0.749427895517118,0,1,alpha-beta T cell activation involved in immune response,BP,
266,GO:0002292,1,0.749427895517118,0,1,T cell differentiation involved in immune response,BP,
267,GO:0002293,1,0.749427895517118,0,1,alpha-beta T cell differentiation involved in immune response,BP,
268,GO:0002294,1,0.749427895517118,0,1,CD4-positive, alpha-beta T cell differentiation involved in immune response,BP,
269,GO:0002295,1,0.749427895517118,0,1,T-helper cell lineage commitment,BP,
273,GO:0002318,1,0.727923995035168,0,1,myeloid progenitor cell differentiation,BP,
274,GO:0002320,1,0.477161613509033,0,2,lymphoid progenitor cell differentiation,BP,
275,GO:0002323,1,0.774047742304058,0,1,natural killer cell activation involved in immune response,BP,
276,GO:0002328,1,0.568202356117225,0,1,pro-B cell differentiation,BP,
278,GO:0002360,1,0.749427895517118,0,1,T cell lineage commitment,BP,
279,GO:0002363,1,0.749427895517118,0,1,alpha-beta T cell lineage commitment,BP,
282,GO:0002374,1,0.643840742286014,0,1,cytokine secretion involved in immune response,BP,
284,GO:0002377,1,0.84015341765014,0,1,immunoglobulin production,BP,
285,GO:0002381,1,0.84015341765014,0,1,immunoglobulin production involved in immunoglobulin mediated immune response,BP,
286,GO:0002385,1,0.831112644014506,0,1,mucosal immune response,BP,
287,GO:0002386,1,0.831112644014506,0,1,immune response in mucosal-associated lymphoid tissue,BP,
289,GO:0002414,1,0.831112644014506,0,1,immunoglobulin transcytosis in epithelial cells,BP,
290,GO:0002415,1,0.831112644014506,0,1,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,BP,
294,GO:0002437,1,0.568202356117225,0,1,inflammatory response to antigenic stimulus,BP,
299,GO:0002448,1,0.540916071183739,0,2,mast cell mediated immunity,BP,
300,GO:0002449,1,0.64977546490638,0,2,lymphocyte mediated immunity,BP,
301,GO:0002456,1,0.774047742304058,0,1,T cell mediated immunity,BP,
302,GO:0002460,1,0.577324118006822,0,3,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
308,GO:0002523,1,0.727923995035168,0,1,leukocyte migration involved in inflammatory response,BP,
311,GO:0002548,1,0.703740432977165,0,2,monocyte chemotaxis,BP,
312,GO:0002551,1,0.822648168832337,0,1,mast cell chemotaxis,BP,
313,GO:0002562,1,0.84015341765014,0,1,somatic diversification of immune receptors via germline recombination within a single locus,BP,
316,GO:0002637,1,0.84015341765014,0,1,regulation of immunoglobulin production,BP,
317,GO:0002639,1,0.84015341765014,0,1,positive regulation of immunoglobulin production,BP,
318,GO:0002673,1,0.507332380321055,0,2,regulation of acute inflammatory response,BP,
319,GO:0002674,1,0.77186369485247,0,1,negative regulation of acute inflammatory response,BP,
320,GO:0002675,1,0.658464044734903,0,1,positive regulation of acute inflammatory response,BP,
321,GO:0002679,1,0.658464044734903,0,1,respiratory burst involved in defense response,BP,
326,GO:0002686,1,0.77186369485247,0,1,negative regulation of leukocyte migration,BP,
333,GO:0002697,1,0.540190744277259,0,2,regulation of immune effector process,BP,
334,GO:0002699,1,0.540190744277259,0,2,positive regulation of immune effector process,BP,
335,GO:0002700,1,0.540190744277259,0,2,regulation of production of molecular mediator of immune response,BP,
336,GO:0002702,1,0.540190744277259,0,2,positive regulation of production of molecular mediator of immune response,BP,
337,GO:0002703,1,0.84015341765014,0,1,regulation of leukocyte mediated immunity,BP,
338,GO:0002705,1,0.84015341765014,0,1,positive regulation of leukocyte mediated immunity,BP,
339,GO:0002706,1,0.84015341765014,0,1,regulation of lymphocyte mediated immunity,BP,
340,GO:0002708,1,0.84015341765014,0,1,positive regulation of lymphocyte mediated immunity,BP,
341,GO:0002712,1,0.84015341765014,0,1,regulation of B cell mediated immunity,BP,
342,GO:0002714,1,0.84015341765014,0,1,positive regulation of B cell mediated immunity,BP,
343,GO:0002718,1,0.643840742286014,0,1,regulation of cytokine production involved in immune response,BP,
344,GO:0002720,1,0.643840742286014,0,1,positive regulation of cytokine production involved in immune response,BP,
345,GO:0002739,1,0.643840742286014,0,1,regulation of cytokine secretion involved in immune response,BP,
346,GO:0002741,1,0.643840742286014,0,1,positive regulation of cytokine secretion involved in immune response,BP,
357,GO:0002793,1,0.374212249179652,0,3,positive regulation of peptide secretion,BP,
358,GO:0002819,1,0.84015341765014,0,1,regulation of adaptive immune response,BP,
359,GO:0002821,1,0.84015341765014,0,1,positive regulation of adaptive immune response,BP,
360,GO:0002822,1,0.84015341765014,0,1,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
361,GO:0002824,1,0.84015341765014,0,1,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
362,GO:0002831,1,0.756901465456182,0,1,regulation of response to biotic stimulus,BP,
363,GO:0002833,1,0.756901465456182,0,1,positive regulation of response to biotic stimulus,BP,
364,GO:0002889,1,0.84015341765014,0,1,regulation of immunoglobulin mediated immune response,BP,
365,GO:0002891,1,0.84015341765014,0,1,positive regulation of immunoglobulin mediated immune response,BP,
366,GO:0002931,1,0.803527095561903,0,1,response to ischemia,BP,
367,GO:0002934,1,0.773259263118995,0,1,desmosome organization,BP,
372,GO:0003009,1,0.76995755234939,0,1,skeletal muscle contraction,BP,
377,GO:0003016,1,0.516435511406103,0,2,respiratory system process,BP,
378,GO:0003018,1,0.138512594189329,0,9,vascular process in circulatory system,BP,
379,GO:0003044,1,0.818949769337691,0,1,regulation of systemic arterial blood pressure mediated by a chemical signal,BP,
380,GO:0003062,1,0.752197563702773,0,1,regulation of heart rate by chemical signal,BP,
381,GO:0003064,1,0.752197563702773,0,1,regulation of heart rate by hormone,BP,
384,GO:0003085,1,0.783315402429935,0,1,negative regulation of systemic arterial blood pressure,BP,
388,GO:0003096,1,0.704092276759398,0,1,renal sodium ion transport,BP,
389,GO:0003100,1,0.818949769337691,0,1,regulation of systemic arterial blood pressure by endothelin,BP,
391,GO:0003128,1,0.841205940583945,0,1,heart field specification,BP,
392,GO:0003129,1,0.634217622687051,0,2,heart induction,BP,
393,GO:0003130,1,0.634217622687051,0,2,BMP signaling pathway involved in heart induction,BP,
394,GO:0003133,1,0.634217622687051,0,2,endodermal-mesodermal cell signaling,BP,
395,GO:0003134,1,0.634217622687051,0,2,endodermal-mesodermal cell signaling involved in heart induction,BP,
396,GO:0003139,1,0.841205940583945,0,1,secondary heart field specification,BP,
398,GO:0003148,1,0.755101228418769,0,2,outflow tract septum morphogenesis,BP,
399,GO:0003149,1,0.841205940583945,0,1,membranous septum morphogenesis,BP,
400,GO:0003151,1,0.297862458584912,0,5,outflow tract morphogenesis,BP,
402,GO:0003157,1,0.433598791464532,0,2,endocardium development,BP,
405,GO:0003160,1,0.568202356117225,0,1,endocardium morphogenesis,BP,
406,GO:0003161,1,0.568202356117225,0,1,cardiac conduction system development,BP,
407,GO:0003162,1,0.568202356117225,0,1,atrioventricular node development,BP,
408,GO:0003169,1,0.568202356117225,0,1,coronary vein morphogenesis,BP,
409,GO:0003170,1,0.124617086768853,0,7,heart valve development,BP,
410,GO:0003171,1,0.194638478942696,0,5,atrioventricular valve development,BP,
411,GO:0003174,1,0.323668320440115,0,3,mitral valve development,BP,
412,GO:0003175,1,0.749427895517118,0,1,tricuspid valve development,BP,
413,GO:0003176,1,0.477161613509033,0,2,aortic valve development,BP,
414,GO:0003177,1,0.294385239605992,0,4,pulmonary valve development,BP,
415,GO:0003179,1,0.124617086768853,0,7,heart valve morphogenesis,BP,
416,GO:0003180,1,0.477161613509033,0,2,aortic valve morphogenesis,BP,
417,GO:0003181,1,0.194638478942696,0,5,atrioventricular valve morphogenesis,BP,
418,GO:0003183,1,0.323668320440115,0,3,mitral valve morphogenesis,BP,
419,GO:0003184,1,0.294385239605992,0,4,pulmonary valve morphogenesis,BP,
420,GO:0003186,1,0.749427895517118,0,1,tricuspid valve morphogenesis,BP,
421,GO:0003188,1,0.341001319891753,0,3,heart valve formation,BP,
422,GO:0003190,1,0.341001319891753,0,3,atrioventricular valve formation,BP,
423,GO:0003192,1,0.424719366756265,0,2,mitral valve formation,BP,
424,GO:0003195,1,0.749427895517118,0,1,tricuspid valve formation,BP,
425,GO:0003197,1,0.138000803462342,0,7,endocardial cushion development,BP,
426,GO:0003198,1,0.311921540381094,0,4,epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
427,GO:0003203,1,0.165009555491049,0,6,endocardial cushion morphogenesis,BP,
428,GO:0003205,1,0.0504476083174836,0,10,cardiac chamber development,BP,
429,GO:0003206,1,0.0662125913340044,0,9,cardiac chamber morphogenesis,BP,
430,GO:0003207,1,0.568202356117225,0,1,cardiac chamber formation,BP,
431,GO:0003208,1,0.45671643656734,0,2,cardiac ventricle morphogenesis,BP,
432,GO:0003209,1,0.158103831669576,0,5,cardiac atrium morphogenesis,BP,
433,GO:0003211,1,0.568202356117225,0,1,cardiac ventricle formation,BP,
434,GO:0003213,1,0.364448111499789,0,2,cardiac right atrium morphogenesis,BP,
435,GO:0003214,1,0.568202356117225,0,1,cardiac left ventricle morphogenesis,BP,
436,GO:0003215,1,0.568202356117225,0,1,cardiac right ventricle morphogenesis,BP,
437,GO:0003219,1,0.568202356117225,0,1,cardiac right ventricle formation,BP,
438,GO:0003222,1,0.568202356117225,0,1,ventricular trabecula myocardium morphogenesis,BP,
439,GO:0003228,1,0.770015098939375,0,1,atrial cardiac muscle tissue development,BP,
440,GO:0003229,1,0.568202356117225,0,1,ventricular cardiac muscle tissue development,BP,
441,GO:0003230,1,0.158103831669576,0,5,cardiac atrium development,BP,
442,GO:0003231,1,0.105871839134539,0,7,cardiac ventricle development,BP,
443,GO:0003241,1,0.568202356117225,0,1,growth involved in heart morphogenesis,BP,
444,GO:0003256,1,0.568202356117225,0,1,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
445,GO:0003264,1,0.568202356117225,0,1,regulation of cardioblast proliferation,BP,
446,GO:0003266,1,0.568202356117225,0,1,regulation of secondary heart field cardioblast proliferation,BP,
447,GO:0003270,1,0.568202356117225,0,1,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,
448,GO:0003272,1,0.220271198816696,0,5,endocardial cushion formation,BP,
449,GO:0003273,1,0.568202356117225,0,1,cell migration involved in endocardial cushion formation,BP,
450,GO:0003274,1,0.764973380564597,0,1,endocardial cushion fusion,BP,
451,GO:0003279,1,0.0663360537984645,0,9,cardiac septum development,BP,
452,GO:0003281,1,0.105871839134539,0,7,ventricular septum development,BP,
453,GO:0003283,1,0.572531244711603,0,2,atrial septum development,BP,
454,GO:0003284,1,0.764973380564597,0,1,septum primum development,BP,
455,GO:0003289,1,0.764973380564597,0,1,atrial septum primum morphogenesis,BP,
456,GO:0003298,1,0.818949769337691,0,1,physiological muscle hypertrophy,BP,
457,GO:0003300,1,0.818949769337691,0,1,cardiac muscle hypertrophy,BP,
458,GO:0003301,1,0.818949769337691,0,1,physiological cardiac muscle hypertrophy,BP,
459,GO:0003306,1,0.484872206947979,0,2,Wnt signaling pathway involved in heart development,BP,
460,GO:0003307,1,0.754619499090771,0,1,regulation of Wnt signaling pathway involved in heart development,BP,
461,GO:0003308,1,0.754619499090771,0,1,negative regulation of Wnt signaling pathway involved in heart development,BP,
464,GO:0003337,1,0.5582502857103,0,3,mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
466,GO:0003339,1,0.664543557958579,0,2,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
467,GO:0003344,1,0.257680747012911,0,3,pericardium morphogenesis,BP,
468,GO:0003348,1,0.433598791464532,0,2,cardiac endothelial cell differentiation,BP,
469,GO:0003365,1,0.619092994523109,0,1,establishment of cell polarity involved in ameboidal cell migration,BP,
470,GO:0003382,1,0.880093604586389,0,1,epithelial cell morphogenesis,BP,
471,GO:0003401,1,0.504079584680703,0,3,axis elongation,BP,
472,GO:0003402,1,0.643840742286014,0,1,planar cell polarity pathway involved in axis elongation,BP,
473,GO:0003408,1,0.643840742286014,0,1,optic cup formation involved in camera-type eye development,BP,
474,GO:0003413,1,0.954312251553925,0,1,chondrocyte differentiation involved in endochondral bone morphogenesis,BP,
475,GO:0003416,1,0.954312251553925,0,1,endochondral bone growth,BP,
476,GO:0003417,1,0.954312251553925,0,1,growth plate cartilage development,BP,
477,GO:0003418,1,0.954312251553925,0,1,growth plate cartilage chondrocyte differentiation,BP,
478,GO:0003419,1,0.954312251553925,0,1,growth plate cartilage chondrocyte proliferation,BP,
484,GO:0003696,1,0.805434907231345,0,1,satellite DNA binding,MF,
486,GO:0003707,1,0.682277403524016,0,1,steroid hormone receptor activity,MF,
489,GO:0003714,1,0.275527804224061,0,4,transcription corepressor activity,MF,
495,GO:0003841,1,0.721084421958727,0,1,1-acylglycerol-3-phosphate O-acyltransferase activity,MF,
496,GO:0003873,1,0.695278396814058,0,1,6-phosphofructo-2-kinase activity,MF,
501,GO:0004175,1,0.540456021813901,0,2,endopeptidase activity,MF,
502,GO:0004252,1,0.540456021813901,0,2,serine-type endopeptidase activity,MF,
503,GO:0004331,1,0.695278396814058,0,1,fructose-2,6-bisphosphate 2-phosphatase activity,MF,
504,GO:0004375,1,0.7203786970807,0,1,glycine dehydrogenase (decarboxylating) activity,MF,
505,GO:0004379,1,0.671264126002153,0,1,glycylpeptide N-tetradecanoyltransferase activity,MF,
506,GO:0004383,1,0.525873339386502,0,2,guanylate cyclase activity,MF,
507,GO:0004407,1,0.66650505420776,0,1,histone deacetylase activity,MF,
509,GO:0004454,1,0.797620800566368,0,1,ketohexokinase activity,MF,
511,GO:0004603,1,0.889123573643436,0,1,phenylethanolamine N-methyltransferase activity,MF,
512,GO:0004620,1,0.77186369485247,0,1,phospholipase activity,MF,
513,GO:0004629,1,0.77186369485247,0,1,phospholipase C activity,MF,
515,GO:0004673,1,0.752197563702773,0,1,protein histidine kinase activity,MF,
517,GO:0004675,1,0.764973380564597,0,1,transmembrane receptor protein serine/threonine kinase activity,MF,
520,GO:0004697,1,0.74170858764155,0,1,protein kinase C activity,MF,
521,GO:0004702,1,0.509941572981842,0,3,signal transducer, downstream of receptor, with serine/threonine kinase activity,MF,
522,GO:0004707,1,0.842807619318256,0,1,MAP kinase activity,MF,
523,GO:0004709,1,0.793099124675889,0,1,MAP kinase kinase kinase activity,MF,
524,GO:0004712,1,0.770418300420706,0,1,protein serine/threonine/tyrosine kinase activity,MF,
525,GO:0004713,1,0.301853968093992,0,6,protein tyrosine kinase activity,MF,
526,GO:0004714,1,0.513171842889961,0,2,transmembrane receptor protein tyrosine kinase activity,MF,
527,GO:0004716,1,0.714080197774154,0,1,signal transducer, downstream of receptor, with protein tyrosine kinase activity,MF,
530,GO:0004745,1,0.754619499090771,0,1,retinol dehydrogenase activity,MF,
531,GO:0004842,1,0.149197213813986,0,5,ubiquitin-protein transferase activity,MF,
535,GO:0004862,1,0.79183939673446,0,1,cAMP-dependent protein kinase inhibitor activity,MF,
541,GO:0004879,1,0.682277403524016,0,1,RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,MF,
542,GO:0004888,1,0.0495412711103297,0,11,transmembrane signaling receptor activity,MF,
543,GO:0004930,1,0.149467610942463,0,7,G-protein coupled receptor activity,MF,
544,GO:0004935,1,0.620119989668987,0,2,adrenergic receptor activity,MF,
545,GO:0004936,1,0.620119989668987,0,2,alpha-adrenergic receptor activity,MF,
546,GO:0004938,1,0.620119989668987,0,2,alpha2-adrenergic receptor activity,MF,
547,GO:0005024,1,0.764973380564597,0,1,transforming growth factor beta-activated receptor activity,MF,
548,GO:0005025,1,0.764973380564597,0,1,transforming growth factor beta receptor activity, type I,MF,
549,GO:0005057,1,0.362703415839621,0,4,signal transducer activity, downstream of receptor,MF,
557,GO:0005104,1,0.740004594272796,0,3,fibroblast growth factor receptor binding,MF,
558,GO:0005105,1,0.883957336336049,0,1,type 1 fibroblast growth factor receptor binding,MF,
559,GO:0005109,1,0.070512628168517,0,10,frizzled binding,MF,
560,GO:0005110,1,0.643840742286014,0,1,frizzled-2 binding,MF,
561,GO:0005111,1,0.824478727477589,0,2,type 2 fibroblast growth factor receptor binding,MF,
564,GO:0005115,1,0.643840742286014,0,1,receptor tyrosine kinase-like orphan receptor binding,MF,
567,GO:0005127,1,0.84015341765014,0,1,ciliary neurotrophic factor receptor binding,MF,
568,GO:0005146,1,0.716190498729619,0,1,leukemia inhibitory factor receptor binding,MF,
569,GO:0005154,1,0.560593960580202,0,2,epidermal growth factor receptor binding,MF,
572,GO:0005160,1,0.209257880007732,0,6,transforming growth factor beta receptor binding,MF,
573,GO:0005161,1,0.538197978417067,0,2,platelet-derived growth factor receptor binding,MF,
577,GO:0005172,1,0.700382636394197,0,1,vascular endothelial growth factor receptor binding,MF,
580,GO:0005179,1,0.586585861210837,0,3,hormone activity,MF,
586,GO:0005225,1,0.824843141866342,0,1,volume-sensitive anion channel activity,MF,
587,GO:0005242,1,0.588493411762287,0,2,inward rectifier potassium channel activity,MF,
588,GO:0005243,1,0.453782796259077,0,3,gap junction channel activity,MF,
591,GO:0005246,1,0.832713125303855,0,1,calcium channel regulator activity,MF,
592,GO:0005249,1,0.347258368948077,0,4,voltage-gated potassium channel activity,MF,
593,GO:0005250,1,0.682141779383763,0,1,A-type (transient outward) potassium channel activity,MF,
594,GO:0005251,1,0.65400438614102,0,2,delayed rectifier potassium channel activity,MF,
595,GO:0005253,1,0.824843141866342,0,1,anion channel activity,MF,
596,GO:0005254,1,0.824843141866342,0,1,chloride channel activity,MF,
599,GO:0005267,1,0.347258368948077,0,4,potassium channel activity,MF,
600,GO:0005351,1,0.74242873973508,0,1,sugar:proton symporter activity,MF,
601,GO:0005355,1,0.81190363278393,0,1,glucose transmembrane transporter activity,MF,
602,GO:0005381,1,0.637913294653459,0,2,iron ion transmembrane transporter activity,MF,
603,GO:0005402,1,0.74242873973508,0,1,cation:sugar symporter activity,MF,
604,GO:0005484,1,0.778147154946065,0,1,SNAP receptor activity,MF,
606,GO:0005496,1,0.682277403524016,0,1,steroid binding,MF,
607,GO:0005499,1,0.682277403524016,0,1,vitamin D binding,MF,
609,GO:0005506,1,0.774076993520791,0,1,iron ion binding,MF,
612,GO:0005513,1,0.779877946733024,0,1,detection of calcium ion,BP,
617,GO:0005521,1,0.657097306241214,0,1,lamin binding,MF,
618,GO:0005522,1,0.689295922426304,0,1,profilin binding,MF,
622,GO:0005540,1,0.833355032768637,0,1,hyaluronic acid binding,MF,
624,GO:0005544,1,0.837875488244045,0,1,calcium-dependent phospholipid binding,MF,
625,GO:0005545,1,0.767524119009516,0,1,1-phosphatidylinositol binding,MF,
627,GO:0005547,1,0.770418300420706,0,1,phosphatidylinositol-3,4,5-trisphosphate binding,MF,
643,GO:0005667,1,0.390306262364333,0,3,transcription factor complex,CC,
654,GO:0005766,1,0.637687377282116,0,2,primary lysosome,CC,
658,GO:0005771,1,0.774047742304058,0,1,multivesicular body,CC,
662,GO:0005776,1,0.659005867453479,0,2,autophagosome,CC,
668,GO:0005790,1,0.824843141866342,0,1,smooth endoplasmic reticulum,CC,
669,GO:0005791,1,0.818949769337691,0,1,rough endoplasmic reticulum,CC,
670,GO:0005793,1,0.803527095561903,0,1,endoplasmic reticulum-Golgi intermediate compartment,CC,
673,GO:0005798,1,0.689295922426304,0,1,Golgi-associated vesicle,CC,
675,GO:0005802,1,0.588979878337882,0,2,trans-Golgi network,CC,
682,GO:0005859,1,0.613902340139758,0,1,muscle myosin complex,CC,
685,GO:0005876,1,0.707212894969842,0,2,spindle microtubule,CC,
686,GO:0005881,1,0.699006888859572,0,2,cytoplasmic microtubule,CC,
687,GO:0005882,1,0.657097306241214,0,1,intermediate filament,CC,
692,GO:0005901,1,0.678121940697822,0,1,caveola,CC,
700,GO:0005916,1,0.6959456816156,0,1,fascia adherens,CC,
701,GO:0005921,1,0.372103247831771,0,4,gap junction,CC,
702,GO:0005922,1,0.372103247831771,0,4,connexin complex,CC,
710,GO:0005944,1,0.658464044734903,0,1,phosphatidylinositol 3-kinase complex, class IB,CC,
712,GO:0005960,1,0.7203786970807,0,1,glycine cleavage complex,CC,
713,GO:0005975,1,0.0833857292269801,0,9,carbohydrate metabolic process,BP,
714,GO:0005976,1,0.459393675927699,0,3,polysaccharide metabolic process,BP,
715,GO:0005977,1,0.770418300420706,0,1,glycogen metabolic process,BP,
716,GO:0005978,1,0.770418300420706,0,1,glycogen biosynthetic process,BP,
717,GO:0005979,1,0.770418300420706,0,1,regulation of glycogen biosynthetic process,BP,
718,GO:0005996,1,0.142015385962965,0,7,monosaccharide metabolic process,BP,
719,GO:0006000,1,0.553786164805125,0,2,fructose metabolic process,BP,
720,GO:0006001,1,0.797620800566368,0,1,fructose catabolic process,BP,
721,GO:0006003,1,0.695278396814058,0,1,fructose 2,6-bisphosphate metabolic process,BP,
722,GO:0006006,1,0.179291934893057,0,6,glucose metabolic process,BP,
723,GO:0006007,1,0.534480969901098,0,2,glucose catabolic process,BP,
729,GO:0006029,1,0.754619499090771,0,1,proteoglycan metabolic process,BP,
731,GO:0006073,1,0.770418300420706,0,1,cellular glucan metabolic process,BP,
734,GO:0006089,1,0.76995755234939,0,1,lactate metabolic process,BP,
735,GO:0006090,1,0.534480969901098,0,2,pyruvate metabolic process,BP,
736,GO:0006091,1,0.296401991390491,0,4,generation of precursor metabolites and energy,BP,
737,GO:0006094,1,0.736825336349041,0,1,gluconeogenesis,BP,
738,GO:0006096,1,0.534480969901098,0,2,glycolytic process,BP,
739,GO:0006109,1,0.276157271164495,0,5,regulation of carbohydrate metabolic process,BP,
740,GO:0006110,1,0.76995755234939,0,1,regulation of glycolytic process,BP,
741,GO:0006111,1,0.736825336349041,0,1,regulation of gluconeogenesis,BP,
742,GO:0006112,1,0.770418300420706,0,1,energy reserve metabolic process,BP,
743,GO:0006113,1,0.76995755234939,0,1,fermentation,BP,
744,GO:0006119,1,0.76995755234939,0,1,oxidative phosphorylation,BP,
746,GO:0006140,1,0.220631132786923,0,6,regulation of nucleotide metabolic process,BP,
748,GO:0006164,1,0.409583288428975,0,4,purine nucleotide biosynthetic process,BP,
749,GO:0006165,1,0.534480969901098,0,2,nucleoside diphosphate phosphorylation,BP,
750,GO:0006171,1,0.818949769337691,0,1,cAMP biosynthetic process,BP,
751,GO:0006182,1,0.501420537884093,0,3,cGMP biosynthetic process,BP,
756,GO:0006261,1,0.636140908138844,0,2,DNA-dependent DNA replication,BP,
758,GO:0006281,1,0.814668025305394,0,2,DNA repair,BP,
759,GO:0006282,1,0.932928362009675,0,1,regulation of DNA repair,BP,
760,GO:0006304,1,0.725317348117967,0,1,DNA modification,BP,
761,GO:0006305,1,0.725317348117967,0,1,DNA alkylation,BP,
762,GO:0006306,1,0.725317348117967,0,1,DNA methylation,BP,
763,GO:0006310,1,0.84015341765014,0,1,DNA recombination,BP,
767,GO:0006354,1,0.741374927768024,0,1,DNA-templated transcription, elongation,BP,
770,GO:0006359,1,0.779399280116173,0,1,regulation of transcription from RNA polymerase III promoter,BP,
773,GO:0006368,1,0.741374927768024,0,1,transcription elongation from RNA polymerase II promoter,BP,
774,GO:0006383,1,0.779399280116173,0,1,transcription from RNA polymerase III promoter,BP,
776,GO:0006401,1,0.365554940761731,0,3,RNA catabolic process,BP,
777,GO:0006402,1,0.365554940761731,0,3,mRNA catabolic process,BP,
778,GO:0006412,1,0.476001866222604,0,3,translation,BP,
779,GO:0006417,1,0.476001866222604,0,3,regulation of translation,BP,
780,GO:0006457,1,0.954312251553925,0,1,protein folding,BP,
787,GO:0006473,1,0.716190498729619,0,1,protein acetylation,BP,
788,GO:0006475,1,0.716190498729619,0,1,internal protein amino acid acetylation,BP,
789,GO:0006476,1,0.66650505420776,0,1,protein deacetylation,BP,
790,GO:0006479,1,0.8343554877042,0,1,protein methylation,BP,
791,GO:0006486,1,0.777493793435671,0,1,protein glycosylation,BP,
792,GO:0006493,1,0.777493793435671,0,1,protein O-linked glycosylation,BP,
794,GO:0006498,1,0.671264126002153,0,1,N-terminal protein lipidation,BP,
795,GO:0006499,1,0.671264126002153,0,1,N-terminal protein myristoylation,BP,
798,GO:0006511,1,0.290250750546732,0,4,ubiquitin-dependent protein catabolic process,BP,
800,GO:0006520,1,0.7203786970807,0,1,cellular amino acid metabolic process,BP,
801,GO:0006544,1,0.7203786970807,0,1,glycine metabolic process,BP,
802,GO:0006546,1,0.7203786970807,0,1,glycine catabolic process,BP,
803,GO:0006582,1,0.643840742286014,0,1,melanin metabolic process,BP,
804,GO:0006584,1,0.624971586376468,0,2,catecholamine metabolic process,BP,
812,GO:0006635,1,0.566889458089637,0,2,fatty acid beta-oxidation,BP,
832,GO:0006702,1,0.716836822491286,0,1,androgen biosynthetic process,BP,
839,GO:0006733,1,0.534480969901098,0,2,oxidoreduction coenzyme metabolic process,BP,
840,GO:0006734,1,0.534480969901098,0,2,NADH metabolic process,BP,
841,GO:0006735,1,0.695278396814058,0,1,NADH regeneration,BP,
843,GO:0006757,1,0.534480969901098,0,2,ATP generation from ADP,BP,
847,GO:0006775,1,0.682277403524016,0,1,fat-soluble vitamin metabolic process,BP,
851,GO:0006801,1,0.581497558373841,0,2,superoxide metabolic process,BP,
853,GO:0006809,1,0.630335029060165,0,2,nitric oxide biosynthetic process,BP,
858,GO:0006814,1,0.35172028360273,0,3,sodium ion transport,BP,
861,GO:0006821,1,0.580070553897152,0,2,chloride transport,BP,
862,GO:0006826,1,0.485624424753243,0,3,iron ion transport,BP,
863,GO:0006835,1,0.77186369485247,0,1,dicarboxylic acid transport,BP,
864,GO:0006836,1,0.657543965312316,0,3,neurotransmitter transport,BP,
866,GO:0006862,1,0.852797932747088,0,1,nucleotide transport,BP,
867,GO:0006865,1,0.77186369485247,0,1,amino acid transport,BP,
870,GO:0006874,1,0.168434503106774,0,6,cellular calcium ion homeostasis,BP,
873,GO:0006879,1,0.585174232726701,0,2,cellular iron ion homeostasis,BP,
874,GO:0006885,1,0.467514910184544,0,4,regulation of pH,BP,
878,GO:0006890,1,0.758709278845637,0,1,retrograde vesicle-mediated transport, Golgi to ER,BP,
879,GO:0006891,1,0.758709278845637,0,1,intra-Golgi vesicle-mediated transport,BP,
880,GO:0006892,1,0.797235719542977,0,1,post-Golgi vesicle-mediated transport,BP,
883,GO:0006904,1,0.594506410650235,0,3,vesicle docking involved in exocytosis,BP,
884,GO:0006906,1,0.427737119754818,0,4,vesicle fusion,BP,
891,GO:0006919,1,0.830438737450604,0,1,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,
892,GO:0006924,1,0.770418300420706,0,1,activation-induced cell death of T cells,BP,
897,GO:0006939,1,0.18752507765448,0,7,smooth muscle contraction,BP,
898,GO:0006940,1,0.390062427118466,0,4,regulation of smooth muscle contraction,BP,
905,GO:0006959,1,0.466553942349431,0,2,humoral immune response,BP,
909,GO:0006975,1,0.842807619318256,0,1,DNA damage induced protein phosphorylation,BP,
915,GO:0007005,1,0.407656273930595,0,4,mitochondrion organization,BP,
916,GO:0007006,1,0.830438737450604,0,1,mitochondrial membrane organization,BP,
920,GO:0007016,1,0.652168350167583,0,1,cytoskeletal anchoring at plasma membrane,BP,
922,GO:0007020,1,0.838308471778822,0,1,microtubule nucleation,BP,
924,GO:0007030,1,0.534748033148175,0,1,Golgi organization,BP,
925,GO:0007032,1,0.774047742304058,0,1,endosome organization,BP,
935,GO:0007051,1,0.84412233261981,0,1,spindle organization,BP,
936,GO:0007052,1,0.84412233261981,0,1,mitotic spindle organization,BP,
937,GO:0007059,1,0.84412233261981,0,1,chromosome segregation,BP,
939,GO:0007080,1,0.84412233261981,0,1,mitotic metaphase plate congression,BP,
940,GO:0007088,1,0.282273626791244,0,6,regulation of mitotic nuclear division,BP,
943,GO:0007098,1,0.662212866216891,0,2,centrosome cycle,BP,
944,GO:0007126,1,0.265874338495922,0,4,meiotic nuclear division,BP,
945,GO:0007140,1,0.812915746321409,0,1,male meiosis,BP,
948,GO:0007156,1,0.0860250236727381,0,6,homophilic cell adhesion via plasma membrane adhesion molecules,BP,
949,GO:0007157,1,0.486412017949109,0,2,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP,
954,GO:0007164,1,0.462131730838942,0,2,establishment of tissue polarity,BP,
958,GO:0007168,1,0.671033848567201,0,2,receptor guanylyl cyclase signaling pathway,BP,
961,GO:0007176,1,0.477596608747123,0,3,regulation of epidermal growth factor-activated receptor activity,BP,
964,GO:0007182,1,0.841205940583945,0,1,common-partner SMAD protein phosphorylation,BP,
965,GO:0007184,1,0.636140908138844,0,2,SMAD protein import into nucleus,BP,
969,GO:0007189,1,0.509257270828109,0,3,adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
970,GO:0007193,1,0.77186369485247,0,1,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,BP,
972,GO:0007202,1,0.840697515380158,0,1,activation of phospholipase C activity,BP,
973,GO:0007204,1,0.351119178323757,0,4,positive regulation of cytosolic calcium ion concentration,BP,
974,GO:0007205,1,0.818949769337691,0,1,protein kinase C-activating G-protein coupled receptor signaling pathway,BP,
977,GO:0007221,1,0.568202356117225,0,1,positive regulation of transcription of Notch receptor target,BP,
978,GO:0007223,1,0.643840742286014,0,1,Wnt signaling pathway, calcium modulating pathway,BP,
981,GO:0007249,1,0.330208792369747,0,4,I-kappaB kinase/NF-kappaB signaling,BP,
982,GO:0007252,1,0.770418300420706,0,1,I-kappaB phosphorylation,BP,
984,GO:0007257,1,0.339887520163641,0,3,activation of JUN kinase activity,BP,
985,GO:0007259,1,0.339934202538491,0,3,JAK-STAT cascade,BP,
986,GO:0007260,1,0.601074730331317,0,2,tyrosine phosphorylation of STAT protein,BP,
987,GO:0007263,1,0.748793081179247,0,1,nitric oxide mediated signal transduction,BP,
993,GO:0007269,1,0.708693839368643,0,2,neurotransmitter secretion,BP,
994,GO:0007270,1,0.716286278351288,0,2,neuron-neuron synaptic transmission,BP,
1001,GO:0007292,1,0.513071573625451,0,3,female gamete generation,BP,
1014,GO:0007398,1,0.719441160584566,0,1,ectoderm development,BP,
1016,GO:0007405,1,0.476746513570409,0,2,neuroblast proliferation,BP,
1019,GO:0007416,1,0.210394217781591,0,5,synapse assembly,BP,
1026,GO:0007440,1,0.568202356117225,0,1,foregut morphogenesis,BP,
1027,GO:0007442,1,0.643840742286014,0,1,hindgut morphogenesis,BP,
1029,GO:0007494,1,0.643840742286014,0,1,midgut development,BP,
1031,GO:0007500,1,0.841205940583945,0,1,mesodermal cell fate determination,BP,
1038,GO:0007566,1,0.514695685047298,0,2,embryo implantation,BP,
1039,GO:0007567,1,0.818949769337691,0,1,parturition,BP,
1043,GO:0007585,1,0.421943629795596,0,3,respiratory gaseous exchange,BP,
1044,GO:0007586,1,0.446660610180465,0,3,digestion,BP,
1045,GO:0007588,1,0.381344736456322,0,4,excretion,BP,
1046,GO:0007589,1,0.139553206595403,0,7,body fluid secretion,BP,
1047,GO:0007595,1,0.490209754064379,0,2,lactation,BP,
1053,GO:0007603,1,0.671264126002153,0,1,phototransduction, visible light,BP,
1055,GO:0007606,1,0.777493793435671,0,1,sensory perception of chemical stimulus,BP,
1056,GO:0007608,1,0.777493793435671,0,1,sensory perception of smell,BP,
1059,GO:0007612,1,0.636133522563452,0,2,learning,BP,
1061,GO:0007622,1,0.77186369485247,0,1,rhythmic behavior,BP,
1062,GO:0007623,1,0.77186369485247,0,1,circadian rhythm,BP,
1064,GO:0007628,1,0.652168350167583,0,1,adult walking behavior,BP,
1065,GO:0007631,1,0.77140024913884,0,1,feeding behavior,BP,
1066,GO:0007638,1,0.77140024913884,0,1,mechanosensory behavior,BP,
1067,GO:0008009,1,0.914847263689534,0,1,chemokine activity,MF,
1075,GO:0008045,1,0.89801195405569,0,1,motor neuron axon guidance,BP,
1079,GO:0008074,1,0.525873339386502,0,2,guanylate cyclase complex, soluble,CC,
1080,GO:0008076,1,0.347258368948077,0,4,voltage-gated potassium channel complex,CC,
1081,GO:0008078,1,0.89801195405569,0,1,mesodermal cell migration,BP,
1084,GO:0008091,1,0.200849608599858,0,3,spectrin,CC,
1087,GO:0008105,1,0.846321998934282,0,1,asymmetric protein localization,BP,
1089,GO:0008138,1,0.790836093256502,0,1,protein tyrosine/serine/threonine phosphatase activity,MF,
1093,GO:0008168,1,0.889123573643436,0,1,methyltransferase activity,MF,
1094,GO:0008170,1,0.889123573643436,0,1,N-methyltransferase activity,MF,
1095,GO:0008180,1,0.619092994523109,0,1,COP9 signalosome,CC,
1096,GO:0008194,1,0.777493793435671,0,1,UDP-glycosyltransferase activity,MF,
1097,GO:0008198,1,0.774076993520791,0,1,ferrous iron binding,MF,
1098,GO:0008199,1,0.774076993520791,0,1,ferric iron binding,MF,
1099,GO:0008200,1,0.704092276759398,0,1,ion channel inhibitor activity,MF,
1104,GO:0008209,1,0.716836822491286,0,1,androgen metabolic process,BP,
1107,GO:0008213,1,0.8343554877042,0,1,protein alkylation,BP,
1110,GO:0008227,1,0.620119989668987,0,2,G-protein coupled amine receptor activity,MF,
1112,GO:0008236,1,0.540456021813901,0,2,serine-type peptidase activity,MF,
1113,GO:0008238,1,0.68260721833079,0,1,exopeptidase activity,MF,
1126,GO:0008344,1,0.605049146120402,0,2,adult locomotory behavior,BP,
1130,GO:0008374,1,0.721084421958727,0,1,O-acyltransferase activity,MF,
1131,GO:0008375,1,0.777493793435671,0,1,acetylglucosaminyltransferase activity,MF,
1132,GO:0008378,1,0.777493793435671,0,1,galactosyltransferase activity,MF,
1136,GO:0008434,1,0.682277403524016,0,1,calcitriol receptor activity,MF,
1137,GO:0008443,1,0.695278396814058,0,1,phosphofructokinase activity,MF,
1138,GO:0008499,1,0.777493793435671,0,1,UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,MF,
1139,GO:0008506,1,0.74242873973508,0,1,sucrose:proton symporter activity,MF,
1140,GO:0008509,1,0.824843141866342,0,1,anion transmembrane transporter activity,MF,
1141,GO:0008515,1,0.74242873973508,0,1,sucrose transmembrane transporter activity,MF,
1142,GO:0008528,1,0.703483707209344,0,1,G-protein coupled peptide receptor activity,MF,
1143,GO:0008532,1,0.777493793435671,0,1,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,MF,
1151,GO:0008603,1,0.79183939673446,0,1,cAMP-dependent protein kinase regulator activity,MF,
1155,GO:0008631,1,0.770418300420706,0,1,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
1156,GO:0008637,1,0.639212907528369,0,2,apoptotic mitochondrial changes,BP,
1160,GO:0008757,1,0.889123573643436,0,1,S-adenosylmethionine-dependent methyltransferase activity,MF,
1161,GO:0009055,1,0.7203786970807,0,1,electron carrier activity,MF,
1166,GO:0009060,1,0.76995755234939,0,1,aerobic respiration,BP,
1167,GO:0009062,1,0.566889458089637,0,2,fatty acid catabolic process,BP,
1168,GO:0009063,1,0.7203786970807,0,1,cellular amino acid catabolic process,BP,
1169,GO:0009069,1,0.7203786970807,0,1,serine family amino acid metabolic process,BP,
1170,GO:0009071,1,0.7203786970807,0,1,serine family amino acid catabolic process,BP,
1174,GO:0009110,1,0.682277403524016,0,1,vitamin biosynthetic process,BP,
1175,GO:0009116,1,0.689295922426304,0,1,nucleoside metabolic process,BP,
1177,GO:0009119,1,0.689295922426304,0,1,ribonucleoside metabolic process,BP,
1178,GO:0009123,1,0.534480969901098,0,2,nucleoside monophosphate metabolic process,BP,
1179,GO:0009126,1,0.534480969901098,0,2,purine nucleoside monophosphate metabolic process,BP,
1180,GO:0009132,1,0.534480969901098,0,2,nucleoside diphosphate metabolic process,BP,
1181,GO:0009135,1,0.534480969901098,0,2,purine nucleoside diphosphate metabolic process,BP,
1182,GO:0009141,1,0.36700905241022,0,3,nucleoside triphosphate metabolic process,BP,
1183,GO:0009144,1,0.36700905241022,0,3,purine nucleoside triphosphate metabolic process,BP,
1185,GO:0009152,1,0.409583288428975,0,4,purine ribonucleotide biosynthetic process,BP,
1187,GO:0009161,1,0.534480969901098,0,2,ribonucleoside monophosphate metabolic process,BP,
1188,GO:0009165,1,0.409583288428975,0,4,nucleotide biosynthetic process,BP,
1190,GO:0009167,1,0.534480969901098,0,2,purine ribonucleoside monophosphate metabolic process,BP,
1191,GO:0009179,1,0.534480969901098,0,2,purine ribonucleoside diphosphate metabolic process,BP,
1192,GO:0009185,1,0.534480969901098,0,2,ribonucleoside diphosphate metabolic process,BP,
1194,GO:0009190,1,0.409583288428975,0,4,cyclic nucleotide biosynthetic process,BP,
1195,GO:0009199,1,0.36700905241022,0,3,ribonucleoside triphosphate metabolic process,BP,
1196,GO:0009205,1,0.36700905241022,0,3,purine ribonucleoside triphosphate metabolic process,BP,
1198,GO:0009250,1,0.770418300420706,0,1,glucan biosynthetic process,BP,
1200,GO:0009260,1,0.409583288428975,0,4,ribonucleotide biosynthetic process,BP,
1213,GO:0009584,1,0.671264126002153,0,1,detection of visible light,BP,
1214,GO:0009593,1,0.779877946733024,0,1,detection of chemical stimulus,BP,
1218,GO:0009612,1,0.238271080280664,0,6,response to mechanical stimulus,BP,
1219,GO:0009615,1,0.576795110288626,0,3,response to virus,BP,
1221,GO:0009620,1,0.822648168832337,0,1,response to fungus,BP,
1226,GO:0009712,1,0.624971586376468,0,2,catechol-containing compound metabolic process,BP,
1227,GO:0009713,1,0.889123573643436,0,1,catechol-containing compound biosynthetic process,BP,
1231,GO:0009744,1,0.797620800566368,0,1,response to sucrose,BP,
1234,GO:0009750,1,0.797620800566368,0,1,response to fructose,BP,
1235,GO:0009755,1,0.406232692496338,0,3,hormone-mediated signaling pathway,BP,
1252,GO:0009895,1,0.0692969352140291,0,8,negative regulation of catabolic process,BP,
1256,GO:0009912,1,0.379506368175979,0,2,auditory receptor cell fate commitment,BP,
1258,GO:0009914,1,0.0816411531629529,0,9,hormone transport,BP,
1259,GO:0009925,1,0.774076993520791,0,1,basal plasma membrane,CC,
1260,GO:0009946,1,0.932928362009675,0,1,proximal/distal axis specification,BP,
1262,GO:0009950,1,0.862545484850912,0,1,dorsal/ventral axis specification,BP,
1269,GO:0009975,1,0.525873339386502,0,2,cyclase activity,MF,
1274,GO:0009994,1,0.513071573625451,0,3,oocyte differentiation,BP,
1275,GO:0009996,1,0.719441160584566,0,1,negative regulation of cell fate specification,BP,
1277,GO:0010002,1,0.568202356117225,0,1,cardioblast differentiation,BP,
1282,GO:0010039,1,0.585174232726701,0,2,response to iron ion,BP,
1283,GO:0010043,1,0.797620800566368,0,1,response to zinc ion,BP,
1284,GO:0010092,1,0.404821161514394,0,6,specification of animal organ identity,BP,
1285,GO:0010159,1,0.841205940583945,0,1,specification of animal organ position,BP,
1288,GO:0010193,1,0.818949769337691,0,1,response to ozone,BP,
1291,GO:0010226,1,0.678121940697822,0,1,response to lithium ion,BP,
1294,GO:0010259,1,0.818949769337691,0,1,multicellular organism aging,BP,
1300,GO:0010453,1,0.604570722216099,0,2,regulation of cell fate commitment,BP,
1301,GO:0010454,1,0.719441160584566,0,1,negative regulation of cell fate commitment,BP,
1302,GO:0010459,1,0.652168350167583,0,1,negative regulation of heart rate,BP,
1303,GO:0010460,1,0.818949769337691,0,1,positive regulation of heart rate,BP,
1304,GO:0010463,1,0.22039204979975,0,5,mesenchymal cell proliferation,BP,
1305,GO:0010464,1,0.415332566241649,0,3,regulation of mesenchymal cell proliferation,BP,
1310,GO:0010470,1,0.466324308029585,0,2,regulation of gastrulation,BP,
1311,GO:0010498,1,0.240026052249789,0,5,proteasomal protein catabolic process,BP,
1313,GO:0010507,1,0.364508469119493,0,3,negative regulation of autophagy,BP,
1315,GO:0010511,1,0.769641285234326,0,1,regulation of phosphatidylinositol biosynthetic process,BP,
1316,GO:0010512,1,0.769641285234326,0,1,negative regulation of phosphatidylinositol biosynthetic process,BP,
1317,GO:0010517,1,0.840697515380158,0,1,regulation of phospholipase activity,BP,
1318,GO:0010518,1,0.840697515380158,0,1,positive regulation of phospholipase activity,BP,
1319,GO:0010522,1,0.779877946733024,0,1,regulation of calcium ion transport into cytosol,BP,
1320,GO:0010523,1,0.779877946733024,0,1,negative regulation of calcium ion transport into cytosol,BP,
1321,GO:0010543,1,0.769641285234326,0,1,regulation of platelet activation,BP,
1322,GO:0010544,1,0.769641285234326,0,1,negative regulation of platelet activation,BP,
1326,GO:0010559,1,0.801501284797587,0,1,regulation of glycoprotein biosynthetic process,BP,
1327,GO:0010561,1,0.801501284797587,0,1,negative regulation of glycoprotein biosynthetic process,BP,
1333,GO:0010586,1,0.889443009650413,0,1,miRNA metabolic process,BP,
1336,GO:0010596,1,0.568202356117225,0,1,negative regulation of endothelial cell migration,BP,
1339,GO:0010608,1,0.441346012385364,0,4,posttranscriptional regulation of gene expression,BP,
1340,GO:0010611,1,0.818949769337691,0,1,regulation of cardiac muscle hypertrophy,BP,
1341,GO:0010613,1,0.818949769337691,0,1,positive regulation of cardiac muscle hypertrophy,BP,
1347,GO:0010633,1,0.568202356117225,0,1,negative regulation of epithelial cell migration,BP,
1351,GO:0010640,1,0.769641285234326,0,1,regulation of platelet-derived growth factor receptor signaling pathway,BP,
1352,GO:0010642,1,0.769641285234326,0,1,negative regulation of platelet-derived growth factor receptor signaling pathway,BP,
1353,GO:0010644,1,0.779877946733024,0,1,cell communication by electrical coupling,BP,
1357,GO:0010649,1,0.779877946733024,0,1,regulation of cell communication by electrical coupling,BP,
1358,GO:0010656,1,0.581497558373841,0,2,negative regulation of muscle cell apoptotic process,BP,
1359,GO:0010657,1,0.581497558373841,0,2,muscle cell apoptotic process,BP,
1360,GO:0010658,1,0.710907860107323,0,1,striated muscle cell apoptotic process,BP,
1361,GO:0010660,1,0.581497558373841,0,2,regulation of muscle cell apoptotic process,BP,
1362,GO:0010662,1,0.710907860107323,0,1,regulation of striated muscle cell apoptotic process,BP,
1363,GO:0010664,1,0.710907860107323,0,1,negative regulation of striated muscle cell apoptotic process,BP,
1364,GO:0010668,1,0.719441160584566,0,1,ectodermal cell differentiation,BP,
1365,GO:0010675,1,0.360511154665845,0,4,regulation of cellular carbohydrate metabolic process,BP,
1366,GO:0010676,1,0.491135553689425,0,3,positive regulation of cellular carbohydrate metabolic process,BP,
1367,GO:0010677,1,0.76995755234939,0,1,negative regulation of cellular carbohydrate metabolic process,BP,
1368,GO:0010700,1,0.620119989668987,0,2,negative regulation of norepinephrine secretion,BP,
1371,GO:0010715,1,0.719956321112888,0,1,regulation of extracellular matrix disassembly,BP,
1372,GO:0010717,1,0.210123675283551,0,4,regulation of epithelial to mesenchymal transition,BP,
1373,GO:0010718,1,0.210123675283551,0,4,positive regulation of epithelial to mesenchymal transition,BP,
1376,GO:0010724,1,0.749427895517118,0,1,regulation of definitive erythrocyte differentiation,BP,
1377,GO:0010746,1,0.770418300420706,0,1,regulation of plasma membrane long-chain fatty acid transport,BP,
1378,GO:0010748,1,0.770418300420706,0,1,negative regulation of plasma membrane long-chain fatty acid transport,BP,
1381,GO:0010763,1,0.770418300420706,0,1,positive regulation of fibroblast migration,BP,
1382,GO:0010765,1,0.770418300420706,0,1,positive regulation of sodium ion transport,BP,
1383,GO:0010766,1,0.704092276759398,0,1,negative regulation of sodium ion transport,BP,
1384,GO:0010769,1,0.305688293536726,0,4,regulation of cell morphogenesis involved in differentiation,BP,
1385,GO:0010770,1,0.862545484850912,0,1,positive regulation of cell morphogenesis involved in differentiation,BP,
1386,GO:0010771,1,0.554678513309543,0,2,negative regulation of cell morphogenesis involved in differentiation,BP,
1387,GO:0010799,1,0.337222092635544,0,3,regulation of peptidyl-threonine phosphorylation,BP,
1388,GO:0010800,1,0.337222092635544,0,3,positive regulation of peptidyl-threonine phosphorylation,BP,
1395,GO:0010818,1,0.422730383114238,0,2,T cell chemotaxis,BP,
1396,GO:0010819,1,0.643840742286014,0,1,regulation of T cell chemotaxis,BP,
1397,GO:0010820,1,0.643840742286014,0,1,positive regulation of T cell chemotaxis,BP,
1398,GO:0010821,1,0.639212907528369,0,2,regulation of mitochondrion organization,BP,
1399,GO:0010822,1,0.830438737450604,0,1,positive regulation of mitochondrion organization,BP,
1400,GO:0010823,1,0.770418300420706,0,1,negative regulation of mitochondrion organization,BP,
1401,GO:0010824,1,0.758709278845637,0,1,regulation of centrosome duplication,BP,
1404,GO:0010830,1,0.568202356117225,0,1,regulation of myotube differentiation,BP,
1405,GO:0010832,1,0.568202356117225,0,1,negative regulation of myotube differentiation,BP,
1406,GO:0010837,1,0.443095315151834,0,3,regulation of keratinocyte proliferation,BP,
1407,GO:0010838,1,0.932928362009675,0,1,positive regulation of keratinocyte proliferation,BP,
1408,GO:0010839,1,0.475529175537021,0,2,negative regulation of keratinocyte proliferation,BP,
1410,GO:0010862,1,0.19270280691915,0,6,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,
1411,GO:0010863,1,0.840697515380158,0,1,positive regulation of phospholipase C activity,BP,
1412,GO:0010869,1,0.818949769337691,0,1,regulation of receptor biosynthetic process,BP,
1413,GO:0010870,1,0.818949769337691,0,1,positive regulation of receptor biosynthetic process,BP,
1415,GO:0010880,1,0.779877946733024,0,1,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
1416,GO:0010881,1,0.779877946733024,0,1,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,BP,
1417,GO:0010882,1,0.779877946733024,0,1,regulation of cardiac muscle contraction by calcium ion signaling,BP,
1418,GO:0010893,1,0.541729739342896,0,2,positive regulation of steroid biosynthetic process,BP,
1420,GO:0010896,1,0.658464044734903,0,1,regulation of triglyceride catabolic process,BP,
1421,GO:0010897,1,0.658464044734903,0,1,negative regulation of triglyceride catabolic process,BP,
1422,GO:0010906,1,0.360511154665845,0,4,regulation of glucose metabolic process,BP,
1423,GO:0010907,1,0.491135553689425,0,3,positive regulation of glucose metabolic process,BP,
1424,GO:0010917,1,0.830438737450604,0,1,negative regulation of mitochondrial membrane potential,BP,
1426,GO:0010922,1,0.754619499090771,0,1,positive regulation of phosphatase activity,BP,
1430,GO:0010935,1,0.643840742286014,0,1,regulation of macrophage cytokine production,BP,
1438,GO:0010962,1,0.770418300420706,0,1,regulation of glucan biosynthetic process,BP,
1442,GO:0010977,1,0.554678513309543,0,2,negative regulation of neuron projection development,BP,
1443,GO:0010979,1,0.682277403524016,0,1,regulation of vitamin D 24-hydroxylase activity,BP,
1444,GO:0010980,1,0.682277403524016,0,1,positive regulation of vitamin D 24-hydroxylase activity,BP,
1445,GO:0010996,1,0.77140024913884,0,1,response to auditory stimulus,BP,
1450,GO:0014004,1,0.751128664163879,0,1,microglia differentiation,BP,
1451,GO:0014005,1,0.751128664163879,0,1,microglia development,BP,
1452,GO:0014009,1,0.568202356117225,0,1,glial cell proliferation,BP,
1453,GO:0014013,1,0.17618336793285,0,5,regulation of gliogenesis,BP,
1454,GO:0014014,1,0.568202356117225,0,1,negative regulation of gliogenesis,BP,
1455,GO:0014015,1,0.255218833644805,0,4,positive regulation of gliogenesis,BP,
1457,GO:0014028,1,0.649653750422083,0,1,notochord formation,BP,
1461,GO:0014037,1,0.458960088770901,0,3,Schwann cell differentiation,BP,
1462,GO:0014044,1,0.590229108970285,0,2,Schwann cell development,BP,
1463,GO:0014045,1,0.605744058874978,0,2,establishment of endothelial blood-brain barrier,BP,
1464,GO:0014046,1,0.928417537918174,0,1,dopamine secretion,BP,
1465,GO:0014047,1,0.77186369485247,0,1,glutamate secretion,BP,
1466,GO:0014048,1,0.77186369485247,0,1,regulation of glutamate secretion,BP,
1467,GO:0014050,1,0.77186369485247,0,1,negative regulation of glutamate secretion,BP,
1468,GO:0014059,1,0.928417537918174,0,1,regulation of dopamine secretion,BP,
1469,GO:0014060,1,0.620119989668987,0,2,regulation of epinephrine secretion,BP,
1470,GO:0014061,1,0.620119989668987,0,2,regulation of norepinephrine secretion,BP,
1473,GO:0014068,1,0.555923554904029,0,2,positive regulation of phosphatidylinositol 3-kinase signaling,BP,
1477,GO:0014701,1,0.779877946733024,0,1,junctional sarcoplasmic reticulum membrane,CC,
1478,GO:0014704,1,0.460631752151068,0,2,intercalated disc,CC,
1480,GO:0014719,1,0.846321998934282,0,1,skeletal muscle satellite cell activation,BP,
1481,GO:0014728,1,0.76995755234939,0,1,regulation of the force of skeletal muscle contraction,BP,
1482,GO:0014731,1,0.583263023522041,0,1,spectrin-associated cytoskeleton,CC,
1483,GO:0014732,1,0.76995755234939,0,1,skeletal muscle atrophy,BP,
1484,GO:0014733,1,0.76995755234939,0,1,regulation of skeletal muscle adaptation,BP,
1485,GO:0014742,1,0.818949769337691,0,1,positive regulation of muscle hypertrophy,BP,
1486,GO:0014743,1,0.818949769337691,0,1,regulation of muscle hypertrophy,BP,
1488,GO:0014808,1,0.779877946733024,0,1,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
1490,GO:0014819,1,0.76995755234939,0,1,regulation of skeletal muscle contraction,BP,
1491,GO:0014820,1,0.818949769337691,0,1,tonic smooth muscle contraction,BP,
1492,GO:0014821,1,0.760052705496766,0,2,phasic smooth muscle contraction,BP,
1493,GO:0014823,1,0.61924131812063,0,2,response to activity,BP,
1494,GO:0014824,1,0.818949769337691,0,1,artery smooth muscle contraction,BP,
1495,GO:0014826,1,0.818949769337691,0,1,vein smooth muscle contraction,BP,
1496,GO:0014829,1,0.700660771856183,0,2,vascular smooth muscle contraction,BP,
1497,GO:0014834,1,0.608265281359644,0,2,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,BP,
1498,GO:0014854,1,0.76995755234939,0,1,response to inactivity,BP,
1499,GO:0014855,1,0.436478869252759,0,2,striated muscle cell proliferation,BP,
1500,GO:0014862,1,0.76995755234939,0,1,regulation of skeletal muscle contraction by chemo-mechanical energy conversion,BP,
1501,GO:0014866,1,0.613902340139758,0,1,skeletal myofibril assembly,BP,
1502,GO:0014870,1,0.76995755234939,0,1,response to muscle inactivity,BP,
1503,GO:0014874,1,0.76995755234939,0,1,response to stimulus involved in regulation of muscle adaptation,BP,
1504,GO:0014877,1,0.76995755234939,0,1,response to muscle inactivity involved in regulation of muscle adaptation,BP,
1505,GO:0014883,1,0.76995755234939,0,1,transition between fast and slow fiber,BP,
1506,GO:0014888,1,0.76995755234939,0,1,striated muscle adaptation,BP,
1507,GO:0014889,1,0.76995755234939,0,1,muscle atrophy,BP,
1508,GO:0014891,1,0.76995755234939,0,1,striated muscle atrophy,BP,
1509,GO:0014894,1,0.76995755234939,0,1,response to denervation involved in regulation of muscle adaptation,BP,
1510,GO:0014896,1,0.818949769337691,0,1,muscle hypertrophy,BP,
1511,GO:0014897,1,0.818949769337691,0,1,striated muscle hypertrophy,BP,
1512,GO:0014902,1,0.568202356117225,0,1,myotube differentiation,BP,
1518,GO:0015077,1,0.347258368948077,0,4,monovalent inorganic cation transmembrane transporter activity,MF,
1519,GO:0015079,1,0.347258368948077,0,4,potassium ion transmembrane transporter activity,MF,
1521,GO:0015091,1,0.774076993520791,0,1,ferric iron transmembrane transporter activity,MF,
1522,GO:0015095,1,0.862773585572262,0,1,magnesium ion transmembrane transporter activity,MF,
1523,GO:0015103,1,0.824843141866342,0,1,inorganic anion transmembrane transporter activity,MF,
1524,GO:0015108,1,0.824843141866342,0,1,chloride transmembrane transporter activity,MF,
1525,GO:0015144,1,0.602115213468231,0,2,carbohydrate transmembrane transporter activity,MF,
1526,GO:0015145,1,0.81190363278393,0,1,monosaccharide transmembrane transporter activity,MF,
1527,GO:0015149,1,0.81190363278393,0,1,hexose transmembrane transporter activity,MF,
1528,GO:0015154,1,0.74242873973508,0,1,disaccharide transmembrane transporter activity,MF,
1529,GO:0015157,1,0.74242873973508,0,1,oligosaccharide transmembrane transporter activity,MF,
1530,GO:0015232,1,0.728409909849621,0,1,heme transporter activity,MF,
1532,GO:0015271,1,0.682141779383763,0,1,outward rectifier potassium channel activity,MF,
1533,GO:0015276,1,0.588493411762287,0,2,ligand-gated ion channel activity,MF,
1534,GO:0015291,1,0.74242873973508,0,1,secondary active transmembrane transporter activity,MF,
1535,GO:0015293,1,0.74242873973508,0,1,symporter activity,MF,
1536,GO:0015294,1,0.74242873973508,0,1,solute:cation symporter activity,MF,
1537,GO:0015295,1,0.74242873973508,0,1,solute:proton symporter activity,MF,
1543,GO:0015682,1,0.774076993520791,0,1,ferric iron transport,BP,
1544,GO:0015684,1,0.774076993520791,0,1,ferrous iron transport,BP,
1545,GO:0015693,1,0.862773585572262,0,1,magnesium ion transport,BP,
1546,GO:0015696,1,0.760052705496766,0,2,ammonium transport,BP,
1547,GO:0015698,1,0.580070553897152,0,2,inorganic anion transport,BP,
1550,GO:0015732,1,0.818949769337691,0,1,prostaglandin transport,BP,
1551,GO:0015748,1,0.852797932747088,0,1,organophosphate ester transport,BP,
1554,GO:0015766,1,0.74242873973508,0,1,disaccharide transport,BP,
1555,GO:0015770,1,0.74242873973508,0,1,sucrose transport,BP,
1556,GO:0015772,1,0.74242873973508,0,1,oligosaccharide transport,BP,
1558,GO:0015837,1,0.363183622586545,0,5,amine transport,BP,
1559,GO:0015844,1,0.472230757341737,0,4,monoamine transport,BP,
1561,GO:0015850,1,0.35605930202599,0,5,organic hydroxy compound transport,BP,
1562,GO:0015858,1,0.77186369485247,0,1,nucleoside transport,BP,
1563,GO:0015865,1,0.852797932747088,0,1,purine nucleotide transport,BP,
1564,GO:0015868,1,0.852797932747088,0,1,purine ribonucleotide transport,BP,
1565,GO:0015872,1,0.928417537918174,0,1,dopamine transport,BP,
1566,GO:0015874,1,0.620119989668987,0,2,norepinephrine transport,BP,
1567,GO:0015886,1,0.728409909849621,0,1,heme transport,BP,
1570,GO:0015909,1,0.770418300420706,0,1,long-chain fatty acid transport,BP,
1571,GO:0015911,1,0.770418300420706,0,1,plasma membrane long-chain fatty acid transport,BP,
1572,GO:0015931,1,0.657726820326536,0,2,nucleobase-containing compound transport,BP,
1573,GO:0015980,1,0.42850666545598,0,3,energy derivation by oxidation of organic compounds,BP,
1577,GO:0016042,1,0.285743071571538,0,4,lipid catabolic process,BP,
1579,GO:0016048,1,0.77186369485247,0,1,detection of temperature stimulus,BP,
1582,GO:0016051,1,0.337109474800801,0,4,carbohydrate biosynthetic process,BP,
1583,GO:0016052,1,0.425257171386855,0,3,carbohydrate catabolic process,BP,
1585,GO:0016054,1,0.407096640539412,0,3,organic acid catabolic process,BP,
1587,GO:0016056,1,0.671264126002153,0,1,rhodopsin mediated signaling pathway,BP,
1588,GO:0016064,1,0.84015341765014,0,1,immunoglobulin mediated immune response,BP,
1590,GO:0016071,1,0.365554940761731,0,3,mRNA metabolic process,BP,
1591,GO:0016079,1,0.837875488244045,0,1,synaptic vesicle exocytosis,BP,
1595,GO:0016176,1,0.769641285234326,0,1,superoxide-generating NADPH oxidase activator activity,MF,
1599,GO:0016209,1,0.736825336349041,0,1,antioxidant activity,MF,
1600,GO:0016236,1,0.174370290466815,0,6,macroautophagy,BP,
1601,GO:0016239,1,0.484473556444782,0,3,positive regulation of macroautophagy,BP,
1602,GO:0016241,1,0.174370290466815,0,6,regulation of macroautophagy,BP,
1603,GO:0016242,1,0.364508469119493,0,3,negative regulation of macroautophagy,BP,
1604,GO:0016247,1,0.585633287776592,0,2,channel regulator activity,MF,
1605,GO:0016248,1,0.704092276759398,0,1,channel inhibitor activity,MF,
1606,GO:0016264,1,0.68478089734747,0,2,gap junction assembly,BP,
1607,GO:0016266,1,0.777493793435671,0,1,O-glycan processing,BP,
1608,GO:0016298,1,0.77186369485247,0,1,lipase activity,MF,
1611,GO:0016307,1,0.47656266860552,0,2,phosphatidylinositol phosphate kinase activity,MF,
1616,GO:0016327,1,0.726059659604141,0,2,apicolateral plasma membrane,CC,
1619,GO:0016332,1,0.716467262155752,0,1,establishment or maintenance of polarity of embryonic epithelium,BP,
1622,GO:0016339,1,0.495688480271739,0,2,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,BP,
1623,GO:0016342,1,0.470872585134369,0,2,catenin complex,CC,
1625,GO:0016361,1,0.764973380564597,0,1,activin receptor activity, type I,MF,
1626,GO:0016363,1,0.652168350167583,0,1,nuclear matrix,CC,
1627,GO:0016410,1,0.671264126002153,0,1,N-acyltransferase activity,MF,
1628,GO:0016411,1,0.721084421958727,0,1,acylglycerol O-acyltransferase activity,MF,
1629,GO:0016441,1,0.841205940583945,0,1,posttranscriptional gene silencing,BP,
1630,GO:0016444,1,0.84015341765014,0,1,somatic cell DNA recombination,BP,
1631,GO:0016445,1,0.84015341765014,0,1,somatic diversification of immunoglobulins,BP,
1632,GO:0016447,1,0.84015341765014,0,1,somatic recombination of immunoglobulin gene segments,BP,
1633,GO:0016458,1,0.841205940583945,0,1,gene silencing,BP,
1635,GO:0016460,1,0.613902340139758,0,1,myosin II complex,CC,
1639,GO:0016480,1,0.779399280116173,0,1,negative regulation of transcription from RNA polymerase III promoter,BP,
1642,GO:0016491,1,0.398671399350898,0,3,oxidoreductase activity,MF,
1644,GO:0016528,1,0.779877946733024,0,1,sarcoplasm,CC,
1645,GO:0016529,1,0.779877946733024,0,1,sarcoplasmic reticulum,CC,
1647,GO:0016567,1,0.0496617807694162,0,10,protein ubiquitination,BP,
1649,GO:0016570,1,0.476304780173291,0,2,histone modification,BP,
1650,GO:0016573,1,0.716190498729619,0,1,histone acetylation,BP,
1651,GO:0016575,1,0.66650505420776,0,1,histone deacetylation,BP,
1653,GO:0016580,1,0.66650505420776,0,1,Sin3 complex,CC,
1654,GO:0016594,1,0.7203786970807,0,1,glycine binding,MF,
1655,GO:0016597,1,0.529909246828402,0,2,amino acid binding,MF,
1656,GO:0016600,1,0.678121940697822,0,1,flotillin complex,CC,
1658,GO:0016605,1,0.652168350167583,0,1,PML body,CC,
1660,GO:0016614,1,0.754619499090771,0,1,oxidoreductase activity, acting on CH-OH group of donors,MF,
1661,GO:0016616,1,0.754619499090771,0,1,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,
1662,GO:0016638,1,0.7203786970807,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors,MF,
1663,GO:0016642,1,0.7203786970807,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor,MF,
1664,GO:0016667,1,0.736825336349041,0,1,oxidoreductase activity, acting on a sulfur group of donors,MF,
1665,GO:0016684,1,0.736825336349041,0,1,oxidoreductase activity, acting on peroxide as acceptor,MF,
1667,GO:0016741,1,0.889123573643436,0,1,transferase activity, transferring one-carbon groups,MF,
1669,GO:0016747,1,0.483019123211698,0,2,transferase activity, transferring acyl groups other than amino-acyl groups,MF,
1670,GO:0016757,1,0.777493793435671,0,1,transferase activity, transferring glycosyl groups,MF,
1671,GO:0016758,1,0.777493793435671,0,1,transferase activity, transferring hexosyl groups,MF,
1674,GO:0016775,1,0.752197563702773,0,1,phosphotransferase activity, nitrogenous group as acceptor,MF,
1678,GO:0016805,1,0.68260721833079,0,1,dipeptidase activity,MF,
1679,GO:0016810,1,0.66650505420776,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,
1680,GO:0016811,1,0.66650505420776,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,
1683,GO:0016829,1,0.377505742702891,0,3,lyase activity,MF,
1684,GO:0016849,1,0.525873339386502,0,2,phosphorus-oxygen lyase activity,MF,
1691,GO:0016936,1,0.878994577289224,0,1,galactoside binding,MF,
1692,GO:0016941,1,0.703483707209344,0,1,natriuretic peptide receptor activity,MF,
1693,GO:0017002,1,0.764973380564597,0,1,activin-activated receptor activity,MF,
1696,GO:0017017,1,0.790836093256502,0,1,MAP kinase tyrosine/serine/threonine phosphatase activity,MF,
1701,GO:0017053,1,0.749427895517118,0,1,transcriptional repressor complex,CC,
1703,GO:0017081,1,0.704092276759398,0,1,chloride channel regulator activity,MF,
1708,GO:0017145,1,0.344032783263555,0,3,stem cell division,BP,
1709,GO:0017147,1,0.540736703248118,0,2,Wnt-protein binding,MF,
1710,GO:0017148,1,0.619220918328307,0,2,negative regulation of translation,BP,
1711,GO:0017156,1,0.363568540131845,0,3,calcium ion regulated exocytosis,BP,
1713,GO:0017158,1,0.475257784898974,0,2,regulation of calcium ion-dependent exocytosis,BP,
1714,GO:0017171,1,0.540456021813901,0,2,serine hydrolase activity,MF,
1715,GO:0018008,1,0.671264126002153,0,1,N-terminal peptidyl-glycine N-myristoylation,BP,
1717,GO:0018107,1,0.196573869079787,0,5,peptidyl-threonine phosphorylation,BP,
1719,GO:0018125,1,0.8343554877042,0,1,peptidyl-cysteine methylation,BP,
1721,GO:0018146,1,0.777493793435671,0,1,keratan sulfate biosynthetic process,BP,
1723,GO:0018198,1,0.8343554877042,0,1,peptidyl-cysteine modification,BP,
1724,GO:0018201,1,0.671264126002153,0,1,peptidyl-glycine modification,BP,
1725,GO:0018205,1,0.716190498729619,0,1,peptidyl-lysine modification,BP,
1727,GO:0018210,1,0.196573869079787,0,5,peptidyl-threonine modification,BP,
1729,GO:0018377,1,0.671264126002153,0,1,protein myristoylation,BP,
1730,GO:0018393,1,0.716190498729619,0,1,internal peptidyl-lysine acetylation,BP,
1731,GO:0018394,1,0.716190498729619,0,1,peptidyl-lysine acetylation,BP,
1733,GO:0018958,1,0.400984481435185,0,3,phenol-containing compound metabolic process,BP,
1740,GO:0019107,1,0.671264126002153,0,1,myristoyltransferase activity,MF,
1741,GO:0019199,1,0.391375397178764,0,3,transmembrane receptor protein kinase activity,MF,
1742,GO:0019200,1,0.553786164805125,0,2,carbohydrate kinase activity,MF,
1743,GO:0019203,1,0.695278396814058,0,1,carbohydrate phosphatase activity,MF,
1745,GO:0019208,1,0.754619499090771,0,1,phosphatase regulator activity,MF,
1748,GO:0019211,1,0.754619499090771,0,1,phosphatase activator activity,MF,
1749,GO:0019213,1,0.66650505420776,0,1,deacetylase activity,MF,
1750,GO:0019215,1,0.657097306241214,0,1,intermediate filament binding,MF,
1752,GO:0019217,1,0.770418300420706,0,1,regulation of fatty acid metabolic process,BP,
1758,GO:0019226,1,0.473691331369579,0,2,transmission of nerve impulse,BP,
1759,GO:0019229,1,0.389324315387808,0,4,regulation of vasoconstriction,BP,
1760,GO:0019233,1,0.52274264840204,0,3,sensory perception of pain,BP,
1761,GO:0019318,1,0.142015385962965,0,7,hexose metabolic process,BP,
1762,GO:0019319,1,0.736825336349041,0,1,hexose biosynthetic process,BP,
1763,GO:0019320,1,0.425257171386855,0,3,hexose catabolic process,BP,
1764,GO:0019362,1,0.534480969901098,0,2,pyridine nucleotide metabolic process,BP,
1767,GO:0019395,1,0.566889458089637,0,2,fatty acid oxidation,BP,
1768,GO:0019430,1,0.710907860107323,0,1,removal of superoxide radicals,BP,
1769,GO:0019433,1,0.658464044734903,0,1,triglyceride catabolic process,BP,
1772,GO:0019464,1,0.7203786970807,0,1,glycine decarboxylation via glycine cleavage system,BP,
1775,GO:0019659,1,0.76995755234939,0,1,glucose catabolic process to lactate,BP,
1776,GO:0019660,1,0.76995755234939,0,1,glycolytic fermentation,BP,
1777,GO:0019661,1,0.76995755234939,0,1,glucose catabolic process to lactate via pyruvate,BP,
1778,GO:0019674,1,0.534480969901098,0,2,NAD metabolic process,BP,
1779,GO:0019682,1,0.797620800566368,0,1,glyceraldehyde-3-phosphate metabolic process,BP,
1781,GO:0019722,1,0.447885852232954,0,4,calcium-mediated signaling,BP,
1782,GO:0019724,1,0.84015341765014,0,1,B cell mediated immunity,BP,
1784,GO:0019730,1,0.822648168832337,0,1,antimicrobial humoral response,BP,
1785,GO:0019748,1,0.643840742286014,0,1,secondary metabolic process,BP,
1787,GO:0019787,1,0.149197213813986,0,5,ubiquitin-like protein transferase activity,MF,
1789,GO:0019828,1,0.649653750422083,0,1,aspartic-type endopeptidase inhibitor activity,MF,
1792,GO:0019842,1,0.490498920008144,0,2,vitamin binding,MF,
1795,GO:0019869,1,0.704092276759398,0,1,chloride channel inhibitor activity,MF,
1799,GO:0019894,1,0.534748033148175,0,1,kinesin binding,MF,
1808,GO:0019905,1,0.651448669347724,0,2,syntaxin binding,MF,
1810,GO:0019932,1,0.333965755603221,0,5,second-messenger-mediated signaling,BP,
1811,GO:0019934,1,0.748793081179247,0,1,cGMP-mediated signaling,BP,
1812,GO:0019935,1,0.748793081179247,0,1,cyclic-nucleotide-mediated signaling,BP,
1813,GO:0019941,1,0.290250750546732,0,4,modification-dependent protein catabolic process,BP,
1815,GO:0019955,1,0.764973380564597,0,1,cytokine binding,MF,
1816,GO:0020037,1,0.54458779056803,0,2,heme binding,MF,
1817,GO:0021502,1,0.710907860107323,0,1,neural fold elevation formation,BP,
1819,GO:0021515,1,0.568202356117225,0,1,cell differentiation in spinal cord,BP,
1821,GO:0021533,1,0.846321998934282,0,1,cell differentiation in hindbrain,BP,
1822,GO:0021536,1,0.162526451774659,0,7,diencephalon development,BP,
1823,GO:0021537,1,0.25224749478843,0,5,telencephalon development,BP,
1824,GO:0021543,1,0.624473694081859,0,2,pallium development,BP,
1825,GO:0021544,1,0.89801195405569,0,1,subpallium development,BP,
1832,GO:0021681,1,0.846321998934282,0,1,cerebellar granular layer development,BP,
1833,GO:0021683,1,0.846321998934282,0,1,cerebellar granular layer morphogenesis,BP,
1834,GO:0021684,1,0.846321998934282,0,1,cerebellar granular layer formation,BP,
1844,GO:0021707,1,0.846321998934282,0,1,cerebellar granule cell differentiation,BP,
1845,GO:0021772,1,0.643840742286014,0,1,olfactory bulb development,BP,
1847,GO:0021784,1,0.928417537918174,0,1,postganglionic parasympathetic fiber development,BP,
1848,GO:0021797,1,0.741374927768024,0,1,forebrain anterior/posterior pattern specification,BP,
1849,GO:0021798,1,0.89801195405569,0,1,forebrain dorsal/ventral pattern formation,BP,
1850,GO:0021846,1,0.759702786591028,0,2,cell proliferation in forebrain,BP,
1851,GO:0021871,1,0.241394584393362,0,6,forebrain regionalization,BP,
1852,GO:0021872,1,0.427039281218843,0,3,forebrain generation of neurons,BP,
1853,GO:0021877,1,0.741374927768024,0,1,forebrain neuron fate commitment,BP,
1854,GO:0021879,1,0.427039281218843,0,3,forebrain neuron differentiation,BP,
1855,GO:0021881,1,0.741374927768024,0,1,Wnt-activated signaling pathway involved in forebrain neuron fate commitment,BP,
1856,GO:0021884,1,0.577630157458715,0,2,forebrain neuron development,BP,
1857,GO:0021885,1,0.714080197774154,0,1,forebrain cell migration,BP,
1858,GO:0021889,1,0.643840742286014,0,1,olfactory bulb interneuron differentiation,BP,
1859,GO:0021891,1,0.643840742286014,0,1,olfactory bulb interneuron development,BP,
1860,GO:0021898,1,0.741374927768024,0,1,commitment of multipotent stem cells to neuronal lineage in forebrain,BP,
1861,GO:0021903,1,0.89801195405569,0,1,rostrocaudal neural tube patterning,BP,
1864,GO:0021952,1,0.652168350167583,0,1,central nervous system projection neuron axonogenesis,BP,
1865,GO:0021953,1,0.153210651956357,0,7,central nervous system neuron differentiation,BP,
1866,GO:0021954,1,0.375259146439153,0,3,central nervous system neuron development,BP,
1867,GO:0021955,1,0.652168350167583,0,1,central nervous system neuron axonogenesis,BP,
1868,GO:0021978,1,0.634217622687051,0,2,telencephalon regionalization,BP,
1869,GO:0021983,1,0.162526451774659,0,7,pituitary gland development,BP,
1870,GO:0021984,1,0.484342640752895,0,3,adenohypophysis development,BP,
1871,GO:0021987,1,0.6959456816156,0,1,cerebral cortex development,BP,
1872,GO:0021988,1,0.643840742286014,0,1,olfactory lobe development,BP,
1873,GO:0021999,1,0.741374927768024,0,1,neural plate anterior/posterior regionalization,BP,
1875,GO:0022009,1,0.605744058874978,0,2,central nervous system vasculogenesis,BP,
1876,GO:0022011,1,0.590229108970285,0,2,myelination in peripheral nervous system,BP,
1878,GO:0022400,1,0.671264126002153,0,1,regulation of rhodopsin mediated signaling pathway,BP,
1886,GO:0022410,1,0.77186369485247,0,1,circadian sleep/wake cycle process,BP,
1890,GO:0022600,1,0.446660610180465,0,3,digestive system process,BP,
1898,GO:0022617,1,0.487209817457882,0,2,extracellular matrix disassembly,BP,
1900,GO:0022804,1,0.74242873973508,0,1,active transmembrane transporter activity,MF,
1901,GO:0022829,1,0.453782796259077,0,3,wide pore channel activity,MF,
1903,GO:0022834,1,0.588493411762287,0,2,ligand-gated channel activity,MF,
1913,GO:0023019,1,0.89801195405569,0,1,signal transduction involved in regulation of gene expression,BP,
1918,GO:0023061,1,0.056912939573794,0,11,signal release,BP,
1921,GO:0030004,1,0.572101934452145,0,3,cellular monovalent inorganic cation homeostasis,BP,
1923,GO:0030011,1,0.649653750422083,0,1,maintenance of cell polarity,BP,
1931,GO:0030032,1,0.843902948514569,0,1,lamellipodium assembly,BP,
1942,GO:0030056,1,0.646748481245743,0,1,hemidesmosome,CC,
1943,GO:0030057,1,0.0947364739844378,0,6,desmosome,CC,
1944,GO:0030072,1,0.442134179232033,0,4,peptide hormone secretion,BP,
1945,GO:0030073,1,0.541138924887088,0,3,insulin secretion,BP,
1960,GO:0030157,1,0.704092276759398,0,1,pancreatic juice secretion,BP,
1961,GO:0030159,1,0.741374927768024,0,1,receptor signaling complex scaffold activity,MF,
1964,GO:0030165,1,0.540736703248118,0,2,PDZ domain binding,MF,
1966,GO:0030170,1,0.7203786970807,0,1,pyridoxal phosphate binding,MF,
1968,GO:0030177,1,0.105381582907074,0,9,positive regulation of Wnt signaling pathway,BP,
1972,GO:0030185,1,0.818949769337691,0,1,nitric oxide transport,BP,
1973,GO:0030193,1,0.497088421933865,0,3,regulation of blood coagulation,BP,
1974,GO:0030195,1,0.497088421933865,0,3,negative regulation of blood coagulation,BP,
1977,GO:0030212,1,0.592238423702372,0,2,hyaluronan metabolic process,BP,
1978,GO:0030213,1,0.769641285234326,0,1,hyaluronan biosynthetic process,BP,
1979,GO:0030216,1,0.0234684361148337,0,9,keratinocyte differentiation,BP,
1980,GO:0030217,1,0.160299642944491,0,6,T cell differentiation,BP,
1981,GO:0030218,1,0.479455236457816,0,3,erythrocyte differentiation,BP,
1982,GO:0030219,1,0.574448486298985,0,2,megakaryocyte differentiation,BP,
1983,GO:0030220,1,0.749427895517118,0,1,platelet formation,BP,
1984,GO:0030224,1,0.841205940583945,0,1,monocyte differentiation,BP,
1985,GO:0030225,1,0.450912234749366,0,3,macrophage differentiation,BP,
1987,GO:0030235,1,0.770418300420706,0,1,nitric-oxide synthase regulator activity,MF,
1988,GO:0030237,1,0.716836822491286,0,1,female sex determination,BP,
1991,GO:0030241,1,0.613902340139758,0,1,skeletal muscle myosin thick filament assembly,BP,
1992,GO:0030246,1,0.878994577289224,0,1,carbohydrate binding,MF,
1996,GO:0030276,1,0.837875488244045,0,1,clathrin binding,MF,
1997,GO:0030278,1,0.0436162471234317,0,10,regulation of ossification,BP,
1998,GO:0030279,1,0.568202356117225,0,1,negative regulation of ossification,BP,
1999,GO:0030280,1,0.657097306241214,0,1,structural constituent of epidermis,MF,
2000,GO:0030282,1,0.183556212996518,0,6,bone mineralization,BP,
2005,GO:0030307,1,0.434085946169346,0,4,positive regulation of cell growth,BP,
2007,GO:0030309,1,0.777493793435671,0,1,poly-N-acetyllactosamine metabolic process,BP,
2008,GO:0030311,1,0.777493793435671,0,1,poly-N-acetyllactosamine biosynthetic process,BP,
2009,GO:0030314,1,0.779877946733024,0,1,junctional membrane complex,CC,
2015,GO:0030326,1,0.139584399675912,0,7,embryonic limb morphogenesis,BP,
2028,GO:0030431,1,0.77186369485247,0,1,sleep,BP,
2029,GO:0030432,1,0.928417537918174,0,1,peristalsis,BP,
2030,GO:0030485,1,0.856088106630298,0,1,smooth muscle contractile fiber,CC,
2031,GO:0030496,1,0.681647470470383,0,2,midbody,CC,
2032,GO:0030500,1,0.183556212996518,0,6,regulation of bone mineralization,BP,
2033,GO:0030501,1,0.183556212996518,0,6,positive regulation of bone mineralization,BP,
2034,GO:0030506,1,0.255527516457394,0,3,ankyrin binding,MF,
2038,GO:0030512,1,0.829306243472219,0,1,negative regulation of transforming growth factor beta receptor signaling pathway,BP,
2039,GO:0030513,1,0.308423100221857,0,3,positive regulation of BMP signaling pathway,BP,
2040,GO:0030514,1,0.287406444203384,0,3,negative regulation of BMP signaling pathway,BP,
2041,GO:0030516,1,0.554678513309543,0,2,regulation of axon extension,BP,
2042,GO:0030517,1,0.554678513309543,0,2,negative regulation of axon extension,BP,
2043,GO:0030522,1,0.682277403524016,0,1,intracellular receptor signaling pathway,BP,
2044,GO:0030529,1,0.507196040392339,0,2,intracellular ribonucleoprotein complex,CC,
2045,GO:0030534,1,0.605049146120402,0,2,adult behavior,BP,
2046,GO:0030538,1,0.932928362009675,0,1,embryonic genitalia morphogenesis,BP,
2048,GO:0030540,1,0.328401731505531,0,4,female genitalia development,BP,
2056,GO:0030641,1,0.572101934452145,0,3,regulation of cellular pH,BP,
2057,GO:0030656,1,0.682277403524016,0,1,regulation of vitamin metabolic process,BP,
2060,GO:0030660,1,0.689295922426304,0,1,Golgi-associated vesicle membrane,CC,
2061,GO:0030662,1,0.397640929195673,0,3,coated vesicle membrane,CC,
2062,GO:0030665,1,0.397640929195673,0,3,clathrin-coated vesicle membrane,CC,
2063,GO:0030666,1,0.0434365734028363,0,12,endocytic vesicle membrane,CC,
2065,GO:0030669,1,0.515188226864952,0,2,clathrin-coated endocytic vesicle membrane,CC,
2066,GO:0030670,1,0.350139478033777,0,4,phagocytic vesicle membrane,CC,
2068,GO:0030673,1,0.77186369485247,0,1,axolemma,CC,
2071,GO:0030728,1,0.751822927145045,0,1,ovulation,BP,
2072,GO:0030742,1,0.725036752822986,0,2,GTP-dependent protein binding,MF,
2073,GO:0030799,1,0.288212320977775,0,5,regulation of cyclic nucleotide metabolic process,BP,
2074,GO:0030800,1,0.818949769337691,0,1,negative regulation of cyclic nucleotide metabolic process,BP,
2075,GO:0030801,1,0.3532771459202,0,4,positive regulation of cyclic nucleotide metabolic process,BP,
2076,GO:0030802,1,0.548710502616905,0,3,regulation of cyclic nucleotide biosynthetic process,BP,
2077,GO:0030803,1,0.818949769337691,0,1,negative regulation of cyclic nucleotide biosynthetic process,BP,
2078,GO:0030804,1,0.671033848567201,0,2,positive regulation of cyclic nucleotide biosynthetic process,BP,
2079,GO:0030808,1,0.548710502616905,0,3,regulation of nucleotide biosynthetic process,BP,
2080,GO:0030809,1,0.818949769337691,0,1,negative regulation of nucleotide biosynthetic process,BP,
2081,GO:0030810,1,0.671033848567201,0,2,positive regulation of nucleotide biosynthetic process,BP,
2082,GO:0030814,1,0.642098757883129,0,3,regulation of cAMP metabolic process,BP,
2083,GO:0030815,1,0.818949769337691,0,1,negative regulation of cAMP metabolic process,BP,
2084,GO:0030816,1,0.822648168832337,0,1,positive regulation of cAMP metabolic process,BP,
2085,GO:0030817,1,0.818949769337691,0,1,regulation of cAMP biosynthetic process,BP,
2086,GO:0030818,1,0.818949769337691,0,1,negative regulation of cAMP biosynthetic process,BP,
2087,GO:0030823,1,0.430728794816355,0,3,regulation of cGMP metabolic process,BP,
2088,GO:0030825,1,0.430728794816355,0,3,positive regulation of cGMP metabolic process,BP,
2089,GO:0030826,1,0.671033848567201,0,2,regulation of cGMP biosynthetic process,BP,
2090,GO:0030828,1,0.671033848567201,0,2,positive regulation of cGMP biosynthetic process,BP,
2097,GO:0030838,1,0.767524119009516,0,1,positive regulation of actin filament polymerization,BP,
2098,GO:0030849,1,0.66650505420776,0,1,autosome,CC,
2099,GO:0030850,1,0.200872342283861,0,5,prostate gland development,BP,
2100,GO:0030851,1,0.749427895517118,0,1,granulocyte differentiation,BP,
2104,GO:0030858,1,0.131635945301295,0,7,positive regulation of epithelial cell differentiation,BP,
2108,GO:0030865,1,0.689295922426304,0,1,cortical cytoskeleton organization,BP,
2109,GO:0030866,1,0.689295922426304,0,1,cortical actin cytoskeleton organization,BP,
2110,GO:0030868,1,0.824843141866342,0,1,smooth endoplasmic reticulum membrane,CC,
2111,GO:0030877,1,0.741374927768024,0,1,beta-catenin destruction complex,CC,
2112,GO:0030878,1,0.837607612777911,0,2,thyroid gland development,BP,
2113,GO:0030879,1,0.0615089022811733,0,10,mammary gland development,BP,
2117,GO:0030900,1,0.0112380023825097,0,15,forebrain development,BP,
2118,GO:0030901,1,0.425977240189957,0,3,midbrain development,BP,
2120,GO:0030903,1,0.417039271313051,0,2,notochord development,BP,
2121,GO:0030910,1,0.741374927768024,0,1,olfactory placode formation,BP,
2122,GO:0030916,1,0.837607612777911,0,2,otic vesicle formation,BP,
2123,GO:0030917,1,0.89801195405569,0,1,midbrain-hindbrain boundary development,BP,
2124,GO:0030947,1,0.65302645003685,0,2,regulation of vascular endothelial growth factor receptor signaling pathway,BP,
2125,GO:0030949,1,0.65302645003685,0,2,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,
2129,GO:0031000,1,0.779877946733024,0,1,response to caffeine,BP,
2133,GO:0031023,1,0.662212866216891,0,2,microtubule organizing center organization,BP,
2135,GO:0031033,1,0.613902340139758,0,1,myosin filament organization,BP,
2136,GO:0031034,1,0.613902340139758,0,1,myosin filament assembly,BP,
2137,GO:0031045,1,0.837875488244045,0,1,dense core granule,CC,
2138,GO:0031047,1,0.841205940583945,0,1,gene silencing by RNA,BP,
2139,GO:0031050,1,0.841205940583945,0,1,dsRNA fragmentation,BP,
2140,GO:0031056,1,0.716190498729619,0,1,regulation of histone modification,BP,
2141,GO:0031058,1,0.716190498729619,0,1,positive regulation of histone modification,BP,
2142,GO:0031069,1,0.529616015255688,0,2,hair follicle morphogenesis,BP,
2143,GO:0031072,1,0.77186369485247,0,1,heat shock protein binding,MF,
2144,GO:0031076,1,0.326925729607868,0,4,embryonic camera-type eye development,BP,
2152,GO:0031102,1,0.727923995035168,0,1,neuron projection regeneration,BP,
2153,GO:0031103,1,0.727923995035168,0,1,axon regeneration,BP,
2154,GO:0031109,1,0.707212894969842,0,2,microtubule polymerization or depolymerization,BP,
2155,GO:0031110,1,0.84412233261981,0,1,regulation of microtubule polymerization or depolymerization,BP,
2156,GO:0031112,1,0.84412233261981,0,1,positive regulation of microtubule polymerization or depolymerization,BP,
2157,GO:0031113,1,0.84412233261981,0,1,regulation of microtubule polymerization,BP,
2158,GO:0031116,1,0.84412233261981,0,1,positive regulation of microtubule polymerization,BP,
2159,GO:0031122,1,0.620899646201563,0,2,cytoplasmic microtubule organization,BP,
2160,GO:0031128,1,0.185711930556982,0,9,developmental induction,BP,
2161,GO:0031133,1,0.846321998934282,0,1,regulation of axon diameter,BP,
2164,GO:0031201,1,0.778147154946065,0,1,SNARE complex,CC,
2167,GO:0031223,1,0.77140024913884,0,1,auditory behavior,BP,
2171,GO:0031232,1,0.774076993520791,0,1,extrinsic component of external side of plasma membrane,CC,
2172,GO:0031234,1,0.507037229375352,0,2,extrinsic component of cytoplasmic side of plasma membrane,CC,
2173,GO:0031235,1,0.583263023522041,0,1,intrinsic component of the cytoplasmic side of the plasma membrane,CC,
2177,GO:0031256,1,0.539760070733042,0,2,leading edge membrane,CC,
2190,GO:0031330,1,0.118986229165048,0,6,negative regulation of cellular catabolic process,BP,
2198,GO:0031348,1,0.550357978712742,0,2,negative regulation of defense response,BP,
2200,GO:0031365,1,0.671264126002153,0,1,N-terminal protein amino acid modification,BP,
2201,GO:0031396,1,0.612002658216457,0,2,regulation of protein ubiquitination,BP,
2202,GO:0031398,1,0.612002658216457,0,2,positive regulation of protein ubiquitination,BP,
2208,GO:0031424,1,0.131529739959322,0,5,keratinization,BP,
2210,GO:0031434,1,0.793099124675889,0,1,mitogen-activated protein kinase kinase binding,MF,
2216,GO:0031503,1,0.573746003741677,0,2,protein complex localization,BP,
2219,GO:0031529,1,0.889443009650413,0,1,ruffle organization,BP,
2220,GO:0031532,1,0.699589127283741,0,3,actin cytoskeleton reorganization,BP,
2224,GO:0031581,1,0.646748481245743,0,1,hemidesmosome assembly,BP,
2225,GO:0031583,1,0.818949769337691,0,1,phospholipase D-activating G-protein coupled receptor signaling pathway,BP,
2226,GO:0031588,1,0.736825336349041,0,1,nucleotide-activated protein kinase complex,CC,
2228,GO:0031624,1,0.646779409103276,0,1,ubiquitin conjugating enzyme binding,MF,
2230,GO:0031638,1,0.790961287654649,0,1,zymogen activation,BP,
2231,GO:0031639,1,0.790961287654649,0,1,plasminogen activation,BP,
2232,GO:0031640,1,0.822648168832337,0,1,killing of cells of other organism,BP,
2233,GO:0031641,1,0.770418300420706,0,1,regulation of myelination,BP,
2234,GO:0031644,1,0.52274264840204,0,3,regulation of neurological system process,BP,
2236,GO:0031648,1,0.754619499090771,0,1,protein destabilization,BP,
2237,GO:0031657,1,0.71843013776377,0,2,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
2238,GO:0031659,1,0.71843013776377,0,2,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
2239,GO:0031663,1,0.582396930435043,0,2,lipopolysaccharide-mediated signaling pathway,BP,
2240,GO:0031664,1,0.756901465456182,0,1,regulation of lipopolysaccharide-mediated signaling pathway,BP,
2241,GO:0031666,1,0.756901465456182,0,1,positive regulation of lipopolysaccharide-mediated signaling pathway,BP,
2247,GO:0031683,1,0.77186369485247,0,1,G-protein beta/gamma-subunit complex binding,MF,
2248,GO:0031690,1,0.829094252739859,0,1,adrenergic receptor binding,MF,
2249,GO:0031694,1,0.829094252739859,0,1,alpha-2A adrenergic receptor binding,MF,
2250,GO:0031705,1,0.818949769337691,0,1,bombesin receptor binding,MF,
2251,GO:0031707,1,0.818949769337691,0,1,endothelin A receptor binding,MF,
2252,GO:0031708,1,0.818949769337691,0,1,endothelin B receptor binding,MF,
2253,GO:0031731,1,0.914847263689534,0,1,CCR6 chemokine receptor binding,MF,
2259,GO:0031932,1,0.532110414166324,0,2,TORC2 complex,CC,
2263,GO:0031945,1,0.716836822491286,0,1,positive regulation of glucocorticoid metabolic process,BP,
2266,GO:0031948,1,0.716836822491286,0,1,positive regulation of glucocorticoid biosynthetic process,BP,
2267,GO:0031952,1,0.769641285234326,0,1,regulation of protein autophosphorylation,BP,
2268,GO:0031954,1,0.769641285234326,0,1,positive regulation of protein autophosphorylation,BP,
2281,GO:0031994,1,0.646748481245743,0,1,insulin-like growth factor I binding,MF,
2282,GO:0031998,1,0.770418300420706,0,1,regulation of fatty acid beta-oxidation,BP,
2283,GO:0031999,1,0.770418300420706,0,1,negative regulation of fatty acid beta-oxidation,BP,
2287,GO:0032026,1,0.756901465456182,0,1,response to magnesium ion,BP,
2288,GO:0032029,1,0.534748033148175,0,1,myosin tail binding,MF,
2289,GO:0032036,1,0.534748033148175,0,1,myosin heavy chain binding,MF,
2290,GO:0032042,1,0.736825336349041,0,1,mitochondrial DNA metabolic process,BP,
2291,GO:0032052,1,0.682277403524016,0,1,bile acid binding,MF,
2292,GO:0032055,1,0.736825336349041,0,1,negative regulation of translation in response to stress,BP,
2293,GO:0032069,1,0.770418300420706,0,1,regulation of nuclease activity,BP,
2294,GO:0032070,1,0.770418300420706,0,1,regulation of deoxyribonuclease activity,BP,
2295,GO:0032071,1,0.770418300420706,0,1,regulation of endodeoxyribonuclease activity,BP,
2296,GO:0032075,1,0.770418300420706,0,1,positive regulation of nuclease activity,BP,
2297,GO:0032077,1,0.770418300420706,0,1,positive regulation of deoxyribonuclease activity,BP,
2298,GO:0032079,1,0.770418300420706,0,1,positive regulation of endodeoxyribonuclease activity,BP,
2299,GO:0032088,1,0.710907860107323,0,1,negative regulation of NF-kappaB transcription factor activity,BP,
2300,GO:0032091,1,0.464508824033762,0,3,negative regulation of protein binding,BP,
2301,GO:0032092,1,0.327732948687349,0,4,positive regulation of protein binding,BP,
2302,GO:0032094,1,0.770418300420706,0,1,response to food,BP,
2304,GO:0032102,1,0.058654290814304,0,9,negative regulation of response to external stimulus,BP,
2315,GO:0032225,1,0.928417537918174,0,1,regulation of synaptic transmission, dopaminergic,BP,
2316,GO:0032228,1,0.77186369485247,0,1,regulation of synaptic transmission, GABAergic,BP,
2317,GO:0032229,1,0.77186369485247,0,1,negative regulation of synaptic transmission, GABAergic,BP,
2320,GO:0032239,1,0.77186369485247,0,1,regulation of nucleobase-containing compound transport,BP,
2321,GO:0032241,1,0.77186369485247,0,1,positive regulation of nucleobase-containing compound transport,BP,
2322,GO:0032242,1,0.77186369485247,0,1,regulation of nucleoside transport,BP,
2323,GO:0032244,1,0.77186369485247,0,1,positive regulation of nucleoside transport,BP,
2324,GO:0032252,1,0.658464044734903,0,1,secretory granule localization,BP,
2325,GO:0032259,1,0.536852176425715,0,3,methylation,BP,
2331,GO:0032273,1,0.647339488853551,0,2,positive regulation of protein polymerization,BP,
2332,GO:0032274,1,0.751822927145045,0,1,gonadotropin secretion,BP,
2333,GO:0032276,1,0.751822927145045,0,1,regulation of gonadotropin secretion,BP,
2334,GO:0032277,1,0.751822927145045,0,1,negative regulation of gonadotropin secretion,BP,
2335,GO:0032278,1,0.751822927145045,0,1,positive regulation of gonadotropin secretion,BP,
2337,GO:0032287,1,0.770418300420706,0,1,peripheral nervous system myelin maintenance,BP,
2338,GO:0032292,1,0.590229108970285,0,2,peripheral nervous system axon ensheathment,BP,
2339,GO:0032303,1,0.818949769337691,0,1,regulation of icosanoid secretion,BP,
2340,GO:0032305,1,0.818949769337691,0,1,positive regulation of icosanoid secretion,BP,
2341,GO:0032306,1,0.818949769337691,0,1,regulation of prostaglandin secretion,BP,
2342,GO:0032308,1,0.818949769337691,0,1,positive regulation of prostaglandin secretion,BP,
2343,GO:0032309,1,0.818949769337691,0,1,icosanoid secretion,BP,
2344,GO:0032310,1,0.818949769337691,0,1,prostaglandin secretion,BP,
2346,GO:0032331,1,0.841205940583945,0,1,negative regulation of chondrocyte differentiation,BP,
2347,GO:0032332,1,0.756901465456182,0,1,positive regulation of chondrocyte differentiation,BP,
2352,GO:0032346,1,0.541729739342896,0,2,positive regulation of aldosterone metabolic process,BP,
2355,GO:0032349,1,0.541729739342896,0,2,positive regulation of aldosterone biosynthetic process,BP,
2358,GO:0032352,1,0.541729739342896,0,2,positive regulation of hormone metabolic process,BP,
2360,GO:0032354,1,0.568202356117225,0,1,response to follicle-stimulating hormone,BP,
2362,GO:0032364,1,0.716467262155752,0,1,oxygen homeostasis,BP,
2363,GO:0032368,1,0.476017609607906,0,3,regulation of lipid transport,BP,
2364,GO:0032369,1,0.770418300420706,0,1,negative regulation of lipid transport,BP,
2365,GO:0032370,1,0.61924131812063,0,2,positive regulation of lipid transport,BP,
2370,GO:0032400,1,0.642756430920381,0,2,melanosome localization,BP,
2371,GO:0032401,1,0.642756430920381,0,2,establishment of melanosome localization,BP,
2372,GO:0032402,1,0.642756430920381,0,2,melanosome transport,BP,
2380,GO:0032418,1,0.540916071183739,0,2,lysosome localization,BP,
2384,GO:0032427,1,0.689295922426304,0,1,GBD domain binding,MF,
2385,GO:0032433,1,0.824843141866342,0,1,filopodium tip,CC,
2386,GO:0032434,1,0.39335338124276,0,3,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
2387,GO:0032436,1,0.497355855535524,0,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
2388,GO:0032438,1,0.869433192415004,0,1,melanosome organization,BP,
2389,GO:0032446,1,0.0496617807694162,0,10,protein modification by small protein conjugation,BP,
2391,GO:0032459,1,0.830438737450604,0,1,regulation of protein oligomerization,BP,
2392,GO:0032461,1,0.830438737450604,0,1,positive regulation of protein oligomerization,BP,
2393,GO:0032479,1,0.644996651056436,0,1,regulation of type I interferon production,BP,
2394,GO:0032495,1,0.568202356117225,0,1,response to muramyl dipeptide,BP,
2399,GO:0032506,1,0.664021257488237,0,1,cytokinetic process,BP,
2400,GO:0032507,1,0.383738623548183,0,3,maintenance of protein location in cell,BP,
2403,GO:0032536,1,0.605744058874978,0,2,regulation of cell projection size,BP,
2404,GO:0032542,1,0.736825336349041,0,1,sulfiredoxin activity,MF,
2411,GO:0032570,1,0.803527095561903,0,1,response to progesterone,BP,
2413,GO:0032585,1,0.774047742304058,0,1,multivesicular body membrane,CC,
2414,GO:0032587,1,0.700382636394197,0,1,ruffle membrane,CC,
2415,GO:0032589,1,0.77186369485247,0,1,neuron projection membrane,CC,
2416,GO:0032602,1,0.481515761992469,0,2,chemokine production,BP,
2417,GO:0032605,1,0.751822927145045,0,1,hepatocyte growth factor production,BP,
2418,GO:0032606,1,0.644996651056436,0,1,type I interferon production,BP,
2420,GO:0032610,1,0.914847263689534,0,1,interleukin-1 alpha production,BP,
2421,GO:0032611,1,0.643840742286014,0,1,interleukin-1 beta production,BP,
2425,GO:0032633,1,0.424719366756265,0,2,interleukin-4 production,BP,
2427,GO:0032637,1,0.643840742286014,0,1,interleukin-8 production,BP,
2429,GO:0032642,1,0.481515761992469,0,2,regulation of chemokine production,BP,
2430,GO:0032646,1,0.751822927145045,0,1,regulation of hepatocyte growth factor production,BP,
2432,GO:0032650,1,0.914847263689534,0,1,regulation of interleukin-1 alpha production,BP,
2433,GO:0032651,1,0.643840742286014,0,1,regulation of interleukin-1 beta production,BP,
2437,GO:0032673,1,0.749427895517118,0,1,regulation of interleukin-4 production,BP,
2439,GO:0032677,1,0.643840742286014,0,1,regulation of interleukin-8 production,BP,
2441,GO:0032686,1,0.751822927145045,0,1,negative regulation of hepatocyte growth factor production,BP,
2445,GO:0032713,1,0.749427895517118,0,1,negative regulation of interleukin-4 production,BP,
2448,GO:0032722,1,0.643840742286014,0,1,positive regulation of chemokine production,BP,
2450,GO:0032730,1,0.914847263689534,0,1,positive regulation of interleukin-1 alpha production,BP,
2451,GO:0032731,1,0.643840742286014,0,1,positive regulation of interleukin-1 beta production,BP,
2452,GO:0032732,1,0.588526850189583,0,2,positive regulation of interleukin-1 production,BP,
2454,GO:0032755,1,0.643840742286014,0,1,positive regulation of interleukin-6 production,BP,
2455,GO:0032757,1,0.643840742286014,0,1,positive regulation of interleukin-8 production,BP,
2457,GO:0032762,1,0.822648168832337,0,1,mast cell cytokine production,BP,
2458,GO:0032768,1,0.486657647521468,0,3,regulation of monooxygenase activity,BP,
2459,GO:0032770,1,0.714942851570802,0,2,positive regulation of monooxygenase activity,BP,
2461,GO:0032781,1,0.932928362009675,0,1,positive regulation of ATPase activity,BP,
2462,GO:0032784,1,0.741374927768024,0,1,regulation of DNA-templated transcription, elongation,BP,
2463,GO:0032785,1,0.741374927768024,0,1,negative regulation of DNA-templated transcription, elongation,BP,
2465,GO:0032794,1,0.521554584882655,0,2,GTPase activating protein binding,MF,
2466,GO:0032795,1,0.77186369485247,0,1,heterotrimeric G-protein binding,MF,
2467,GO:0032800,1,0.818949769337691,0,1,receptor biosynthetic process,BP,
2469,GO:0032808,1,0.932928362009675,0,1,lacrimal gland development,BP,
2470,GO:0032811,1,0.620119989668987,0,2,negative regulation of epinephrine secretion,BP,
2479,GO:0032846,1,0.447667317392939,0,3,positive regulation of homeostatic process,BP,
2484,GO:0032873,1,0.770418300420706,0,1,negative regulation of stress-activated MAPK cascade,BP,
2488,GO:0032881,1,0.592238423702372,0,2,regulation of polysaccharide metabolic process,BP,
2489,GO:0032885,1,0.592238423702372,0,2,regulation of polysaccharide biosynthetic process,BP,
2491,GO:0032890,1,0.485494993932986,0,3,regulation of organic acid transport,BP,
2492,GO:0032891,1,0.59395529716623,0,2,negative regulation of organic acid transport,BP,
2493,GO:0032892,1,0.818949769337691,0,1,positive regulation of organic acid transport,BP,
2494,GO:0032898,1,0.77186369485247,0,1,neurotrophin production,BP,
2495,GO:0032899,1,0.77186369485247,0,1,regulation of neurotrophin production,BP,
2496,GO:0032900,1,0.77186369485247,0,1,negative regulation of neurotrophin production,BP,
2497,GO:0032924,1,0.422699776634292,0,4,activin receptor signaling pathway,BP,
2498,GO:0032925,1,0.563912908928944,0,3,regulation of activin receptor signaling pathway,BP,
2499,GO:0032926,1,0.604969338042843,0,2,negative regulation of activin receptor signaling pathway,BP,
2501,GO:0032941,1,0.505720947299359,0,3,secretion by tissue,BP,
2506,GO:0032947,1,0.741374927768024,0,1,protein complex scaffold,MF,
2513,GO:0032982,1,0.613902340139758,0,1,myosin filament,CC,
2518,GO:0033002,1,0.0921594003082182,0,9,muscle cell proliferation,BP,
2519,GO:0033010,1,0.727923995035168,0,1,paranodal junction,CC,
2520,GO:0033017,1,0.779877946733024,0,1,sarcoplasmic reticulum membrane,CC,
2521,GO:0033018,1,0.779877946733024,0,1,sarcoplasmic reticulum lumen,CC,
2531,GO:0033044,1,0.716190498729619,0,1,regulation of chromosome organization,BP,
2533,GO:0033077,1,0.215520264201364,0,5,T cell differentiation in thymus,BP,
2534,GO:0033079,1,0.602376048476982,0,2,immature T cell proliferation,BP,
2535,GO:0033080,1,0.602376048476982,0,2,immature T cell proliferation in thymus,BP,
2536,GO:0033081,1,0.841205940583945,0,1,regulation of T cell differentiation in thymus,BP,
2537,GO:0033083,1,0.841205940583945,0,1,regulation of immature T cell proliferation,BP,
2538,GO:0033084,1,0.841205940583945,0,1,regulation of immature T cell proliferation in thymus,BP,
2539,GO:0033085,1,0.841205940583945,0,1,negative regulation of T cell differentiation in thymus,BP,
2540,GO:0033087,1,0.841205940583945,0,1,negative regulation of immature T cell proliferation,BP,
2541,GO:0033088,1,0.841205940583945,0,1,negative regulation of immature T cell proliferation in thymus,BP,
2542,GO:0033093,1,0.633313935343867,0,2,Weibel-Palade body,CC,
2546,GO:0033139,1,0.716190498729619,0,1,regulation of peptidyl-serine phosphorylation of STAT protein,BP,
2547,GO:0033141,1,0.716190498729619,0,1,positive regulation of peptidyl-serine phosphorylation of STAT protein,BP,
2551,GO:0033162,1,0.672509525495492,0,2,melanosome membrane,CC,
2552,GO:0033173,1,0.76995755234939,0,1,calcineurin-NFAT signaling cascade,BP,
2555,GO:0033267,1,0.389840640078791,0,3,axon part,CC,
2556,GO:0033268,1,0.652168350167583,0,1,node of Ranvier,CC,
2557,GO:0033270,1,0.652168350167583,0,1,paranode region of axon,CC,
2560,GO:0033278,1,0.494826506536024,0,2,cell proliferation in midbrain,BP,
2561,GO:0033280,1,0.484015240958911,0,2,response to vitamin D,BP,
2564,GO:0033363,1,0.869433192415004,0,1,secretory granule organization,BP,
2566,GO:0033483,1,0.716467262155752,0,1,gas homeostasis,BP,
2568,GO:0033549,1,0.790836093256502,0,1,MAP kinase phosphatase activity,MF,
2570,GO:0033558,1,0.66650505420776,0,1,protein deacetylase activity,MF,
2573,GO:0033563,1,0.89801195405569,0,1,dorsal/ventral axon guidance,BP,
2574,GO:0033572,1,0.774076993520791,0,1,transferrin transport,BP,
2576,GO:0033598,1,0.643840742286014,0,1,mammary gland epithelial cell proliferation,BP,
2577,GO:0033603,1,0.928417537918174,0,1,positive regulation of dopamine secretion,BP,
2578,GO:0033604,1,0.509257270828109,0,3,negative regulation of catecholamine secretion,BP,
2579,GO:0033605,1,0.928417537918174,0,1,positive regulation of catecholamine secretion,BP,
2580,GO:0033612,1,0.339033573401607,0,4,receptor serine/threonine kinase binding,MF,
2581,GO:0033613,1,0.749427895517118,0,1,activating transcription factor binding,MF,
2582,GO:0033627,1,0.362782501352125,0,3,cell adhesion mediated by integrin,BP,
2583,GO:0033628,1,0.51996011929035,0,2,regulation of cell adhesion mediated by integrin,BP,
2584,GO:0033631,1,0.700382636394197,0,1,cell-cell adhesion mediated by integrin,BP,
2587,GO:0033687,1,0.754619499090771,0,1,osteoblast proliferation,BP,
2588,GO:0033688,1,0.754619499090771,0,1,regulation of osteoblast proliferation,BP,
2589,GO:0033690,1,0.754619499090771,0,1,positive regulation of osteoblast proliferation,BP,
2590,GO:0033692,1,0.598304791236485,0,2,cellular polysaccharide biosynthetic process,BP,
2595,GO:0034101,1,0.479455236457816,0,3,erythrocyte homeostasis,BP,
2596,GO:0034103,1,0.506462365601483,0,2,regulation of tissue remodeling,BP,
2597,GO:0034104,1,0.743693968038284,0,1,negative regulation of tissue remodeling,BP,
2598,GO:0034105,1,0.682277403524016,0,1,positive regulation of tissue remodeling,BP,
2600,GO:0034113,1,0.328169334537975,0,3,heterotypic cell-cell adhesion,BP,
2601,GO:0034114,1,0.710907860107323,0,1,regulation of heterotypic cell-cell adhesion,BP,
2602,GO:0034116,1,0.710907860107323,0,1,positive regulation of heterotypic cell-cell adhesion,BP,
2603,GO:0034121,1,0.714080197774154,0,1,regulation of toll-like receptor signaling pathway,BP,
2604,GO:0034122,1,0.714080197774154,0,1,negative regulation of toll-like receptor signaling pathway,BP,
2607,GO:0034219,1,0.81190363278393,0,1,carbohydrate transmembrane transport,BP,
2609,GO:0034236,1,0.79183939673446,0,1,protein kinase A catalytic subunit binding,MF,
2610,GO:0034243,1,0.741374927768024,0,1,regulation of transcription elongation from RNA polymerase II promoter,BP,
2611,GO:0034244,1,0.741374927768024,0,1,negative regulation of transcription elongation from RNA polymerase II promoter,BP,
2612,GO:0034248,1,0.476001866222604,0,3,regulation of cellular amide metabolic process,BP,
2613,GO:0034249,1,0.619220918328307,0,2,negative regulation of cellular amide metabolic process,BP,
2616,GO:0034285,1,0.797620800566368,0,1,response to disaccharide,BP,
2622,GO:0034340,1,0.643840742286014,0,1,response to type I interferon,BP,
2627,GO:0034390,1,0.818949769337691,0,1,smooth muscle cell apoptotic process,BP,
2628,GO:0034391,1,0.818949769337691,0,1,regulation of smooth muscle cell apoptotic process,BP,
2629,GO:0034392,1,0.818949769337691,0,1,negative regulation of smooth muscle cell apoptotic process,BP,
2631,GO:0034399,1,0.652168350167583,0,1,nuclear periphery,CC,
2632,GO:0034405,1,0.770418300420706,0,1,response to fluid shear stress,BP,
2633,GO:0034440,1,0.566889458089637,0,2,lipid oxidation,BP,
2635,GO:0034452,1,0.534748033148175,0,1,dynactin binding,MF,
2638,GO:0034505,1,0.847352128579167,0,1,tooth mineralization,BP,
2646,GO:0034629,1,0.808086260451893,0,1,cellular protein complex localization,BP,
2647,GO:0034637,1,0.598304791236485,0,2,cellular carbohydrate biosynthetic process,BP,
2655,GO:0034660,1,0.889443009650413,0,1,ncRNA metabolic process,BP,
2659,GO:0034694,1,0.630335029060165,0,2,response to prostaglandin,BP,
2660,GO:0034695,1,0.770418300420706,0,1,response to prostaglandin E,BP,
2661,GO:0034696,1,0.818949769337691,0,1,response to prostaglandin F,BP,
2666,GO:0034705,1,0.347258368948077,0,4,potassium channel complex,CC,
2667,GO:0034707,1,0.824843141866342,0,1,chloride channel complex,CC,
2669,GO:0034755,1,0.824843141866342,0,1,iron ion transmembrane transport,BP,
2679,GO:0035005,1,0.47656266860552,0,2,1-phosphatidylinositol-4-phosphate 3-kinase activity,MF,
2681,GO:0035019,1,0.560236263208708,0,3,somatic stem cell population maintenance,BP,
2686,GO:0035054,1,0.754619499090771,0,1,embryonic heart tube anterior/posterior pattern specification,BP,
2687,GO:0035065,1,0.716190498729619,0,1,regulation of histone acetylation,BP,
2688,GO:0035066,1,0.716190498729619,0,1,positive regulation of histone acetylation,BP,
2691,GO:0035090,1,0.649653750422083,0,1,maintenance of apical/basal cell polarity,BP,
2693,GO:0035094,1,0.818949769337691,0,1,response to nicotine,BP,
2696,GO:0035112,1,0.932928362009675,0,1,genitalia morphogenesis,BP,
2697,GO:0035113,1,0.139584399675912,0,7,embryonic appendage morphogenesis,BP,
2698,GO:0035115,1,0.72961825935898,0,2,embryonic forelimb morphogenesis,BP,
2699,GO:0035116,1,0.310546345688896,0,5,embryonic hindlimb morphogenesis,BP,
2700,GO:0035136,1,0.72961825935898,0,2,forelimb morphogenesis,BP,
2701,GO:0035137,1,0.310546345688896,0,5,hindlimb morphogenesis,BP,
2703,GO:0035150,1,0.138512594189329,0,9,regulation of tube size,BP,
2705,GO:0035194,1,0.841205940583945,0,1,posttranscriptional gene silencing by RNA,BP,
2706,GO:0035195,1,0.841205940583945,0,1,gene silencing by miRNA,BP,
2707,GO:0035196,1,0.841205940583945,0,1,production of miRNAs involved in gene silencing by miRNA,BP,
2710,GO:0035249,1,0.77186369485247,0,1,synaptic transmission, glutamatergic,BP,
2711,GO:0035250,1,0.777493793435671,0,1,UDP-galactosyltransferase activity,MF,
2712,GO:0035257,1,0.682277403524016,0,1,nuclear hormone receptor binding,MF,
2713,GO:0035264,1,0.449977969821551,0,3,multicellular organism growth,BP,
2719,GO:0035296,1,0.138512594189329,0,9,regulation of tube diameter,BP,
2721,GO:0035304,1,0.77186369485247,0,1,regulation of protein dephosphorylation,BP,
2723,GO:0035306,1,0.581728090855632,0,2,positive regulation of dephosphorylation,BP,
2724,GO:0035307,1,0.77186369485247,0,1,positive regulation of protein dephosphorylation,BP,
2725,GO:0035313,1,0.473588214248536,0,3,wound healing, spreading of epidermal cells,BP,
2727,GO:0035329,1,0.619092994523109,0,1,hippo signaling,BP,
2734,GO:0035411,1,0.719441160584566,0,1,catenin import into nucleus,BP,
2735,GO:0035412,1,0.719441160584566,0,1,regulation of catenin import into nucleus,BP,
2736,GO:0035418,1,0.544181611588407,0,2,protein localization to synapse,BP,
2737,GO:0035428,1,0.81190363278393,0,1,hexose transmembrane transport,BP,
2740,GO:0035493,1,0.778147154946065,0,1,SNARE complex assembly,BP,
2743,GO:0035567,1,0.27825405447642,0,4,non-canonical Wnt signaling pathway,BP,
2744,GO:0035577,1,0.637687377282116,0,2,azurophil granule membrane,CC,
2745,GO:0035579,1,0.46925460251146,0,3,specific granule membrane,CC,
2746,GO:0035580,1,0.774047742304058,0,1,specific granule lumen,CC,
2747,GO:0035584,1,0.914847263689534,0,1,calcium-mediated signaling using intracellular calcium source,BP,
2748,GO:0035586,1,0.77186369485247,0,1,purinergic receptor activity,MF,
2749,GO:0035587,1,0.77186369485247,0,1,purinergic receptor signaling pathway,BP,
2750,GO:0035588,1,0.77186369485247,0,1,G-protein coupled purinergic receptor signaling pathway,BP,
2752,GO:0035601,1,0.66650505420776,0,1,protein deacylation,BP,
2753,GO:0035624,1,0.620119989668987,0,2,receptor transactivation,BP,
2754,GO:0035625,1,0.620119989668987,0,2,epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway,BP,
2755,GO:0035630,1,0.754619499090771,0,1,bone mineralization involved in bone maturation,BP,
2756,GO:0035635,1,0.678121940697822,0,1,entry of bacterium into host cell,BP,
2757,GO:0035637,1,0.0626848614765539,0,9,multicellular organismal signaling,BP,
2760,GO:0035646,1,0.869433192415004,0,1,endosome to melanosome transport,BP,
2761,GO:0035650,1,0.869433192415004,0,1,AP-1 adaptor complex binding,MF,
2762,GO:0035651,1,0.869433192415004,0,1,AP-3 adaptor complex binding,MF,
2763,GO:0035655,1,0.592238423702372,0,2,interleukin-18-mediated signaling pathway,BP,
2764,GO:0035659,1,0.846321998934282,0,1,Wnt signaling pathway involved in wound healing, spreading of epidermal cells,BP,
2767,GO:0035710,1,0.749427895517118,0,1,CD4-positive, alpha-beta T cell activation,BP,
2768,GO:0035728,1,0.748318025747012,0,1,response to hepatocyte growth factor,BP,
2769,GO:0035729,1,0.748318025747012,0,1,cellular response to hepatocyte growth factor stimulus,BP,
2770,GO:0035747,1,0.658464044734903,0,1,natural killer cell chemotaxis,BP,
2772,GO:0035767,1,0.568202356117225,0,1,endothelial cell chemotaxis,BP,
2773,GO:0035787,1,0.769641285234326,0,1,cell migration involved in kidney development,BP,
2774,GO:0035788,1,0.769641285234326,0,1,cell migration involved in metanephros development,BP,
2775,GO:0035789,1,0.769641285234326,0,1,metanephric mesenchymal cell migration,BP,
2776,GO:0035791,1,0.769641285234326,0,1,platelet-derived growth factor receptor-beta signaling pathway,BP,
2777,GO:0035793,1,0.769641285234326,0,1,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
2778,GO:0035794,1,0.830438737450604,0,1,positive regulation of mitochondrial membrane permeability,BP,
2781,GO:0035809,1,0.575405774167621,0,2,regulation of urine volume,BP,
2782,GO:0035810,1,0.575405774167621,0,2,positive regulation of urine volume,BP,
2783,GO:0035812,1,0.443029110557772,0,3,renal sodium excretion,BP,
2784,GO:0035813,1,0.443029110557772,0,3,regulation of renal sodium excretion,BP,
2785,GO:0035814,1,0.77186369485247,0,1,negative regulation of renal sodium excretion,BP,
2786,GO:0035815,1,0.575405774167621,0,2,positive regulation of renal sodium excretion,BP,
2787,GO:0035821,1,0.822648168832337,0,1,modification of morphology or physiology of other organism,BP,
2788,GO:0035844,1,0.841205940583945,0,1,cloaca development,BP,
2790,GO:0035855,1,0.749427895517118,0,1,megakaryocyte development,BP,
2791,GO:0035859,1,0.736825336349041,0,1,Seh1-associated complex,CC,
2793,GO:0035878,1,0.646748481245743,0,1,nail development,BP,
2795,GO:0035886,1,0.436265323476629,0,2,vascular smooth muscle cell differentiation,BP,
2796,GO:0035900,1,0.889443009650413,0,1,response to isolation stress,BP,
2798,GO:0035904,1,0.284478189622873,0,4,aorta development,BP,
2799,GO:0035907,1,0.805434907231345,0,1,dorsal aorta development,BP,
2800,GO:0035909,1,0.284478189622873,0,4,aorta morphogenesis,BP,
2801,GO:0035912,1,0.805434907231345,0,1,dorsal aorta morphogenesis,BP,
2802,GO:0035914,1,0.568202356117225,0,1,skeletal muscle cell differentiation,BP,
2804,GO:0035929,1,0.756901465456182,0,1,steroid hormone secretion,BP,
2805,GO:0035930,1,0.756901465456182,0,1,corticosteroid hormone secretion,BP,
2806,GO:0035931,1,0.756901465456182,0,1,mineralocorticoid secretion,BP,
2807,GO:0035932,1,0.756901465456182,0,1,aldosterone secretion,BP,
2808,GO:0035939,1,0.805434907231345,0,1,microsatellite binding,MF,
2811,GO:0035970,1,0.790836093256502,0,1,peptidyl-threonine dephosphorylation,BP,
2814,GO:0035989,1,0.841205940583945,0,1,tendon development,BP,
2815,GO:0035990,1,0.841205940583945,0,1,tendon cell differentiation,BP,
2816,GO:0035992,1,0.841205940583945,0,1,tendon formation,BP,
2817,GO:0035993,1,0.841205940583945,0,1,deltoid tuberosity development,BP,
2818,GO:0035994,1,0.818949769337691,0,1,response to muscle stretch,BP,
2819,GO:0036003,1,0.417521948666134,0,2,positive regulation of transcription from RNA polymerase II promoter in response to stress,BP,
2828,GO:0036035,1,0.743693968038284,0,1,osteoclast development,BP,
2830,GO:0036075,1,0.494801655974952,0,3,replacement ossification,BP,
2831,GO:0036089,1,0.664021257488237,0,1,cleavage furrow formation,BP,
2832,GO:0036091,1,0.736825336349041,0,1,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
2835,GO:0036118,1,0.710907860107323,0,1,hyaluranon cable assembly,BP,
2836,GO:0036151,1,0.721084421958727,0,1,phosphatidylcholine acyl-chain remodeling,BP,
2837,GO:0036152,1,0.721084421958727,0,1,phosphatidylethanolamine acyl-chain remodeling,BP,
2838,GO:0036166,1,0.769641285234326,0,1,phenotypic switching,BP,
2841,GO:0036257,1,0.774047742304058,0,1,multivesicular body organization,BP,
2843,GO:0036294,1,0.208353549398637,0,5,cellular response to decreased oxygen levels,BP,
2845,GO:0036304,1,0.805434907231345,0,1,umbilical cord morphogenesis,BP,
2848,GO:0036342,1,0.643840742286014,0,1,post-anal tail morphogenesis,BP,
2849,GO:0036344,1,0.749427895517118,0,1,platelet morphogenesis,BP,
2851,GO:0036461,1,0.869433192415004,0,1,BLOC-2 complex binding,MF,
2852,GO:0036465,1,0.708693839368643,0,2,synaptic vesicle recycling,BP,
2853,GO:0036473,1,0.770418300420706,0,1,cell death in response to oxidative stress,BP,
2855,GO:0036490,1,0.736825336349041,0,1,regulation of translation in response to endoplasmic reticulum stress,BP,
2856,GO:0036514,1,0.643840742286014,0,1,dopaminergic neuron axon guidance,BP,
2857,GO:0036515,1,0.643840742286014,0,1,serotonergic neuron axon guidance,BP,
2858,GO:0036517,1,0.643840742286014,0,1,chemoattraction of serotonergic neuron axon,BP,
2859,GO:0036518,1,0.643840742286014,0,1,chemorepulsion of dopaminergic neuron axon,BP,
2860,GO:0038001,1,0.769641285234326,0,1,paracrine signaling,BP,
2862,GO:0038028,1,0.725317348117967,0,1,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,BP,
2863,GO:0038030,1,0.32989362907719,0,3,non-canonical Wnt signaling pathway via MAPK cascade,BP,
2864,GO:0038031,1,0.462131730838942,0,2,non-canonical Wnt signaling pathway via JNK cascade,BP,
2866,GO:0038060,1,0.748793081179247,0,1,nitric oxide-cGMP-mediated signaling pathway,BP,
2867,GO:0038061,1,0.770418300420706,0,1,NIK/NF-kappaB signaling,BP,
2868,GO:0038062,1,0.719956321112888,0,1,protein tyrosine kinase collagen receptor activity,MF,
2869,GO:0038063,1,0.719956321112888,0,1,collagen-activated tyrosine kinase receptor signaling pathway,BP,
2870,GO:0038064,1,0.719956321112888,0,1,collagen receptor activity,MF,
2871,GO:0038065,1,0.719956321112888,0,1,collagen-activated signaling pathway,BP,
2872,GO:0038066,1,0.658634903970994,0,2,p38MAPK cascade,BP,
2873,GO:0038083,1,0.719956321112888,0,1,peptidyl-tyrosine autophosphorylation,BP,
2881,GO:0038132,1,0.646748481245743,0,1,neuregulin binding,MF,
2883,GO:0038179,1,0.748318025747012,0,1,neurotrophin signaling pathway,BP,
2884,GO:0038181,1,0.682277403524016,0,1,bile acid receptor activity,MF,
2885,GO:0038183,1,0.682277403524016,0,1,bile acid signaling pathway,BP,
2886,GO:0038186,1,0.682277403524016,0,1,lithocholic acid receptor activity,MF,
2887,GO:0038201,1,0.532110414166324,0,2,TOR complex,CC,
2888,GO:0038202,1,0.736825336349041,0,1,TORC1 signaling,BP,
2889,GO:0038203,1,0.723357618254592,0,1,TORC2 signaling,BP,
2891,GO:0039706,1,0.634217622687051,0,2,co-receptor binding,MF,
2892,GO:0040001,1,0.932928362009675,0,1,establishment of mitotic spindle localization,BP,
2898,GO:0040014,1,0.449977969821551,0,3,regulation of multicellular organism growth,BP,
2900,GO:0040018,1,0.652168350167583,0,1,positive regulation of multicellular organism growth,BP,
2901,GO:0040019,1,0.253555305554823,0,5,positive regulation of embryonic development,BP,
2902,GO:0040020,1,0.328386525477303,0,3,regulation of meiotic nuclear division,BP,
2903,GO:0040029,1,0.841205940583945,0,1,regulation of gene expression, epigenetic,BP,
2905,GO:0040036,1,0.460448464623875,0,2,regulation of fibroblast growth factor receptor signaling pathway,BP,
2906,GO:0040037,1,0.460448464623875,0,2,negative regulation of fibroblast growth factor receptor signaling pathway,BP,
2907,GO:0042033,1,0.643840742286014,0,1,chemokine biosynthetic process,BP,
2908,GO:0042035,1,0.329389134088692,0,4,regulation of cytokine biosynthetic process,BP,
2909,GO:0042036,1,0.562647245187463,0,2,negative regulation of cytokine biosynthetic process,BP,
2910,GO:0042044,1,0.818949769337691,0,1,fluid transport,BP,
2911,GO:0042045,1,0.818949769337691,0,1,epithelial fluid transport,BP,
2912,GO:0042056,1,0.346516386369555,0,5,chemoattractant activity,MF,
2913,GO:0042058,1,0.2896076580286,0,5,regulation of epidermal growth factor receptor signaling pathway,BP,
2914,GO:0042059,1,0.793099124675889,0,1,negative regulation of epidermal growth factor receptor signaling pathway,BP,
2917,GO:0042074,1,0.229677780300396,0,4,cell migration involved in gastrulation,BP,
2918,GO:0042088,1,0.889443009650413,0,1,T-helper 1 type immune response,BP,
2919,GO:0042089,1,0.329389134088692,0,4,cytokine biosynthetic process,BP,
2920,GO:0042093,1,0.749427895517118,0,1,T-helper cell differentiation,BP,
2921,GO:0042095,1,0.749427895517118,0,1,interferon-gamma biosynthetic process,BP,
2922,GO:0042097,1,0.749427895517118,0,1,interleukin-4 biosynthetic process,BP,
2925,GO:0042107,1,0.329389134088692,0,4,cytokine metabolic process,BP,
2926,GO:0042108,1,0.439895665232123,0,3,positive regulation of cytokine biosynthetic process,BP,
2929,GO:0042116,1,0.643840742286014,0,1,macrophage activation,BP,
2934,GO:0042147,1,0.758709278845637,0,1,retrograde transport, endosome to Golgi,BP,
2938,GO:0042171,1,0.721084421958727,0,1,lysophosphatidic acid acyltransferase activity,MF,
2944,GO:0042222,1,0.914847263689534,0,1,interleukin-1 biosynthetic process,BP,
2945,GO:0042246,1,0.320393888007326,0,4,tissue regeneration,BP,
2946,GO:0042249,1,0.643840742286014,0,1,establishment of planar polarity of embryonic epithelium,BP,
2947,GO:0042267,1,0.774047742304058,0,1,natural killer cell mediated cytotoxicity,BP,
2949,GO:0042278,1,0.689295922426304,0,1,purine nucleoside metabolic process,BP,
2950,GO:0042297,1,0.77140024913884,0,1,vocal learning,BP,
2955,GO:0042310,1,0.332341211248634,0,5,vasoconstriction,BP,
2956,GO:0042311,1,0.77186369485247,0,1,vasodilation,BP,
2957,GO:0042313,1,0.818949769337691,0,1,protein kinase C deactivation,BP,
2958,GO:0042321,1,0.77186369485247,0,1,negative regulation of circadian sleep/wake cycle, sleep,BP,
2959,GO:0042323,1,0.77186369485247,0,1,negative regulation of circadian sleep/wake cycle, non-REM sleep,BP,
2964,GO:0042339,1,0.777493793435671,0,1,keratan sulfate metabolic process,BP,
2965,GO:0042345,1,0.710907860107323,0,1,regulation of NF-kappaB import into nucleus,BP,
2966,GO:0042347,1,0.710907860107323,0,1,negative regulation of NF-kappaB import into nucleus,BP,
2967,GO:0042348,1,0.710907860107323,0,1,NF-kappaB import into nucleus,BP,
2968,GO:0042359,1,0.682277403524016,0,1,vitamin D metabolic process,BP,
2969,GO:0042362,1,0.682277403524016,0,1,fat-soluble vitamin biosynthetic process,BP,
2970,GO:0042368,1,0.682277403524016,0,1,vitamin D biosynthetic process,BP,
2971,GO:0042379,1,0.914847263689534,0,1,chemokine receptor binding,MF,
2972,GO:0042383,1,0.6959456816156,0,1,sarcolemma,CC,
2974,GO:0042414,1,0.889123573643436,0,1,epinephrine metabolic process,BP,
2975,GO:0042417,1,0.703483707209344,0,1,dopamine metabolic process,BP,
2976,GO:0042418,1,0.889123573643436,0,1,epinephrine biosynthetic process,BP,
2977,GO:0042423,1,0.889123573643436,0,1,catecholamine biosynthetic process,BP,
2978,GO:0042438,1,0.643840742286014,0,1,melanin biosynthetic process,BP,
2979,GO:0042440,1,0.643840742286014,0,1,pigment metabolic process,BP,
2987,GO:0042474,1,0.818949769337691,0,1,middle ear morphogenesis,BP,
2990,GO:0042481,1,0.392957606110302,0,5,regulation of odontogenesis,BP,
2991,GO:0042482,1,0.522329366490872,0,3,positive regulation of odontogenesis,BP,
2992,GO:0042487,1,0.568938871840216,0,3,regulation of odontogenesis of dentin-containing tooth,BP,
2995,GO:0042492,1,0.670232484294963,0,1,gamma-delta T cell differentiation,BP,
2997,GO:0042501,1,0.716190498729619,0,1,serine phosphorylation of STAT protein,BP,
2998,GO:0042503,1,0.601074730331317,0,2,tyrosine phosphorylation of Stat3 protein,BP,
2999,GO:0042508,1,0.716190498729619,0,1,tyrosine phosphorylation of Stat1 protein,BP,
3000,GO:0042509,1,0.601074730331317,0,2,regulation of tyrosine phosphorylation of STAT protein,BP,
3001,GO:0042510,1,0.716190498729619,0,1,regulation of tyrosine phosphorylation of Stat1 protein,BP,
3002,GO:0042511,1,0.716190498729619,0,1,positive regulation of tyrosine phosphorylation of Stat1 protein,BP,
3003,GO:0042516,1,0.601074730331317,0,2,regulation of tyrosine phosphorylation of Stat3 protein,BP,
3004,GO:0042517,1,0.601074730331317,0,2,positive regulation of tyrosine phosphorylation of Stat3 protein,BP,
3005,GO:0042531,1,0.601074730331317,0,2,positive regulation of tyrosine phosphorylation of STAT protein,BP,
3008,GO:0042551,1,0.652168350167583,0,1,neuron maturation,BP,
3010,GO:0042554,1,0.818949769337691,0,1,superoxide anion generation,BP,
3014,GO:0042581,1,0.361981053710176,0,4,specific granule,CC,
3015,GO:0042582,1,0.637687377282116,0,2,azurophil granule,CC,
3016,GO:0042583,1,0.822648168832337,0,1,chromaffin granule,CC,
3017,GO:0042588,1,0.8343554877042,0,1,zymogen granule,CC,
3023,GO:0042629,1,0.540916071183739,0,2,mast cell granule,CC,
3025,GO:0042634,1,0.643840742286014,0,1,regulation of hair cycle,BP,
3026,GO:0042635,1,0.643840742286014,0,1,positive regulation of hair cycle,BP,
3027,GO:0042640,1,0.643840742286014,0,1,anagen,BP,
3028,GO:0042659,1,0.719441160584566,0,1,regulation of cell fate specification,BP,
3029,GO:0042665,1,0.719441160584566,0,1,regulation of ectodermal cell fate specification,BP,
3030,GO:0042666,1,0.719441160584566,0,1,negative regulation of ectodermal cell fate specification,BP,
3033,GO:0042695,1,0.643840742286014,0,1,thelarche,BP,
3036,GO:0042730,1,0.790961287654649,0,1,fibrinolysis,BP,
3037,GO:0042733,1,0.257737309077074,0,4,embryonic digit morphogenesis,BP,
3038,GO:0042734,1,0.77186369485247,0,1,presynaptic membrane,CC,
3039,GO:0042742,1,0.752296647626335,0,2,defense response to bacterium,BP,
3040,GO:0042745,1,0.77186369485247,0,1,circadian sleep/wake cycle,BP,
3041,GO:0042748,1,0.77186369485247,0,1,circadian sleep/wake cycle, non-REM sleep,BP,
3042,GO:0042749,1,0.77186369485247,0,1,regulation of circadian sleep/wake cycle,BP,
3043,GO:0042752,1,0.77186369485247,0,1,regulation of circadian rhythm,BP,
3044,GO:0042754,1,0.77186369485247,0,1,negative regulation of circadian rhythm,BP,
3048,GO:0042787,1,0.478493341878579,0,2,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
3051,GO:0042813,1,0.540736703248118,0,2,Wnt-activated receptor activity,MF,
3052,GO:0042832,1,0.889443009650413,0,1,defense response to protozoan,BP,
3055,GO:0042974,1,0.682277403524016,0,1,retinoic acid receptor binding,MF,
3057,GO:0042989,1,0.767524119009516,0,1,sequestering of actin monomers,BP,
3060,GO:0042992,1,0.710907860107323,0,1,negative regulation of transcription factor import into nucleus,BP,
3070,GO:0043029,1,0.639212907528369,0,2,T cell homeostasis,BP,
3071,GO:0043030,1,0.643840742286014,0,1,regulation of macrophage activation,BP,
3072,GO:0043032,1,0.643840742286014,0,1,positive regulation of macrophage activation,BP,
3074,GO:0043043,1,0.476001866222604,0,3,peptide biosynthetic process,BP,
3086,GO:0043113,1,0.6959456816156,0,1,receptor clustering,BP,
3087,GO:0043114,1,0.703483707209344,0,1,regulation of vascular permeability,BP,
3088,GO:0043122,1,0.330208792369747,0,4,regulation of I-kappaB kinase/NF-kappaB signaling,BP,
3089,GO:0043123,1,0.625672547261632,0,2,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,
3090,GO:0043124,1,0.530507442897593,0,2,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,
3095,GO:0043161,1,0.290250750546732,0,4,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,
3101,GO:0043179,1,0.818949769337691,0,1,rhythmic excitation,BP,
3102,GO:0043184,1,0.700382636394197,0,1,vascular endothelial growth factor receptor 2 binding,MF,
3103,GO:0043194,1,0.652168350167583,0,1,axon initial segment,CC,
3104,GO:0043195,1,0.599937262845393,0,2,terminal bouton,CC,
3106,GO:0043198,1,0.655874422953194,0,1,dendritic shaft,CC,
3108,GO:0043201,1,0.736825336349041,0,1,response to leucine,BP,
3110,GO:0043203,1,0.652168350167583,0,1,axon hillock,CC,
3111,GO:0043204,1,0.612770134407683,0,1,perikaryon,CC,
3114,GO:0043217,1,0.770418300420706,0,1,myelin maintenance,BP,
3115,GO:0043218,1,0.727923995035168,0,1,compact myelin,CC,
3116,GO:0043220,1,0.727923995035168,0,1,Schmidt-Lanterman incisure,CC,
3133,GO:0043255,1,0.43517923801703,0,3,regulation of carbohydrate biosynthetic process,BP,
3143,GO:0043276,1,0.162818396101154,0,5,anoikis,BP,
3145,GO:0043279,1,0.638099234099867,0,2,response to alkaloid,BP,
3153,GO:0043303,1,0.540916071183739,0,2,mast cell degranulation,BP,
3155,GO:0043316,1,0.774047742304058,0,1,cytotoxic T cell degranulation,BP,
3156,GO:0043320,1,0.774047742304058,0,1,natural killer cell degranulation,BP,
3157,GO:0043325,1,0.770418300420706,0,1,phosphatidylinositol-3,4-bisphosphate binding,MF,
3158,GO:0043330,1,0.808086260451893,0,1,response to exogenous dsRNA,BP,
3159,GO:0043331,1,0.563319800167223,0,3,response to dsRNA,BP,
3160,GO:0043367,1,0.749427895517118,0,1,CD4-positive, alpha-beta T cell differentiation,BP,
3161,GO:0043368,1,0.749427895517118,0,1,positive T cell selection,BP,
3162,GO:0043369,1,0.749427895517118,0,1,CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,BP,
3163,GO:0043373,1,0.749427895517118,0,1,CD4-positive, alpha-beta T cell lineage commitment,BP,
3164,GO:0043392,1,0.805434907231345,0,1,negative regulation of DNA binding,BP,
3165,GO:0043393,1,0.186777722391223,0,6,regulation of protein binding,BP,
3166,GO:0043401,1,0.406232692496338,0,3,steroid hormone mediated signaling pathway,BP,
3167,GO:0043403,1,0.608265281359644,0,2,skeletal muscle tissue regeneration,BP,
3170,GO:0043407,1,0.471411828720772,0,3,negative regulation of MAP kinase activity,BP,
3172,GO:0043409,1,0.257704462542462,0,5,negative regulation of MAPK cascade,BP,
3175,GO:0043413,1,0.777493793435671,0,1,macromolecule glycosylation,BP,
3176,GO:0043414,1,0.604535767348557,0,2,macromolecule methylation,BP,
3180,GO:0043455,1,0.643840742286014,0,1,regulation of secondary metabolic process,BP,
3181,GO:0043457,1,0.557665762757227,0,2,regulation of cellular respiration,BP,
3182,GO:0043462,1,0.932928362009675,0,1,regulation of ATPase activity,BP,
3183,GO:0043465,1,0.76995755234939,0,1,regulation of fermentation,BP,
3184,GO:0043467,1,0.42850666545598,0,3,regulation of generation of precursor metabolites and energy,BP,
3185,GO:0043470,1,0.76995755234939,0,1,regulation of carbohydrate catabolic process,BP,
3187,GO:0043476,1,0.869433192415004,0,1,pigment accumulation,BP,
3188,GO:0043482,1,0.869433192415004,0,1,cellular pigment accumulation,BP,
3190,GO:0043485,1,0.869433192415004,0,1,endosome to pigment granule transport,BP,
3191,GO:0043487,1,0.714942851570802,0,2,regulation of RNA stability,BP,
3192,GO:0043488,1,0.714942851570802,0,2,regulation of mRNA stability,BP,
3193,GO:0043489,1,0.928417537918174,0,1,RNA stabilization,BP,
3195,GO:0043500,1,0.62995686789774,0,2,muscle adaptation,BP,
3196,GO:0043501,1,0.76995755234939,0,1,skeletal muscle adaptation,BP,
3197,GO:0043502,1,0.62995686789774,0,2,regulation of muscle adaptation,BP,
3198,GO:0043506,1,0.207454142789548,0,5,regulation of JUN kinase activity,BP,
3199,GO:0043507,1,0.207454142789548,0,5,positive regulation of JUN kinase activity,BP,
3200,GO:0043516,1,0.830438737450604,0,1,regulation of DNA damage response, signal transduction by p53 class mediator,BP,
3201,GO:0043517,1,0.830438737450604,0,1,positive regulation of DNA damage response, signal transduction by p53 class mediator,BP,
3202,GO:0043523,1,0.319466206591295,0,6,regulation of neuron apoptotic process,BP,
3203,GO:0043524,1,0.319466206591295,0,6,negative regulation of neuron apoptotic process,BP,
3205,GO:0043532,1,0.619092994523109,0,1,angiostatin binding,MF,
3206,GO:0043534,1,0.142316844075269,0,5,blood vessel endothelial cell migration,BP,
3207,GO:0043535,1,0.33489806667257,0,3,regulation of blood vessel endothelial cell migration,BP,
3208,GO:0043536,1,0.592238423702372,0,2,positive regulation of blood vessel endothelial cell migration,BP,
3209,GO:0043537,1,0.568202356117225,0,1,negative regulation of blood vessel endothelial cell migration,BP,
3211,GO:0043543,1,0.479722359633152,0,2,protein acylation,BP,
3217,GO:0043552,1,0.769641285234326,0,1,positive regulation of phosphatidylinositol 3-kinase activity,BP,
3218,GO:0043555,1,0.736825336349041,0,1,regulation of translation in response to stress,BP,
3222,GO:0043567,1,0.754619499090771,0,1,regulation of insulin-like growth factor receptor signaling pathway,BP,
3223,GO:0043569,1,0.754619499090771,0,1,negative regulation of insulin-like growth factor receptor signaling pathway,BP,
3224,GO:0043576,1,0.77186369485247,0,1,regulation of respiratory gaseous exchange,BP,
3226,GO:0043584,1,0.57113380215551,0,2,nose development,BP,
3227,GO:0043585,1,0.77140024913884,0,1,nose morphogenesis,BP,
3230,GO:0043604,1,0.476001866222604,0,3,amide biosynthetic process,BP,
3231,GO:0043616,1,0.443095315151834,0,3,keratinocyte proliferation,BP,
3232,GO:0043618,1,0.417521948666134,0,2,regulation of transcription from RNA polymerase II promoter in response to stress,BP,
3233,GO:0043619,1,0.736825336349041,0,1,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
3234,GO:0043620,1,0.417521948666134,0,2,regulation of DNA-templated transcription in response to stress,BP,
3235,GO:0043621,1,0.534748033148175,0,1,protein self-association,MF,
3239,GO:0043632,1,0.290250750546732,0,4,modification-dependent macromolecule catabolic process,BP,
3240,GO:0043679,1,0.49652213773288,0,3,axon terminus,CC,
3242,GO:0043696,1,0.769641285234326,0,1,dedifferentiation,BP,
3243,GO:0043697,1,0.769641285234326,0,1,cell dedifferentiation,BP,
3244,GO:0043900,1,0.306112726504979,0,4,regulation of multi-organism process,BP,
3245,GO:0043901,1,0.954312251553925,0,1,negative regulation of multi-organism process,BP,
3246,GO:0043902,1,0.321247407133494,0,3,positive regulation of multi-organism process,BP,
3247,GO:0043903,1,0.568202356117225,0,1,regulation of symbiosis, encompassing mutualism through parasitism,BP,
3248,GO:0043931,1,0.754619499090771,0,1,ossification involved in bone maturation,BP,
3251,GO:0043966,1,0.716190498729619,0,1,histone H3 acetylation,BP,
3252,GO:0043974,1,0.716190498729619,0,1,histone H3-K27 acetylation,BP,
3253,GO:0044028,1,0.725317348117967,0,1,DNA hypomethylation,BP,
3254,GO:0044029,1,0.725317348117967,0,1,hypomethylation of CpG island,BP,
3255,GO:0044030,1,0.725317348117967,0,1,regulation of DNA methylation,BP,
3256,GO:0044042,1,0.770418300420706,0,1,glucan metabolic process,BP,
3258,GO:0044058,1,0.656490505490585,0,2,regulation of digestive system process,BP,
3259,GO:0044060,1,0.347895533957607,0,3,regulation of endocrine process,BP,
3260,GO:0044062,1,0.443029110557772,0,3,regulation of excretion,BP,
3261,GO:0044065,1,0.77186369485247,0,1,regulation of respiratory system process,BP,
3262,GO:0044070,1,0.39941912950337,0,4,regulation of anion transport,BP,
3265,GO:0044088,1,0.808086260451893,0,1,regulation of vacuole organization,BP,
3267,GO:0044090,1,0.808086260451893,0,1,positive regulation of vacuole organization,BP,
3268,GO:0044091,1,0.6959456816156,0,1,membrane biogenesis,BP,
3277,GO:0044242,1,0.371824539188052,0,3,cellular lipid catabolic process,BP,
3286,GO:0044262,1,0.15249137374832,0,7,cellular carbohydrate metabolic process,BP,
3287,GO:0044264,1,0.598304791236485,0,2,cellular polysaccharide metabolic process,BP,
3294,GO:0044282,1,0.17085263345896,0,6,small molecule catabolic process,BP,
3296,GO:0044291,1,0.333960381061017,0,3,cell-cell contact zone,CC,
3298,GO:0044304,1,0.502462788071968,0,2,main axon,CC,
3299,GO:0044306,1,0.391938305739861,0,4,neuron projection terminus,CC,
3301,GO:0044319,1,0.339526463862964,0,4,wound healing, spreading of cells,BP,
3302,GO:0044320,1,0.751822927145045,0,1,cellular response to leptin stimulus,BP,
3303,GO:0044321,1,0.615073354070267,0,2,response to leptin,BP,
3305,GO:0044331,1,0.446947225260861,0,2,cell-cell adhesion mediated by cadherin,BP,
3306,GO:0044338,1,0.862545484850912,0,1,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,BP,
3307,GO:0044339,1,0.862545484850912,0,1,canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
3308,GO:0044340,1,0.862545484850912,0,1,canonical Wnt signaling pathway involved in regulation of cell proliferation,BP,
3311,GO:0044364,1,0.822648168832337,0,1,disruption of cells of other organism,BP,
3314,GO:0044390,1,0.646779409103276,0,1,ubiquitin-like protein conjugating enzyme binding,MF,
3337,GO:0044445,1,0.525873339386502,0,2,cytosolic part,CC,
3343,GO:0044454,1,0.66650505420776,0,1,nuclear chromosome part,CC,
3348,GO:0044550,1,0.643840742286014,0,1,secondary metabolite biosynthetic process,BP,
3349,GO:0044557,1,0.77186369485247,0,1,relaxation of smooth muscle,BP,
3361,GO:0044723,1,0.0833857292269801,0,9,single-organism carbohydrate metabolic process,BP,
3362,GO:0044724,1,0.425257171386855,0,3,single-organism carbohydrate catabolic process,BP,
3363,GO:0044728,1,0.725317348117967,0,1,DNA methylation or demethylation,BP,
3366,GO:0044752,1,0.803527095561903,0,1,response to human chorionic gonadotropin,BP,
3370,GO:0044766,1,0.565153934981435,0,2,multi-organism transport,BP,
3378,GO:0044798,1,0.682277403524016,0,1,nuclear transcription factor complex,CC,
3387,GO:0044848,1,0.643840742286014,0,1,biological phase,BP,
3388,GO:0044851,1,0.643840742286014,0,1,hair cycle phase,BP,
3389,GO:0044853,1,0.470872585134369,0,2,plasma membrane raft,CC,
3392,GO:0045009,1,0.672509525495492,0,2,chitosome,CC,
3393,GO:0045010,1,0.767524119009516,0,1,actin nucleation,BP,
3398,GO:0045054,1,0.774047742304058,0,1,constitutive secretory pathway,BP,
3400,GO:0045056,1,0.831112644014506,0,1,transcytosis,BP,
3401,GO:0045058,1,0.501339993459599,0,2,T cell selection,BP,
3402,GO:0045061,1,0.670232484294963,0,1,thymic T cell selection,BP,
3403,GO:0045069,1,0.568202356117225,0,1,regulation of viral genome replication,BP,
3404,GO:0045070,1,0.568202356117225,0,1,positive regulation of viral genome replication,BP,
3405,GO:0045072,1,0.749427895517118,0,1,regulation of interferon-gamma biosynthetic process,BP,
3406,GO:0045073,1,0.643840742286014,0,1,regulation of chemokine biosynthetic process,BP,
3407,GO:0045078,1,0.749427895517118,0,1,positive regulation of interferon-gamma biosynthetic process,BP,
3408,GO:0045080,1,0.643840742286014,0,1,positive regulation of chemokine biosynthetic process,BP,
3412,GO:0045103,1,0.657097306241214,0,1,intermediate filament-based process,BP,
3413,GO:0045104,1,0.657097306241214,0,1,intermediate filament cytoskeleton organization,BP,
3414,GO:0045109,1,0.657097306241214,0,1,intermediate filament organization,BP,
3415,GO:0045110,1,0.657097306241214,0,1,intermediate filament bundle assembly,BP,
3416,GO:0045111,1,0.657097306241214,0,1,intermediate filament cytoskeleton,CC,
3417,GO:0045117,1,0.818949769337691,0,1,azole transport,BP,
3419,GO:0045123,1,0.658464044734903,0,1,cellular extravasation,BP,
3420,GO:0045124,1,0.743693968038284,0,1,regulation of bone resorption,BP,
3421,GO:0045125,1,0.840697515380158,0,1,bioactive lipid receptor activity,MF,
3422,GO:0045136,1,0.643840742286014,0,1,development of secondary sexual characteristics,BP,
3424,GO:0045161,1,0.652168350167583,0,1,neuronal ion channel clustering,BP,
3425,GO:0045162,1,0.652168350167583,0,1,clustering of voltage-gated sodium channels,BP,
3432,GO:0045185,1,0.383738623548183,0,3,maintenance of protein location,BP,
3433,GO:0045187,1,0.77186369485247,0,1,regulation of circadian sleep/wake cycle, sleep,BP,
3434,GO:0045188,1,0.77186369485247,0,1,regulation of circadian sleep/wake cycle, non-REM sleep,BP,
3435,GO:0045190,1,0.84015341765014,0,1,isotype switching,BP,
3436,GO:0045191,1,0.84015341765014,0,1,regulation of isotype switching,BP,
3439,GO:0045199,1,0.649653750422083,0,1,maintenance of epithelial cell apical/basal polarity,BP,
3442,GO:0045211,1,0.210536448091032,0,4,postsynaptic membrane,CC,
3447,GO:0045294,1,0.537302107440689,0,2,alpha-catenin binding,MF,
3448,GO:0045295,1,0.470872585134369,0,2,gamma-catenin binding,MF,
3452,GO:0045333,1,0.557665762757227,0,2,cellular respiration,BP,
3453,GO:0045334,1,0.515188226864952,0,2,clathrin-coated endocytic vesicle,CC,
3455,GO:0045360,1,0.914847263689534,0,1,regulation of interleukin-1 biosynthetic process,BP,
3456,GO:0045362,1,0.914847263689534,0,1,positive regulation of interleukin-1 biosynthetic process,BP,
3457,GO:0045402,1,0.749427895517118,0,1,regulation of interleukin-4 biosynthetic process,BP,
3458,GO:0045403,1,0.749427895517118,0,1,negative regulation of interleukin-4 biosynthetic process,BP,
3459,GO:0045428,1,0.630335029060165,0,2,regulation of nitric oxide biosynthetic process,BP,
3460,GO:0045429,1,0.630335029060165,0,2,positive regulation of nitric oxide biosynthetic process,BP,
3461,GO:0045444,1,0.114362225845229,0,8,fat cell differentiation,BP,
3464,GO:0045453,1,0.619897600463604,0,2,bone resorption,BP,
3466,GO:0045494,1,0.713669696483845,0,1,photoreceptor cell maintenance,BP,
3467,GO:0045505,1,0.534748033148175,0,1,dynein intermediate chain binding,MF,
3468,GO:0045576,1,0.540916071183739,0,2,mast cell activation,BP,
3469,GO:0045580,1,0.841205940583945,0,1,regulation of T cell differentiation,BP,
3470,GO:0045581,1,0.841205940583945,0,1,negative regulation of T cell differentiation,BP,
3474,GO:0045598,1,0.165083962147193,0,6,regulation of fat cell differentiation,BP,
3475,GO:0045599,1,0.355694753816916,0,3,negative regulation of fat cell differentiation,BP,
3476,GO:0045600,1,0.470377294101264,0,3,positive regulation of fat cell differentiation,BP,
3477,GO:0045601,1,0.296041894741294,0,4,regulation of endothelial cell differentiation,BP,
3478,GO:0045603,1,0.296041894741294,0,4,positive regulation of endothelial cell differentiation,BP,
3481,GO:0045606,1,0.324080681742483,0,3,positive regulation of epidermal cell differentiation,BP,
3484,GO:0045616,1,0.386380329051779,0,2,regulation of keratinocyte differentiation,BP,
3485,GO:0045618,1,0.386380329051779,0,2,positive regulation of keratinocyte differentiation,BP,
3487,GO:0045620,1,0.841205940583945,0,1,negative regulation of lymphocyte differentiation,BP,
3496,GO:0045646,1,0.749427895517118,0,1,regulation of erythrocyte differentiation,BP,
3497,GO:0045649,1,0.716190498729619,0,1,regulation of macrophage differentiation,BP,
3498,GO:0045651,1,0.716190498729619,0,1,positive regulation of macrophage differentiation,BP,
3499,GO:0045652,1,0.767524119009516,0,1,regulation of megakaryocyte differentiation,BP,
3500,GO:0045654,1,0.767524119009516,0,1,positive regulation of megakaryocyte differentiation,BP,
3506,GO:0045667,1,0.0690772290753404,0,9,regulation of osteoblast differentiation,BP,
3507,GO:0045668,1,0.568202356117225,0,1,negative regulation of osteoblast differentiation,BP,
3513,GO:0045684,1,0.207019746849941,0,4,positive regulation of epidermis development,BP,
3514,GO:0045685,1,0.255218833644805,0,4,regulation of glial cell differentiation,BP,
3515,GO:0045686,1,0.568202356117225,0,1,negative regulation of glial cell differentiation,BP,
3516,GO:0045687,1,0.255218833644805,0,4,positive regulation of glial cell differentiation,BP,
3517,GO:0045725,1,0.770418300420706,0,1,positive regulation of glycogen biosynthetic process,BP,
3518,GO:0045730,1,0.658464044734903,0,1,respiratory burst,BP,
3521,GO:0045737,1,0.465056989088183,0,4,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
3522,GO:0045739,1,0.932928362009675,0,1,positive regulation of DNA repair,BP,
3524,GO:0045741,1,0.477596608747123,0,3,positive regulation of epidermal growth factor-activated receptor activity,BP,
3525,GO:0045742,1,0.366694322915482,0,4,positive regulation of epidermal growth factor receptor signaling pathway,BP,
3527,GO:0045745,1,0.822648168832337,0,1,positive regulation of G-protein coupled receptor protein signaling pathway,BP,
3528,GO:0045746,1,0.57185423250348,0,2,negative regulation of Notch signaling pathway,BP,
3532,GO:0045776,1,0.6039375022917,0,2,negative regulation of blood pressure,BP,
3533,GO:0045777,1,0.77186369485247,0,1,positive regulation of blood pressure,BP,
3534,GO:0045778,1,0.0785863848243567,0,9,positive regulation of ossification,BP,
3535,GO:0045779,1,0.743693968038284,0,1,negative regulation of bone resorption,BP,
3539,GO:0045792,1,0.770418300420706,0,1,negative regulation of cell size,BP,
3540,GO:0045793,1,0.818949769337691,0,1,positive regulation of cell size,BP,
3543,GO:0045820,1,0.76995755234939,0,1,negative regulation of glycolytic process,BP,
3544,GO:0045822,1,0.329330268302916,0,3,negative regulation of heart contraction,BP,
3546,GO:0045824,1,0.714080197774154,0,1,negative regulation of innate immune response,BP,
3547,GO:0045830,1,0.84015341765014,0,1,positive regulation of isotype switching,BP,
3549,GO:0045834,1,0.233699424247624,0,5,positive regulation of lipid metabolic process,BP,
3550,GO:0045835,1,0.716190498729619,0,1,negative regulation of meiotic nuclear division,BP,
3551,GO:0045836,1,0.460448464623875,0,2,positive regulation of meiotic nuclear division,BP,
3552,GO:0045837,1,0.830438737450604,0,1,negative regulation of membrane potential,BP,
3553,GO:0045839,1,0.597379799532382,0,2,negative regulation of mitotic nuclear division,BP,
3554,GO:0045840,1,0.564875728352272,0,3,positive regulation of mitotic nuclear division,BP,
3555,GO:0045843,1,0.407951451636496,0,4,negative regulation of striated muscle tissue development,BP,
3557,GO:0045851,1,0.572101934452145,0,3,pH reduction,BP,
3565,GO:0045907,1,0.638173958163248,0,2,positive regulation of vasoconstriction,BP,
3566,GO:0045911,1,0.84015341765014,0,1,positive regulation of DNA recombination,BP,
3567,GO:0045912,1,0.76995755234939,0,1,negative regulation of carbohydrate metabolic process,BP,
3568,GO:0045913,1,0.3767466147158,0,4,positive regulation of carbohydrate metabolic process,BP,
3569,GO:0045920,1,0.568202356117225,0,1,negative regulation of exocytosis,BP,
3571,GO:0045922,1,0.770418300420706,0,1,negative regulation of fatty acid metabolic process,BP,
3575,GO:0045931,1,0.526460079884074,0,4,positive regulation of mitotic cell cycle,BP,
3576,GO:0045932,1,0.419667930166078,0,3,negative regulation of muscle contraction,BP,
3583,GO:0045940,1,0.541729739342896,0,2,positive regulation of steroid metabolic process,BP,
3585,GO:0045955,1,0.568202356117225,0,1,negative regulation of calcium ion-dependent exocytosis,BP,
3586,GO:0045980,1,0.62995686789774,0,2,negative regulation of nucleotide metabolic process,BP,
3587,GO:0045981,1,0.270706974496181,0,5,positive regulation of nucleotide metabolic process,BP,
3588,GO:0045986,1,0.639374843713865,0,2,negative regulation of smooth muscle contraction,BP,
3589,GO:0045987,1,0.818949769337691,0,1,positive regulation of smooth muscle contraction,BP,
3590,GO:0045988,1,0.507332380321055,0,2,negative regulation of striated muscle contraction,BP,
3594,GO:0046031,1,0.534480969901098,0,2,ADP metabolic process,BP,
3595,GO:0046034,1,0.534480969901098,0,2,ATP metabolic process,BP,
3596,GO:0046039,1,0.689295922426304,0,1,GTP metabolic process,BP,
3598,GO:0046068,1,0.321180032193038,0,4,cGMP metabolic process,BP,
3599,GO:0046128,1,0.689295922426304,0,1,purine ribonucleoside metabolic process,BP,
3600,GO:0046148,1,0.643840742286014,0,1,pigment biosynthetic process,BP,
3603,GO:0046189,1,0.571877634302923,0,2,phenol-containing compound biosynthetic process,BP,
3604,GO:0046209,1,0.630335029060165,0,2,nitric oxide metabolic process,BP,
3605,GO:0046320,1,0.770418300420706,0,1,regulation of fatty acid oxidation,BP,
3606,GO:0046322,1,0.770418300420706,0,1,negative regulation of fatty acid oxidation,BP,
3611,GO:0046329,1,0.770418300420706,0,1,negative regulation of JNK cascade,BP,
3614,GO:0046332,1,0.426210019643125,0,3,SMAD binding,MF,
3615,GO:0046364,1,0.736825336349041,0,1,monosaccharide biosynthetic process,BP,
3616,GO:0046365,1,0.425257171386855,0,3,monosaccharide catabolic process,BP,
3617,GO:0046390,1,0.409583288428975,0,4,ribose phosphate biosynthetic process,BP,
3619,GO:0046395,1,0.407096640539412,0,3,carboxylic acid catabolic process,BP,
3620,GO:0046425,1,0.339934202538491,0,3,regulation of JAK-STAT cascade,BP,
3621,GO:0046427,1,0.339934202538491,0,3,positive regulation of JAK-STAT cascade,BP,
3625,GO:0046461,1,0.658464044734903,0,1,neutral lipid catabolic process,BP,
3626,GO:0046464,1,0.658464044734903,0,1,acylglycerol catabolic process,BP,
3627,GO:0046470,1,0.721084421958727,0,1,phosphatidylcholine metabolic process,BP,
3631,GO:0046487,1,0.7203786970807,0,1,glyoxylate metabolic process,BP,
3633,GO:0046496,1,0.534480969901098,0,2,nicotinamide nucleotide metabolic process,BP,
3634,GO:0046503,1,0.658464044734903,0,1,glycerolipid catabolic process,BP,
3636,GO:0046532,1,0.568202356117225,0,1,regulation of photoreceptor cell differentiation,BP,
3637,GO:0046533,1,0.568202356117225,0,1,negative regulation of photoreceptor cell differentiation,BP,
3638,GO:0046541,1,0.932928362009675,0,1,saliva secretion,BP,
3639,GO:0046543,1,0.643840742286014,0,1,development of secondary female sexual characteristics,BP,
3645,GO:0046605,1,0.758709278845637,0,1,regulation of centrosome cycle,BP,
3649,GO:0046629,1,0.670232484294963,0,1,gamma-delta T cell activation,BP,
3650,GO:0046631,1,0.749427895517118,0,1,alpha-beta T cell activation,BP,
3651,GO:0046632,1,0.749427895517118,0,1,alpha-beta T cell differentiation,BP,
3656,GO:0046676,1,0.751822927145045,0,1,negative regulation of insulin secretion,BP,
3657,GO:0046677,1,0.803527095561903,0,1,response to antibiotic,BP,
3660,GO:0046686,1,0.770418300420706,0,1,response to cadmium ion,BP,
3661,GO:0046697,1,0.390758741550345,0,3,decidualization,BP,
3663,GO:0046717,1,0.631521347969442,0,2,acid secretion,BP,
3665,GO:0046777,1,0.244502321447777,0,5,protein autophosphorylation,BP,
3666,GO:0046785,1,0.707212894969842,0,2,microtubule polymerization,BP,
3667,GO:0046789,1,0.751822927145045,0,1,host cell surface receptor binding,MF,
3668,GO:0046794,1,0.671264126002153,0,1,transport of virus,BP,
3669,GO:0046812,1,0.751822927145045,0,1,host cell surface binding,MF,
3677,GO:0046835,1,0.553786164805125,0,2,carbohydrate phosphorylation,BP,
3679,GO:0046849,1,0.619897600463604,0,2,bone remodeling,BP,
3680,GO:0046850,1,0.743693968038284,0,1,regulation of bone remodeling,BP,
3681,GO:0046851,1,0.743693968038284,0,1,negative regulation of bone remodeling,BP,
3685,GO:0046875,1,0.45884742163466,0,2,ephrin receptor binding,MF,
3686,GO:0046877,1,0.932928362009675,0,1,regulation of saliva secretion,BP,
3687,GO:0046879,1,0.0816411531629529,0,9,hormone secretion,BP,
3688,GO:0046880,1,0.751822927145045,0,1,regulation of follicle-stimulating hormone secretion,BP,
3689,GO:0046881,1,0.751822927145045,0,1,positive regulation of follicle-stimulating hormone secretion,BP,
3690,GO:0046882,1,0.751822927145045,0,1,negative regulation of follicle-stimulating hormone secretion,BP,
3691,GO:0046883,1,0.0816411531629529,0,9,regulation of hormone secretion,BP,
3692,GO:0046884,1,0.751822927145045,0,1,follicle-stimulating hormone secretion,BP,
3694,GO:0046886,1,0.541729739342896,0,2,positive regulation of hormone biosynthetic process,BP,
3695,GO:0046887,1,0.464444818214211,0,3,positive regulation of hormone secretion,BP,
3696,GO:0046888,1,0.126024084516425,0,7,negative regulation of hormone secretion,BP,
3697,GO:0046889,1,0.41621387093912,0,3,positive regulation of lipid biosynthetic process,BP,
3699,GO:0046902,1,0.830438737450604,0,1,regulation of mitochondrial membrane permeability,BP,
3701,GO:0046906,1,0.54458779056803,0,2,tetrapyrrole binding,MF,
3705,GO:0046915,1,0.637913294653459,0,2,transition metal ion transmembrane transporter activity,MF,
3709,GO:0046939,1,0.534480969901098,0,2,nucleotide phosphorylation,BP,
3714,GO:0046965,1,0.682277403524016,0,1,retinoid X receptor binding,MF,
3717,GO:0047144,1,0.721084421958727,0,1,2-acylglycerol-3-phosphate O-acyltransferase activity,MF,
3721,GO:0048008,1,0.575183405286932,0,2,platelet-derived growth factor receptor signaling pathway,BP,
3724,GO:0048011,1,0.748318025747012,0,1,neurotrophin TRK receptor signaling pathway,BP,
3725,GO:0048012,1,0.748318025747012,0,1,hepatocyte growth factor receptor signaling pathway,BP,
3726,GO:0048013,1,0.620768680884736,0,2,ephrin receptor signaling pathway,BP,
3728,GO:0048016,1,0.62995686789774,0,2,inositol phosphate-mediated signaling,BP,
3731,GO:0048020,1,0.914847263689534,0,1,CCR chemokine receptor binding,MF,
3732,GO:0048021,1,0.643840742286014,0,1,regulation of melanin biosynthetic process,BP,
3733,GO:0048022,1,0.643840742286014,0,1,negative regulation of melanin biosynthetic process,BP,
3734,GO:0048037,1,0.7203786970807,0,1,cofactor binding,MF,
3736,GO:0048048,1,0.258893523366879,0,4,embryonic eye morphogenesis,BP,
3740,GO:0048103,1,0.344032783263555,0,3,somatic stem cell division,BP,
3744,GO:0048167,1,0.448744500196019,0,3,regulation of synaptic plasticity,BP,
3745,GO:0048168,1,0.889443009650413,0,1,regulation of neuronal synaptic plasticity,BP,
3746,GO:0048169,1,0.889443009650413,0,1,regulation of long-term neuronal synaptic plasticity,BP,
3747,GO:0048175,1,0.751822927145045,0,1,hepatocyte growth factor biosynthetic process,BP,
3748,GO:0048176,1,0.751822927145045,0,1,regulation of hepatocyte growth factor biosynthetic process,BP,
3749,GO:0048178,1,0.751822927145045,0,1,negative regulation of hepatocyte growth factor biosynthetic process,BP,
3750,GO:0048179,1,0.764973380564597,0,1,activin receptor complex,CC,
3751,GO:0048185,1,0.604969338042843,0,2,activin binding,MF,
3754,GO:0048237,1,0.818949769337691,0,1,rough endoplasmic reticulum lumen,CC,
3755,GO:0048241,1,0.620119989668987,0,2,epinephrine transport,BP,
3756,GO:0048242,1,0.620119989668987,0,2,epinephrine secretion,BP,
3757,GO:0048243,1,0.620119989668987,0,2,norepinephrine secretion,BP,
3759,GO:0048251,1,0.613902340139758,0,1,elastic fiber assembly,BP,
3760,GO:0048255,1,0.928417537918174,0,1,mRNA stabilization,BP,
3762,GO:0048260,1,0.774076993520791,0,1,positive regulation of receptor-mediated endocytosis,BP,
3764,GO:0048262,1,0.764973380564597,0,1,determination of dorsal/ventral asymmetry,BP,
3765,GO:0048263,1,0.764973380564597,0,1,determination of dorsal identity,BP,
3766,GO:0048278,1,0.594506410650235,0,3,vesicle docking,BP,
3767,GO:0048284,1,0.427737119754818,0,4,organelle fusion,BP,
3769,GO:0048286,1,0.43154665459612,0,4,lung alveolus development,BP,
3770,GO:0048289,1,0.84015341765014,0,1,isotype switching to IgE isotypes,BP,
3771,GO:0048293,1,0.84015341765014,0,1,regulation of isotype switching to IgE isotypes,BP,
3772,GO:0048295,1,0.84015341765014,0,1,positive regulation of isotype switching to IgE isotypes,BP,
3773,GO:0048306,1,0.779877946733024,0,1,calcium-dependent protein binding,MF,
3774,GO:0048318,1,0.741374927768024,0,1,axial mesoderm development,BP,
3775,GO:0048319,1,0.741374927768024,0,1,axial mesoderm morphogenesis,BP,
3776,GO:0048320,1,0.741374927768024,0,1,axial mesoderm formation,BP,
3779,GO:0048339,1,0.643840742286014,0,1,paraxial mesoderm development,BP,
3780,GO:0048340,1,0.643840742286014,0,1,paraxial mesoderm morphogenesis,BP,
3781,GO:0048341,1,0.643840742286014,0,1,paraxial mesoderm formation,BP,
3782,GO:0048382,1,0.89801195405569,0,1,mesendoderm development,BP,
3783,GO:0048389,1,0.841205940583945,0,1,intermediate mesoderm development,BP,
3784,GO:0048390,1,0.841205940583945,0,1,intermediate mesoderm morphogenesis,BP,
3785,GO:0048391,1,0.841205940583945,0,1,intermediate mesoderm formation,BP,
3786,GO:0048392,1,0.841205940583945,0,1,intermediate mesodermal cell differentiation,BP,
3787,GO:0048407,1,0.769641285234326,0,1,platelet-derived growth factor binding,MF,
3791,GO:0048477,1,0.513071573625451,0,3,oogenesis,BP,
3792,GO:0048483,1,0.928417537918174,0,1,autonomic nervous system development,BP,
3793,GO:0048484,1,0.928417537918174,0,1,enteric nervous system development,BP,
3794,GO:0048485,1,0.928417537918174,0,1,sympathetic nervous system development,BP,
3795,GO:0048486,1,0.928417537918174,0,1,parasympathetic nervous system development,BP,
3796,GO:0048488,1,0.837875488244045,0,1,synaptic vesicle endocytosis,BP,
3797,GO:0048489,1,0.547652772809584,0,3,synaptic vesicle transport,BP,
3800,GO:0048512,1,0.77186369485247,0,1,circadian behavior,BP,
3806,GO:0048520,1,0.77140024913884,0,1,positive regulation of behavior,BP,
3807,GO:0048521,1,0.77186369485247,0,1,negative regulation of behavior,BP,
3810,GO:0048524,1,0.568202356117225,0,1,positive regulation of viral process,BP,
3811,GO:0048531,1,0.777493793435671,0,1,beta-1,3-galactosyltransferase activity,MF,
3814,GO:0048536,1,0.932928362009675,0,1,spleen development,BP,
3815,GO:0048537,1,0.840479796371432,0,1,mucosal-associated lymphoid tissue development,BP,
3816,GO:0048538,1,0.932928362009675,0,1,thymus development,BP,
3817,GO:0048541,1,0.840479796371432,0,1,Peyer's patch development,BP,
3819,GO:0048546,1,0.218295631006029,0,5,digestive tract morphogenesis,BP,
3820,GO:0048557,1,0.932928362009675,0,1,embryonic digestive tract morphogenesis,BP,
3824,GO:0048566,1,0.719347208647805,0,2,embryonic digestive tract development,BP,
3827,GO:0048570,1,0.417039271313051,0,2,notochord morphogenesis,BP,
3831,GO:0048588,1,0.32490701159831,0,4,developmental cell growth,BP,
3835,GO:0048596,1,0.351035763466342,0,3,embryonic camera-type eye morphogenesis,BP,
3837,GO:0048599,1,0.513071573625451,0,3,oocyte development,BP,
3844,GO:0048635,1,0.407951451636496,0,4,negative regulation of muscle organ development,BP,
3848,GO:0048640,1,0.465719953788084,0,3,negative regulation of developmental growth,BP,
3851,GO:0048644,1,0.11053183901512,0,6,muscle organ morphogenesis,BP,
3854,GO:0048659,1,0.215853358822515,0,7,smooth muscle cell proliferation,BP,
3855,GO:0048660,1,0.215853358822515,0,7,regulation of smooth muscle cell proliferation,BP,
3856,GO:0048661,1,0.324411552632694,0,5,positive regulation of smooth muscle cell proliferation,BP,
3857,GO:0048662,1,0.703483707209344,0,1,negative regulation of smooth muscle cell proliferation,BP,
3862,GO:0048668,1,0.862545484850912,0,1,collateral sprouting,BP,
3863,GO:0048669,1,0.862545484850912,0,1,collateral sprouting in absence of injury,BP,
3864,GO:0048670,1,0.862545484850912,0,1,regulation of collateral sprouting,BP,
3865,GO:0048672,1,0.862545484850912,0,1,positive regulation of collateral sprouting,BP,
3866,GO:0048675,1,0.554678513309543,0,2,axon extension,BP,
3867,GO:0048678,1,0.727923995035168,0,1,response to axon injury,BP,
3868,GO:0048696,1,0.862545484850912,0,1,regulation of collateral sprouting in absence of injury,BP,
3869,GO:0048697,1,0.862545484850912,0,1,positive regulation of collateral sprouting in absence of injury,BP,
3871,GO:0048701,1,0.841205940583945,0,1,embryonic cranial skeleton morphogenesis,BP,
3872,GO:0048704,1,0.441705951012269,0,3,embryonic skeletal system morphogenesis,BP,
3874,GO:0048706,1,0.282706217094085,0,4,embryonic skeletal system development,BP,
3876,GO:0048709,1,0.425690760311313,0,2,oligodendrocyte differentiation,BP,
3877,GO:0048710,1,0.255218833644805,0,4,regulation of astrocyte differentiation,BP,
3878,GO:0048711,1,0.255218833644805,0,4,positive regulation of astrocyte differentiation,BP,
3879,GO:0048713,1,0.568202356117225,0,1,regulation of oligodendrocyte differentiation,BP,
3880,GO:0048715,1,0.568202356117225,0,1,negative regulation of oligodendrocyte differentiation,BP,
3882,GO:0048730,1,0.529616015255688,0,2,epidermis morphogenesis,BP,
3885,GO:0048736,1,0.0826879963119446,0,9,appendage development,BP,
3887,GO:0048739,1,0.515651971727448,0,2,cardiac muscle fiber development,BP,
3888,GO:0048745,1,0.648361139861816,0,2,smooth muscle tissue development,BP,
3889,GO:0048747,1,0.515651971727448,0,2,muscle fiber development,BP,
3890,GO:0048752,1,0.932928362009675,0,1,semicircular canal morphogenesis,BP,
3891,GO:0048753,1,0.869433192415004,0,1,pigment granule organization,BP,
3893,GO:0048757,1,0.869433192415004,0,1,pigment granule maturation,BP,
3896,GO:0048771,1,0.250519345570843,0,6,tissue remodeling,BP,
3897,GO:0048786,1,0.77186369485247,0,1,presynaptic active zone,CC,
3898,GO:0048791,1,0.837875488244045,0,1,calcium ion-regulated exocytosis of neurotransmitter,BP,
3899,GO:0048799,1,0.754619499090771,0,1,animal organ maturation,BP,
3901,GO:0048807,1,0.932928362009675,0,1,female genitalia morphogenesis,BP,
3902,GO:0048808,1,0.932928362009675,0,1,male genitalia morphogenesis,BP,
3904,GO:0048813,1,0.554380805983401,0,2,dendrite morphogenesis,BP,
3905,GO:0048814,1,0.655874422953194,0,1,regulation of dendrite morphogenesis,BP,
3906,GO:0048818,1,0.643840742286014,0,1,positive regulation of hair follicle maturation,BP,
3907,GO:0048819,1,0.643840742286014,0,1,regulation of hair follicle maturation,BP,
3908,GO:0048820,1,0.643840742286014,0,1,hair follicle maturation,BP,
3910,GO:0048841,1,0.554678513309543,0,2,regulation of axon extension involved in axon guidance,BP,
3911,GO:0048843,1,0.554678513309543,0,2,negative regulation of axon extension involved in axon guidance,BP,
3912,GO:0048844,1,0.182667219834333,0,6,artery morphogenesis,BP,
3913,GO:0048845,1,0.395646254351599,0,2,venous blood vessel morphogenesis,BP,
3914,GO:0048846,1,0.554678513309543,0,2,axon extension involved in axon guidance,BP,
3915,GO:0048850,1,0.643840742286014,0,1,hypophysis morphogenesis,BP,
3916,GO:0048852,1,0.643840742286014,0,1,diencephalon morphogenesis,BP,
3917,GO:0048853,1,0.577630157458715,0,2,forebrain morphogenesis,BP,
3918,GO:0048854,1,0.400663043466411,0,3,brain morphogenesis,BP,
3921,GO:0048861,1,0.716190498729619,0,1,leukemia inhibitory factor signaling pathway,BP,
3929,GO:0050000,1,0.84412233261981,0,1,chromosome localization,BP,
3931,GO:0050308,1,0.695278396814058,0,1,sugar-phosphatase activity,MF,
3933,GO:0050431,1,0.764973380564597,0,1,transforming growth factor beta binding,MF,
3934,GO:0050432,1,0.472230757341737,0,4,catecholamine secretion,BP,
3935,GO:0050433,1,0.472230757341737,0,4,regulation of catecholamine secretion,BP,
3940,GO:0050673,1,0.0136907451005369,0,15,epithelial cell proliferation,BP,
3941,GO:0050674,1,0.932928362009675,0,1,urothelial cell proliferation,BP,
3942,GO:0050675,1,0.932928362009675,0,1,regulation of urothelial cell proliferation,BP,
3943,GO:0050677,1,0.932928362009675,0,1,positive regulation of urothelial cell proliferation,BP,
3944,GO:0050678,1,0.0136907451005369,0,15,regulation of epithelial cell proliferation,BP,
3945,GO:0050679,1,0.0373122401954533,0,12,positive regulation of epithelial cell proliferation,BP,
3946,GO:0050680,1,0.207584771976841,0,5,negative regulation of epithelial cell proliferation,BP,
3948,GO:0050702,1,0.643840742286014,0,1,interleukin-1 beta secretion,BP,
3950,GO:0050706,1,0.643840742286014,0,1,regulation of interleukin-1 beta secretion,BP,
3956,GO:0050714,1,0.486347575160135,0,2,positive regulation of protein secretion,BP,
3957,GO:0050715,1,0.643840742286014,0,1,positive regulation of cytokine secretion,BP,
3958,GO:0050716,1,0.643840742286014,0,1,positive regulation of interleukin-1 secretion,BP,
3959,GO:0050718,1,0.643840742286014,0,1,positive regulation of interleukin-1 beta secretion,BP,
3960,GO:0050719,1,0.914847263689534,0,1,interleukin-1 alpha biosynthetic process,BP,
3961,GO:0050721,1,0.914847263689534,0,1,regulation of interleukin-1 alpha biosynthetic process,BP,
3962,GO:0050726,1,0.914847263689534,0,1,positive regulation of interleukin-1 alpha biosynthetic process,BP,
3963,GO:0050727,1,0.230707004402601,0,4,regulation of inflammatory response,BP,
3964,GO:0050728,1,0.550357978712742,0,2,negative regulation of inflammatory response,BP,
3965,GO:0050729,1,0.422730383114238,0,2,positive regulation of inflammatory response,BP,
3968,GO:0050755,1,0.643840742286014,0,1,chemokine metabolic process,BP,
3974,GO:0050770,1,0.468577171226564,0,3,regulation of axonogenesis,BP,
3975,GO:0050771,1,0.554678513309543,0,2,negative regulation of axonogenesis,BP,
3976,GO:0050772,1,0.862545484850912,0,1,positive regulation of axonogenesis,BP,
3977,GO:0050773,1,0.385656638330527,0,3,regulation of dendrite development,BP,
3979,GO:0050777,1,0.714080197774154,0,1,negative regulation of immune response,BP,
3983,GO:0050792,1,0.568202356117225,0,1,regulation of viral process,BP,
3986,GO:0050795,1,0.594715291371727,0,2,regulation of behavior,BP,
3987,GO:0050796,1,0.541138924887088,0,3,regulation of insulin secretion,BP,
3989,GO:0050802,1,0.77186369485247,0,1,circadian sleep/wake cycle, sleep,BP,
3990,GO:0050803,1,0.312592481794041,0,4,regulation of synapse structure or activity,BP,
3991,GO:0050804,1,0.286388452135143,0,6,modulation of synaptic transmission,BP,
3992,GO:0050805,1,0.77186369485247,0,1,negative regulation of synaptic transmission,BP,
3993,GO:0050806,1,0.652712794292049,0,2,positive regulation of synaptic transmission,BP,
3994,GO:0050807,1,0.312592481794041,0,4,regulation of synapse organization,BP,
3998,GO:0050818,1,0.497088421933865,0,3,regulation of coagulation,BP,
3999,GO:0050819,1,0.497088421933865,0,3,negative regulation of coagulation,BP,
4001,GO:0050829,1,0.822648168832337,0,1,defense response to Gram-negative bacterium,BP,
4002,GO:0050830,1,0.822648168832337,0,1,defense response to Gram-positive bacterium,BP,
4003,GO:0050832,1,0.822648168832337,0,1,defense response to fungus,BP,
4006,GO:0050848,1,0.599786417413167,0,2,regulation of calcium-mediated signaling,BP,
4007,GO:0050849,1,0.599786417413167,0,2,negative regulation of calcium-mediated signaling,BP,
4010,GO:0050853,1,0.748318025747012,0,1,B cell receptor signaling pathway,BP,
4019,GO:0050872,1,0.932928362009675,0,1,white fat cell differentiation,BP,
4022,GO:0050879,1,0.76995755234939,0,1,multicellular organismal movement,BP,
4023,GO:0050880,1,0.138512594189329,0,9,regulation of blood vessel size,BP,
4024,GO:0050881,1,0.76995755234939,0,1,musculoskeletal movement,BP,
4026,GO:0050886,1,0.283846329854639,0,4,endocrine process,BP,
4029,GO:0050892,1,0.682277403524016,0,1,intestinal absorption,BP,
4033,GO:0050906,1,0.77186369485247,0,1,detection of stimulus involved in sensory perception,BP,
4034,GO:0050918,1,0.290196664865182,0,6,positive chemotaxis,BP,
4035,GO:0050919,1,0.643840742286014,0,1,negative chemotaxis,BP,
4038,GO:0050922,1,0.31349786519128,0,3,negative regulation of chemotaxis,BP,
4039,GO:0050926,1,0.783866926973774,0,2,regulation of positive chemotaxis,BP,
4040,GO:0050927,1,0.783866926973774,0,2,positive regulation of positive chemotaxis,BP,
4041,GO:0050930,1,0.783866926973774,0,2,induction of positive chemotaxis,BP,
4045,GO:0050951,1,0.77186369485247,0,1,sensory perception of temperature stimulus,BP,
4049,GO:0050961,1,0.77186369485247,0,1,detection of temperature stimulus involved in sensory perception,BP,
4050,GO:0050965,1,0.77186369485247,0,1,detection of temperature stimulus involved in sensory perception of pain,BP,
4051,GO:0050994,1,0.285743071571538,0,4,regulation of lipid catabolic process,BP,
4052,GO:0050995,1,0.389685163243223,0,3,negative regulation of lipid catabolic process,BP,
4053,GO:0050996,1,0.736825336349041,0,1,positive regulation of lipid catabolic process,BP,
4055,GO:0050999,1,0.770418300420706,0,1,regulation of nitric-oxide synthase activity,BP,
4056,GO:0051000,1,0.770418300420706,0,1,positive regulation of nitric-oxide synthase activity,BP,
4058,GO:0051014,1,0.767524119009516,0,1,actin filament severing,BP,
4061,GO:0051018,1,0.79183939673446,0,1,protein kinase A binding,MF,
4063,GO:0051040,1,0.754619499090771,0,1,regulation of calcium-independent cell-cell adhesion,BP,
4064,GO:0051042,1,0.754619499090771,0,1,negative regulation of calcium-independent cell-cell adhesion,BP,
4072,GO:0051053,1,0.954312251553925,0,1,negative regulation of DNA metabolic process,BP,
4079,GO:0051091,1,0.310161765127657,0,4,positive regulation of sequence-specific DNA binding transcription factor activity,BP,
4080,GO:0051092,1,0.643840742286014,0,1,positive regulation of NF-kappaB transcription factor activity,BP,
4083,GO:0051098,1,0.105879238572077,0,8,regulation of binding,BP,
4084,GO:0051099,1,0.327732948687349,0,4,positive regulation of binding,BP,
4085,GO:0051100,1,0.37300752631626,0,4,negative regulation of binding,BP,
4086,GO:0051101,1,0.576117962351074,0,2,regulation of DNA binding,BP,
4087,GO:0051117,1,0.808086260451893,0,1,ATPase binding,MF,
4088,GO:0051119,1,0.602115213468231,0,2,sugar transmembrane transporter activity,MF,
4089,GO:0051125,1,0.767524119009516,0,1,regulation of actin nucleation,BP,
4090,GO:0051127,1,0.767524119009516,0,1,positive regulation of actin nucleation,BP,
4098,GO:0051149,1,0.27912377692699,0,5,positive regulation of muscle cell differentiation,BP,
4101,GO:0051153,1,0.144789955486144,0,6,regulation of striated muscle cell differentiation,BP,
4102,GO:0051154,1,0.306310239549245,0,3,negative regulation of striated muscle cell differentiation,BP,
4103,GO:0051155,1,0.479737407611924,0,3,positive regulation of striated muscle cell differentiation,BP,
4113,GO:0051181,1,0.728409909849621,0,1,cofactor transport,BP,
4115,GO:0051184,1,0.728409909849621,0,1,cofactor transporter activity,MF,
4118,GO:0051193,1,0.76995755234939,0,1,regulation of cofactor metabolic process,BP,
4119,GO:0051194,1,0.76995755234939,0,1,positive regulation of cofactor metabolic process,BP,
4120,GO:0051195,1,0.76995755234939,0,1,negative regulation of cofactor metabolic process,BP,
4121,GO:0051196,1,0.76995755234939,0,1,regulation of coenzyme metabolic process,BP,
4122,GO:0051197,1,0.76995755234939,0,1,positive regulation of coenzyme metabolic process,BP,
4123,GO:0051198,1,0.76995755234939,0,1,negative regulation of coenzyme metabolic process,BP,
4124,GO:0051204,1,0.830438737450604,0,1,protein insertion into mitochondrial membrane,BP,
4126,GO:0051208,1,0.779877946733024,0,1,sequestering of calcium ion,BP,
4127,GO:0051209,1,0.779877946733024,0,1,release of sequestered calcium ion into cytosol,BP,
4130,GO:0051220,1,0.770418300420706,0,1,cytoplasmic sequestering of protein,BP,
4136,GO:0051235,1,0.298041272107383,0,4,maintenance of location,BP,
4137,GO:0051238,1,0.779877946733024,0,1,sequestering of metal ion,BP,
4159,GO:0051279,1,0.779877946733024,0,1,regulation of release of sequestered calcium ion into cytosol,BP,
4160,GO:0051280,1,0.779877946733024,0,1,negative regulation of release of sequestered calcium ion into cytosol,BP,
4161,GO:0051282,1,0.779877946733024,0,1,regulation of sequestering of calcium ion,BP,
4162,GO:0051283,1,0.779877946733024,0,1,negative regulation of sequestering of calcium ion,BP,
4163,GO:0051284,1,0.779877946733024,0,1,positive regulation of sequestering of calcium ion,BP,
4166,GO:0051293,1,0.932928362009675,0,1,establishment of spindle localization,BP,
4167,GO:0051294,1,0.932928362009675,0,1,establishment of spindle orientation,BP,
4168,GO:0051297,1,0.662212866216891,0,2,centrosome organization,BP,
4169,GO:0051298,1,0.758709278845637,0,1,centrosome duplication,BP,
4172,GO:0051303,1,0.84412233261981,0,1,establishment of chromosome localization,BP,
4173,GO:0051310,1,0.84412233261981,0,1,metaphase plate congression,BP,
4177,GO:0051341,1,0.397486512055212,0,4,regulation of oxidoreductase activity,BP,
4182,GO:0051353,1,0.397486512055212,0,4,positive regulation of oxidoreductase activity,BP,
4184,GO:0051379,1,0.620119989668987,0,2,epinephrine binding,MF,
4187,GO:0051402,1,0.319466206591295,0,6,neuron apoptotic process,BP,
4190,GO:0051427,1,0.650781334339161,0,2,hormone receptor binding,MF,
4191,GO:0051428,1,0.954312251553925,0,1,peptide hormone receptor binding,MF,
4192,GO:0051438,1,0.612002658216457,0,2,regulation of ubiquitin-protein transferase activity,BP,
4193,GO:0051443,1,0.612002658216457,0,2,positive regulation of ubiquitin-protein transferase activity,BP,
4195,GO:0051446,1,0.460448464623875,0,2,positive regulation of meiotic cell cycle,BP,
4197,GO:0051452,1,0.572101934452145,0,3,intracellular pH reduction,BP,
4198,GO:0051453,1,0.572101934452145,0,3,regulation of intracellular pH,BP,
4199,GO:0051480,1,0.249077904558872,0,5,regulation of cytosolic calcium ion concentration,BP,
4200,GO:0051482,1,0.818949769337691,0,1,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,BP,
4209,GO:0051541,1,0.801501284797587,0,1,elastin metabolic process,BP,
4210,GO:0051542,1,0.801501284797587,0,1,elastin biosynthetic process,BP,
4211,GO:0051543,1,0.801501284797587,0,1,regulation of elastin biosynthetic process,BP,
4212,GO:0051545,1,0.801501284797587,0,1,negative regulation of elastin biosynthetic process,BP,
4213,GO:0051546,1,0.747460297097077,0,2,keratinocyte migration,BP,
4214,GO:0051547,1,0.747460297097077,0,2,regulation of keratinocyte migration,BP,
4215,GO:0051549,1,0.747460297097077,0,2,positive regulation of keratinocyte migration,BP,
4216,GO:0051580,1,0.928417537918174,0,1,regulation of neurotransmitter uptake,BP,
4217,GO:0051583,1,0.928417537918174,0,1,dopamine uptake involved in synaptic transmission,BP,
4218,GO:0051584,1,0.928417537918174,0,1,regulation of dopamine uptake involved in synaptic transmission,BP,
4219,GO:0051588,1,0.928417537918174,0,1,regulation of neurotransmitter transport,BP,
4222,GO:0051601,1,0.808086260451893,0,1,exocyst localization,BP,
4223,GO:0051602,1,0.822335646668929,0,1,response to electrical stimulus,BP,
4224,GO:0051603,1,0.240026052249789,0,5,proteolysis involved in cellular protein catabolic process,BP,
4227,GO:0051607,1,0.830438737450604,0,1,defense response to virus,BP,
4228,GO:0051608,1,0.818949769337691,0,1,histamine transport,BP,
4235,GO:0051651,1,0.383738623548183,0,3,maintenance of location in cell,BP,
4236,GO:0051653,1,0.932928362009675,0,1,spindle localization,BP,
4238,GO:0051668,1,0.6959456816156,0,1,localization within membrane,BP,
4240,GO:0051693,1,0.153089508028105,0,4,actin filament capping,BP,
4246,GO:0051721,1,0.770418300420706,0,1,protein phosphatase 2A binding,MF,
4248,GO:0051767,1,0.748908598656095,0,2,nitric-oxide synthase biosynthetic process,BP,
4249,GO:0051769,1,0.748908598656095,0,2,regulation of nitric-oxide synthase biosynthetic process,BP,
4250,GO:0051770,1,0.914847263689534,0,1,positive regulation of nitric-oxide synthase biosynthetic process,BP,
4251,GO:0051771,1,0.818949769337691,0,1,negative regulation of nitric-oxide synthase biosynthetic process,BP,
4252,GO:0051781,1,0.69073949063841,0,2,positive regulation of cell division,BP,
4253,GO:0051783,1,0.0904162799495447,0,9,regulation of nuclear division,BP,
4254,GO:0051784,1,0.426586239916027,0,3,negative regulation of nuclear division,BP,
4255,GO:0051785,1,0.258060806408384,0,5,positive regulation of nuclear division,BP,
4256,GO:0051797,1,0.643840742286014,0,1,regulation of hair follicle development,BP,
4257,GO:0051798,1,0.643840742286014,0,1,positive regulation of hair follicle development,BP,
4261,GO:0051881,1,0.830438737450604,0,1,regulation of mitochondrial membrane potential,BP,
4262,GO:0051884,1,0.643840742286014,0,1,regulation of timing of anagen,BP,
4263,GO:0051885,1,0.643840742286014,0,1,positive regulation of timing of anagen,BP,
4268,GO:0051899,1,0.615380815860644,0,2,membrane depolarization,BP,
4272,GO:0051926,1,0.779877946733024,0,1,negative regulation of calcium ion transport,BP,
4273,GO:0051928,1,0.769641285234326,0,1,positive regulation of calcium ion transport,BP,
4274,GO:0051930,1,0.52274264840204,0,3,regulation of sensory perception of pain,BP,
4275,GO:0051931,1,0.52274264840204,0,3,regulation of sensory perception,BP,
4276,GO:0051932,1,0.77186369485247,0,1,synaptic transmission, GABAergic,BP,
4277,GO:0051934,1,0.928417537918174,0,1,catecholamine uptake involved in synaptic transmission,BP,
4278,GO:0051937,1,0.472230757341737,0,4,catecholamine transport,BP,
4279,GO:0051940,1,0.928417537918174,0,1,regulation of catecholamine uptake involved in synaptic transmission,BP,
4280,GO:0051952,1,0.363183622586545,0,5,regulation of amine transport,BP,
4281,GO:0051953,1,0.391843866689673,0,4,negative regulation of amine transport,BP,
4282,GO:0051954,1,0.928417537918174,0,1,positive regulation of amine transport,BP,
4283,GO:0051955,1,0.77186369485247,0,1,regulation of amino acid transport,BP,
4284,GO:0051956,1,0.77186369485247,0,1,negative regulation of amino acid transport,BP,
4288,GO:0051963,1,0.451350989704978,0,3,regulation of synapse assembly,BP,
4289,GO:0051964,1,0.643840742286014,0,1,negative regulation of synapse assembly,BP,
4290,GO:0051965,1,0.846321998934282,0,1,positive regulation of synapse assembly,BP,
4291,GO:0051966,1,0.77186369485247,0,1,regulation of synaptic transmission, glutamatergic,BP,
4292,GO:0051967,1,0.77186369485247,0,1,negative regulation of synaptic transmission, glutamatergic,BP,
4295,GO:0052652,1,0.409583288428975,0,4,cyclic purine nucleotide metabolic process,BP,
4303,GO:0055008,1,0.155915891420143,0,5,cardiac muscle tissue morphogenesis,BP,
4304,GO:0055009,1,0.770015098939375,0,1,atrial cardiac muscle tissue morphogenesis,BP,
4305,GO:0055010,1,0.568202356117225,0,1,ventricular cardiac muscle tissue morphogenesis,BP,
4307,GO:0055017,1,0.356426061261106,0,3,cardiac muscle tissue growth,BP,
4308,GO:0055018,1,0.841205940583945,0,1,regulation of cardiac muscle fiber development,BP,
4309,GO:0055020,1,0.841205940583945,0,1,positive regulation of cardiac muscle fiber development,BP,
4310,GO:0055021,1,0.356426061261106,0,3,regulation of cardiac muscle tissue growth,BP,
4311,GO:0055023,1,0.356426061261106,0,3,positive regulation of cardiac muscle tissue growth,BP,
4312,GO:0055024,1,0.0987574476886749,0,8,regulation of cardiac muscle tissue development,BP,
4313,GO:0055025,1,0.207252250596787,0,5,positive regulation of cardiac muscle tissue development,BP,
4314,GO:0055026,1,0.486113245984712,0,3,negative regulation of cardiac muscle tissue development,BP,
4315,GO:0055037,1,0.190958811526373,0,6,recycling endosome,CC,
4316,GO:0055038,1,0.406689737172127,0,4,recycling endosome membrane,CC,
4317,GO:0055056,1,0.81190363278393,0,1,D-glucose transmembrane transporter activity,MF,
4319,GO:0055067,1,0.187726443827467,0,7,monovalent inorganic cation homeostasis,BP,
4321,GO:0055072,1,0.445319376162545,0,3,iron ion homeostasis,BP,
4322,GO:0055074,1,0.168434503106774,0,6,calcium ion homeostasis,BP,
4323,GO:0055075,1,0.752197563702773,0,1,potassium ion homeostasis,BP,
4325,GO:0055078,1,0.443029110557772,0,3,sodium ion homeostasis,BP,
4330,GO:0055088,1,0.736825336349041,0,1,lipid homeostasis,BP,
4331,GO:0055090,1,0.736825336349041,0,1,acylglycerol homeostasis,BP,
4333,GO:0055111,1,0.649653750422083,0,1,ingression involved in gastrulation with mouth forming second,BP,
4334,GO:0055114,1,0.115938393666037,0,7,oxidation-reduction process,BP,
4336,GO:0055118,1,0.507332380321055,0,2,negative regulation of cardiac muscle contraction,BP,
4339,GO:0055131,1,0.752197563702773,0,1,C3HC4-type RING finger domain binding,MF,
4340,GO:0060019,1,0.648883266035468,0,2,radial glial cell differentiation,BP,
4341,GO:0060021,1,0.298809107739861,0,4,palate development,BP,
4342,GO:0060024,1,0.818949769337691,0,1,rhythmic synaptic transmission,BP,
4343,GO:0060026,1,0.643840742286014,0,1,convergent extension,BP,
4344,GO:0060027,1,0.643840742286014,0,1,convergent extension involved in gastrulation,BP,
4345,GO:0060028,1,0.643840742286014,0,1,convergent extension involved in axis elongation,BP,
4346,GO:0060029,1,0.643840742286014,0,1,convergent extension involved in organogenesis,BP,
4347,GO:0060031,1,0.643840742286014,0,1,mediolateral intercalation,BP,
4348,GO:0060037,1,0.408654203546377,0,4,pharyngeal system development,BP,
4349,GO:0060038,1,0.436478869252759,0,2,cardiac muscle cell proliferation,BP,
4353,GO:0060043,1,0.436478869252759,0,2,regulation of cardiac muscle cell proliferation,BP,
4354,GO:0060045,1,0.436478869252759,0,2,positive regulation of cardiac muscle cell proliferation,BP,
4357,GO:0060054,1,0.566989845907346,0,3,positive regulation of epithelial cell proliferation involved in wound healing,BP,
4358,GO:0060056,1,0.682277403524016,0,1,mammary gland involution,BP,
4359,GO:0060057,1,0.682277403524016,0,1,apoptotic process involved in mammary gland involution,BP,
4360,GO:0060058,1,0.682277403524016,0,1,positive regulation of apoptotic process involved in mammary gland involution,BP,
4361,GO:0060061,1,0.862545484850912,0,1,Spemann organizer formation,BP,
4362,GO:0060064,1,0.862545484850912,0,1,Spemann organizer formation at the anterior end of the primitive streak,BP,
4363,GO:0060065,1,0.418642806631443,0,3,uterus development,BP,
4364,GO:0060066,1,0.846321998934282,0,1,oviduct development,BP,
4365,GO:0060067,1,0.643840742286014,0,1,cervix development,BP,
4366,GO:0060068,1,0.458666811538641,0,2,vagina development,BP,
4368,GO:0060071,1,0.462131730838942,0,2,Wnt signaling pathway, planar cell polarity pathway,BP,
4369,GO:0060075,1,0.783315402429935,0,1,regulation of resting membrane potential,BP,
4371,GO:0060078,1,0.652712794292049,0,2,regulation of postsynaptic membrane potential,BP,
4372,GO:0060079,1,0.652712794292049,0,2,excitatory postsynaptic potential,BP,
4373,GO:0060087,1,0.77186369485247,0,1,relaxation of vascular smooth muscle,BP,
4380,GO:0060120,1,0.379506368175979,0,2,inner ear receptor cell fate commitment,BP,
4382,GO:0060126,1,0.716836822491286,0,1,somatotropin secreting cell differentiation,BP,
4383,GO:0060128,1,0.677231102720913,0,2,corticotropin hormone secreting cell differentiation,BP,
4384,GO:0060129,1,0.484342640752895,0,3,thyroid-stimulating hormone-secreting cell differentiation,BP,
4387,GO:0060137,1,0.818949769337691,0,1,maternal process involved in parturition,BP,
4388,GO:0060147,1,0.841205940583945,0,1,regulation of posttranscriptional gene silencing,BP,
4389,GO:0060148,1,0.841205940583945,0,1,positive regulation of posttranscriptional gene silencing,BP,
4390,GO:0060155,1,0.869433192415004,0,1,platelet dense granule organization,BP,
4391,GO:0060157,1,0.643840742286014,0,1,urinary bladder development,BP,
4392,GO:0060170,1,0.534748033148175,0,1,ciliary membrane,CC,
4393,GO:0060173,1,0.0826879963119446,0,9,limb development,BP,
4394,GO:0060174,1,0.804477811936357,0,2,limb bud formation,BP,
4395,GO:0060178,1,0.808086260451893,0,1,regulation of exocyst localization,BP,
4396,GO:0060191,1,0.840697515380158,0,1,regulation of lipase activity,BP,
4397,GO:0060193,1,0.840697515380158,0,1,positive regulation of lipase activity,BP,
4398,GO:0060197,1,0.841205940583945,0,1,cloacal septation,BP,
4400,GO:0060215,1,0.749427895517118,0,1,primitive hemopoiesis,BP,
4401,GO:0060216,1,0.749427895517118,0,1,definitive hemopoiesis,BP,
4403,GO:0060235,1,0.841205940583945,0,1,lens induction in camera-type eye,BP,
4404,GO:0060236,1,0.84412233261981,0,1,regulation of mitotic spindle organization,BP,
4406,GO:0060251,1,0.568202356117225,0,1,regulation of glial cell proliferation,BP,
4407,GO:0060253,1,0.568202356117225,0,1,negative regulation of glial cell proliferation,BP,
4410,GO:0060272,1,0.441705951012269,0,3,embryonic skeletal joint morphogenesis,BP,
4411,GO:0060278,1,0.751822927145045,0,1,regulation of ovulation,BP,
4412,GO:0060279,1,0.751822927145045,0,1,positive regulation of ovulation,BP,
4413,GO:0060281,1,0.954312251553925,0,1,regulation of oocyte development,BP,
4414,GO:0060283,1,0.954312251553925,0,1,negative regulation of oocyte development,BP,
4416,GO:0060292,1,0.77186369485247,0,1,long term synaptic depression,BP,
4417,GO:0060297,1,0.818949769337691,0,1,regulation of sarcomere organization,BP,
4418,GO:0060298,1,0.818949769337691,0,1,positive regulation of sarcomere organization,BP,
4419,GO:0060306,1,0.585899995163405,0,2,regulation of membrane repolarization,BP,
4420,GO:0060307,1,0.752197563702773,0,1,regulation of ventricular cardiac muscle cell membrane repolarization,BP,
4421,GO:0060314,1,0.779877946733024,0,1,regulation of ryanodine-sensitive calcium-release channel activity,BP,
4422,GO:0060315,1,0.779877946733024,0,1,negative regulation of ryanodine-sensitive calcium-release channel activity,BP,
4423,GO:0060317,1,0.179039428947093,0,6,cardiac epithelial to mesenchymal transition,BP,
4424,GO:0060318,1,0.749427895517118,0,1,definitive erythrocyte differentiation,BP,
4425,GO:0060319,1,0.749427895517118,0,1,primitive erythrocyte differentiation,BP,
4431,GO:0060337,1,0.643840742286014,0,1,type I interferon signaling pathway,BP,
4432,GO:0060338,1,0.643840742286014,0,1,regulation of type I interferon-mediated signaling pathway,BP,
4433,GO:0060340,1,0.643840742286014,0,1,positive regulation of type I interferon-mediated signaling pathway,BP,
4435,GO:0060343,1,0.805434907231345,0,1,trabecula formation,BP,
4436,GO:0060347,1,0.805434907231345,0,1,heart trabecula formation,BP,
4437,GO:0060348,1,0.174620494128126,0,8,bone development,BP,
4438,GO:0060349,1,0.471742103206908,0,4,bone morphogenesis,BP,
4439,GO:0060350,1,0.471742103206908,0,4,endochondral bone morphogenesis,BP,
4440,GO:0060351,1,0.954312251553925,0,1,cartilage development involved in endochondral bone morphogenesis,BP,
4441,GO:0060363,1,0.841205940583945,0,1,cranial suture morphogenesis,BP,
4442,GO:0060374,1,0.749427895517118,0,1,mast cell differentiation,BP,
4443,GO:0060375,1,0.749427895517118,0,1,regulation of mast cell differentiation,BP,
4444,GO:0060377,1,0.749427895517118,0,1,negative regulation of mast cell differentiation,BP,
4445,GO:0060379,1,0.568202356117225,0,1,cardiac muscle cell myoblast differentiation,BP,
4446,GO:0060389,1,0.19270280691915,0,6,pathway-restricted SMAD protein phosphorylation,BP,
4447,GO:0060390,1,0.636140908138844,0,2,regulation of SMAD protein import into nucleus,BP,
4448,GO:0060391,1,0.636140908138844,0,2,positive regulation of SMAD protein import into nucleus,BP,
4449,GO:0060393,1,0.19270280691915,0,6,regulation of pathway-restricted SMAD protein phosphorylation,BP,
4450,GO:0060395,1,0.253533486267578,0,5,SMAD protein signal transduction,BP,
4453,GO:0060402,1,0.779877946733024,0,1,calcium ion transport into cytosol,BP,
4454,GO:0060411,1,0.0869538595776431,0,8,cardiac septum morphogenesis,BP,
4455,GO:0060412,1,0.138467089626321,0,6,ventricular septum morphogenesis,BP,
4456,GO:0060413,1,0.572531244711603,0,2,atrial septum morphogenesis,BP,
4457,GO:0060415,1,0.155915891420143,0,5,muscle tissue morphogenesis,BP,
4462,GO:0060423,1,0.622412494942637,0,2,foregut regionalization,BP,
4463,GO:0060424,1,0.622412494942637,0,2,lung field specification,BP,
4464,GO:0060425,1,0.221389183618206,0,7,lung morphogenesis,BP,
4465,GO:0060426,1,0.551657767657858,0,2,lung vasculature development,BP,
4466,GO:0060428,1,0.331100826717567,0,5,lung epithelium development,BP,
4468,GO:0060430,1,0.719347208647805,0,2,lung saccule development,BP,
4469,GO:0060431,1,0.622412494942637,0,2,primary lung bud formation,BP,
4470,GO:0060432,1,0.932928362009675,0,1,lung pattern specification process,BP,
4471,GO:0060433,1,0.602064622063973,0,2,bronchus development,BP,
4472,GO:0060435,1,0.932928362009675,0,1,bronchiole development,BP,
4473,GO:0060436,1,0.932928362009675,0,1,bronchiole morphogenesis,BP,
4474,GO:0060437,1,0.932928362009675,0,1,lung growth,BP,
4475,GO:0060438,1,0.602064622063973,0,2,trachea development,BP,
4476,GO:0060439,1,0.602064622063973,0,2,trachea morphogenesis,BP,
4477,GO:0060440,1,0.841205940583945,0,1,trachea formation,BP,
4478,GO:0060441,1,0.487152207880568,0,4,epithelial tube branching involved in lung morphogenesis,BP,
4479,GO:0060442,1,0.597379799532382,0,2,branching involved in prostate gland morphogenesis,BP,
4480,GO:0060443,1,0.174251339346273,0,6,mammary gland morphogenesis,BP,
4481,GO:0060444,1,0.22370921610755,0,4,branching involved in mammary gland duct morphogenesis,BP,
4483,GO:0060447,1,0.932928362009675,0,1,bud outgrowth involved in lung branching,BP,
4484,GO:0060449,1,0.784545183223706,0,2,bud elongation involved in lung branching,BP,
4486,GO:0060457,1,0.704092276759398,0,1,negative regulation of digestive system process,BP,
4487,GO:0060462,1,0.716190498729619,0,1,lung lobe development,BP,
4488,GO:0060463,1,0.716190498729619,0,1,lung lobe morphogenesis,BP,
4489,GO:0060479,1,0.932928362009675,0,1,lung cell differentiation,BP,
4490,GO:0060482,1,0.716467262155752,0,1,lobar bronchus development,BP,
4492,GO:0060487,1,0.932928362009675,0,1,lung epithelial cell differentiation,BP,
4494,GO:0060492,1,0.622412494942637,0,2,lung induction,BP,
4495,GO:0060495,1,0.932928362009675,0,1,cell-cell signaling involved in lung development,BP,
4496,GO:0060496,1,0.932928362009675,0,1,mesenchymal-epithelial cell signaling involved in lung development,BP,
4497,GO:0060501,1,0.770015098939375,0,1,positive regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
4498,GO:0060502,1,0.647193644639787,0,2,epithelial cell proliferation involved in lung morphogenesis,BP,
4499,GO:0060503,1,0.841205940583945,0,1,bud dilation involved in lung branching,BP,
4500,GO:0060510,1,0.932928362009675,0,1,Type II pneumocyte differentiation,BP,
4501,GO:0060512,1,0.200872342283861,0,5,prostate gland morphogenesis,BP,
4502,GO:0060513,1,0.35690401107492,0,4,prostatic bud formation,BP,
4503,GO:0060525,1,0.568202356117225,0,1,prostate glandular acinus development,BP,
4504,GO:0060528,1,0.568202356117225,0,1,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,BP,
4505,GO:0060534,1,0.716467262155752,0,1,trachea cartilage development,BP,
4506,GO:0060535,1,0.716467262155752,0,1,trachea cartilage morphogenesis,BP,
4507,GO:0060536,1,0.716467262155752,0,1,cartilage morphogenesis,BP,
4513,GO:0060556,1,0.682277403524016,0,1,regulation of vitamin D biosynthetic process,BP,
4514,GO:0060558,1,0.682277403524016,0,1,regulation of calcidiol 1-monooxygenase activity,BP,
4515,GO:0060560,1,0.123952118603786,0,7,developmental growth involved in morphogenesis,BP,
4516,GO:0060561,1,0.18165613298813,0,4,apoptotic process involved in morphogenesis,BP,
4524,GO:0060584,1,0.818949769337691,0,1,regulation of prostaglandin-endoperoxide synthase activity,BP,
4525,GO:0060585,1,0.818949769337691,0,1,positive regulation of prostaglandin-endoperoxide synthase activity,BP,
4526,GO:0060586,1,0.756901465456182,0,1,multicellular organismal iron ion homeostasis,BP,
4528,GO:0060592,1,0.784545183223706,0,2,mammary gland formation,BP,
4529,GO:0060594,1,0.932928362009675,0,1,mammary gland specification,BP,
4530,GO:0060595,1,0.932928362009675,0,1,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,BP,
4531,GO:0060599,1,0.643840742286014,0,1,lateral sprouting involved in mammary gland duct morphogenesis,BP,
4532,GO:0060601,1,0.35690401107492,0,4,lateral sprouting from an epithelium,BP,
4533,GO:0060602,1,0.504079584680703,0,3,branch elongation of an epithelium,BP,
4534,GO:0060603,1,0.208189968883133,0,5,mammary gland duct morphogenesis,BP,
4536,GO:0060612,1,0.725317348117967,0,1,adipose tissue development,BP,
4537,GO:0060615,1,0.932928362009675,0,1,mammary gland bud formation,BP,
4539,GO:0060638,1,0.484706774407514,0,3,mesenchymal-epithelial cell signaling,BP,
4540,GO:0060644,1,0.770418300420706,0,1,mammary gland epithelial cell differentiation,BP,
4541,GO:0060648,1,0.932928362009675,0,1,mammary gland bud morphogenesis,BP,
4542,GO:0060661,1,0.932928362009675,0,1,submandibular salivary gland formation,BP,
4543,GO:0060664,1,0.932928362009675,0,1,epithelial cell proliferation involved in salivary gland morphogenesis,BP,
4544,GO:0060665,1,0.932928362009675,0,1,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,BP,
4545,GO:0060667,1,0.932928362009675,0,1,branch elongation involved in salivary gland morphogenesis,BP,
4546,GO:0060669,1,0.508393076179155,0,2,embryonic placenta morphogenesis,BP,
4549,GO:0060676,1,0.928417537918174,0,1,ureteric bud formation,BP,
4550,GO:0060677,1,0.841205940583945,0,1,ureteric bud elongation,BP,
4551,GO:0060681,1,0.841205940583945,0,1,branch elongation involved in ureteric bud branching,BP,
4552,GO:0060684,1,0.71238703074591,0,2,epithelial-mesenchymal cell signaling,BP,
4553,GO:0060685,1,0.383173701730543,0,3,regulation of prostatic bud formation,BP,
4554,GO:0060686,1,0.383173701730543,0,3,negative regulation of prostatic bud formation,BP,
4555,GO:0060687,1,0.597379799532382,0,2,regulation of branching involved in prostate gland morphogenesis,BP,
4556,GO:0060688,1,0.203884555840022,0,7,regulation of morphogenesis of a branching structure,BP,
4557,GO:0060693,1,0.932928362009675,0,1,regulation of branching involved in salivary gland morphogenesis,BP,
4558,GO:0060706,1,0.550952131581595,0,2,cell differentiation involved in embryonic placenta development,BP,
4559,GO:0060707,1,0.716190498729619,0,1,trophoblast giant cell differentiation,BP,
4560,GO:0060708,1,0.716190498729619,0,1,spongiotrophoblast differentiation,BP,
4561,GO:0060709,1,0.770418300420706,0,1,glycogen cell differentiation involved in embryonic placenta development,BP,
4562,GO:0060710,1,0.508393076179155,0,2,chorio-allantoic fusion,BP,
4563,GO:0060711,1,0.240049932358096,0,5,labyrinthine layer development,BP,
4564,GO:0060712,1,0.550952131581595,0,2,spongiotrophoblast layer development,BP,
4565,GO:0060713,1,0.508393076179155,0,2,labyrinthine layer morphogenesis,BP,
4566,GO:0060716,1,0.476268785508921,0,3,labyrinthine layer blood vessel development,BP,
4567,GO:0060740,1,0.200872342283861,0,5,prostate gland epithelium morphogenesis,BP,
4568,GO:0060742,1,0.568202356117225,0,1,epithelial cell differentiation involved in prostate gland development,BP,
4569,GO:0060744,1,0.643840742286014,0,1,mammary gland branching involved in thelarche,BP,
4570,GO:0060745,1,0.488074119378224,0,2,mammary gland branching involved in pregnancy,BP,
4571,GO:0060748,1,0.716836822491286,0,1,tertiary branching involved in mammary gland duct morphogenesis,BP,
4572,GO:0060749,1,0.719956321112888,0,1,mammary gland alveolus development,BP,
4573,GO:0060750,1,0.643840742286014,0,1,epithelial cell proliferation involved in mammary gland duct elongation,BP,
4574,GO:0060751,1,0.643840742286014,0,1,branch elongation involved in mammary gland duct branching,BP,
4578,GO:0060762,1,0.643840742286014,0,1,regulation of branching involved in mammary gland duct morphogenesis,BP,
4579,GO:0060767,1,0.568202356117225,0,1,epithelial cell proliferation involved in prostate gland development,BP,
4580,GO:0060768,1,0.568202356117225,0,1,regulation of epithelial cell proliferation involved in prostate gland development,BP,
4581,GO:0060775,1,0.643840742286014,0,1,planar cell polarity pathway involved in gastrula mediolateral intercalation,BP,
4582,GO:0060788,1,0.741374927768024,0,1,ectodermal placode formation,BP,
4583,GO:0060795,1,0.604570722216099,0,2,cell fate commitment involved in formation of primary germ layer,BP,
4584,GO:0060804,1,0.754619499090771,0,1,positive regulation of Wnt signaling pathway by BMP signaling pathway,BP,
4585,GO:0060809,1,0.643840742286014,0,1,mesodermal to mesenchymal transition involved in gastrulation,BP,
4586,GO:0060823,1,0.741374927768024,0,1,canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
4591,GO:0060840,1,0.182667219834333,0,6,artery development,BP,
4592,GO:0060841,1,0.395646254351599,0,2,venous blood vessel development,BP,
4594,GO:0060843,1,0.568202356117225,0,1,venous endothelial cell differentiation,BP,
4599,GO:0060856,1,0.605744058874978,0,2,establishment of blood-brain barrier,BP,
4600,GO:0060872,1,0.932928362009675,0,1,semicircular canal development,BP,
4601,GO:0060876,1,0.932928362009675,0,1,semicircular canal formation,BP,
4602,GO:0060879,1,0.932928362009675,0,1,semicircular canal fusion,BP,
4603,GO:0060896,1,0.741374927768024,0,1,neural plate pattern specification,BP,
4604,GO:0060897,1,0.741374927768024,0,1,neural plate regionalization,BP,
4605,GO:0060900,1,0.495722160163446,0,2,embryonic camera-type eye formation,BP,
4606,GO:0060907,1,0.643840742286014,0,1,positive regulation of macrophage cytokine production,BP,
4608,GO:0060914,1,0.841205940583945,0,1,heart formation,BP,
4609,GO:0060915,1,0.932928362009675,0,1,mesenchymal cell differentiation involved in lung development,BP,
4611,GO:0060947,1,0.568202356117225,0,1,cardiac vascular smooth muscle cell differentiation,BP,
4612,GO:0060948,1,0.568202356117225,0,1,cardiac vascular smooth muscle cell development,BP,
4613,GO:0060956,1,0.433598791464532,0,2,endocardial cell differentiation,BP,
4614,GO:0060957,1,0.764973380564597,0,1,endocardial cell fate commitment,BP,
4615,GO:0060964,1,0.841205940583945,0,1,regulation of gene silencing by miRNA,BP,
4616,GO:0060966,1,0.841205940583945,0,1,regulation of gene silencing by RNA,BP,
4617,GO:0060968,1,0.841205940583945,0,1,regulation of gene silencing,BP,
4619,GO:0060973,1,0.568202356117225,0,1,cell migration involved in heart development,BP,
4620,GO:0060976,1,0.477161613509033,0,2,coronary vasculature development,BP,
4621,GO:0060977,1,0.568202356117225,0,1,coronary vasculature morphogenesis,BP,
4622,GO:0060979,1,0.568202356117225,0,1,vasculogenesis involved in coronary vascular morphogenesis,BP,
4623,GO:0060982,1,0.568202356117225,0,1,coronary artery morphogenesis,BP,
4624,GO:0060986,1,0.347895533957607,0,3,endocrine hormone secretion,BP,
4626,GO:0060994,1,0.841205940583945,0,1,regulation of transcription from RNA polymerase II promoter involved in kidney development,BP,
4628,GO:0060997,1,0.846321998934282,0,1,dendritic spine morphogenesis,BP,
4629,GO:0061004,1,0.841205940583945,0,1,pattern specification involved in kidney development,BP,
4632,GO:0061013,1,0.365554940761731,0,3,regulation of mRNA catabolic process,BP,
4633,GO:0061014,1,0.723357618254592,0,1,positive regulation of mRNA catabolic process,BP,
4636,GO:0061027,1,0.805434907231345,0,1,umbilical cord development,BP,
4638,GO:0061029,1,0.77140024913884,0,1,eyelid development in camera-type eye,BP,
4640,GO:0061033,1,0.932928362009675,0,1,secretion by lung epithelial cell involved in lung growth,BP,
4642,GO:0061036,1,0.306706555560781,0,4,positive regulation of cartilage development,BP,
4643,GO:0061037,1,0.841205940583945,0,1,negative regulation of cartilage development,BP,
4644,GO:0061038,1,0.652319815642295,0,2,uterus morphogenesis,BP,
4645,GO:0061041,1,0.25118068544923,0,6,regulation of wound healing,BP,
4646,GO:0061045,1,0.354896436902785,0,4,negative regulation of wound healing,BP,
4647,GO:0061046,1,0.522761250783608,0,3,regulation of branching involved in lung morphogenesis,BP,
4648,GO:0061047,1,0.522761250783608,0,3,positive regulation of branching involved in lung morphogenesis,BP,
4649,GO:0061049,1,0.818949769337691,0,1,cell growth involved in cardiac muscle cell development,BP,
4650,GO:0061050,1,0.818949769337691,0,1,regulation of cell growth involved in cardiac muscle cell development,BP,
4651,GO:0061051,1,0.818949769337691,0,1,positive regulation of cell growth involved in cardiac muscle cell development,BP,
4653,GO:0061054,1,0.716836822491286,0,1,dermatome development,BP,
4655,GO:0061072,1,0.622412494942637,0,2,iris morphogenesis,BP,
4656,GO:0061081,1,0.643840742286014,0,1,positive regulation of myeloid leukocyte cytokine production involved in immune response,BP,
4660,GO:0061101,1,0.484342640752895,0,3,neuroendocrine cell differentiation,BP,
4662,GO:0061110,1,0.822648168832337,0,1,dense core granule biogenesis,BP,
4663,GO:0061115,1,0.932928362009675,0,1,lung proximal/distal axis specification,BP,
4666,GO:0061136,1,0.39335338124276,0,3,regulation of proteasomal protein catabolic process,BP,
4668,GO:0061140,1,0.932928362009675,0,1,lung secretory cell differentiation,BP,
4669,GO:0061143,1,0.77140024913884,0,1,alveolar primary septum development,BP,
4670,GO:0061146,1,0.840479796371432,0,1,Peyer's patch morphogenesis,BP,
4671,GO:0061149,1,0.841205940583945,0,1,BMP signaling pathway involved in ureter morphogenesis,BP,
4672,GO:0061150,1,0.841205940583945,0,1,renal system segmentation,BP,
4673,GO:0061151,1,0.841205940583945,0,1,BMP signaling pathway involved in renal system segmentation,BP,
4675,GO:0061155,1,0.841205940583945,0,1,pulmonary artery endothelial tube morphogenesis,BP,
4676,GO:0061156,1,0.648361139861816,0,2,pulmonary artery morphogenesis,BP,
4678,GO:0061180,1,0.0737473083291826,0,9,mammary gland epithelium development,BP,
4679,GO:0061183,1,0.716836822491286,0,1,regulation of dermatome development,BP,
4680,GO:0061184,1,0.716836822491286,0,1,positive regulation of dermatome development,BP,
4681,GO:0061205,1,0.55215756058021,0,2,paramesonephric duct development,BP,
4682,GO:0061209,1,0.634217622687051,0,2,cell proliferation involved in mesonephros development,BP,
4684,GO:0061216,1,0.841205940583945,0,1,regulation of transcription from RNA polymerase II promoter involved in mesonephros development,BP,
4686,GO:0061218,1,0.841205940583945,0,1,negative regulation of mesonephros development,BP,
4687,GO:0061227,1,0.841205940583945,0,1,pattern specification involved in mesonephros development,BP,
4691,GO:0061302,1,0.568700714761145,0,2,smooth muscle cell-matrix adhesion,BP,
4692,GO:0061303,1,0.685141835077735,0,2,cornea development in camera-type eye,BP,
4693,GO:0061311,1,0.139450061252511,0,6,cell surface receptor signaling pathway involved in heart development,BP,
4694,GO:0061312,1,0.642944204063632,0,2,BMP signaling pathway involved in heart development,BP,
4695,GO:0061314,1,0.45671643656734,0,2,Notch signaling involved in heart development,BP,
4697,GO:0061323,1,0.841205940583945,0,1,cell proliferation involved in heart morphogenesis,BP,
4698,GO:0061325,1,0.841205940583945,0,1,cell proliferation involved in outflow tract morphogenesis,BP,
4701,GO:0061337,1,0.0872587628963789,0,8,cardiac conduction,BP,
4703,GO:0061341,1,0.643840742286014,0,1,non-canonical Wnt signaling pathway involved in heart development,BP,
4704,GO:0061343,1,0.764973380564597,0,1,cell adhesion involved in heart morphogenesis,BP,
4705,GO:0061346,1,0.643840742286014,0,1,planar cell polarity pathway involved in heart morphogenesis,BP,
4706,GO:0061347,1,0.643840742286014,0,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP,
4707,GO:0061348,1,0.643840742286014,0,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP,
4708,GO:0061349,1,0.643840742286014,0,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,
4709,GO:0061350,1,0.643840742286014,0,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,
4710,GO:0061351,1,0.0984737668716434,0,8,neural precursor cell proliferation,BP,
4711,GO:0061354,1,0.643840742286014,0,1,planar cell polarity pathway involved in pericardium morphogenesis,BP,
4712,GO:0061369,1,0.716836822491286,0,1,negative regulation of testicular blood vessel morphogenesis,BP,
4713,GO:0061370,1,0.716836822491286,0,1,testosterone biosynthetic process,BP,
4715,GO:0061377,1,0.719956321112888,0,1,mammary gland lobule development,BP,
4716,GO:0061383,1,0.32328259079513,0,3,trabecula morphogenesis,BP,
4717,GO:0061384,1,0.32328259079513,0,3,heart trabecula morphogenesis,BP,
4718,GO:0061387,1,0.554678513309543,0,2,regulation of extent of cell growth,BP,
4719,GO:0061418,1,0.568202356117225,0,1,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
4720,GO:0061419,1,0.568202356117225,0,1,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
4723,GO:0061438,1,0.841205940583945,0,1,renal system vasculature morphogenesis,BP,
4724,GO:0061439,1,0.841205940583945,0,1,kidney vasculature morphogenesis,BP,
4726,GO:0061443,1,0.764973380564597,0,1,endocardial cushion cell differentiation,BP,
4727,GO:0061445,1,0.764973380564597,0,1,endocardial cushion cell fate commitment,BP,
4731,GO:0061515,1,0.416837498563776,0,3,myeloid cell development,BP,
4732,GO:0061525,1,0.643840742286014,0,1,hindgut development,BP,
4735,GO:0061614,1,0.580046122204865,0,2,pri-miRNA transcription from RNA polymerase II promoter,BP,
4736,GO:0061615,1,0.695278396814058,0,1,glycolytic process through fructose-6-phosphate,BP,
4737,GO:0061620,1,0.695278396814058,0,1,glycolytic process through glucose-6-phosphate,BP,
4738,GO:0061621,1,0.695278396814058,0,1,canonical glycolysis,BP,
4739,GO:0061624,1,0.797620800566368,0,1,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,BP,
4740,GO:0061626,1,0.841205940583945,0,1,pharyngeal arch artery morphogenesis,BP,
4741,GO:0061630,1,0.646779409103276,0,1,ubiquitin protein ligase activity,MF,
4742,GO:0061640,1,0.664021257488237,0,1,cytoskeleton-dependent cytokinesis,BP,
4743,GO:0061642,1,0.643840742286014,0,1,chemoattraction of axon,BP,
4744,GO:0061643,1,0.643840742286014,0,1,chemorepulsion of axon,BP,
4745,GO:0061659,1,0.646779409103276,0,1,ubiquitin-like protein ligase activity,MF,
4747,GO:0061700,1,0.736825336349041,0,1,GATOR2 complex,CC,
4748,GO:0061718,1,0.695278396814058,0,1,glucose catabolic process to pyruvate,BP,
4749,GO:0061724,1,0.736825336349041,0,1,lipophagy,BP,
4755,GO:0070011,1,0.367500146398542,0,3,peptidase activity, acting on L-amino acid peptides,MF,
4757,GO:0070016,1,0.741374927768024,0,1,armadillo repeat domain binding,MF,
4758,GO:0070050,1,0.714080197774154,0,1,neuron cellular homeostasis,BP,
4760,GO:0070059,1,0.830438737450604,0,1,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
4762,GO:0070075,1,0.932928362009675,0,1,tear secretion,BP,
4764,GO:0070085,1,0.777493793435671,0,1,glycosylation,BP,
4765,GO:0070098,1,0.748908598656095,0,2,chemokine-mediated signaling pathway,BP,
4766,GO:0070099,1,0.818949769337691,0,1,regulation of chemokine-mediated signaling pathway,BP,
4767,GO:0070101,1,0.818949769337691,0,1,positive regulation of chemokine-mediated signaling pathway,BP,
4768,GO:0070141,1,0.770418300420706,0,1,response to UV-A,BP,
4771,GO:0070162,1,0.614924777843263,0,1,adiponectin secretion,BP,
4772,GO:0070163,1,0.614924777843263,0,1,regulation of adiponectin secretion,BP,
4773,GO:0070164,1,0.614924777843263,0,1,negative regulation of adiponectin secretion,BP,
4776,GO:0070169,1,0.154709496153712,0,7,positive regulation of biomineral tissue development,BP,
4777,GO:0070170,1,0.847352128579167,0,1,regulation of tooth mineralization,BP,
4778,GO:0070172,1,0.847352128579167,0,1,positive regulation of tooth mineralization,BP,
4780,GO:0070227,1,0.41555201655839,0,3,lymphocyte apoptotic process,BP,
4781,GO:0070228,1,0.540871679044505,0,2,regulation of lymphocyte apoptotic process,BP,
4782,GO:0070229,1,0.841205940583945,0,1,negative regulation of lymphocyte apoptotic process,BP,
4783,GO:0070230,1,0.643840742286014,0,1,positive regulation of lymphocyte apoptotic process,BP,
4784,GO:0070231,1,0.41555201655839,0,3,T cell apoptotic process,BP,
4785,GO:0070232,1,0.540871679044505,0,2,regulation of T cell apoptotic process,BP,
4786,GO:0070233,1,0.841205940583945,0,1,negative regulation of T cell apoptotic process,BP,
4787,GO:0070234,1,0.643840742286014,0,1,positive regulation of T cell apoptotic process,BP,
4788,GO:0070242,1,0.540871679044505,0,2,thymocyte apoptotic process,BP,
4789,GO:0070243,1,0.540871679044505,0,2,regulation of thymocyte apoptotic process,BP,
4790,GO:0070244,1,0.841205940583945,0,1,negative regulation of thymocyte apoptotic process,BP,
4791,GO:0070245,1,0.643840742286014,0,1,positive regulation of thymocyte apoptotic process,BP,
4793,GO:0070254,1,0.77186369485247,0,1,mucus secretion,BP,
4794,GO:0070255,1,0.77186369485247,0,1,regulation of mucus secretion,BP,
4795,GO:0070256,1,0.77186369485247,0,1,negative regulation of mucus secretion,BP,
4796,GO:0070268,1,0.131529739959322,0,5,cornification,BP,
4799,GO:0070279,1,0.7203786970807,0,1,vitamin B6 binding,MF,
4801,GO:0070294,1,0.704092276759398,0,1,renal sodium ion absorption,BP,
4802,GO:0070296,1,0.779877946733024,0,1,sarcoplasmic reticulum calcium ion transport,BP,
4805,GO:0070303,1,0.770418300420706,0,1,negative regulation of stress-activated protein kinase signaling cascade,BP,
4807,GO:0070306,1,0.49078722365639,0,3,lens fiber cell differentiation,BP,
4808,GO:0070307,1,0.49078722365639,0,3,lens fiber cell development,BP,
4812,GO:0070328,1,0.736825336349041,0,1,triglyceride homeostasis,BP,
4813,GO:0070341,1,0.932928362009675,0,1,fat cell proliferation,BP,
4814,GO:0070343,1,0.932928362009675,0,1,white fat cell proliferation,BP,
4815,GO:0070344,1,0.932928362009675,0,1,regulation of fat cell proliferation,BP,
4816,GO:0070346,1,0.932928362009675,0,1,positive regulation of fat cell proliferation,BP,
4817,GO:0070350,1,0.932928362009675,0,1,regulation of white fat cell proliferation,BP,
4818,GO:0070352,1,0.932928362009675,0,1,positive regulation of white fat cell proliferation,BP,
4821,GO:0070373,1,0.716190498729619,0,1,negative regulation of ERK1 and ERK2 cascade,BP,
4824,GO:0070384,1,0.932928362009675,0,1,Harderian gland development,BP,
4825,GO:0070391,1,0.914847263689534,0,1,response to lipoteichoic acid,BP,
4827,GO:0070411,1,0.741374927768024,0,1,I-SMAD binding,MF,
4828,GO:0070444,1,0.6959456816156,0,1,oligodendrocyte progenitor proliferation,BP,
4829,GO:0070445,1,0.6959456816156,0,1,regulation of oligodendrocyte progenitor proliferation,BP,
4830,GO:0070471,1,0.829094252739859,0,1,uterine smooth muscle contraction,BP,
4831,GO:0070472,1,0.829094252739859,0,1,regulation of uterine smooth muscle contraction,BP,
4832,GO:0070473,1,0.829094252739859,0,1,negative regulation of uterine smooth muscle contraction,BP,
4834,GO:0070486,1,0.710907860107323,0,1,leukocyte aggregation,BP,
4835,GO:0070487,1,0.710907860107323,0,1,monocyte aggregation,BP,
4837,GO:0070509,1,0.599539119632082,0,2,calcium ion import,BP,
4839,GO:0070528,1,0.494584796097088,0,2,protein kinase C signaling,BP,
4841,GO:0070555,1,0.748908598656095,0,2,response to interleukin-1,BP,
4843,GO:0070561,1,0.682277403524016,0,1,vitamin D receptor signaling pathway,BP,
4844,GO:0070585,1,0.639212907528369,0,2,protein localization to mitochondrion,BP,
4847,GO:0070627,1,0.774076993520791,0,1,ferrous iron import,BP,
4848,GO:0070633,1,0.818949769337691,0,1,transepithelial transport,BP,
4849,GO:0070644,1,0.682277403524016,0,1,vitamin D response element binding,MF,
4861,GO:0070696,1,0.339033573401607,0,4,transmembrane receptor protein serine/threonine kinase binding,MF,
4862,GO:0070700,1,0.339033573401607,0,4,BMP receptor binding,MF,
4863,GO:0070724,1,0.754619499090771,0,1,BMP receptor complex,CC,
4865,GO:0070728,1,0.736825336349041,0,1,leucine binding,MF,
4867,GO:0070820,1,0.402625262300692,0,3,tertiary granule,CC,
4868,GO:0070821,1,0.614838168630069,0,2,tertiary granule membrane,CC,
4869,GO:0070822,1,0.66650505420776,0,1,Sin3-type complex,CC,
4873,GO:0070849,1,0.770418300420706,0,1,response to epidermal growth factor,BP,
4874,GO:0070851,1,0.316713980913078,0,6,growth factor receptor binding,MF,
4875,GO:0070852,1,0.652168350167583,0,1,cell body fiber,CC,
4876,GO:0070873,1,0.770418300420706,0,1,regulation of glycogen metabolic process,BP,
4877,GO:0070875,1,0.770418300420706,0,1,positive regulation of glycogen metabolic process,BP,
4878,GO:0070884,1,0.76995755234939,0,1,regulation of calcineurin-NFAT signaling cascade,BP,
4879,GO:0070885,1,0.76995755234939,0,1,negative regulation of calcineurin-NFAT signaling cascade,BP,
4881,GO:0070915,1,0.840697515380158,0,1,lysophosphatidic acid receptor activity,MF,
4882,GO:0070918,1,0.841205940583945,0,1,production of small RNA involved in gene silencing by RNA,BP,
4883,GO:0070920,1,0.841205940583945,0,1,regulation of production of small RNA involved in gene silencing by RNA,BP,
4885,GO:0070977,1,0.754619499090771,0,1,bone maturation,BP,
4887,GO:0070997,1,0.160914419812121,0,9,neuron death,BP,
4888,GO:0071062,1,0.700382636394197,0,1,alphav-beta3 integrin-vitronectin complex,CC,
4889,GO:0071071,1,0.769641285234326,0,1,regulation of phospholipid biosynthetic process,BP,
4890,GO:0071072,1,0.769641285234326,0,1,negative regulation of phospholipid biosynthetic process,BP,
4898,GO:0071223,1,0.914847263689534,0,1,cellular response to lipoteichoic acid,BP,
4901,GO:0071233,1,0.736825336349041,0,1,cellular response to leucine,BP,
4904,GO:0071260,1,0.507964074923316,0,3,cellular response to mechanical stimulus,BP,
4905,GO:0071276,1,0.770418300420706,0,1,cellular response to cadmium ion,BP,
4906,GO:0071277,1,0.526474061300313,0,2,cellular response to calcium ion,BP,
4907,GO:0071281,1,0.585174232726701,0,2,cellular response to iron ion,BP,
4909,GO:0071285,1,0.678121940697822,0,1,cellular response to lithium ion,BP,
4911,GO:0071300,1,0.147661802454663,0,7,cellular response to retinoic acid,BP,
4912,GO:0071305,1,0.682277403524016,0,1,cellular response to vitamin D,BP,
4915,GO:0071312,1,0.779877946733024,0,1,cellular response to alkaloid,BP,
4916,GO:0071313,1,0.779877946733024,0,1,cellular response to caffeine,BP,
4922,GO:0071335,1,0.932928362009675,0,1,hair follicle cell proliferation,BP,
4923,GO:0071336,1,0.932928362009675,0,1,regulation of hair follicle cell proliferation,BP,
4924,GO:0071338,1,0.932928362009675,0,1,positive regulation of hair follicle cell proliferation,BP,
4927,GO:0071347,1,0.748908598656095,0,2,cellular response to interleukin-1,BP,
4928,GO:0071351,1,0.592238423702372,0,2,cellular response to interleukin-18,BP,
4930,GO:0071357,1,0.643840742286014,0,1,cellular response to type I interferon,BP,
4931,GO:0071359,1,0.679284607799164,0,2,cellular response to dsRNA,BP,
4932,GO:0071360,1,0.808086260451893,0,1,cellular response to exogenous dsRNA,BP,
4934,GO:0071364,1,0.770418300420706,0,1,cellular response to epidermal growth factor stimulus,BP,
4936,GO:0071372,1,0.568202356117225,0,1,cellular response to follicle-stimulating hormone stimulus,BP,
4940,GO:0071379,1,0.770418300420706,0,1,cellular response to prostaglandin stimulus,BP,
4941,GO:0071380,1,0.770418300420706,0,1,cellular response to prostaglandin E stimulus,BP,
4942,GO:0071383,1,0.212572332544522,0,6,cellular response to steroid hormone stimulus,BP,
4943,GO:0071384,1,0.528688174071357,0,3,cellular response to corticosteroid stimulus,BP,
4944,GO:0071385,1,0.528688174071357,0,3,cellular response to glucocorticoid stimulus,BP,
4945,GO:0071389,1,0.818949769337691,0,1,cellular response to mineralocorticoid stimulus,BP,
4950,GO:0071415,1,0.779877946733024,0,1,cellular response to purine-containing compound,BP,
4953,GO:0071435,1,0.752197563702773,0,1,potassium ion export,BP,
4956,GO:0071450,1,0.710907860107323,0,1,cellular response to oxygen radical,BP,
4957,GO:0071451,1,0.710907860107323,0,1,cellular response to superoxide,BP,
4958,GO:0071453,1,0.208353549398637,0,5,cellular response to oxygen levels,BP,
4959,GO:0071456,1,0.208353549398637,0,5,cellular response to hypoxia,BP,
4967,GO:0071505,1,0.769641285234326,0,1,response to mycophenolic acid,BP,
4968,GO:0071506,1,0.769641285234326,0,1,cellular response to mycophenolic acid,BP,
4969,GO:0071514,1,0.725317348117967,0,1,genetic imprinting,BP,
4970,GO:0071542,1,0.381799535490096,0,4,dopaminergic neuron differentiation,BP,
4972,GO:0071549,1,0.803527095561903,0,1,cellular response to dexamethasone stimulus,BP,
4975,GO:0071599,1,0.837607612777911,0,2,otic vesicle development,BP,
4976,GO:0071600,1,0.837607612777911,0,2,otic vesicle morphogenesis,BP,
4978,GO:0071617,1,0.721084421958727,0,1,lysophospholipid acyltransferase activity,MF,
4980,GO:0071622,1,0.595460655369225,0,2,regulation of granulocyte chemotaxis,BP,
4981,GO:0071624,1,0.818949769337691,0,1,positive regulation of granulocyte chemotaxis,BP,
4982,GO:0071674,1,0.703740432977165,0,2,mononuclear cell migration,BP,
4983,GO:0071680,1,0.678121940697822,0,1,response to indole-3-methanol,BP,
4984,GO:0071681,1,0.678121940697822,0,1,cellular response to indole-3-methanol,BP,
4985,GO:0071688,1,0.613902340139758,0,1,striated muscle myosin thick filament assembly,BP,
4986,GO:0071695,1,0.484872206947979,0,2,anatomical structure maturation,BP,
4987,GO:0071696,1,0.741374927768024,0,1,ectodermal placode development,BP,
4988,GO:0071697,1,0.741374927768024,0,1,ectodermal placode morphogenesis,BP,
4989,GO:0071698,1,0.741374927768024,0,1,olfactory placode development,BP,
4990,GO:0071699,1,0.741374927768024,0,1,olfactory placode morphogenesis,BP,
4995,GO:0071709,1,0.6959456816156,0,1,membrane assembly,BP,
4996,GO:0071715,1,0.818949769337691,0,1,icosanoid transport,BP,
4997,GO:0071731,1,0.748793081179247,0,1,response to nitric oxide,BP,
4998,GO:0071732,1,0.748793081179247,0,1,cellular response to nitric oxide,BP,
4999,GO:0071733,1,0.749427895517118,0,1,transcriptional activation by promoter-enhancer looping,BP,
5012,GO:0071847,1,0.743693968038284,0,1,TNFSF11-mediated signaling pathway,BP,
5014,GO:0071855,1,0.818949769337691,0,1,neuropeptide receptor binding,MF,
5021,GO:0071875,1,0.509257270828109,0,3,adrenergic receptor signaling pathway,BP,
5022,GO:0071880,1,0.509257270828109,0,3,adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
5023,GO:0071883,1,0.620119989668987,0,2,activation of MAPK activity by adrenergic receptor signaling pathway,BP,
5025,GO:0071889,1,0.770418300420706,0,1,14-3-3 protein binding,MF,
5026,GO:0071893,1,0.841205940583945,0,1,BMP signaling pathway involved in nephric duct formation,BP,
5032,GO:0071963,1,0.843902948514569,0,1,establishment or maintenance of cell polarity regulating cell shape,BP,
5034,GO:0071985,1,0.774047742304058,0,1,multivesicular body sorting pathway,BP,
5037,GO:0072007,1,0.372601381566993,0,3,mesangial cell differentiation,BP,
5038,GO:0072008,1,0.372601381566993,0,3,glomerular mesangial cell differentiation,BP,
5043,GO:0072015,1,0.841205940583945,0,1,glomerular visceral epithelial cell development,BP,
5044,GO:0072017,1,0.398832307462738,0,2,distal tubule development,BP,
5046,GO:0072033,1,0.716836822491286,0,1,renal vesicle formation,BP,
5047,GO:0072034,1,0.716836822491286,0,1,renal vesicle induction,BP,
5048,GO:0072038,1,0.710907860107323,0,1,mesenchymal stem cell maintenance involved in nephron morphogenesis,BP,
5049,GO:0072039,1,0.710907860107323,0,1,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
5050,GO:0072040,1,0.710907860107323,0,1,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
5051,GO:0072044,1,0.340498413909248,0,3,collecting duct development,BP,
5052,GO:0072048,1,0.841205940583945,0,1,renal system pattern specification,BP,
5053,GO:0072049,1,0.841205940583945,0,1,comma-shaped body morphogenesis,BP,
5055,GO:0072053,1,0.716467262155752,0,1,renal inner medulla development,BP,
5056,GO:0072054,1,0.716467262155752,0,1,renal outer medulla development,BP,
5057,GO:0072060,1,0.716467262155752,0,1,outer medullary collecting duct development,BP,
5058,GO:0072061,1,0.716467262155752,0,1,inner medullary collecting duct development,BP,
5063,GO:0072076,1,0.710907860107323,0,1,nephrogenic mesenchyme development,BP,
5064,GO:0072077,1,0.398788371163054,0,4,renal vesicle morphogenesis,BP,
5066,GO:0072079,1,0.786454572494151,0,2,nephron tubule formation,BP,
5068,GO:0072087,1,0.398788371163054,0,4,renal vesicle development,BP,
5072,GO:0072095,1,0.841205940583945,0,1,regulation of branch elongation involved in ureteric bud branching,BP,
5073,GO:0072096,1,0.841205940583945,0,1,negative regulation of branch elongation involved in ureteric bud branching,BP,
5074,GO:0072097,1,0.841205940583945,0,1,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway,BP,
5075,GO:0072098,1,0.841205940583945,0,1,anterior/posterior pattern specification involved in kidney development,BP,
5076,GO:0072099,1,0.841205940583945,0,1,anterior/posterior pattern specification involved in ureteric bud development,BP,
5077,GO:0072100,1,0.841205940583945,0,1,specification of ureteric bud anterior/posterior symmetry,BP,
5078,GO:0072101,1,0.841205940583945,0,1,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway,BP,
5079,GO:0072102,1,0.841205940583945,0,1,glomerulus morphogenesis,BP,
5080,GO:0072103,1,0.841205940583945,0,1,glomerulus vasculature morphogenesis,BP,
5081,GO:0072104,1,0.841205940583945,0,1,glomerular capillary formation,BP,
5082,GO:0072106,1,0.928417537918174,0,1,regulation of ureteric bud formation,BP,
5083,GO:0072107,1,0.928417537918174,0,1,positive regulation of ureteric bud formation,BP,
5084,GO:0072108,1,0.664543557958579,0,2,positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
5091,GO:0072126,1,0.769641285234326,0,1,positive regulation of glomerular mesangial cell proliferation,BP,
5092,GO:0072131,1,0.710907860107323,0,1,kidney mesenchyme morphogenesis,BP,
5093,GO:0072132,1,0.0891770975681125,0,8,mesenchyme morphogenesis,BP,
5094,GO:0072133,1,0.710907860107323,0,1,metanephric mesenchyme morphogenesis,BP,
5095,GO:0072134,1,0.710907860107323,0,1,nephrogenic mesenchyme morphogenesis,BP,
5096,GO:0072135,1,0.710907860107323,0,1,kidney mesenchymal cell proliferation,BP,
5097,GO:0072136,1,0.710907860107323,0,1,metanephric mesenchymal cell proliferation involved in metanephros development,BP,
5098,GO:0072138,1,0.634217622687051,0,2,mesenchymal cell proliferation involved in ureteric bud development,BP,
5099,GO:0072143,1,0.372601381566993,0,3,mesangial cell development,BP,
5100,GO:0072144,1,0.372601381566993,0,3,glomerular mesangial cell development,BP,
5102,GO:0072156,1,0.704092276759398,0,1,distal tubule morphogenesis,BP,
5103,GO:0072160,1,0.716190498729619,0,1,nephron tubule epithelial cell differentiation,BP,
5104,GO:0072161,1,0.602376048476982,0,2,mesenchymal cell differentiation involved in kidney development,BP,
5105,GO:0072162,1,0.716836822491286,0,1,metanephric mesenchymal cell differentiation,BP,
5109,GO:0072170,1,0.365810676048132,0,3,metanephric tubule development,BP,
5111,GO:0072172,1,0.928417537918174,0,1,mesonephric tubule formation,BP,
5112,GO:0072173,1,0.716836822491286,0,1,metanephric tubule morphogenesis,BP,
5113,GO:0072174,1,0.716836822491286,0,1,metanephric tubule formation,BP,
5115,GO:0072176,1,0.586933582470314,0,2,nephric duct development,BP,
5116,GO:0072178,1,0.586933582470314,0,2,nephric duct morphogenesis,BP,
5117,GO:0072179,1,0.841205940583945,0,1,nephric duct formation,BP,
5118,GO:0072182,1,0.716190498729619,0,1,regulation of nephron tubule epithelial cell differentiation,BP,
5119,GO:0072189,1,0.841205940583945,0,1,ureter development,BP,
5120,GO:0072190,1,0.841205940583945,0,1,ureter urothelium development,BP,
5121,GO:0072191,1,0.841205940583945,0,1,ureter smooth muscle development,BP,
5122,GO:0072192,1,0.841205940583945,0,1,ureter epithelial cell differentiation,BP,
5123,GO:0072193,1,0.841205940583945,0,1,ureter smooth muscle cell differentiation,BP,
5124,GO:0072197,1,0.841205940583945,0,1,ureter morphogenesis,BP,
5125,GO:0072198,1,0.841205940583945,0,1,mesenchymal cell proliferation involved in ureter development,BP,
5126,GO:0072199,1,0.841205940583945,0,1,regulation of mesenchymal cell proliferation involved in ureter development,BP,
5127,GO:0072200,1,0.841205940583945,0,1,negative regulation of mesenchymal cell proliferation involved in ureter development,BP,
5128,GO:0072201,1,0.540871679044505,0,2,negative regulation of mesenchymal cell proliferation,BP,
5129,GO:0072202,1,0.30560112484956,0,5,cell differentiation involved in metanephros development,BP,
5131,GO:0072205,1,0.602064622063973,0,2,metanephric collecting duct development,BP,
5133,GO:0072209,1,0.769641285234326,0,1,metanephric mesangial cell differentiation,BP,
5140,GO:0072234,1,0.512189270481988,0,2,metanephric nephron tubule development,BP,
5141,GO:0072236,1,0.716467262155752,0,1,metanephric loop of Henle development,BP,
5143,GO:0072243,1,0.512189270481988,0,2,metanephric nephron epithelium development,BP,
5144,GO:0072254,1,0.769641285234326,0,1,metanephric glomerular mesangial cell differentiation,BP,
5145,GO:0072255,1,0.769641285234326,0,1,metanephric glomerular mesangial cell development,BP,
5146,GO:0072257,1,0.716190498729619,0,1,metanephric nephron tubule epithelial cell differentiation,BP,
5149,GO:0072278,1,0.841205940583945,0,1,metanephric comma-shaped body morphogenesis,BP,
5150,GO:0072283,1,0.5582502857103,0,3,metanephric renal vesicle morphogenesis,BP,
5156,GO:0072307,1,0.716190498729619,0,1,regulation of metanephric nephron tubule epithelial cell differentiation,BP,
5157,GO:0072310,1,0.841205940583945,0,1,glomerular epithelial cell development,BP,
5159,GO:0072320,1,0.824843141866342,0,1,volume-sensitive chloride channel activity,MF,
5160,GO:0072329,1,0.566889458089637,0,2,monocarboxylic acid catabolic process,BP,
5172,GO:0072497,1,0.862545484850912,0,1,mesenchymal stem cell differentiation,BP,
5173,GO:0072498,1,0.441705951012269,0,3,embryonic skeletal joint development,BP,
5174,GO:0072503,1,0.168434503106774,0,6,cellular divalent inorganic cation homeostasis,BP,
5175,GO:0072507,1,0.168434503106774,0,6,divalent inorganic cation homeostasis,BP,
5177,GO:0072510,1,0.774076993520791,0,1,trivalent inorganic cation transmembrane transporter activity,MF,
5179,GO:0072512,1,0.774076993520791,0,1,trivalent inorganic cation transport,BP,
5181,GO:0072522,1,0.409583288428975,0,4,purine-containing compound biosynthetic process,BP,
5183,GO:0072524,1,0.534480969901098,0,2,pyridine-containing compound metabolic process,BP,
5185,GO:0072574,1,0.817200303317026,0,1,hepatocyte proliferation,BP,
5186,GO:0072575,1,0.817200303317026,0,1,epithelial cell proliferation involved in liver morphogenesis,BP,
5187,GO:0072576,1,0.817200303317026,0,1,liver morphogenesis,BP,
5193,GO:0072595,1,0.770418300420706,0,1,maintenance of protein localization in organelle,BP,
5194,GO:0072602,1,0.568202356117225,0,1,interleukin-4 secretion,BP,
5196,GO:0072606,1,0.643840742286014,0,1,interleukin-8 secretion,BP,
5197,GO:0072655,1,0.639212907528369,0,2,establishment of protein localization to mitochondrion,BP,
5198,GO:0072656,1,0.770418300420706,0,1,maintenance of protein location in mitochondrion,BP,
5203,GO:0072672,1,0.658464044734903,0,1,neutrophil extravasation,BP,
5206,GO:0072679,1,0.914847263689534,0,1,thymocyte migration,BP,
5207,GO:0075733,1,0.671264126002153,0,1,intracellular transport of virus,BP,
5213,GO:0086001,1,0.498089368524584,0,2,cardiac muscle cell action potential,BP,
5214,GO:0086002,1,0.498089368524584,0,2,cardiac muscle cell action potential involved in contraction,BP,
5217,GO:0086005,1,0.498089368524584,0,2,ventricular cardiac muscle cell action potential,BP,
5218,GO:0086008,1,0.752197563702773,0,1,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,MF,
5219,GO:0086009,1,0.585899995163405,0,2,membrane repolarization,BP,
5220,GO:0086010,1,0.752197563702773,0,1,membrane depolarization during action potential,BP,
5221,GO:0086011,1,0.752197563702773,0,1,membrane repolarization during action potential,BP,
5222,GO:0086013,1,0.752197563702773,0,1,membrane repolarization during cardiac muscle cell action potential,BP,
5223,GO:0086019,1,0.779877946733024,0,1,cell-cell signaling involved in cardiac conduction,BP,
5224,GO:0086023,1,0.822648168832337,0,1,adrenergic receptor signaling pathway involved in heart process,BP,
5225,GO:0086029,1,0.779877946733024,0,1,Purkinje myocyte to ventricular cardiac muscle cell signaling,BP,
5226,GO:0086030,1,0.822648168832337,0,1,adrenergic receptor signaling pathway involved in cardiac muscle relaxation,BP,
5227,GO:0086042,1,0.663449592946197,0,1,cardiac muscle cell-cardiac muscle cell adhesion,BP,
5228,GO:0086065,1,0.516527472667163,0,2,cell communication involved in cardiac conduction,BP,
5229,GO:0086068,1,0.779877946733024,0,1,Purkinje myocyte to ventricular cardiac muscle cell communication,BP,
5230,GO:0086069,1,0.663449592946197,0,1,bundle of His cell to Purkinje myocyte communication,BP,
5231,GO:0086073,1,0.663449592946197,0,1,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,BP,
5232,GO:0086080,1,0.663449592946197,0,1,protein binding involved in heterotypic cell-cell adhesion,MF,
5233,GO:0086083,1,0.663449592946197,0,1,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,MF,
5234,GO:0086091,1,0.498089368524584,0,2,regulation of heart rate by cardiac conduction,BP,
5236,GO:0086103,1,0.822648168832337,0,1,G-protein coupled receptor signaling pathway involved in heart process,BP,
5240,GO:0090005,1,0.689295922426304,0,1,negative regulation of establishment of protein localization to plasma membrane,BP,
5241,GO:0090009,1,0.643840742286014,0,1,primitive streak formation,BP,
5242,GO:0090022,1,0.595460655369225,0,2,regulation of neutrophil chemotaxis,BP,
5243,GO:0090023,1,0.818949769337691,0,1,positive regulation of neutrophil chemotaxis,BP,
5245,GO:0090031,1,0.541729739342896,0,2,positive regulation of steroid hormone biosynthetic process,BP,
5247,GO:0090036,1,0.643840742286014,0,1,regulation of protein kinase C signaling,BP,
5248,GO:0090037,1,0.643840742286014,0,1,positive regulation of protein kinase C signaling,BP,
5249,GO:0090049,1,0.568202356117225,0,1,regulation of cell migration involved in sprouting angiogenesis,BP,
5250,GO:0090051,1,0.568202356117225,0,1,negative regulation of cell migration involved in sprouting angiogenesis,BP,
5257,GO:0090100,1,0.0689702556365001,0,8,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,
5258,GO:0090101,1,0.1803994983921,0,5,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,
5259,GO:0090102,1,0.643840742286014,0,1,cochlea development,BP,
5260,GO:0090103,1,0.643840742286014,0,1,cochlea morphogenesis,BP,
5263,GO:0090131,1,0.856088106630298,0,1,mesenchyme migration,BP,
5265,GO:0090133,1,0.89801195405569,0,1,mesendoderm migration,BP,
5266,GO:0090134,1,0.89801195405569,0,1,cell migration involved in mesendoderm migration,BP,
5268,GO:0090138,1,0.727923995035168,0,1,regulation of actin cytoskeleton organization by cell-cell adhesion,BP,
5271,GO:0090174,1,0.427737119754818,0,4,organelle membrane fusion,BP,
5272,GO:0090175,1,0.462131730838942,0,2,regulation of establishment of planar polarity,BP,
5273,GO:0090177,1,0.643840742286014,0,1,establishment of planar polarity involved in neural tube closure,BP,
5274,GO:0090178,1,0.643840742286014,0,1,regulation of establishment of planar polarity involved in neural tube closure,BP,
5275,GO:0090179,1,0.643840742286014,0,1,planar cell polarity pathway involved in neural tube closure,BP,
5279,GO:0090186,1,0.704092276759398,0,1,regulation of pancreatic juice secretion,BP,
5280,GO:0090188,1,0.704092276759398,0,1,negative regulation of pancreatic juice secretion,BP,
5281,GO:0090189,1,0.631024778099643,0,3,regulation of branching involved in ureteric bud morphogenesis,BP,
5282,GO:0090190,1,0.750915424135599,0,2,positive regulation of branching involved in ureteric bud morphogenesis,BP,
5283,GO:0090191,1,0.841205940583945,0,1,negative regulation of branching involved in ureteric bud morphogenesis,BP,
5285,GO:0090193,1,0.769641285234326,0,1,positive regulation of glomerulus development,BP,
5287,GO:0090199,1,0.639212907528369,0,2,regulation of release of cytochrome c from mitochondria,BP,
5288,GO:0090200,1,0.830438737450604,0,1,positive regulation of release of cytochrome c from mitochondria,BP,
5289,GO:0090201,1,0.770418300420706,0,1,negative regulation of release of cytochrome c from mitochondria,BP,
5290,GO:0090202,1,0.749427895517118,0,1,gene looping,BP,
5291,GO:0090207,1,0.658464044734903,0,1,regulation of triglyceride metabolic process,BP,
5292,GO:0090209,1,0.658464044734903,0,1,negative regulation of triglyceride metabolic process,BP,
5293,GO:0090218,1,0.769641285234326,0,1,positive regulation of lipid kinase activity,BP,
5294,GO:0090224,1,0.84412233261981,0,1,regulation of spindle organization,BP,
5296,GO:0090263,1,0.164363570060572,0,7,positive regulation of canonical Wnt signaling pathway,BP,
5297,GO:0090276,1,0.541138924887088,0,3,regulation of peptide hormone secretion,BP,
5298,GO:0090278,1,0.751822927145045,0,1,negative regulation of peptide hormone secretion,BP,
5299,GO:0090279,1,0.599539119632082,0,2,regulation of calcium ion import,BP,
5300,GO:0090280,1,0.769641285234326,0,1,positive regulation of calcium ion import,BP,
5301,GO:0090281,1,0.779877946733024,0,1,negative regulation of calcium ion import,BP,
5303,GO:0090288,1,0.168818210197964,0,5,negative regulation of cellular response to growth factor stimulus,BP,
5304,GO:0090303,1,0.712503495588033,0,2,positive regulation of wound healing,BP,
5308,GO:0090322,1,0.710907860107323,0,1,regulation of superoxide metabolic process,BP,
5309,GO:0090324,1,0.76995755234939,0,1,negative regulation of oxidative phosphorylation,BP,
5310,GO:0090329,1,0.636140908138844,0,2,regulation of DNA-dependent DNA replication,BP,
5312,GO:0090383,1,0.572101934452145,0,3,phagosome acidification,BP,
5313,GO:0090385,1,0.658795898523649,0,2,phagosome-lysosome fusion,BP,
5318,GO:0090493,1,0.928417537918174,0,1,catecholamine uptake,BP,
5319,GO:0090494,1,0.928417537918174,0,1,dopamine uptake,BP,
5320,GO:0090504,1,0.339526463862964,0,4,epiboly,BP,
5321,GO:0090505,1,0.339526463862964,0,4,epiboly involved in wound healing,BP,
5322,GO:0090526,1,0.736825336349041,0,1,regulation of gluconeogenesis involved in cellular glucose homeostasis,BP,
5324,GO:0090559,1,0.830438737450604,0,1,regulation of membrane permeability,BP,
5325,GO:0090575,1,0.682277403524016,0,1,RNA polymerase II transcription factor complex,CC,
5326,GO:0090579,1,0.749427895517118,0,1,dsDNA loop formation,BP,
5328,GO:0090598,1,0.932928362009675,0,1,male anatomical structure morphogenesis,BP,
5329,GO:0090630,1,0.643840742286014,0,1,activation of GTPase activity,BP,
5330,GO:0090659,1,0.652168350167583,0,1,walking behavior,BP,
5331,GO:0090677,1,0.769641285234326,0,1,reversible differentiation,BP,
5332,GO:0090678,1,0.769641285234326,0,1,cell dedifferentiation involved in phenotypic switching,BP,
5334,GO:0097011,1,0.770418300420706,0,1,cellular response to granulocyte macrophage colony-stimulating factor stimulus,BP,
5335,GO:0097012,1,0.770418300420706,0,1,response to granulocyte macrophage colony-stimulating factor,BP,
5338,GO:0097021,1,0.840479796371432,0,1,lymphocyte migration into lymphoid organs,BP,
5342,GO:0097058,1,0.84015341765014,0,1,CRLF-CLCF1 complex,CC,
5343,GO:0097059,1,0.84015341765014,0,1,CNTFR-CLCF1 complex,CC,
5347,GO:0097070,1,0.77140024913884,0,1,ductus arteriosus closure,BP,
5348,GO:0097084,1,0.568202356117225,0,1,vascular smooth muscle cell development,BP,
5349,GO:0097091,1,0.6959456816156,0,1,synaptic vesicle clustering,BP,
5350,GO:0097094,1,0.841205940583945,0,1,craniofacial suture morphogenesis,BP,
5353,GO:0097104,1,0.6959456816156,0,1,postsynaptic membrane assembly,BP,
5354,GO:0097106,1,0.6959456816156,0,1,postsynaptic density organization,BP,
5356,GO:0097118,1,0.6959456816156,0,1,neuroligin clustering involved in postsynaptic membrane assembly,BP,
5357,GO:0097119,1,0.6959456816156,0,1,postsynaptic density protein 95 clustering,BP,
5359,GO:0097152,1,0.710907860107323,0,1,mesenchymal cell apoptotic process,BP,
5361,GO:0097164,1,0.506316604460422,0,2,ammonium ion metabolic process,BP,
5362,GO:0097178,1,0.889443009650413,0,1,ruffle assembly,BP,
5368,GO:0097186,1,0.646748481245743,0,1,amelogenesis,BP,
5373,GO:0097194,1,0.770418300420706,0,1,execution phase of apoptosis,BP,
5374,GO:0097197,1,0.847131192931472,0,1,tetraspanin-enriched microdomain,CC,
5379,GO:0097278,1,0.774047742304058,0,1,complement-dependent cytotoxicity,BP,
5380,GO:0097284,1,0.658464044734903,0,1,hepatocyte apoptotic process,BP,
5381,GO:0097286,1,0.774076993520791,0,1,iron ion import,BP,
5383,GO:0097306,1,0.521554584882655,0,2,cellular response to alcohol,BP,
5384,GO:0097325,1,0.643840742286014,0,1,melanocyte proliferation,BP,
5386,GO:0097345,1,0.830438737450604,0,1,mitochondrial outer membrane permeabilization,BP,
5388,GO:0097381,1,0.534748033148175,0,1,photoreceptor disc membrane,CC,
5389,GO:0097386,1,0.803527095561903,0,1,glial cell projection,CC,
5391,GO:0097425,1,0.824843141866342,0,1,smooth endoplasmic reticulum part,CC,
5393,GO:0097449,1,0.803527095561903,0,1,astrocyte projection,CC,
5395,GO:0097459,1,0.774076993520791,0,1,iron ion import into cell,BP,
5396,GO:0097460,1,0.774076993520791,0,1,ferrous iron import into cell,BP,
5397,GO:0097479,1,0.379673828618757,0,4,synaptic vesicle localization,BP,
5398,GO:0097480,1,0.547652772809584,0,3,establishment of synaptic vesicle localization,BP,
5402,GO:0097531,1,0.822648168832337,0,1,mast cell migration,BP,
5404,GO:0097553,1,0.779877946733024,0,1,calcium ion transmembrane import into cytosol,BP,
5405,GO:0097581,1,0.843902948514569,0,1,lamellipodium organization,BP,
5407,GO:0097623,1,0.752197563702773,0,1,potassium ion export across plasma membrane,BP,
5410,GO:0097696,1,0.339934202538491,0,3,STAT cascade,BP,
5413,GO:0097720,1,0.76995755234939,0,1,calcineurin-mediated signaling,BP,
5418,GO:0097746,1,0.138512594189329,0,9,regulation of blood vessel diameter,BP,
5419,GO:0097755,1,0.736343321385503,0,2,positive regulation of blood vessel diameter,BP,
5420,GO:0097756,1,0.208881966569816,0,7,negative regulation of blood vessel diameter,BP,
5421,GO:0098531,1,0.682277403524016,0,1,transcription factor activity, direct ligand regulated sequence-specific DNA binding,MF,
5422,GO:0098542,1,0.554382998377286,0,4,defense response to other organism,BP,
5429,GO:0098596,1,0.77140024913884,0,1,imitative learning,BP,
5430,GO:0098597,1,0.77140024913884,0,1,observational learning,BP,
5431,GO:0098598,1,0.77140024913884,0,1,learned vocalization behavior or vocal learning,BP,
5434,GO:0098631,1,0.512118372425494,0,2,protein binding involved in cell adhesion,MF,
5435,GO:0098632,1,0.512118372425494,0,2,protein binding involved in cell-cell adhesion,MF,
5437,GO:0098641,1,0.773259263118995,0,1,cadherin binding involved in cell-cell adhesion,MF,
5439,GO:0098656,1,0.634888959063051,0,2,anion transmembrane transport,BP,
5440,GO:0098657,1,0.718343443979177,0,2,import into cell,BP,
5441,GO:0098659,1,0.774076993520791,0,1,inorganic cation import into cell,BP,
5443,GO:0098661,1,0.824843141866342,0,1,inorganic anion transmembrane transport,BP,
5445,GO:0098668,1,0.752197563702773,0,1,potassium ion export from cell,BP,
5447,GO:0098732,1,0.66650505420776,0,1,macromolecule deacylation,BP,
5450,GO:0098751,1,0.556537810796044,0,2,bone cell development,BP,
5451,GO:0098754,1,0.522911379667393,0,2,detoxification,BP,
5455,GO:0098791,1,0.588979878337882,0,2,Golgi subcompartment,CC,
5463,GO:0098810,1,0.928417537918174,0,1,neurotransmitter reuptake,BP,
5464,GO:0098811,1,0.434779495991242,0,2,transcriptional repressor activity, RNA polymerase II activating transcription factor binding,MF,
5465,GO:0098813,1,0.84412233261981,0,1,nuclear chromosome segregation,BP,
5466,GO:0098815,1,0.846321998934282,0,1,modulation of excitatory postsynaptic potential,BP,
5472,GO:0098868,1,0.954312251553925,0,1,bone growth,BP,
5473,GO:0098869,1,0.522911379667393,0,2,cellular oxidant detoxification,BP,
5474,GO:0098900,1,0.663449592946197,0,1,regulation of action potential,BP,
5475,GO:0098901,1,0.663449592946197,0,1,regulation of cardiac muscle cell action potential,BP,
5476,GO:0098911,1,0.663449592946197,0,1,regulation of ventricular cardiac muscle cell action potential,BP,
5477,GO:0098915,1,0.752197563702773,0,1,membrane repolarization during ventricular cardiac muscle cell action potential,BP,
5481,GO:0099003,1,0.547652772809584,0,3,vesicle-mediated transport in synapse,BP,
5482,GO:0099023,1,0.808086260451893,0,1,tethering complex,CC,
5484,GO:0099054,1,0.544181611588407,0,2,presynapse assembly,BP,
5485,GO:0099068,1,0.377344010726496,0,3,postsynapse assembly,BP,
5488,GO:0099084,1,0.6959456816156,0,1,postsynaptic specialization organization,BP,
5489,GO:0099094,1,0.588493411762287,0,2,ligand-gated cation channel activity,MF,
5490,GO:0099106,1,0.585633287776592,0,2,ion channel regulator activity,MF,
5493,GO:0099504,1,0.492099442612326,0,3,synaptic vesicle cycle,BP,
5496,GO:0099531,1,0.657543965312316,0,3,presynaptic process involved in chemical synaptic transmission,BP,
5499,GO:0099565,1,0.501851641073257,0,3,chemical synaptic transmission, postsynaptic,BP,
5502,GO:0099587,1,0.774076993520791,0,1,inorganic ion import into cell,BP,
5503,GO:0099600,1,0.0283357421539297,0,13,transmembrane receptor activity,MF,
5504,GO:0099622,1,0.752197563702773,0,1,cardiac muscle cell membrane repolarization,BP,
5505,GO:0099623,1,0.752197563702773,0,1,regulation of cardiac muscle cell membrane repolarization,BP,
5506,GO:0099625,1,0.752197563702773,0,1,ventricular cardiac muscle cell membrane repolarization,BP,
5507,GO:0099643,1,0.708693839368643,0,2,signal release from synapse,BP,
5508,GO:0100002,1,0.770418300420706,0,1,negative regulation of protein kinase activity by protein phosphorylation,BP,
5510,GO:0101003,1,0.657097306241214,0,1,ficolin-1-rich granule membrane,CC,
5514,GO:1900006,1,0.710907860107323,0,1,positive regulation of dendrite development,BP,
5515,GO:1900019,1,0.643840742286014,0,1,regulation of protein kinase C activity,BP,
5516,GO:1900020,1,0.643840742286014,0,1,positive regulation of protein kinase C activity,BP,
5517,GO:1900027,1,0.889443009650413,0,1,regulation of ruffle assembly,BP,
5518,GO:1900029,1,0.889443009650413,0,1,positive regulation of ruffle assembly,BP,
5519,GO:1900046,1,0.497088421933865,0,3,regulation of hemostasis,BP,
5520,GO:1900047,1,0.497088421933865,0,3,negative regulation of hemostasis,BP,
5525,GO:1900104,1,0.710907860107323,0,1,regulation of hyaluranon cable assembly,BP,
5526,GO:1900106,1,0.710907860107323,0,1,positive regulation of hyaluranon cable assembly,BP,
5527,GO:1900125,1,0.769641285234326,0,1,regulation of hyaluronan biosynthetic process,BP,
5528,GO:1900127,1,0.769641285234326,0,1,positive regulation of hyaluronan biosynthetic process,BP,
5536,GO:1900193,1,0.954312251553925,0,1,regulation of oocyte maturation,BP,
5537,GO:1900194,1,0.954312251553925,0,1,negative regulation of oocyte maturation,BP,
5538,GO:1900238,1,0.769641285234326,0,1,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
5539,GO:1900239,1,0.769641285234326,0,1,regulation of phenotypic switching,BP,
5540,GO:1900241,1,0.769641285234326,0,1,positive regulation of phenotypic switching,BP,
5541,GO:1900274,1,0.840697515380158,0,1,regulation of phospholipase C activity,BP,
5542,GO:1900371,1,0.548710502616905,0,3,regulation of purine nucleotide biosynthetic process,BP,
5543,GO:1900372,1,0.818949769337691,0,1,negative regulation of purine nucleotide biosynthetic process,BP,
5544,GO:1900373,1,0.671033848567201,0,2,positive regulation of purine nucleotide biosynthetic process,BP,
5545,GO:1900376,1,0.643840742286014,0,1,regulation of secondary metabolite biosynthetic process,BP,
5546,GO:1900377,1,0.643840742286014,0,1,negative regulation of secondary metabolite biosynthetic process,BP,
5547,GO:1900407,1,0.54687236796968,0,2,regulation of cellular response to oxidative stress,BP,
5548,GO:1900408,1,0.770418300420706,0,1,negative regulation of cellular response to oxidative stress,BP,
5549,GO:1900452,1,0.77186369485247,0,1,regulation of long term synaptic depression,BP,
5550,GO:1900453,1,0.77186369485247,0,1,negative regulation of long term synaptic depression,BP,
5551,GO:1900542,1,0.220631132786923,0,6,regulation of purine nucleotide metabolic process,BP,
5552,GO:1900543,1,0.62995686789774,0,2,negative regulation of purine nucleotide metabolic process,BP,
5553,GO:1900544,1,0.270706974496181,0,5,positive regulation of purine nucleotide metabolic process,BP,
5554,GO:1900736,1,0.822648168832337,0,1,regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
5555,GO:1900738,1,0.822648168832337,0,1,positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
5556,GO:1900739,1,0.830438737450604,0,1,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
5557,GO:1900740,1,0.830438737450604,0,1,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
5558,GO:1900744,1,0.658634903970994,0,2,regulation of p38MAPK cascade,BP,
5559,GO:1900745,1,0.658634903970994,0,2,positive regulation of p38MAPK cascade,BP,
5566,GO:1901020,1,0.779877946733024,0,1,negative regulation of calcium ion transmembrane transporter activity,BP,
5567,GO:1901028,1,0.830438737450604,0,1,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
5568,GO:1901030,1,0.830438737450604,0,1,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
5569,GO:1901031,1,0.522911379667393,0,2,regulation of response to reactive oxygen species,BP,
5570,GO:1901068,1,0.689295922426304,0,1,guanosine-containing compound metabolic process,BP,
5573,GO:1901079,1,0.822648168832337,0,1,positive regulation of relaxation of muscle,BP,
5574,GO:1901099,1,0.66659189787644,0,3,negative regulation of signal transduction in absence of ligand,BP,
5578,GO:1901145,1,0.710907860107323,0,1,mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
5579,GO:1901184,1,0.230962221898368,0,6,regulation of ERBB signaling pathway,BP,
5580,GO:1901185,1,0.635076075328155,0,2,negative regulation of ERBB signaling pathway,BP,
5581,GO:1901186,1,0.366694322915482,0,4,positive regulation of ERBB signaling pathway,BP,
5582,GO:1901201,1,0.568202356117225,0,1,regulation of extracellular matrix assembly,BP,
5583,GO:1901213,1,0.363804772957571,0,3,regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
5584,GO:1901214,1,0.160914419812121,0,9,regulation of neuron death,BP,
5585,GO:1901215,1,0.200286023180512,0,8,negative regulation of neuron death,BP,
5586,GO:1901264,1,0.657726820326536,0,2,carbohydrate derivative transport,BP,
5589,GO:1901293,1,0.409583288428975,0,4,nucleoside phosphate biosynthetic process,BP,
5590,GO:1901338,1,0.620119989668987,0,2,catecholamine binding,MF,
5601,GO:1901476,1,0.602115213468231,0,2,carbohydrate transporter activity,MF,
5602,GO:1901522,1,0.31380212504827,0,3,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP,
5603,GO:1901532,1,0.568202356117225,0,1,regulation of hematopoietic progenitor cell differentiation,BP,
5604,GO:1901533,1,0.568202356117225,0,1,negative regulation of hematopoietic progenitor cell differentiation,BP,
5605,GO:1901550,1,0.825402620386163,0,1,regulation of endothelial cell development,BP,
5606,GO:1901552,1,0.825402620386163,0,1,positive regulation of endothelial cell development,BP,
5612,GO:1901571,1,0.818949769337691,0,1,fatty acid derivative transport,BP,
5615,GO:1901605,1,0.7203786970807,0,1,alpha-amino acid metabolic process,BP,
5616,GO:1901606,1,0.7203786970807,0,1,alpha-amino acid catabolic process,BP,
5621,GO:1901623,1,0.643840742286014,0,1,regulation of lymphocyte chemotaxis,BP,
5622,GO:1901626,1,0.6959456816156,0,1,regulation of postsynaptic membrane organization,BP,
5627,GO:1901657,1,0.689295922426304,0,1,glycosyl compound metabolic process,BP,
5628,GO:1901674,1,0.716190498729619,0,1,regulation of histone H3-K27 acetylation,BP,
5629,GO:1901676,1,0.716190498729619,0,1,positive regulation of histone H3-K27 acetylation,BP,
5630,GO:1901678,1,0.728409909849621,0,1,iron coordination entity transport,BP,
5638,GO:1901724,1,0.769641285234326,0,1,positive regulation of cell proliferation involved in kidney development,BP,
5639,GO:1901796,1,0.639212907528369,0,2,regulation of signal transduction by p53 class mediator,BP,
5640,GO:1901798,1,0.830438737450604,0,1,positive regulation of signal transduction by p53 class mediator,BP,
5641,GO:1901800,1,0.497355855535524,0,2,positive regulation of proteasomal protein catabolic process,BP,
5644,GO:1901862,1,0.407951451636496,0,4,negative regulation of muscle tissue development,BP,
5653,GO:1901899,1,0.822648168832337,0,1,positive regulation of relaxation of cardiac muscle,BP,
5654,GO:1901963,1,0.841205940583945,0,1,regulation of cell proliferation involved in outflow tract morphogenesis,BP,
5655,GO:1901964,1,0.841205940583945,0,1,positive regulation of cell proliferation involved in outflow tract morphogenesis,BP,
5656,GO:1901976,1,0.770418300420706,0,1,regulation of cell cycle checkpoint,BP,
5658,GO:1901983,1,0.716190498729619,0,1,regulation of protein acetylation,BP,
5659,GO:1901985,1,0.716190498729619,0,1,positive regulation of protein acetylation,BP,
5664,GO:1901998,1,0.842953509888315,0,1,toxin transport,BP,
5665,GO:1902001,1,0.770418300420706,0,1,fatty acid transmembrane transport,BP,
5666,GO:1902010,1,0.736825336349041,0,1,negative regulation of translation in response to endoplasmic reticulum stress,BP,
5669,GO:1902041,1,0.830438737450604,0,1,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,
5670,GO:1902043,1,0.830438737450604,0,1,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,
5671,GO:1902074,1,0.818949769337691,0,1,response to salt,BP,
5672,GO:1902098,1,0.682277403524016,0,1,calcitriol binding,MF,
5676,GO:1902108,1,0.830438737450604,0,1,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
5677,GO:1902110,1,0.830438737450604,0,1,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
5680,GO:1902121,1,0.682277403524016,0,1,lithocholic acid binding,MF,
5681,GO:1902170,1,0.748793081179247,0,1,cellular response to reactive nitrogen species,BP,
5682,GO:1902175,1,0.770418300420706,0,1,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
5683,GO:1902176,1,0.770418300420706,0,1,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
5685,GO:1902235,1,0.830438737450604,0,1,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
5686,GO:1902237,1,0.830438737450604,0,1,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
5687,GO:1902263,1,0.568202356117225,0,1,apoptotic process involved in embryonic digit morphogenesis,BP,
5688,GO:1902271,1,0.682277403524016,0,1,D3 vitamins binding,MF,
5689,GO:1902275,1,0.716190498729619,0,1,regulation of chromatin organization,BP,
5690,GO:1902282,1,0.752197563702773,0,1,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,MF,
5691,GO:1902284,1,0.554678513309543,0,2,neuron projection extension involved in neuron projection guidance,BP,
5692,GO:1902302,1,0.752197563702773,0,1,regulation of potassium ion export,BP,
5693,GO:1902303,1,0.752197563702773,0,1,negative regulation of potassium ion export,BP,
5694,GO:1902337,1,0.484015240958911,0,2,regulation of apoptotic process involved in morphogenesis,BP,
5695,GO:1902338,1,0.710907860107323,0,1,negative regulation of apoptotic process involved in morphogenesis,BP,
5696,GO:1902339,1,0.682277403524016,0,1,positive regulation of apoptotic process involved in morphogenesis,BP,
5697,GO:1902369,1,0.507196040392339,0,2,negative regulation of RNA catabolic process,BP,
5698,GO:1902373,1,0.507196040392339,0,2,negative regulation of mRNA catabolic process,BP,
5699,GO:1902379,1,0.643840742286014,0,1,chemoattractant activity involved in axon guidance,MF,
5703,GO:1902455,1,0.710907860107323,0,1,negative regulation of stem cell population maintenance,BP,
5704,GO:1902473,1,0.544181611588407,0,2,regulation of protein localization to synapse,BP,
5705,GO:1902474,1,0.544181611588407,0,2,positive regulation of protein localization to synapse,BP,
5706,GO:1902476,1,0.824843141866342,0,1,chloride transmembrane transport,BP,
5715,GO:1902579,1,0.565153934981435,0,2,multi-organism localization,BP,
5717,GO:1902581,1,0.671264126002153,0,1,multi-organism cellular localization,BP,
5719,GO:1902583,1,0.671264126002153,0,1,multi-organism intracellular transport,BP,
5724,GO:1902622,1,0.595460655369225,0,2,regulation of neutrophil migration,BP,
5725,GO:1902624,1,0.818949769337691,0,1,positive regulation of neutrophil migration,BP,
5728,GO:1902656,1,0.779877946733024,0,1,calcium ion import into cytosol,BP,
5729,GO:1902667,1,0.554678513309543,0,2,regulation of axon guidance,BP,
5730,GO:1902668,1,0.554678513309543,0,2,negative regulation of axon guidance,BP,
5733,GO:1902686,1,0.830438737450604,0,1,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,
5734,GO:1902688,1,0.76995755234939,0,1,regulation of NAD metabolic process,BP,
5735,GO:1902690,1,0.76995755234939,0,1,positive regulation of NAD metabolic process,BP,
5736,GO:1902692,1,0.568202356117225,0,1,regulation of neuroblast proliferation,BP,
5737,GO:1902742,1,0.18165613298813,0,4,apoptotic process involved in development,BP,
5742,GO:1902850,1,0.84412233261981,0,1,microtubule cytoskeleton organization involved in mitosis,BP,
5743,GO:1902882,1,0.401699508470201,0,3,regulation of response to oxidative stress,BP,
5744,GO:1902883,1,0.770418300420706,0,1,negative regulation of response to oxidative stress,BP,
5745,GO:1902893,1,0.580046122204865,0,2,regulation of pri-miRNA transcription from RNA polymerase II promoter,BP,
5746,GO:1902894,1,0.769641285234326,0,1,negative regulation of pri-miRNA transcription from RNA polymerase II promoter,BP,
5747,GO:1902895,1,0.580046122204865,0,2,positive regulation of pri-miRNA transcription from RNA polymerase II promoter,BP,
5748,GO:1902897,1,0.6959456816156,0,1,regulation of postsynaptic density protein 95 clustering,BP,
5753,GO:1902930,1,0.682277403524016,0,1,regulation of alcohol biosynthetic process,BP,
5758,GO:1903010,1,0.743693968038284,0,1,regulation of bone development,BP,
5759,GO:1903011,1,0.743693968038284,0,1,negative regulation of bone development,BP,
5760,GO:1903018,1,0.801501284797587,0,1,regulation of glycoprotein metabolic process,BP,
5761,GO:1903019,1,0.801501284797587,0,1,negative regulation of glycoprotein metabolic process,BP,
5762,GO:1903025,1,0.716190498729619,0,1,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
5763,GO:1903034,1,0.25118068544923,0,6,regulation of response to wounding,BP,
5764,GO:1903035,1,0.354896436902785,0,4,negative regulation of response to wounding,BP,
5765,GO:1903036,1,0.712503495588033,0,2,positive regulation of response to wounding,BP,
5769,GO:1903046,1,0.265874338495922,0,4,meiotic cell cycle process,BP,
5771,GO:1903050,1,0.290250750546732,0,4,regulation of proteolysis involved in cellular protein catabolic process,BP,
5772,GO:1903052,1,0.367448664858954,0,3,positive regulation of proteolysis involved in cellular protein catabolic process,BP,
5773,GO:1903053,1,0.407889407990603,0,2,regulation of extracellular matrix organization,BP,
5775,GO:1903077,1,0.689295922426304,0,1,negative regulation of protein localization to plasma membrane,BP,
5778,GO:1903131,1,0.841205940583945,0,1,mononuclear cell differentiation,BP,
5779,GO:1903140,1,0.825402620386163,0,1,regulation of establishment of endothelial barrier,BP,
5780,GO:1903142,1,0.825402620386163,0,1,positive regulation of establishment of endothelial barrier,BP,
5782,GO:1903170,1,0.779877946733024,0,1,negative regulation of calcium ion transmembrane transport,BP,
5783,GO:1903201,1,0.770418300420706,0,1,regulation of oxidative stress-induced cell death,BP,
5784,GO:1903202,1,0.770418300420706,0,1,negative regulation of oxidative stress-induced cell death,BP,
5785,GO:1903232,1,0.869433192415004,0,1,melanosome assembly,BP,
5786,GO:1903305,1,0.304944724052361,0,4,regulation of regulated secretory pathway,BP,
5787,GO:1903306,1,0.568202356117225,0,1,negative regulation of regulated secretory pathway,BP,
5788,GO:1903307,1,0.645274061510633,0,2,positive regulation of regulated secretory pathway,BP,
5789,GO:1903311,1,0.365554940761731,0,3,regulation of mRNA metabolic process,BP,
5790,GO:1903312,1,0.507196040392339,0,2,negative regulation of mRNA metabolic process,BP,
5791,GO:1903313,1,0.723357618254592,0,1,positive regulation of mRNA metabolic process,BP,
5793,GO:1903320,1,0.612002658216457,0,2,regulation of protein modification by small protein conjugation or removal,BP,
5794,GO:1903322,1,0.612002658216457,0,2,positive regulation of protein modification by small protein conjugation or removal,BP,
5800,GO:1903409,1,0.486878523214294,0,3,reactive oxygen species biosynthetic process,BP,
5801,GO:1903426,1,0.486878523214294,0,3,regulation of reactive oxygen species biosynthetic process,BP,
5802,GO:1903428,1,0.486878523214294,0,3,positive regulation of reactive oxygen species biosynthetic process,BP,
5803,GO:1903429,1,0.954312251553925,0,1,regulation of cell maturation,BP,
5804,GO:1903430,1,0.954312251553925,0,1,negative regulation of cell maturation,BP,
5805,GO:1903432,1,0.736825336349041,0,1,regulation of TORC1 signaling,BP,
5806,GO:1903433,1,0.774047742304058,0,1,regulation of constitutive secretory pathway,BP,
5807,GO:1903435,1,0.774047742304058,0,1,positive regulation of constitutive secretory pathway,BP,
5812,GO:1903510,1,0.459393675927699,0,3,mucopolysaccharide metabolic process,BP,
5813,GO:1903514,1,0.779877946733024,0,1,calcium ion transport from endoplasmic reticulum to cytosol,BP,
5814,GO:1903519,1,0.682277403524016,0,1,regulation of mammary gland involution,BP,
5815,GO:1903521,1,0.682277403524016,0,1,positive regulation of mammary gland involution,BP,
5817,GO:1903523,1,0.329330268302916,0,3,negative regulation of blood circulation,BP,
5833,GO:1903578,1,0.76995755234939,0,1,regulation of ATP metabolic process,BP,
5834,GO:1903579,1,0.76995755234939,0,1,negative regulation of ATP metabolic process,BP,
5835,GO:1903580,1,0.76995755234939,0,1,positive regulation of ATP metabolic process,BP,
5839,GO:1903671,1,0.568202356117225,0,1,negative regulation of sprouting angiogenesis,BP,
5844,GO:1903715,1,0.76995755234939,0,1,regulation of aerobic respiration,BP,
5845,GO:1903719,1,0.770418300420706,0,1,regulation of I-kappaB phosphorylation,BP,
5846,GO:1903721,1,0.770418300420706,0,1,positive regulation of I-kappaB phosphorylation,BP,
5848,GO:1903726,1,0.769641285234326,0,1,negative regulation of phospholipid metabolic process,BP,
5849,GO:1903727,1,0.769641285234326,0,1,positive regulation of phospholipid metabolic process,BP,
5851,GO:1903747,1,0.830438737450604,0,1,regulation of establishment of protein localization to mitochondrion,BP,
5852,GO:1903749,1,0.830438737450604,0,1,positive regulation of establishment of protein localization to mitochondrion,BP,
5853,GO:1903779,1,0.522370397522252,0,3,regulation of cardiac conduction,BP,
5854,GO:1903792,1,0.59395529716623,0,2,negative regulation of anion transport,BP,
5855,GO:1903793,1,0.818949769337691,0,1,positive regulation of anion transport,BP,
5856,GO:1903798,1,0.841205940583945,0,1,regulation of production of miRNAs involved in gene silencing by miRNA,BP,
5857,GO:1903800,1,0.841205940583945,0,1,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP,
5858,GO:1903825,1,0.770418300420706,0,1,organic acid transmembrane transport,BP,
5862,GO:1903830,1,0.862773585572262,0,1,magnesium ion transmembrane transport,BP,
5864,GO:1903845,1,0.829306243472219,0,1,negative regulation of cellular response to transforming growth factor beta stimulus,BP,
5865,GO:1903847,1,0.395646254351599,0,2,regulation of aorta morphogenesis,BP,
5866,GO:1903849,1,0.395646254351599,0,2,positive regulation of aorta morphogenesis,BP,
5867,GO:1903867,1,0.710907860107323,0,1,extraembryonic membrane development,BP,
5868,GO:1903900,1,0.568202356117225,0,1,regulation of viral life cycle,BP,
5869,GO:1903902,1,0.568202356117225,0,1,positive regulation of viral life cycle,BP,
5870,GO:1903959,1,0.770418300420706,0,1,regulation of anion transmembrane transport,BP,
5871,GO:1903960,1,0.770418300420706,0,1,negative regulation of anion transmembrane transport,BP,
5874,GO:1904023,1,0.76995755234939,0,1,regulation of glucose catabolic process to lactate via pyruvate,BP,
5875,GO:1904025,1,0.76995755234939,0,1,positive regulation of glucose catabolic process to lactate via pyruvate,BP,
5884,GO:1904238,1,0.372601381566993,0,3,pericyte cell differentiation,BP,
5885,GO:1904262,1,0.736825336349041,0,1,negative regulation of TORC1 signaling,BP,
5887,GO:1904376,1,0.689295922426304,0,1,negative regulation of protein localization to cell periphery,BP,
5890,GO:1904407,1,0.630335029060165,0,2,positive regulation of nitric oxide metabolic process,BP,
5891,GO:1904502,1,0.736825336349041,0,1,regulation of lipophagy,BP,
5892,GO:1904504,1,0.736825336349041,0,1,positive regulation of lipophagy,BP,
5896,GO:1904659,1,0.81190363278393,0,1,glucose transmembrane transport,BP,
5897,GO:1904672,1,0.710907860107323,0,1,regulation of somatic stem cell population maintenance,BP,
5898,GO:1904673,1,0.710907860107323,0,1,negative regulation of somatic stem cell population maintenance,BP,
5899,GO:1904705,1,0.769641285234326,0,1,regulation of vascular smooth muscle cell proliferation,BP,
5900,GO:1904707,1,0.769641285234326,0,1,positive regulation of vascular smooth muscle cell proliferation,BP,
5901,GO:1904738,1,0.769641285234326,0,1,vascular associated smooth muscle cell migration,BP,
5902,GO:1904746,1,0.710907860107323,0,1,negative regulation of apoptotic process involved in development,BP,
5903,GO:1904747,1,0.682277403524016,0,1,positive regulation of apoptotic process involved in development,BP,
5904,GO:1904748,1,0.484015240958911,0,2,regulation of apoptotic process involved in development,BP,
5905,GO:1904752,1,0.769641285234326,0,1,regulation of vascular associated smooth muscle cell migration,BP,
5906,GO:1904754,1,0.769641285234326,0,1,positive regulation of vascular associated smooth muscle cell migration,BP,
5908,GO:1904837,1,0.747475702708194,0,1,beta-catenin-TCF complex assembly,BP,
5909,GO:1904861,1,0.544181611588407,0,2,excitatory synapse assembly,BP,
5910,GO:1904862,1,0.643840742286014,0,1,inhibitory synapse assembly,BP,
5911,GO:1904885,1,0.741374927768024,0,1,beta-catenin destruction complex assembly,BP,
5912,GO:1904886,1,0.741374927768024,0,1,beta-catenin destruction complex disassembly,BP,
5913,GO:1904888,1,0.841205940583945,0,1,cranial skeletal system development,BP,
5914,GO:1904889,1,0.846321998934282,0,1,regulation of excitatory synapse assembly,BP,
5915,GO:1904891,1,0.846321998934282,0,1,positive regulation of excitatory synapse assembly,BP,
5916,GO:1904892,1,0.339934202538491,0,3,regulation of STAT cascade,BP,
5917,GO:1904894,1,0.339934202538491,0,3,positive regulation of STAT cascade,BP,
5918,GO:1904933,1,0.643840742286014,0,1,regulation of cell proliferation in midbrain,BP,
5919,GO:1904934,1,0.643840742286014,0,1,negative regulation of cell proliferation in midbrain,BP,
5920,GO:1904938,1,0.643840742286014,0,1,planar cell polarity pathway involved in axon guidance,BP,
5921,GO:1904948,1,0.425977240189957,0,3,midbrain dopaminergic neuron differentiation,BP,
5924,GO:1904953,1,0.425977240189957,0,3,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
5925,GO:1904954,1,0.66367689320964,0,2,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
5926,GO:1904955,1,0.643840742286014,0,1,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,BP,
5927,GO:1905005,1,0.764973380564597,0,1,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
5928,GO:1905007,1,0.764973380564597,0,1,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
5929,GO:1905037,1,0.808086260451893,0,1,autophagosome organization,BP,
5930,GO:1905039,1,0.770418300420706,0,1,carboxylic acid transmembrane transport,BP,
5931,GO:1905063,1,0.769641285234326,0,1,regulation of vascular smooth muscle cell differentiation,BP,
5932,GO:1905064,1,0.769641285234326,0,1,negative regulation of vascular smooth muscle cell differentiation,BP,
5933,GO:1905069,1,0.710907860107323,0,1,allantois development,BP,
5935,GO:1905174,1,0.769641285234326,0,1,regulation of vascular smooth muscle cell dedifferentiation,BP,
5936,GO:1905176,1,0.769641285234326,0,1,positive regulation of vascular smooth muscle cell dedifferentiation,BP,
5937,GO:1905207,1,0.258015388436677,0,5,regulation of cardiocyte differentiation,BP,
5938,GO:1905208,1,0.54205903249387,0,2,negative regulation of cardiocyte differentiation,BP,
5939,GO:1905209,1,0.479737407611924,0,3,positive regulation of cardiocyte differentiation,BP,
5940,GO:1905269,1,0.716190498729619,0,1,positive regulation of chromatin organization,BP,
5941,GO:1905276,1,0.597311133097606,0,2,regulation of epithelial tube formation,BP,
5942,GO:1905278,1,0.928417537918174,0,1,positive regulation of epithelial tube formation,BP,
5943,GO:1905314,1,0.294385239605992,0,4,semi-lunar valve development,BP,
5944,GO:1905330,1,0.0728152344694482,0,10,regulation of morphogenesis of an epithelium,BP,
5945,GO:1905331,1,0.383173701730543,0,3,negative regulation of morphogenesis of an epithelium,BP,
5946,GO:1905332,1,0.246243859381975,0,6,positive regulation of morphogenesis of an epithelium,BP,
5947,GO:1905383,1,0.846321998934282,0,1,protein localization to presynapse,BP,
5948,GO:1905384,1,0.846321998934282,0,1,regulation of protein localization to presynapse,BP,
5949,GO:1905386,1,0.846321998934282,0,1,positive regulation of protein localization to presynapse,BP,
5950,GO:1905438,1,0.643840742286014,0,1,non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
5951,GO:1905456,1,0.568202356117225,0,1,regulation of lymphoid progenitor cell differentiation,BP,
5952,GO:1905457,1,0.568202356117225,0,1,negative regulation of lymphoid progenitor cell differentiation,BP,
5953,GO:1905474,1,0.862545484850912,0,1,canonical Wnt signaling pathway involved in stem cell proliferation,BP,
5955,GO:1905476,1,0.689295922426304,0,1,negative regulation of protein localization to membrane,BP,
5957,GO:1905651,1,0.395646254351599,0,2,regulation of artery morphogenesis,BP,
5958,GO:1905653,1,0.395646254351599,0,2,positive regulation of artery morphogenesis,BP,
5961,GO:1905710,1,0.830438737450604,0,1,positive regulation of membrane permeability,BP,
5962,GO:1905809,1,0.643840742286014,0,1,negative regulation of synapse organization,BP,
5963,GO:1905867,1,0.68478089734747,0,2,epididymis development,BP,
5964,GO:1905874,1,0.6959456816156,0,1,regulation of postsynaptic density organization,BP,
5965,GO:1905879,1,0.954312251553925,0,1,regulation of oogenesis,BP,
5966,GO:1905880,1,0.954312251553925,0,1,negative regulation of oogenesis,BP,
5972,GO:1905950,1,0.81190363278393,0,1,monosaccharide transmembrane transport,BP,
5973,GO:1905952,1,0.476017609607906,0,3,regulation of lipid localization,BP,
5974,GO:1905953,1,0.770418300420706,0,1,negative regulation of lipid localization,BP,
5975,GO:1905954,1,0.61924131812063,0,2,positive regulation of lipid localization,BP,
5976,GO:1990089,1,0.770418300420706,0,1,response to nerve growth factor,BP,
5977,GO:1990090,1,0.770418300420706,0,1,cellular response to nerve growth factor stimulus,BP,
5978,GO:1990124,1,0.507196040392339,0,2,messenger ribonucleoprotein complex,CC,
5979,GO:1990134,1,0.670232484294963,0,1,epithelial cell apoptotic process involved in palatal shelf morphogenesis,BP,
5980,GO:1990138,1,0.398050446002191,0,3,neuron projection extension,BP,
5983,GO:1990204,1,0.7203786970807,0,1,oxidoreductase complex,CC,
5987,GO:1990316,1,0.736825336349041,0,1,ATG1/ULK1 kinase complex,CC,
5989,GO:1990418,1,0.770418300420706,0,1,response to insulin-like growth factor stimulus,BP,
5993,GO:1990459,1,0.774076993520791,0,1,transferrin receptor binding,MF,
5995,GO:1990712,1,0.774076993520791,0,1,HFE-transferrin receptor complex,CC,
5996,GO:1990748,1,0.522911379667393,0,2,cellular detoxification,BP,
5997,GO:1990769,1,0.837875488244045,0,1,proximal neuron projection,CC,
6002,GO:1990837,1,0.602946944780727,0,2,sequence-specific double-stranded DNA binding,MF,
6004,GO:1990851,1,0.752787419174966,0,1,Wnt-Frizzled-LRP5/6 complex,CC,
6005,GO:1990874,1,0.769641285234326,0,1,vascular smooth muscle cell proliferation,BP,
6006,GO:1990904,1,0.507196040392339,0,2,ribonucleoprotein complex,CC,
6007,GO:1990909,1,0.66367689320964,0,2,Wnt signalosome,CC,
6008,GO:1990936,1,0.769641285234326,0,1,vascular smooth muscle cell dedifferentiation,BP,
6009,GO:1990967,1,0.842953509888315,0,1,multi-organism toxin transport,BP,
6010,GO:2000004,1,0.841205940583945,0,1,regulation of metanephric S-shaped body morphogenesis,BP,
6011,GO:2000005,1,0.841205940583945,0,1,negative regulation of metanephric S-shaped body morphogenesis,BP,
6012,GO:2000006,1,0.841205940583945,0,1,regulation of metanephric comma-shaped body morphogenesis,BP,
6013,GO:2000007,1,0.841205940583945,0,1,negative regulation of metanephric comma-shaped body morphogenesis,BP,
6016,GO:2000015,1,0.764973380564597,0,1,regulation of determination of dorsal identity,BP,
6017,GO:2000017,1,0.764973380564597,0,1,positive regulation of determination of dorsal identity,BP,
6019,GO:2000019,1,0.716836822491286,0,1,negative regulation of male gonad development,BP,
6021,GO:2000021,1,0.344279294833362,0,4,regulation of ion homeostasis,BP,
6024,GO:2000036,1,0.710907860107323,0,1,regulation of stem cell population maintenance,BP,
6026,GO:2000047,1,0.643840742286014,0,1,regulation of cell-cell adhesion mediated by cadherin,BP,
6027,GO:2000049,1,0.643840742286014,0,1,positive regulation of cell-cell adhesion mediated by cadherin,BP,
6028,GO:2000050,1,0.643840742286014,0,1,regulation of non-canonical Wnt signaling pathway,BP,
6029,GO:2000052,1,0.643840742286014,0,1,positive regulation of non-canonical Wnt signaling pathway,BP,
6030,GO:2000058,1,0.741374927768024,0,1,regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
6031,GO:2000060,1,0.741374927768024,0,1,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
6034,GO:2000066,1,0.716836822491286,0,1,positive regulation of cortisol biosynthetic process,BP,
6035,GO:2000097,1,0.790961287654649,0,1,regulation of smooth muscle cell-matrix adhesion,BP,
6036,GO:2000105,1,0.636140908138844,0,2,positive regulation of DNA-dependent DNA replication,BP,
6039,GO:2000108,1,0.643840742286014,0,1,positive regulation of leukocyte apoptotic process,BP,
6044,GO:2000121,1,0.710907860107323,0,1,regulation of removal of superoxide radicals,BP,
6046,GO:2000136,1,0.477161613509033,0,2,regulation of cell proliferation involved in heart morphogenesis,BP,
6047,GO:2000137,1,0.841205940583945,0,1,negative regulation of cell proliferation involved in heart morphogenesis,BP,
6048,GO:2000138,1,0.841205940583945,0,1,positive regulation of cell proliferation involved in heart morphogenesis,BP,
6052,GO:2000177,1,0.205094678378018,0,4,regulation of neural precursor cell proliferation,BP,
6053,GO:2000178,1,0.52534242435353,0,2,negative regulation of neural precursor cell proliferation,BP,
6054,GO:2000179,1,0.568202356117225,0,1,positive regulation of neural precursor cell proliferation,BP,
6056,GO:2000191,1,0.630335029060165,0,2,regulation of fatty acid transport,BP,
6057,GO:2000192,1,0.770418300420706,0,1,negative regulation of fatty acid transport,BP,
6058,GO:2000193,1,0.818949769337691,0,1,positive regulation of fatty acid transport,BP,
6061,GO:2000209,1,0.212781554918138,0,4,regulation of anoikis,BP,
6062,GO:2000224,1,0.716836822491286,0,1,regulation of testosterone biosynthetic process,BP,
6063,GO:2000225,1,0.716836822491286,0,1,negative regulation of testosterone biosynthetic process,BP,
6067,GO:2000249,1,0.889443009650413,0,1,regulation of actin cytoskeleton reorganization,BP,
6068,GO:2000251,1,0.889443009650413,0,1,positive regulation of actin cytoskeleton reorganization,BP,
6071,GO:2000272,1,0.779877946733024,0,1,negative regulation of receptor activity,BP,
6074,GO:2000345,1,0.817200303317026,0,1,regulation of hepatocyte proliferation,BP,
6075,GO:2000346,1,0.817200303317026,0,1,negative regulation of hepatocyte proliferation,BP,
6081,GO:2000383,1,0.719441160584566,0,1,regulation of ectoderm development,BP,
6082,GO:2000384,1,0.719441160584566,0,1,negative regulation of ectoderm development,BP,
6084,GO:2000403,1,0.588526850189583,0,2,positive regulation of lymphocyte migration,BP,
6085,GO:2000404,1,0.588526850189583,0,2,regulation of T cell migration,BP,
6086,GO:2000406,1,0.588526850189583,0,2,positive regulation of T cell migration,BP,
6089,GO:2000463,1,0.846321998934282,0,1,positive regulation of excitatory postsynaptic potential,BP,
6090,GO:2000479,1,0.582723352876063,0,2,regulation of cAMP-dependent protein kinase activity,BP,
6091,GO:2000480,1,0.79183939673446,0,1,negative regulation of cAMP-dependent protein kinase activity,BP,
6092,GO:2000482,1,0.643840742286014,0,1,regulation of interleukin-8 secretion,BP,
6093,GO:2000484,1,0.643840742286014,0,1,positive regulation of interleukin-8 secretion,BP,
6099,GO:2000542,1,0.719441160584566,0,1,negative regulation of gastrulation,BP,
6100,GO:2000573,1,0.769641285234326,0,1,positive regulation of DNA biosynthetic process,BP,
6101,GO:2000586,1,0.769641285234326,0,1,regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
6102,GO:2000587,1,0.769641285234326,0,1,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
6103,GO:2000589,1,0.769641285234326,0,1,regulation of metanephric mesenchymal cell migration,BP,
6104,GO:2000591,1,0.769641285234326,0,1,positive regulation of metanephric mesenchymal cell migration,BP,
6105,GO:2000628,1,0.889443009650413,0,1,regulation of miRNA metabolic process,BP,
6106,GO:2000630,1,0.889443009650413,0,1,positive regulation of miRNA metabolic process,BP,
6107,GO:2000637,1,0.841205940583945,0,1,positive regulation of gene silencing by miRNA,BP,
6111,GO:2000653,1,0.725317348117967,0,1,regulation of genetic imprinting,BP,
6114,GO:2000677,1,0.576117962351074,0,2,regulation of transcription regulatory region DNA binding,BP,
6115,GO:2000678,1,0.805434907231345,0,1,negative regulation of transcription regulatory region DNA binding,BP,
6116,GO:2000696,1,0.664543557958579,0,2,regulation of epithelial cell differentiation involved in kidney development,BP,
6117,GO:2000698,1,0.664543557958579,0,2,positive regulation of epithelial cell differentiation involved in kidney development,BP,
6118,GO:2000705,1,0.822648168832337,0,1,regulation of dense core granule biogenesis,BP,
6119,GO:2000707,1,0.822648168832337,0,1,positive regulation of dense core granule biogenesis,BP,
6120,GO:2000725,1,0.258015388436677,0,5,regulation of cardiac muscle cell differentiation,BP,
6121,GO:2000726,1,0.54205903249387,0,2,negative regulation of cardiac muscle cell differentiation,BP,
6122,GO:2000727,1,0.479737407611924,0,3,positive regulation of cardiac muscle cell differentiation,BP,
6123,GO:2000736,1,0.527035399074685,0,2,regulation of stem cell differentiation,BP,
6124,GO:2000737,1,0.568202356117225,0,1,negative regulation of stem cell differentiation,BP,
6125,GO:2000756,1,0.716190498729619,0,1,regulation of peptidyl-lysine acetylation,BP,
6126,GO:2000758,1,0.716190498729619,0,1,positive regulation of peptidyl-lysine acetylation,BP,
6127,GO:2000785,1,0.808086260451893,0,1,regulation of autophagosome assembly,BP,
6128,GO:2000786,1,0.808086260451893,0,1,positive regulation of autophagosome assembly,BP,
6129,GO:2000794,1,0.770015098939375,0,1,regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
6130,GO:2000807,1,0.6959456816156,0,1,regulation of synaptic vesicle clustering,BP,
6131,GO:2000809,1,0.6959456816156,0,1,positive regulation of synaptic vesicle clustering,BP,
6133,GO:2000811,1,0.212781554918138,0,4,negative regulation of anoikis,BP,
6134,GO:2000820,1,0.805434907231345,0,1,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
6135,GO:2000826,1,0.273219194159001,0,4,regulation of heart morphogenesis,BP,
6136,GO:2000831,1,0.756901465456182,0,1,regulation of steroid hormone secretion,BP,
6137,GO:2000833,1,0.756901465456182,0,1,positive regulation of steroid hormone secretion,BP,
6138,GO:2000846,1,0.756901465456182,0,1,regulation of corticosteroid hormone secretion,BP,
6139,GO:2000848,1,0.756901465456182,0,1,positive regulation of corticosteroid hormone secretion,BP,
6140,GO:2000855,1,0.756901465456182,0,1,regulation of mineralocorticoid secretion,BP,
6141,GO:2000857,1,0.756901465456182,0,1,positive regulation of mineralocorticoid secretion,BP,
6142,GO:2000858,1,0.756901465456182,0,1,regulation of aldosterone secretion,BP,
6143,GO:2000860,1,0.756901465456182,0,1,positive regulation of aldosterone secretion,BP,
6144,GO:2000973,1,0.568202356117225,0,1,regulation of pro-B cell differentiation,BP,
6145,GO:2000974,1,0.568202356117225,0,1,negative regulation of pro-B cell differentiation,BP,
6148,GO:2001012,1,0.602376048476982,0,2,mesenchymal cell differentiation involved in renal system development,BP,
6149,GO:2001020,1,0.774488149481281,0,2,regulation of response to DNA damage stimulus,BP,
6150,GO:2001022,1,0.774488149481281,0,2,positive regulation of response to DNA damage stimulus,BP,
6151,GO:2001026,1,0.568202356117225,0,1,regulation of endothelial cell chemotaxis,BP,
6152,GO:2001027,1,0.568202356117225,0,1,negative regulation of endothelial cell chemotaxis,BP,
6153,GO:2001044,1,0.817200303317026,0,1,regulation of integrin-mediated signaling pathway,BP,
6154,GO:2001046,1,0.817200303317026,0,1,positive regulation of integrin-mediated signaling pathway,BP,
6155,GO:2001053,1,0.710907860107323,0,1,regulation of mesenchymal cell apoptotic process,BP,
6156,GO:2001054,1,0.710907860107323,0,1,negative regulation of mesenchymal cell apoptotic process,BP,
6158,GO:2001057,1,0.630335029060165,0,2,reactive nitrogen species metabolic process,BP,
6164,GO:2001204,1,0.743693968038284,0,1,regulation of osteoclast development,BP,
6165,GO:2001205,1,0.743693968038284,0,1,negative regulation of osteoclast development,BP,
6166,GO:2001212,1,0.805434907231345,0,1,regulation of vasculogenesis,BP,
6167,GO:2001233,1,0.187941372870125,0,8,regulation of apoptotic signaling pathway,BP,
6168,GO:2001234,1,0.304511296436265,0,6,negative regulation of apoptotic signaling pathway,BP,
6169,GO:2001235,1,0.623738966762708,0,2,positive regulation of apoptotic signaling pathway,BP,
6170,GO:2001236,1,0.353496935462963,0,6,regulation of extrinsic apoptotic signaling pathway,BP,
6171,GO:2001237,1,0.427021620511981,0,5,negative regulation of extrinsic apoptotic signaling pathway,BP,
6172,GO:2001238,1,0.830438737450604,0,1,positive regulation of extrinsic apoptotic signaling pathway,BP,
6173,GO:2001239,1,0.66659189787644,0,3,regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
6174,GO:2001240,1,0.66659189787644,0,3,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
6175,GO:2001242,1,0.639212907528369,0,2,regulation of intrinsic apoptotic signaling pathway,BP,
6176,GO:2001243,1,0.770418300420706,0,1,negative regulation of intrinsic apoptotic signaling pathway,BP,
6177,GO:2001244,1,0.830438737450604,0,1,positive regulation of intrinsic apoptotic signaling pathway,BP,
6178,GO:2001252,1,0.716190498729619,0,1,positive regulation of chromosome organization,BP,
6180,GO:2001258,1,0.779877946733024,0,1,negative regulation of cation channel activity,BP,
3508,GO:0045669,1,0.12395796775577,0,8,positive regulation of osteoblast differentiation,BP,
4519,GO:0060571,1,0.220201343555968,0,6,morphogenesis of an epithelial fold,BP,
4520,GO:0060572,1,0.220201343555968,0,6,morphogenesis of an epithelial bud,BP,
